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ABSTRACT 
The thesis explores the severity of diagnosed chronic kidney disease 
(CKD) with particular reference to its impact in Edo state, Nigeria. 
There has been a scarcity of studies on the prevalence and spatial 
patterns of CKD in developing countries even though the costs of 
treatment at the late stage of the disease are extremely expensive and 
the inevitable outcome for the vast majority of sufferers is renal 
failure. CKD is a growing problem in Nigeria, presenting challenges 
to the nation’s health and economy. This thesis presents an analysis of 
442 patients with CKD referred to the renal department at the 
University of Benin Teaching Hospital, Nigeria, which is currently the 
only fully functioning CKD treatment centre in Edo state. The 
research study evaluates the factors that are associated with the 
severity of CKD in Edo State as well as the temporal and spatial 
trends of diagnosed CKD across the state.  
The results of this thesis highlights the spatial distribution of 
diagnosed CKD and evaluates the likely predictors for the severity of 
CKD at the time of diagnosis in Edo State by examining the socio-
demographic and known biological risk factors such as diagnosed 
hypertension, and diabetes. It also highlights the areas of concern 
regarding the spatial distribution of diagnosed CKD within the state. 
Although there are attempts at raising the awareness of CKD across 
the study area, many patients are still being diagnosed at the last stage 
of the disease. This means that there is the probability that many cases 
are left undetected until it is too late. 
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The findings derived from this research study would be helpful both in 
the policy-making decisions that pertain to the health sector and the 
development of a healthcare accessibility model for CKD patients that 
could be beneficial in the location of new healthcare centres.  
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Chapter 1 Introduction 
In many affluent countries, chronic diseases such as diabetes are 
showing significant increases in prevalence, posing considerable 
burdens on those who suffer from them and their carers, and 
increasing costs of healthcare systems. Chronic kidney disease (CKD) 
is another condition showing the same trends as diabetes. However, 
the disease is much less well known than diabetes. This disease can 
remain undetected until a late stage, when the health interventions 
involve dialysis and kidney transplants.  
There has been a scarcity of studies by health geographers on the 
prevalence and spatial patterns of such chronic diseases in developing 
countries. This is particularly the case with CKD, for which the costs 
of late stage treatment are extremely expensive and the inevitable 
outcome for the vast majority of sufferers is renal failure. 
The rise in the incidence and prevalence of CKD in both developed 
and developing countries has resulted in a renewed interest in global 
CKD prevention because many countries now regard CKD as a public 
health threat (Arogundade and Barsoum, 2008). In all countries, it is 
important to diagnose the disease early, however, for poorer countries, 
early diagnosis is essential to prevent mortality, as the majority of 
sufferers cannot afford the cost of treatment at the last stage of the 
disease.  
 
 
2 
 
1.1 Chronic Kidney Disease (CKD) in Nigeria 
The actual data on the prevailing health status of Nigeria is currently 
inconclusive because there are no current or accurate registries or a 
health database to monitor the various diseases or health deficiencies 
that contribute to the nation’s burden of disease.   
Notwithstanding, a health issue that has become a growing problem in 
Nigeria is the prevalence of CKD. However, the exact prevalence rate 
of CKD in Nigeria is not known. Hospital based data in Nigeria has 
been used to estimate that the prevalence of CKD among annual 
medical admissions was between 2% and 4% (Akinsola et al., 2004), 
however, according to another report in 2007, the estimation of the 
annual medical admissions was placed between 10% and 12% 
(Kidney Consultants International, 2007).  
Similar to other developing countries, Nigeria does not have a reliable 
register or database to show the current impact of CKD on its 
population. This therefore makes it difficult to verify the reported 
statistics on CKD rates within the country. Studies have shown that 
the commonest causes of CKD in Nigeria are chronic 
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glomerulonephritis
1
, Type 2 diabetes
2
, hypertension, and obstructive 
uropathy
3
 (Akinsola et al., 1989; Alebiosu and Ayodele, 2005; 2006).  
In Nigeria, the majority of those with CKD die because of lack of 
funds and access to adequate healthcare. This has been compounded 
by the fact that within the current healthcare system, the financial 
burden for the treatment of CKD is the sole responsibility of the 
patient, as the cost of treatment is not subsidised by the government, 
nor is there any health insurance policy available to cover the cost of 
treatment. According to previous studies, the majority of patients are 
diagnosed at the final stage of the disease when the cost of treatment 
is very expensive, usually beyond the financial capacity of the average 
citizen (Arogundade and Barsoum, 2008; Ulasi and Ijoma, 2010). 
According to a medical report by a Nephrology agency in Nigeria, the 
average yearly costs of kidney management for stage 5 CKD patients 
is 2,401,340 naira, which is approximately £11,000 (Kidney 
Consultants International, 2007). However, the country’s average 
household annual net income is estimated at N126,895, which is 
approximately £500 (Oseni and Winters, 2009). Given the high cost of 
treatment for the last stage of CKD, it is clear that majority of the 
                                                 
1
 Chronic glomerulonephritis is the advanced stage of a group of kidney disorders that 
results in the inflammation and progressive destruction of internal kidney structures called 
glomeruli. 
2
 Type 2 diabetes is a disease caused by insufficient insulin production or lack of 
responsiveness to insulin, resulting in high blood glucose levels 
3
 Obstructive uropathy is a structural or functional hindrance of normal urine flow, 
sometimes leading to renal dysfunction 
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patients are unable to either begin or continue treatment, once 
diagnosed with the disease (Arije et al., 2000; Bamgboye, 2003). 
The problems posed by CKD on the population and the economy of 
Nigeria point to the need for interventions such as the creation of a 
National Kidney Foundation and a functional National Health 
Insurance Scheme aimed at the prevention and early treatment of 
CKD in the country (Bamgboye, 2003). However, there is currently 
no government-funded/aided national prevention programme for CKD 
within the country (Arogundade and Barsoum, 2008). In order to 
combat the disease, the main route taken by the Nephrology society in 
the country is to raise awareness of CKD among the public using 
events organised during World Kidney Day (WKD) programme that 
began in 2006, however, this has not effectively improved the 
management of the disease within the country (discussed in chapter 
five).  
1.2 Why is this research study original? 
Although there have been studies researching the prevalence and 
impact of CKD, there are currently few published research studies by 
health geographers which have focused on the spatial variability in the 
prevalence and impact of CKD. Furthermore, no such study has been 
carried out within a developing country. Therefore, the originality of 
this study lies in the spatial analysis of CKD using geographical 
information systems (GIS) in the study of chronic kidney disease 
within Nigeria. This would equally contribute to an understanding of 
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the spatial impact of CKD in other African settings as no such study 
has been carried out on the prevalence of CKD within any African 
country. It is therefore hoped that this research study will contribute to 
the improvement in managing CKD within the study area in particular 
and the country in general. 
1.3 Contribution to the academic field of knowledge 
In recent years, medical researchers have studied the increasing 
prevalence of chronic diseases such as hypertension, diabetes, and 
chronic kidney disease. However, the contributions of health 
geographers to the study of these chronic diseases especially within 
developing countries have been rather limited. Therefore, it is hoped 
that the main findings of this study will contribute to the field of 
health geography by applying a spatial perspective to the study of the 
available CKD dataset from a developing country that had previously 
been only made available to medical researchers particularly in the 
absence of a national CKD registry. 
1.4 Study Area 
The study area for this research study was Edo state, which is one of 
the 36 states in Nigeria located in the Niger-delta region of the 
country.  
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Figure 1.1 : The study area including an inset map of Nigeria, which shows the location 
of Edo state 
Edo State shares boundaries with Delta state on the South, Ondo state 
on the West, Kogi state on the Northeast and the state’s capital is 
Benin City. There are eighteen local government areas (LGAs) in Edo 
State with an average of 10 political wards in each LGA. In total, 
there are 193 wards within the state. The wards are currently the 
smallest unit of health services delivery in the state and the country in 
general.  
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The population within Edo state can be regarded as having a diverse 
population structure because of the many ethnic groups within the 
state. The main ethnic groups in Edo State are the Binis, Afemais, 
Esans, Owans, and Akoko Edos. According to a report (Edo State 
Government, 2009), the Bini speaking people who occupy seven out 
of the 18 Local Government Areas of the state constitute 57.54% 
while others include Esan (17.14%), Afemai comprising of Etsako 
(12.19%), Owan (7.43%), and Akoko Edo (5.70%). However, the 
Igala-speaking communities exist in Esan South-East, Igbira related 
communities in Akoko and Afemai Areas as well as Urhobos, Izons, 
Itsekiris and Yoruba communities in Ovia North-East and Ovia South-
West Local Government Areas especially in the borderlands. 
Edo State was chosen as my study area because it is my home state 
and because of the established access to the management body of the 
nephrology department for the hospital where I collected the CKD 
data used in the study. 
1.5 Aim of the research study 
Due to the problem of late diagnosis of CKD among the general 
population, this research aims to examine the factors that are likely to 
contribute to the early or late diagnosis of CKD in patients in Nigeria. 
Using secondary data (i.e. data from health records of CKD patients), 
it attempts to identify any variation(s) among the factors associated 
with CKD patients and determine if it can be regarded as an influential 
factor on the severity of CKD at the time of diagnosis. This could help 
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contribute to the development of interventions that are more effective 
in the prevention and management of the disease. The study also 
investigates the accessibility of patients with CKD to healthcare to 
determine the efficiency of the health service available to CKD 
patients in the area. The results could identify any accessibility issues 
relating to the number of CKD patients that are being treated by the 
hospital. At the moment, there is only one healthcare service that 
treats CKD in the state and this is the University of Benin Teaching 
Hospital (UBTH). As a result, UBTH was where CKD data was 
collected and used for this research study. The study involved the 
analysis of CKD patients diagnosed from 2006 to 2009. The reason 
for selecting CKD patients from this study period is because the 
global awareness programme for Kidney disease termed “World 
Kidney Day” first started in 2006 and Nigeria is among the African 
nations that has been participating in the awareness programme since 
2006 (ISN, 2006). That year marked the turning point in the 
awareness of CKD as this programme has led to an increase in the 
number of charity organisations that are affiliated with kidney 
awareness within the country. These charities along with the Nigerian 
Association of Nephrologists (NAN) routinely carry out these 
awareness programmes every year since 2006. It is therefore hoped by 
the Nigerian Association of Nephrologists and the affiliated charities 
that there would be a steady improvement in the number of early 
diagnosis of CKD within the population. The year 2009 marked the 
end of the study period as this was the year I proceeded with the data 
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collection for my research study. Therefore, at the beginning of this 
research study, I had hoped that this study period would produce the 
highest possible number of diagnosed cases. However, in the course of 
carrying out this study, this did not prove to be the case because there 
was no significant increase in the number of diagnosed CKD cases 
especially for patients that were diagnosed at the earlier stages 
(discussed in chapter five). 
1.5.1 Research Questions 
The analysis presented in this thesis addresses the following research 
questions: 
1. Is there an association between socio-demographic factors 
and the severity of CKD at first presentation? 
2. Is there a relationship between the severity of CKD at first 
presentation in Edo state and known biological risk factors of 
CKD? 
3. What factors are likely to lead to the late diagnosis of CKD 
among patients in Edo State? 
4. What is the trend of diagnosed CKD within Edo state?  
5. What is the spatial pattern of diagnosed CKD cases within 
Edo state?  
6. Is the prevalence and distribution of CKD in the state 
appropriately serviced by the available CKD healthcare 
service? 
It is hoped that this research will provide the platform for modelling 
national CKD future risk and projected distribution based on national 
census data and maps as well as the future application of GIS 
technology and expertise on national CKD data. 
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1.6 Structure of the Thesis 
The thesis is organised into eight chapters outlined below: 
Chapter 2 begins with the theoretical framework of the thesis. This is 
followed by a brief explanation of the functions of the kidney, 
description of CKD, the causes, the symptoms, and treatment of the 
disease. The chapter also reviews literatures from the most relevant 
fields of research. These include research studies on chronic kidney 
disease and its associated risk factors, studies on spatial epidemiology 
with particular references to the spatial distribution of CKD as well as 
the application of geographical information systems (GIS) in the study 
of health outcomes particularly within developing countries where 
detailed datasets are not readily available.  
In chapter 3, the research design, data collection process, and 
methods selected are discussed. The limitations of the available 
datasets are also discussed within this chapter. Given the limitations 
associated with the available datasets, a pragmatic approach was used 
in determining the methods that appeared best suited to address the 
research questions outlined above. An overview of the chosen 
statistical and spatial methods included within the study is briefly 
discussed. The chapter concludes with a brief discussion on other 
methods that were considered but not applied in the study. 
In chapter 4, the CKD dataset used in the study is evaluated. This can 
be described as the preliminary analysis chapter as it involves the 
descriptive analysis of the variables within the dataset. The outcome 
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of the preliminary analysis provides a profile of diagnosed CKD 
patients represented within the dataset. 
Chapter 5 focuses on answering the first four research questions 
outlined above. The findings within this chapter are primarily derived 
using statistical analyses. It attempts to determine the factors 
associated with the severity of CKD at the time of diagnosis and also 
evaluates the trend of diagnosed CKD within the study period. The 
results are discussed and the justification for taking research further is 
briefly outlined. 
Chapter 6 focuses on the spatial analyses of the CKD dataset with the 
aim of answering the fifth research question. It involves determining 
the rates of diagnosed CKD across the study area in order to identify 
areas with high rates of diagnosed CKD and areas with low rates or 
absence of diagnosed CKD. The problems experienced in carrying out 
the analyses, how they were resolved, along with the findings of these 
spatial analyses are discussed.  
In chapter 7, which is regarded as the final analysis chapter, the 
accessibility to CKD healthcare service within the study area is 
examined. It involves the use of travel time models to explore the 
efficiency of the current structure of healthcare for CKD patients 
within the study area as well as evaluate potential scenarios that could 
improve the CKD healthcare service in the area. 
Chapter 8 is the concluding chapter, which summarises the findings 
of the research study. The limitations of the research study, the 
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implications of the findings and the recommendations for further 
studies are also discussed. 
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Chapter 2 Evaluating CKD from a geographical perspective  
2.1 Introduction 
Scientific studies indicate that there are more occurrences of kidney 
disease than had been previously thought (Collins et al., 2006). 
Among these kidney diseases, chronic kidney disease (CKD) has been 
found to be widely prevalent in the general population (Coresh et al., 
2007a). The number of patients with CKD is increasing and is 
anticipated to rise further (Mahon, 2006). Some of this increase has 
been attributed to better healthcare services, which resulted in better 
diagnosis (Peres et al., 2010) along with population growth which has 
also resulted in an increase in the number of older people who have a 
higher risk of developing CKD (Stevens et al., 2010).  Worldwide, it 
is estimated that over 1.1 million patients with the final stage of CKD 
require maintenance dialysis, and this number is increasing at a rate of 
7% per year (Paraskevas et al., 2010). Efforts are therefore being made 
by nephrologists to increase the awareness of CKD prevalence among 
the general public. This is because although the disease is less well 
recognised than other chronic diseases such as diabetes and cancer by 
the general public, its impact is being regarded as a growing threat in 
both rich and poor countries (Harman, 2009). One such effort is the 
initiation of the “World Kidney Day” programme, which aims to 
address the problem of poor awareness of CKD thereby enabling the 
general public to take better care of their kidneys and seek treatment 
early to avoid preventable complications. The programme was first 
launched in 2006 and is held on the second Thursday of March each 
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year as a joint initiative of the International Society of Nephrology 
(ISN) and the International Federations of Kidney Foundation (IFKF). 
The programme is marked by a number of events designed to raise 
awareness among the general public as well as among medical 
professionals (discussed further in chapter five).  
This chapter begins with the theoretical framework of the thesis. The 
second segment of the chapter provides an overview of the kidney and 
its functions within the body. The definition of CKD and the various 
stages of CKD, the symptoms that are associated with the disease, the 
likely causes of the disease, and how the disease is currently managed 
are then discussed. The third segment of the chapter discusses the 
various socio-demographic variables that are currently associated with 
health outcomes especially CKD related outcomes. The fourth 
segment examines the international prevalence of CKD as well as the 
prevalence in Nigeria. The fifth section of this chapter reviews the 
application of Geographical Information System (GIS) within the 
African health sector, taking into account the advantages of spatial 
evaluation in healthcare particularly the use of GIS as a method to 
spatially evaluate health outcomes within the African health sector. 
This section attempts to evaluate the benefits of the utilisation of GIS 
within the African setting given the limited yet essential resources 
required in effective healthcare management. The final section 
reviews the utilisation of GIS in the study of CKD in order to 
highlight the advantages of spatial analysis using GIS in CKD 
research and management.  
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2.2 Theoretical framework 
This research aims to examine the factors that are likely to contribute 
to the early or late diagnosis of CKD in patients in Nigeria. Therefore, 
access to available CKD healthcare within the state will be examined 
in order to determine if it conforms with the inverse care law (Hart, 
1971). This law proposes that healthcare services are distributed 
inversely to population health needs and mainly operates where 
medical care is exposed to market forces. When Hart initially 
described the inverse care law in 1971, he was mainly concerned with 
the effects of market forces on healthcare in the British National 
Health Service (NHS). This was due to existing demands on the 
private sector, to provide solutions to healthcare delivery problems 
(Watt, 2002). Hart argued that under no circumstances would any 
market move its investment from where it is most lucrative to where 
there is a greater need and as such a market based approach will not be 
effective in providing a rational and effective healthcare system (Hart, 
2001; 2006). It can therefore be argued that inequality is a major 
feature in any society where market forces determine an individual’s 
access to healthcare. This suggests that those with the greatest 
healthcare needs often receive the least adequate healthcare and this 
pattern of inequality can be driven by profit (Fiscella and Shin, 2005). 
Since the inverse care law is still present in the NHS ‘where financial 
barriers to care have been largely removed’, it can be said that ‘other 
processes are at work’ (Watt, 2002, p. 252). These processes are likely 
to be present in other countries as the inverse care law has been found 
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to be present in the provision of healthcare in other countries although 
healthcare is generally regarded as a human right, unsuited to trade 
(Hart, 2006). It can be argued that the limited access and affordability 
of treatment by people in low socio-economic status areas is a 
common factor associated with the presence of the inverse care law 
(Bishai et al., 2007; Furler et al., 2002; Ross, 2005). Evidence 
indicates that patients with low socioeconomic status are more likely 
to become ill (and to do so earlier) than patients from more affluent 
groups, but their communities are less attractive to doctors (Carlisle 
and Johnstone, 1996; Hart, 2006). This can be attributed to the poor 
living standard of people within these communities, which has lasting 
consequences on their social and biological health (Hart, 2006). 
Therefore, as affluent groups within any society accumulate ‘the 
public-health benefits of effective clinical interventions, the effect of 
evidence-based medicine’ will be to increase health inequality, which 
is consistent with the presence of the inverse care law (Watt, 2002, 
p.253).  
When Hart proposed the inverse care law in 1971, he did not use his 
own data for the inverse care law but he did draw on the findings of 
others to support it. This included a study by Ann Cartwright (1967) 
that consisted of 1370 randomly sampled adults in representative areas 
of England and their 552 doctors, which Hart used while investigating 
the evidence of ‘selective redistribution of care’ between the middle 
class and the working class (Hart, 1971, p. 407). He suggested that her 
findings indicated that the ‘better-endowed, better-equipped, better-
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staffed areas of the service draw to themselves more and better staff, 
and more and better equipment’ and this led to an accumulation of 
better facilities in more affluent and equally healthier areas (Hart, 
1971, p. 408). The inverse care law therefore has implications for 
healthcare access and outcomes for less affluent members of the 
society because they are less likely to gain access to adequate 
healthcare. 
Much evidence has been collected in favour of the inverse care law 
since 1971 (Cooper, 2010). Many of the studies providing evidence of 
the inverse care law focused on specific health outcomes such as 
healthcare access (Kruger et al., 2011), consultation length (Furler et 
al., 2002), quality of service (Mercer and Watt, 2007), likelihood of 
diagnosis, and referrals to secondary and tertiary healthcare services 
(Baird et al., 2008). 
2.2.1 The inverse care law and access to care in Nigeria 
Since the postulation of the inverse care law, one of the factors that 
have been associated with the law in many societies is the issue of 
access to healthcare. Access to healthcare can be defined as "the 
ability to secure a specified range of services at a specified level of 
quality, subject to a specified maximum level of personal 
inconvenience and costs, whilst in the possession of a specified level 
of information" (Goddard and Smith, 2001 p. 1151). Therefore, 
accessing available healthcare does not only refer to geographical 
accessibility, it equally includes affordability of the health service and 
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awareness of the healthcare services available to the individual or 
community.  
In Nigeria, the provision of healthcare is currently managed by the 
three tiers of Government (Acho, 2005; Akhtar, 1991). The federal 
government's role involves coordinating the affairs of the university 
teaching hospitals, which provide tertiary
4
 healthcare while the state 
government manages the general hospitals (secondary healthcare) and 
the local government focuses on primary healthcare. Furthermore, 
Nigeria does not currently offer free healthcare to patients; patients are 
expected to pay for any healthcare service that they receive. There are 
also privately owned healthcare facilities within the country but none 
of them are classified as tertiary hospitals. The payment for treatment 
within the public and private healthcare system has continued to raise 
the issue of inequalities in the access to healthcare and the utilisation 
of health services by all socio-economic groups (Onwujekwe, 2005). 
Due to the high population in urban areas and the fact that the cost of 
treatment within the Nigerian healthcare system is paid by patients 
and/or family members, healthcare providers tend to locate their 
facilities in urban areas where they can improve the demand for their 
health service(s). This is because the urban areas have a higher 
population than the rural areas therefore the urban areas are likely to 
have more health cases than the rural areas and also there is the 
likelihood that more people in urban areas can afford the cost of 
                                                 
4
 Tertiary healthcare are specialised consultative health care and patients are usually 
referred from primary and secondary healthcare centres 
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treatment. This could explain why all the tertiary hospitals and most 
secondary hospitals are located in urban areas. For example, according 
to a report on the number of registered healthcare facilities in Edo 
state, all the tertiary hospitals are located in urban centres in the state 
and 59.2% of all privately owned hospitals and clinics are located 
within Benin City despite the fact that Benin City has a population of 
1125058, which is approximately 35% of the total population in the 
state (Edo State Government, 2009). In addition, a study that 
examined the deprivation index within the LGAs in Nigeria, indicated 
that within Edo state, six of the LGAs (approximately 25% of the 
population), which are predominantly rural areas, had a high index of 
above 121 for areas that are more than one hour away from the nearest 
health facility (Ojo et al., 2010).  
It should be noted that although the urban areas have a higher 
population than their rural counterparts, an aggregate of the total 
population living in rural areas are higher than the total population 
living in urban areas. For example, in Edo state, Benin City has 
approximately 35% of the total population in the state while the 
remaining notable urban areas namely Irrua, Ekpoma, Auchi, and 
Uromi have a combined population of approximately 10.4%, which 
means that approximately 54.6% of the population resides in rural 
areas (Nigerian Population commission, 2006). Therefore, it can be 
argued that within the current healthcare structure in the country, only 
the smallest proportion of the population access tertiary care as these 
are located in urban cities. This is because the larger proportion live in 
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rural areas and most of the rural population are too poor to pay for the 
service and even if they could afford the treatment, there is the 
absence of an efficient transportation system (Ipingbemi, 2008), which 
makes it difficult to access tertiary care facilities that are located in 
urban areas. Evidence from past censuses conducted within the 
country indicates that over 70 percent of rural dwellers are within the 
low socioeconomic groups (NPC, 2005). This suggests that rural 
dwellers appear to have a limited access to specialist care and 
laboratory support for the much needed screening and diagnosis of 
chronic illnesses (Ogunbiyi, 2011). It can be argued that access to 
healthcare supports the evidence of the inverse care law because the 
cost of available treatment could be too high for many rural dwellers. 
Therefore, strategies to overcome this inverse care provision should be 
put in place within the healthcare system, such as subsidising cost of 
treatment, increasing the number of doctors within disadvantaged 
areas, provision of incentives for doctors in rural areas, and 
strengthening health promotion and community health services in 
disadvantaged areas (Furler, 2002). Furthermore, there is evidence 
that the socio-economic status and region-specific knowledge about 
healthcare access positively affects a patient’s health outcome in 
Nigeria (Agee, 2010). In September 2004, a revised national health 
policy for Nigeria derived from the National Health Policy and 
Strategy
5
 promulgated in 1988 had as its long term goal to provide the 
                                                 
5
 The National Health Policy and Strategy of 1988, emphasized Primary Health Care as the 
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entire population with adequate access, not only to primary health care 
but also to secondary and tertiary services through a well-functioning 
referral system (Federal Ministry of Health, 2004; Ogunbiyi, 2011).  
The policy also aims to ensure an “equitable distribution of human 
resources for healthcare delivery between urban and rural areas, 
including difficult terrain, such as mountainous, riverine, and 
inaccessible areas of the country” (Federal Ministry of Health, 2004 p. 
31). However, there has not been any noted change within the 
Nigerian healthcare structure since the introduction of the revised 
policy in 2004. Studies have indicated that there is unequal access to 
healthcare within the country, which suggests that distance to 
improved healthcare and the total cost of seeking health care need to 
be reduced to enhance access to improved health services by various 
socio-economic groups in the country (Antai et al., 2010; Awoyemi et 
al., 2011; Omonzejele, 2010).  
In summary, it can be argued that the literature on access to healthcare 
in Nigeria appears to support the presence of the inverse care law 
within the Nigerian health sector because in the provision of 
healthcare services, the market forces are the main forces in operation. 
This is particularly evident in the provision of specialised care because 
market forces have greatly influenced the distribution of specialised 
healthcare services than the need of the population. Evidence suggests 
that these healthcare services are provided where they are likely to be 
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profitable rather than on the basis of need alone and this could have an 
impact on the access to healthcare within the country. Given the 
current literature on access to healthcare within Nigeria, this study 
considers whether an inverse care law can be observed in the 
provision of CKD healthcare for CKD patients by evaluating whether 
the access to available healthcare could have influenced the spatial 
distribution of diagnosed CKD patients within the state. 
The rest of this chapter will discuss the functions of the kidney, and 
the causes, symptoms, and treatment of chronic kidney disease. The 
chapter also reviews research literatures on CKD that relates to 
addressing the research questions outlined at the beginning of the 
thesis (see section 1.5.1). 
2.3 The Kidney 
The kidneys are vital organs that keep the blood clean and chemically 
balanced. They are located just below the rib cage, on each side of the 
spine (see Figure 2.1). The kidneys weigh about 0.1 kg each and 
process approximately 200 litres of blood daily to remove waste 
products as well as excess water from the body (Mercer and Watt, 
2007). These waste products include urea, creatinine
6
, potassium, 
sodium, phosphorus and fluids (Kidney Consultants International, 
2007). This becomes urine, which flows to the bladder. A failure of 
                                                 
6
 Creatinine is a breakdown product of creatine phosphate (which is a molecule that serves 
as a high-energy phosphate that is formed from certain amino acids) in the muscles, usually 
produced at a fairly constant rate by the body depending on the mass of the muscle. 
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the kidneys could therefore lead to many negative complications and 
could gradually affect the other organs of the body. 
 
Figure 2.1: The human Kidney 
Source: BURRELL, JOHN (2010) Click4biology (online) http://Click4biology.info/ 
 
2.3.1 Functions of the kidney 
Apart from the removal of waste products and excess fluids from the 
body, the kidney performs a number of functions that are vital for a 
healthy body. These include the following (Kidney Consultants 
International, 2007; Peter, 2007): 
1. They help to reabsorb useful substances like glucose and 
protein into the body in precise levels needed for the body to 
function properly. 
2. They produce hormones that help various organs carry out 
their specific functions. Healthy kidneys make hormones 
including renin and angiotensin, which regulate how much 
sodium and fluid the body keeps, and how well the blood 
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vessels can expand and contract. This process helps control 
blood pressure. 
3.  They help to produce red blood cells, and maintain healthy 
bones. Healthy kidneys produce a hormone known as 
erythropoietin (EPO), which is carried in the blood to the bone 
marrow where it stimulates the production of red blood cells. 
These cells carry oxygen throughout the body. 
4. They help to produce vitamin D, which maintains the health of 
bones. Healthy kidneys produce a hormone called calcitriol, 
which maintains the right levels of calcium and phosphate in 
the blood and bones.  
In summary, “the kidneys function as excretory, biosynthetic7, and 
metabolic organs, vital for maintaining normal physiology” (Peter 
2007, p. S2) 
2.4 Chronic Kidney Disease (CKD) 
Chronic kidney disease (CKD) is a gradual loss of kidney function, 
usually taking months, or years to develop. In 2002, the National 
Kidney Federation’s (NKF) Kidney Disease Outcomes Quality 
Initiative (KDOQI) Work Group developed a staging system to define 
CKD according to the presence or absence of kidney damage and 
level of kidney function. The increased severity of CKD is divided 
into five stages (see Table 2.1) with the fifth stage categorised as a 
                                                 
7
 Biosynthetic: is a chemical reaction that occurs in cells of living organisms whereby the 
substance acted upon by an enzyme are converted to more complex 
products.  
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total or near-total loss of kidney function, which results in a patient 
requiring some form of renal replacement therapy such as dialysis or a 
kidney transplant. The stages of CKD are determined by a 
measurement of the kidney’s function known as glomerular8 filtration 
rate (GFR) (NKDEP, 2009; Poggio et al., 2006).  
Table 2.1 Stages of Chronic Kidney Disease 
Stage Description GFR* 
mL/min/1.73m2 
1 Slight kidney damage with normal or increased filtration More than 90 
2 Mild decrease in kidney function 60-89 
3 Moderate decrease in kidney function 30-59 
4 Severe decrease in kidney function 15-29 
5 Kidney failure requiring dialysis or transplantation Less than 15 
Source: http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g1.htm 
Anyone with a GFR < 60 mL per minute per 1.73 m
2
 for more than 3 
months is classified as having CKD and this represents a loss of 50% 
or more of the adult level of normal kidney function (Peter, 2007; 
National Kidney Foundation, 2002).  
2.4.1 Symptoms of CKD 
As the kidneys perform so many functions for the body, chronic 
kidney disease can affect the body in different ways. Therefore, 
symptoms tend to vary greatly. Symptoms of chronic renal disease are 
characterized by a combination of many of the following factors 
(Murphy et al., 2009; Murtagh et al., 2007; NKDEP, 2009): 
1. Fatigue and weakness (from anaemia - shortage of red blood cells) 
or accumulation of waste products in the body) 
2. Loss of appetite, also nausea and vomiting 
                                                 
8
 Glomerular : A tiny structure in the kidney that filters the blood to form urine 
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3. Swelling of the legs and puffiness around the eyes due to fluid 
retention 
4. Itching, easy bruising, and pale skin (from anaemia) 
5. Headaches, numbness in the feet or hands, disturbed sleep, altered 
mental status, and restless legs syndrome 
6. High blood pressure, chest pain due to inflammation around the 
heart 
7. Shortness of breath from fluid in lungs 
8. Bleeding (poor blood clotting) 
9. Bone pain and fractures 
2.4.2 Causes of CKD 
There are a number of factors that can lead to the development of 
CKD, including diseases of the kidneys themselves; however, the 
major risk factors are diabetes and hypertension (Peter, 2007). Other 
noted risk factors include; chronic glomerulonephritis, toxic 
nephropathy, obesity, HIV infection, sickle cell disease, heroin abuse, 
amyloidosis
9
, chronic kidney infections, certain cancers, and 
obstructive uropathy
10
 e.g. kidney stones, clogging and hardening of 
the arteries (atherosclerosis) that lead to the kidneys thereby causing a 
condition called ischemic nephropathy (Pranay, 2007). In order to 
identify how CKD could develop in an individual, a few of the listed 
risk factors are briefly discussed below. 
A number of studies have identified diabetes as one of the main risk 
factors for CKD. This covers countries including the USA (Collins et 
al., 2005; Vassalotti et al., 2010), Latin American countries (Dirks et 
                                                 
9
 Amyloidosis: A condition in which a protein-like material builds up in one or more 
organs, this material cannot be broken down and interferes with the normal 
function of that organ. 
10
 Obstructive uropathy: is the obstruction of normal urine flow, sometimes leading to the 
disturbance in the functioning of the kidney  
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al., 2006), countries in sub-Saharan Africa (Mbanya et al., 2010), and 
China (Zhang et al., 2008). Diabetes is a disease characterized by high 
glucose levels which are usually associated with insulin deficiency, 
which causes complications to the kidneys and nerves and also 
increases the risk for heart disease (Herman, 2007).  There are 
currently three main tests used to measure the level of the blood 
glucose in a person in order to identify higher than normal glucose 
level in that individual. These tests are relatively cheap and simple to 
carry out. Therefore, an early diagnosis of diabetes could help reduce 
the possibility of developing kidney complications and potentially 
CKD. 
Hypertension is a disease classified by an abnormally elevated blood 
pressure. It is a known risk factor for heart disease (such as stroke and
 
heart failure) and kidney disease (Carretero and Oparil, 2000). 
Currently, the diagnosis of hypertension is dependent on the 
measurement of blood pressure (Hemmelgarn et al., 2006). Again, an 
early detection and management of hypertension in an individual 
could reduce the possibility of developing CKD. 
Chronic glomerulonephritis is a progressive inflammatory disease that 
leads to the destruction of the glomeruli of the kidney, which 
gradually results in the loss of kidney function (Kalyuzhina and 
Kalyuzhin, 2004; Sadjadi, 2007). Due to the gradual progression of 
the disease, it is usually detected during a routine medical test such as 
urine test to detect blood and protein but the disease is usually 
 
28 
 
confirmed with a kidney biopsy (Sadjadi, 2007). As a result, cases 
may not be detected early, which could lead to complications, 
including CKD. Should the disease be left undetected for too long, it 
could lead to a more advanced stage of CKD when it is finally 
diagnosed. In poor countries, it should be noted that a kidney biopsy is 
an expensive and potentially risky surgical procedure. 
Toxic nephropathy is a general term that describes kidney damage 
caused by toxins that were either ingested or originated within the 
body thereby leading to a disruption in the function of the kidneys 
(Wali and Henrich, 2002). Many industrial and environmental 
chemicals have been shown in experimental studies to be toxic to the 
kidneys (WHO, 1991). When toxic nephropathy is not treated early, it 
could result in the development of CKD. The use of traditional/herbal 
treatments along with self-medication has been known to contribute to 
the development of toxic nephropathy in many patients particularly in 
African and Asian communities (Imai and Matsuo, 2008; Jha and 
Chugh, 2003a). A number of these medications, which are usually 
unregulated by the health authorities, are found to have compounds 
that may be contaminated with drugs or heavy metals (Bagnis et al., 
2004).  
Past studies have shown that patients are likely to take traditional 
treatment before visiting a health centre for treatment and some are 
known to take traditional treatments and modern medications 
simultaneously (Ezegwui, 2010; Jombo et al., 2010; Omorodion, 
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1993). The use of these traditional/herbal treatments along with self-
medications is known to contribute to the development of toxic 
nephropathy in most patients (Imai and Matsuo, 2008).  
Toxic nephropathy on the kidneys is usually diagnosed as an 
underlying cause of kidney failure during a thorough examination of 
the patient's medical history. This means that the development of 
CKD in a patient who has toxic nephropathy is sometimes determined 
by the severity of the toxin’s damage to the kidney. There are 
indications that the influence of toxic nephropathy on the development 
of CKD in an individual is under-estimated, as the CKD cases might 
not be tested for toxic nephropathy at the time of CKD diagnosis 
(Brewster and Perazella, 2004; Simon, 1999; Soderland et al., 2010).   
2.4.3 Treatment of CKD 
There is currently no cure for CKD but it can be managed in order to 
slow the progression of the disease by treating underlying causes and 
contributing factors, complications, and by replacing lost kidney 
function. A patient with stage 1 CKD is classified as having some 
evidence of kidney disease with normal kidney function. In patients 
with Stage 2 CKD, their kidney function is classified at 60-90% (see 
Table 2.1). Most patients with stages 1 and 2 CKD just need a routine 
test each month to monitor the function rate of their kidneys and in 
most cases, they may also require a special diet. However, some of 
these patients may need further investigation due to other risk factors 
that are present such as hypertension and diabetes that equally require 
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treatment, which could result in more complications if left untreated. 
Although these tests can be regarded as a simple routine test within 
developed countries like the UK, in poorer countries, the cost could be 
unaffordable to most of the patients. 
It should be noted that most patients at the first four stages require 
medical treatments that typically involve drugs and most cases a 
special diet. Patients diagnosed at stage 3 CKD have a similar 
treatment to patients with stages 1 and 2, but with more frequent 
monitoring. Patients diagnosed at the fourth stage of CKD require 
about three tests each month in order to monitor the functioning 
capacity of their kidney. Although the functioning capacity of the 
kidney at this stage is rather low (approximately 15%-30%), evidence 
shows that the disease can be appropriately managed without it 
deteriorating to the final stage (El Nahas, 2005). Patients with stage 5 
CKD are classified as having the last stage of the disease, which 
means that their kidneys are functioning at less than 15%. Patients at 
this stage require some form of kidney replacement treatment, as their 
kidneys are no longer functioning properly on their own. At this point, 
renal replacement therapy (RRT) is the recommended maintenance 
treatment.  
Renal replacement therapies take over a portion of the function of the 
failing kidneys to remove the fluid and waste. There are three types: 
kidney transplantation, haemodialysis, and peritoneal dialysis. 
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Kidney transplantation involves taking a kidney from a donor and 
implanting it. In haemodialysis, the patient's blood is pumped through 
a dialysis machine to remove waste products and excess fluids; this 
procedure is done weekly although three times a week is regarded as 
the standard recommendation (Locatelli et al., 2005). Peritoneal 
dialysis uses the patient's own body tissues inside of the belly to act as 
a filter. The abdomen is filled with special solutions that help remove 
toxins. This form of dialysis can be performed at home, but must be 
done every day (NKF-K/DOQI, 2001).  
2.4.3.1 Treatment of CKD patients at the University of Benin Teaching 
Hospital (UBTH) 
According to the nephrologists at the renal unit in UBTH, once a 
patient has been diagnosed with CKD, the patient would have to 
undergo mandatory health investigations to monitor the progress of 
the disease at certain intervals. Each investigation costs approximately 
nine thousand naira (N9000). Those who are diagnosed at early stages 
of the disease (such as stages 1- 3) may require approximately one 
mandatory investigation per month. A patient diagnosed at stage 4 is 
expected to have a mandatory investigation every two weeks. A 
patient diagnosed with stage 5 CKD is expected to have a mandatory 
investigation every week and also have dialysis sessions. The 
nephrologists at the hospital indicated that three dialysis sessions per 
week are the optimal number of dialysis sessions required. However, 
this has not been possible, as most patients cannot afford the cost. 
They disclosed that the cost of each dialysis session is approximately 
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twenty thousand naira (N20000), therefore a patient with stage 5 CKD 
is expected to spend approximately sixty nine thousand naira 
(N69000) per week. The difference in the cost of managing the 
disease varies significantly across the different stages of the disease 
and the cost is exceptionally high among stage 5 cases. This means 
that each month, a patient diagnosed with the first three stages of 
CKD spends N9000, and a patient diagnosed at stage 4 spends 
N18000, while a stage 5 CKD patient spends N276000. Since 
healthcare costs are the full responsibilities of the patient or their 
family, it has been observed that most stage 5 CKD patients that 
require dialysis sessions often go for the “No Treatment” option 
because the cost of treatment is too expensive. The recently 
introduced National Health Insurance Scheme in Nigeria does not 
cover CKD patients, which rules out the option of relying on the use 
of the health insurance to cover the treatment of the disease (Ulasi and 
Ijoma, 2010). 
2.5 Socio-demographic determinants of health and its 
association with CKD 
Socio-demographic trends have had an effect in the spread of diseases 
within the human population. Presently, most demographers and 
epidemiologists are convinced of the close association between human 
demography and infectious diseases (Cohen, 1999). A number of 
studies have also carried out research studies on the relationship 
between demographical factors and non-infectious disease and in most 
cases there has been a significant association obtained from the results 
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(Duthé and Pison, 2008; Goldman, 2001; Guralnik et al., 1993; 
Ukraintseva and Yashin, 2003).  
2.5.1 Sex and health 
There is a substantial body of evidence of differences between males 
and females in a wide range of health outcomes (MacIntyre et al., 
1996). Whilst male life expectancy is shorter, females have poorer 
health through life than men (Macintyre, 1993; Verbrugge, 1989; 
Haavio-Mannila, 1986). This has been disputed stating that these 
studies often fail to take into account factors such as the gendered 
distribution of social roles, age, and morbidity measures (MacIntyre et 
al., 1996; Verbrugge, 1976; Wingard et al., 1989).  
In relation to access to health care, there have been indications of 
discrimination. Women’s accessibility to healthcare might be 
dependent upon variables such as their status in the specific culture 
and society to which they belong (MacCormack, 1988; Berhane et al., 
2002), their position in the labour force, and in several cases, their 
ethnicity (Puentes-Markides, 1992; Kim et al., 2007). There is 
evidence of sex discrimination in the diagnosis of various diseases 
particularly chronic disease like hypertension (Basu et al., 2010), heart 
disease (Bönte et al., 2008) and CKD (Ulasi, 2008). This has mainly 
been attributed to the biased approaches in the diagnosis of these 
diseases in men and women. 
There is evidence of higher prevalence of CKD among the male 
population than female population (Jones et al., 1998; Jungers et al., 
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1996). However, it has been argued by Perrone and his colleagues 
(1992) that the higher prevalence of CKD amongst males could be 
attributed to the use of a single cut-off serum creatinine (SCr) value 
for both males and females although these SCr values do not equate 
with similar Glomerular filtration rates (GFR). The measurement of 
the serum creatinine is regarded as a simple test that is used as an 
indicator of renal function. However, this test is not suitable for 
detecting early-stage kidney disease as a rise in blood creatinine level 
is only observed with marked damage to functioning nephrons (Peake 
and Whiting, 2006). Perrone and his colleagues argued that because 
the SCr levels vary depending on age, sex, muscle mass, and diet, 
therefore, what would be regarded as “normal” serum levels can 
drastically mask reduced kidney function. This could lead to problems 
in identifying actual CKD patients from the general population as 
most female patients may be denied early referral if the approach to 
their diagnosis is based on applying SCr level to guide referral, rather 
than calculated GFR. This results in males being diagnosed earlier, 
and referred for treatment earlier. Their argument has been supported 
by similar studies that identified the problems associated with using a 
single cut-off serum creatinine value in the diagnosis of CKD (Peake 
and Whiting, 2006; Shephard et al., 2010). 
2.5.2 Age and health 
Age is a significant indicator of many health outcomes, as there is a 
general perception that older age groups have a higher risk of poor 
health because they are more prone to diseases. Older age groups are 
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at risk of diseases such as heart disease (Lloyd-Jones et al., 1999; 
Seeman et al., 1993) and cancer (Carter et al., 1999; Parkin et al., 
2001).  
Similarly, there are indications that the youngest and oldest age 
groups are more at risk than other age groups to certain diseases. For 
example, children younger than two years old and those above the age 
of sixty-five years are at a higher risk of developing influenza 
complications that could cause severe illness or death (WHO, 2009).  
In relation to kidney diseases, there are indications that suggest that 
the kidney functions decline with age (Garg et al., 2004) which 
increases the risk of developing CKD. This is supported by O’Hare et 
al (2006; 2007), who indicated that the risk of CKD appeared to 
increase with age.  However, the disease has been known to affect 
young children (Atkinson et al., 2010; Mak and Bakris, 2010; Michael 
and Gabriel, 2003; Olowu, 2003). Vassalotti et al (2010) have argued 
that people aged 55 and above are more at risk while others have 
argued that younger age groups are equally at risk especially in 
developing countries (Naicker, 2010a). This could be attributed to 
lower life expectancies in most developing countries (Mathers et al., 
2004). As a result, there will be less CKD cases registered among the 
older population within developing countries than the number of CKD 
cases registered among the older population in developed countries. 
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2.5.3 Marital status and health 
For both infectious and chronic diseases, there is evidence of an 
association between marital status and health outcomes (Kaplan and 
Kronick, 2006). Studies have indicated a positive correlation between 
being married and experiencing good health (LaHorgue, 1960; Ross 
and Wu, 1996; Verbrugge and Wingard, 1987). This positive 
relationship has been supported by research suggesting an association 
between being single (having never married) and lower life 
expectancy (Kaplan and Kronick, 2006; Blazer, 1982; Oechsli, 1975). 
Widowhood may also be an important predictor of mortality among 
the elderly population (Johnson et al., 2000; Welin et al., 1992).  
Shortridge and James (2010) suggested that marital status has an 
impact on the health outcome of CKD patients as married patients had 
better outcomes. They argued that this might be attributed to the 
support of the spouses of the married CKD patients. Bruce et al (2010) 
found that the prevalence of CKD was lower among people who were 
married. In addition, being married was associated with better access 
to renal transplantation compared to those who were never married or 
were widowed (Khattak et al., 2010). Bapat et al (2008) found that 
marital status was significantly associated with accepting renal 
replacement therapy by CKD patients. They argued that most CKD 
patients who accepted the required form of treatment were more likely 
to be married, suggesting that the patients’ spouses were a form of 
social support for the patients that enabled them to accept and respond 
better to treatment.  
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Nevertheless, it is still not clear how marital status combine with other 
factors to impact on the development and progression of CKD in 
individuals at risk of the disease (Bruce et al., 2009).  
2.5.4 Education, occupational status, and health 
Education and occupational status are regarded as important measures 
for determining the socio-economic status of an individual with 
education being the most frequently-used measure because it does not 
usually change after young adulthood (Kaplan and Keil, 1993). 
The positive association between education and health is well 
established (Ross and Wu, 1996). The well-educated have better 
health than the poorly educated, as indicated by high levels of self-
reported health and physical functioning and low levels of morbidity, 
disability, and mortality (Feldman et al., 1989; Guralnik et al., 1993; 
Gutzwiller et al., 1989; Liu et al., 1982; Winkleby et al., 1992).  
Whilst some suggest that there is a significant association between the 
levels of education and the prevalence of CKD (Tarver-Carr et al., 
2002; Young, 2010; Singh et al., 2009), however, Bruce and his 
colleagues (2010) found no significant association between the 
prevalence of CKD and educational levels within their study of the 
Jackson area in Mississippi, USA. The general consensus is that the 
educational level of a person is highly correlated with their socio-
economic status (SES), and that there is a significant association 
between the prevalence of CKD and those with low SES (Crews et al., 
2010; Young, 2010). 
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There has been evidence that suggests that individuals with higher 
occupational status are less likely to develop a poor health outcome 
than those with a lower occupational status (Kunst et al., 1998). This 
has been attributed to their accessibility to better resources such as 
higher education, higher income, job security, and sense of control 
(Carroll et al., 1996; Charlton and White, 1995; Kunst et al., 1998). In 
addition, job related stress has a negative impact on the health 
outcome of an individual (Yarnell, 2008) although its impact appears 
to vary across the occupational classes. 
There is some evidence linking occupational hazards to health 
outcomes including the development of CKD. Occupational diseases 
include silicosis
11
 in miners and asthma in workers at plastic making 
industries as well as among painters and artisan (Dryson et al., 1995; 
Torres et al., 2010). Studies have indicated that exposure to silicon-
containing compounds such as sand, cement, coal, and rocks, may be 
related to CKD developing among manual workers handling these 
materials (Nuyts et al., 1995; Steenland et al., 1990; Stratta et al., 
2001). The exposure results in gradual damage to the kidney, 
eventually leading to the development of CKD. CKD risks were 
higher among agricultural workers (Cerdas, 2005; Trabanino et al., 
2002), attributed to long-term exposures to heavy metals in 
agricultural insecticides or pesticides (Trabanino et al., 2002). As 
discussed in section 2.4.2, the effects of the exposure of these toxic 
                                                 
11
 Silicosis is a respiratory  disease caused by inhaling silica dust 
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compounds are classified as toxic nephropathy and when they are not 
diagnosed and treated early, they lead to the development of CKD in 
the individual. 
2.5.5 Ethnicity and health 
Before evaluating the association between ethnicity and health, there 
is the need to clarify the term “ethnicity”. The term has been loosely 
used to classify various racial groups particularly within nations that 
have a multi-racial population such the United States of America, the 
United Kingdom, and Australia. However, the concept of ethnicity is 
not just associated with racial groups but it is equally associated with 
culture, religion, language, and nationality (Betancourt and Lopez, 
1993; Omi and Winant, 1994). Ethnicity within a local context tends 
to refer to people with similar cultures usually based on kinship or 
tribal affiliation. These groups can be classified as local ethnic groups 
as they precede state, or national affiliations.  
Numerous studies have associated poorer health with minority ethnic 
or racial groups in their study areas (Crocker et al., 2009; Winkleby et 
al., 1998). Although there are racial and ethnic differences in the 
causes and prevalence of certain diseases such as sickle cell disease, 
other studies have questioned whether there is any significance in 
using race or ethnicity to identify factors that contribute to health or 
disease (Burchard et al., 2003; Collins, 2004; Cooper et al., 2003). 
They argued that although these variables should not be discarded, the 
correlation between these variables and health is rather weak and 
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attention should be moved beyond these weak relationships in order to 
get to the root causes of health and disease, whether they are 
hereditary, environmental or both. 
In spite of these arguments, there have been studies that found a 
higher prevalence of certain diseases among certain ethnic groups 
(Mbanya et al., 2010; Schena, 2000; Zhang and Rothenbacher, 2008). 
One of such disparities is the higher prevalence of CKD among those 
of African (Atkinson et al., 2010; Kramer et al., 2008) and Asian 
descent (Domrongkitchaiporn et al., 2005; Ong-Ajyooth et al., 2009; 
Schena, 2000). 
Although these studies included minority ethnic groups so as to 
identify the ethnic groups that registered a higher CKD prevalence, it 
was interesting to note that not all the ethnic groups present within 
some study areas were included in order to give a more reliable result. 
Interestingly, studies within the USA focused on certain racial/ethnic 
groups such as the African-Americans, Hispanic Americans, and the 
Caucasians (Alves and Lewis, 2010; Crews et al., 2010; Mehrotra et 
al., 2008). However, few research studies included the Asians and the 
Native American ethnic groups (Hall et al., 2005; Norris and Agodoa, 
2005) even though these ethnic groups are part of the minority groups 
within the country. Within the UK, it was interesting to note that 
where ethnicity data were available, most of the ethnic groups present 
were included within the studies of the association of ethnicity and 
CKD (Dreyer et al., 2009). Such ethnic groups included the African 
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ethnic groups (i.e. Black African, Black Caribbean, Black British, and 
mixed Black), Asian (south Asian e.g. Indian, Sri Lankan; East Asian 
e.g. Chinese and Japanese), and White (British, Irish, other European 
Caucasians). Most studies however, reclassified these ethnic groups 
into fewer groups for ease of analyses.   
Although the authors identified ethnicity as a determinant of the health 
outcome, they suggested that the socio-economic status of the study 
population had a significant impact on the outcome of the results. 
These suggestions appear to support the arguments disputing the 
significance found between ethnicity and health outcomes. These 
authors argued that racial or ethnic differences in health are more 
likely to reflect differences in people's experiences from birth onward, 
based on the relatively advantaged or disadvantaged position in 
society of the race or ethnic group of the families into which they are 
born (Burchard et al., 2003; Collins, 2004).  
2.5.6 Religion and health 
Religion can be viewed as participation in the institutionally 
sanctioned beliefs and activities of a faith group (Koenig et al., 2001), 
which gives meaning to one’s life, illness, and death, and this usually 
exists both within and outside of traditional religious systems 
(Puchalski and Romer, 2000). The relationships between religion and 
health have been studied extensively. This ranges from the association 
between religion and good physical health (Krause, 2002) to its 
association with mental health (Schieman et al., 2006) and with 
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mortality (Hummer et al., 1999). The search for an association 
between religion and health may be found in various disciplines 
including public health, medicine, psychiatry, nursing, 
biology/physiology, sociology, psychology, ethics, and history 
(Krause, 2010).  
Associations between religion (or practicing faith) and health are 
predominantly positive (McCullough et al., 2000; Powell et al., 2003; 
Seybold and Hill, 2001). More studies have been found to focus on the 
association of religion and mental health than on physical health (Lee 
and Newberg, 2005), such as the association between religion and 
depression (Ellison, 1995; Miller et al., 1997). There have been 
studies on the association between religion and chronic disease such 
as breast cancer (Van Ness et al., 2003) and infectious diseases such 
as HIV (Jenkins, 1995; Trinitapoli and Regnerus, 2006). These studies 
indicated that there was a significant association between religion and 
these patients with these diseases as they found that the patients’ 
religious beliefs enabled them to find a renewed sense of purpose in 
life.  In the past decade, studies have evaluated the association of 
religion with CKD. Ko et al (2007) explained the relationship between 
religion and the quality of life of CKD patients that were undergoing 
haemodialysis and found that as the patients’ health declined, their 
religious beliefs became stronger. All of these studies focused on the 
association of religion and the patients’ recovery or survival rather 
than the causes. Currently, there are no published studies on the 
association between the prevalence of CKD and religious practices. 
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Notwithstanding, some have questioned the quality of these research 
inferences (Sloan and Bagiella, 2001), while others have pointed out 
that the benefits or costs of religion may vary depending on the 
indicator of religious involvement (Krause and Wulff, 2004; 
Pargament, 2002).  
2.6 Evaluating the spatial prevalence of CKD 
The burden of CKD as a health problem is not just felt by the patients 
and their carers or family members but also by the health-care system 
that is currently in place. The general consensus of nephrologists both 
globally and locally is that early identification of patients with CKD 
may allow health-care systems to implement effective interventions 
(Bosa, 2006; de Lusignan et al., 2005; Dirks et al., 2006; Stevens et 
al., 2007; Iseki et al., 2003). These interventions would be aimed at 
decreasing the progression and eventually the morbidity and mortality 
from the disease among the population.  
Although the actual number of people with CKD cannot be 
determined as the first and second stages of CKD are not detected 
easily, the prevalence of stages 3-5 of CKD in the UK is estimated 
between 5% and 8.5% (de Lusignan et al., 2005; Stevens et al., 2007). 
In the UK, there are indications that early nephrology referrals have 
resulted in an improvement in the survival rates of CKD patients 
(Jones et al., 2006; Richards et al., 2008). Screening the whole 
population for CKD was not found to be a cost-effective strategy 
(Boulware et al., 2003; Stevens et al., 2007). Screening of at risk 
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populations has however been found to be effective in recognizing 
undiagnosed CKD (KEEP, 2005; Stevens et al., 2007). According to 
El Nahas (2005), CKD does not affect all sectors of the population 
equally, with higher prevalence in the elderly, patients of South Asian, 
African, and Afro-Caribbean origin and the socially disadvantaged. 
Therefore, he argued that an effective screening programme has to be 
in place to adequately identify CKD patients within the population. 
Although the risk of developing the last stage of CKD among those 
classified as at risk population was low (Hallan et al., 2006b). 
Diabetic renal disease was the single most common cause of renal 
failure accounting for 24% of all diagnosed CKD cases (Tomson, 
2010).  
Screening for CKD usually involves a urine test to identify the 
presence of blood, which is used to detect the presence of CKD. 
However, a laboratory blood test, which involves determining the 
estimated glomerular filtration rate (eGFR) from serum creatinine has 
generally been accepted as a better method (Jones et al., 2006; 
Richards et al., 2008; Stevens et al., 2007). The computerized 
reporting of the eGFR was widely introduced throughout the National 
Health Service (NHS) in April 2006 following recommendations of 
part II of the National Service Framework for Renal Disease 
(Department of Health, 2005) and the Joint Royal College guidelines 
on the identification, management and referral of patients with chronic 
kidney disease (Vanholder, 2006). Given the computerized reporting 
of the eGFR within the UK, it is easy to see why the screening of high 
 
45 
 
risk patients using eGFR has effectively identified patients with CKD 
within the UK.  
The population prevalence of CKD in Australia was estimated at 
11.5% (95% CI, 9.42-14.1), which was approximated at 1.4 million 
adults (White et al., 2010). The CKD prevalence in Australia was 
comparable to a study that estimated the CKD prevalence in Norway 
at 10.2% (Hallan et al., 2006a). A national report indicated that 1 in 9 
adults over age 25 years had at least one clinical symptom that 
suggested the presence of CKD in the individual (Kidney Health 
Australia, 2011).  
The prevelence of CKD within the United States has been found to 
have increased over the past two decades (Coresh et al., 2007b). This 
could be attributed to the increasing health problems or risk factors 
commonly associated with CKD such as diabetes and hypertension 
(Lu et al., 2008; Ito et al., 2008). According to a report by the National 
Health and Nutrition Examination Survey (NHANES), it was 
estimated that 13% of the US adult population had CKD (Coresh et 
al., 2007b). The country currently lacks a complete and efficient 
surveillance programme that captures and monitors the impact of 
CKD in the population however, there are plans to put that programme 
in place as the system could support efforts toward prevention, earlier 
detection, and implementation of optimal disease management 
strategies (Saran et al., 2010). This can likely result in increased 
awareness of CKD, thereby decreasing the rates of CKD progression, 
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lowered mortality from the disease, and ultimately reducing resource 
utilisation currently spent in managing the disease. 
Although research studies has shown that CKD is more prevalent in 
people of African and Asian decent as opposed to other ethnic groups 
(El Nahas, 2005; Kramer et al., 2008; Ong-Ajyooth et al., 2009), there 
has been a steady rise in the disease in Latin America (Cusumano and 
González Bedat, 2008). The prevalence of CKD in Latin America has 
an annual growth of 6.8% since 2003 (Cusumano and González Bedat, 
2008). The rise of the disease has been attributed to a number of 
factors. These include; increase in the life expectancy at birth within 
the region resulting in a growth in the older population over 65years 
(UNDP, 2006), an increasing prevalence of diabetes in most Latin 
countries (Cusumano et al., 2009), fast lifestyle changes associated 
with migration from rural to urban areas that could result in being 
inactive and overweight (CEPAL, 2005). Diabetes remained the 
primary cause of CKD, and the highest CKD incidences were reported 
in Puerto Rico (65%), Mexico (51%), Venezuela (42%), and 
Colombia (35%) (Cusumano et al., 2009). A number of suggestions 
have been put forward to address the rise in the prevalence of CKD in 
Latin America. These include; careful data collection and screening 
for risk factors (Dirks et al., 2006). Other suggestions include the 
initiation of public awareness campaigns by reaching out to primary 
care physicians and the general public, and the inclusion of CKD 
patients and the progression of their disease in a database, in order to 
identify those at risk of developing the worst outcome (Cusumano and 
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González Bedat, 2008). However, there is still the problem of 
insufficient data on the prevalence of the risk factors associated with 
CKD progression as well as the distribution of these risk factors, 
which are very important when developing public health policies and 
programmes. Attempts at addressing this problem are ongoing. This 
was attempted by 11 countries, which have either implemented or 
developed national CKD detection programmes recommended by the 
Latin American Dialysis and Kidney Transplant Registry (LADKTR) 
committee in 2005 in order to raise public health awareness about the 
burden of CKD (Dirks et al., 2006). 
Asia now accounts for 60% of the world’s population with many of 
the eastern Asian countries experiencing an increase in life 
expectancy, notably in China, Japan, South Korea, and Taiwan, where 
birth rates have been on a decline over the last 30years (United 
Nations, 2007). These changes have resulted in the development of a 
rapidly aging population in Asia where chronic diseases such as 
diabetes and hypertension have become common and this has also 
resulted in the prevalence of CKD within the past 10years (Imai and 
Matsuo, 2008).  
Factors that could be responsible for high prevalence in Asia, include 
Chronic glomerulonephritis - the leading risk factor of CKD in China 
accounting for 47.3% of all CKD cases (Zhang et al., 2008) and the 
second leading risk factor in Japan with 25.6% (Imai and Matsuo, 
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2008). In China and Japan, haematuria
12
 accounts for 3.5% (Zhang et 
al., 2008) and 9.0% (Imai et al., 2007) of the population with CKD 
respectively. Proteinuria
13
 accounts for 4·1% of the population in 
Japan (Imai et al., 2007) 7·9% in Taiwan (Wen et al., 2008) and 0·5% 
in China (Zhang et al., 2008). Another risk factor that would account 
for the high prevalence of CKD is the presence of toxic nephropathy 
caused by nephrotoxic
14
 herbal medicines which is also common 
throughout Asia (Imai and Matsuo, 2008). According to reports from 
Japan, Korea, and China, the proportion of adults with CKD ranges 
between 8.7% - 18.7% (Imai and Matsuo, 2008; Iseki et al., 2003). 
India with a population exceeding one billion, has been projected to 
become the main reservoir of chronic disease (Srinath Reddy et al., 
2005) with 25% - 40% of these expected to develop CKD (Modi and 
Jha, 2006).  
Studies carried out on the awareness of CKD among the general 
public in Japan and Taiwan have shown that CKD awareness is 
generally low even among CKD patients. Reports show that only 
3.5% and 7.9% in Taiwan and China respectively are aware of the 
disease (Imai and Matsuo, 2008; Wen et al., 2008). One of the 
problems faced by Asia is the low number of nephrologists especially 
in the southeastern parts of the continent (Sitprija, 2003). For 
example, Cambodia and Laos do not have any nephrologists while 
                                                 
12
 haematuria is the presence of blood in the urine 
13
 proteinuria means too much protein in the urine. This may be a sign of kidney damage 
14
 Nephrotoxic refers to something that is toxic to the kidney 
 
49 
 
Burma has only 10 and Indonesia only 43 (Imai and Matsuo, 2008). 
Therefore, the general consensus on reducing the rate of progression 
of CKD has been to improve the awareness of the disease amongst the 
general public as well as educate the health practitioners (Imai and 
Matsuo, 2008; Iseki et al., 2003). Screening for the disease has also 
been suggested as the best method for targeting the disease at its early 
stage as well as targeting high-risk patients e.g. those with diagnosed 
risk factors such as diabetes, hypertension, and family history of CKD 
(Imai and Matsuo, 2008; Iseki et al., 2003). This is because the earlier 
stages of CKD can be effectively managed and the progression of the 
disease can be halted or slowed. Although there are no registers or 
current data on the incidence of CKD in some of the Asian countries 
especially those in southern Asia (such as Bangladesh, India, and 
Pakistan), attempts have been made by developing the Asian forum of 
CKD initiatives, which was implemented in 2007 by Asian 
nephrologists. Their aim is to get Asian medical colleagues together to 
clarify the status of CKD in the Asian region and exchange 
information. They expect that future collaborative studies could be 
performed to compare the CKD incidence and prevalence in Asian 
countries (Iseki et al., 2003). A progress report on the outcome of this 
forum indicated that there has been an improvement in collaborative 
studies between developed and developing Asian countries 
(Tsukamoto et al., 2009). However, there is room for improvement 
because the collaborative studies were usually done between two 
countries when the forum aims to have collaborative studies among 
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multiple countries in order to develop an international registry of CKD 
patients among multiple Asian countries and establish a network on 
the CKD Initiative in Asia.  
The actual prevalence of CKD within Africa is currently unknown and 
this is attributed to the unavailability of a reliable register of the 
disease in African countries. The delivery of renal care within African 
countries has been classified as really challenging because the ratio of 
nephrologists to the general population in Africa is likely the lowest in 
the world (Katz et al., 2011). The highest rate is found in Egypt with 
6.5 nephrologists per million persons, compared to 23.1 nephrologists 
per million persons within the USA (Katz et al., 2011; Rosenberg, 
2007). There are indications that there are no nephrologists in many 
African countries (El Matri, 2007; Katz et al., 2011). 
Within Nigeria, where this research is situated, similar strategies like 
the general consensus reached by the LADKTR committee in Latin 
America and the Asian forum of chronic kidney disease initiatives on 
reducing the prevalence of CKD are currently being put into practice. 
These include carrying out routine screening (Bosa, 2006) and 
intensifying the awareness of CKD among the general public. 
However, little has been done about the implementation of a CKD 
register. I believe that in the interim, a model could be created for the 
management of renal health by combining renal health programmes 
such as CKD awareness campaigns and screening sessions with an 
established national health prevention programme. Currently no 
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attempt has been made at creating such a model that can be combined 
with nationally recognised prevention programmes such as the 
National Malaria Control Program (NMCP) and the National AIDS 
Control and Prevention Program (NACPP), as both programmes are 
well established and could be used as a platform in raising CKD 
awareness among the public.  
Due to the absence of a reliable CKD register within African 
countries, the primary challenge of combating the disease is to 
determine the prevalence of CKD both within African countries and 
within the continent in order to provide evidence that CKD is a public 
health problem (Katz et al., 2011). 
This challenge can be classified as a multi-dimensional task. Issues 
such as the practical screening test to use, the location of screening 
centres for easy access by the population at risk, as well as the 
development of healthcare policies for the efficient management of 
CKD cases, are all important factors. The reality is that there are not 
sufficient resources for healthcare in many developing countries, 
especially for expensive treatment such as RRT. This emphasises the 
need to detect CKD at an early stage when the cost of intervention and 
treatment are cheaper. As suggested by Rizvi and his colleagues 
(2005), an effective framework to manage CKD diagnosis would have 
to be created in order to efficiently identify patients at risk of CKD 
and to enable early intervening strategies aimed at preventing the 
disease. 
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2.6.1 Impact of renal replacement therapy (RRT) 
It has been estimated that more than a million patients have undergone 
Renal Replacement Therapy (RRT) worldwide and this is expected to 
reach 2.2 million by the year 2030 (El Nahas and Bello, 2005; Naicker 
et al., 2005; Snyder and Collins, 2009). RRT, which consists of 
dialysis or kidney transplant represent very expensive procedures for 
stage 5 CKD patients and this, has financial implications on not only 
the patient but also on the health care system. According to a report by 
the ERA-EDTA
15
 Registry (2010), the prevalence of renal 
replacement therapy in 2008 for the whole of Europe was estimated at 
221,538 patients, which came to a total of 881 pmp
16
. RRT was first 
introduced in the United Kingdom in 1946 (Turner, 2004) and it has 
become an established surgical procedure. The assumed rate of 
patients needing RRT has risen progressively to about 110 pmp per 
annum (The Renal Association, 2007). According to the UK Renal 
Registry’s report, by the end of 2008, 47,525 adult patients were 
receiving RRT in the UK and there is an annual increase in RRT 
prevalence of approximately 4.4% (Tomson, 2010). 
van Woerden et al (2007) examined the effect of gender, age and 
geographical location on the population’s prevalence of RRT in 
Wales. They showed that out of the 2434 patients on RRT, the RRT 
age-specific prevalence rate peaked at around 70 years with a rate of 
                                                 
15
 ERA-EDTA refers to the European Renal Association - European Dialysis and 
Transplant Association 
16
 PMP= Per Million Population 
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approximately 1790 pmp. The study showed significant variation in 
the provision of RRT by gender, age, and the prevalence rates of RRT 
for various geographical locations in Wales. However, a higher 
significance was found in gender and age, but less by geographical 
location. According to their findings, there was a higher RRT rate 
among males and also there was the probability that RRT patients in 
Wales under the age of 50 years had a greater than 50% chance of 
having a kidney transplant while patients over the age of 75 years had 
a high likelihood of being on dialysis. They also indicated that there 
was the probability that the areas in Wales that showed a higher rate 
of RRT than the average rate in Wales was not a chance phenomenon.  
A national report on RRT in Australia indicated that only 6% of the 
people on dialysis received a transplant in 2008 and the average 
waiting time for a transplant was about 4 years but waits of up to 7 
years were not uncommon (Kidney Health Australia, 2011). Similar to 
the studies in Wales, there have also been studies on the geographical 
disparities in access to renal transplantation. Among these was a study 
in Australia by Chapman and Russ (2003), who were able to identify a 
significant variation between states concerning patients’ access to the 
transplant waiting list. Their findings suggested that the variation in 
accessing the waiting list was attributed to the dominant policy 
operation in each state i.e. whether the operating policy for each state 
was focused on the general community or determined from a patient’s 
perspective. They also suggested that the variation across the states of 
patients that actually received kidney transplants were more as a result 
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of each states’ cadaveric donation17 rates modified by increasing use 
of living donors (Chapman and Russ, 2003).  
A similar result was also observed in the United States, as the 
researchers were able to identify a significant variation in the pre-
transplantation waiting times across the regions in the United States 
(Ellison et al., 2003). Their result showed that for four months after 
listing, the transplant rate for all U.S. kidney transplant candidates was 
10.9%. Regionally the 4-month transplant rate ranged from 4.2% to 
18.5% for highly sensitized patients
18
 and from 5.4% to 19.6% for 
non-sensitized patients. This result has a significant impact on stage 5 
CKD patients especially those that require immediate kidney 
transplant due to the severity of the disease. Ellison and her colleagues 
concluded their findings by carrying out a computer-simulated model 
that suggested that a redrawing of the organ distribution boundaries 
could reduce but not eliminate geographic variations in the pre-
transplantation waiting times across the United States. 
At the end of a 4-month follow-up period in France, a study showed 
that 22% of 2,207 CKD patients received kidney transplants (Roudot-
Thoraval et al., 2003).  The transplantation percentage for all organs 
transplant in the country was found to have decreased from 63% in the 
West to 43% in the Paris region and mortality increased from 2% in 
                                                 
17
 Cadaveric donation comprises organ donation—that is, taking organs (heart, lungs, 
kidneys, liver, pancreas) from brain dead
 
people.  
18
 highly sensitized patients are those whose immune system are very sensitive to foreign 
cells or organ and therefore produces antibodies that attacks the foreign cells or organ even 
when it is a life-saving transplanted organ 
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the West to 7% in the Southeast. This result equally included CKD 
patients and therefore had a significant impact on CKD patients that 
needed kidney transplants. All tests of inter-regional differences were 
statistically significant. They therefore concluded that the factors 
explaining geographic differences related to the background of 
transplant teams, activity of organ procurement, and severity of the 
patients’ illness on the transplant list. 
In many developing countries, the prevalence of chronic kidney 
disease and the number of patients requiring RRT are not actually 
known.  Specialized care is not readily available within many of these 
countries. As such, a number of patients would have to travel to far 
places sometimes, outside their own countries, to seek medical help. 
Hence, data from places within the developing countries where 
specialized care for CKD is offered, may not reflect the incidence and 
prevalence of stage 5 CKD in the nearby geographical areas (Jha and 
Chugh, 2005). Attempts have however been made to collect data 
indirectly, such as the reported causes of death collected by the 
government in Egypt and through the institute of social security in 
Mexico (Barsoum, 2002) as well as by other means e.g. questionnaires 
from nephrologists. The responses were usually found to be 
incomplete (Jha and Chugh, 2005). A large proportion of patients 
living in the rural areas in the developing countries do not seek 
medical advice because of ignorance and poverty. Based on this 
notion, the precise incidence and prevalence of CKD patients 
requiring RRT in the developing countries can only be determined by 
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organizing community-based detection programmes. Unfortunately, 
the availability of such organized community programmes are very 
few and may be classified as non-existent in many developing 
countries.  
A significant number of patients in developing countries come to 
medical attention for the first time only after the development of CKD 
at stage 5 (Jha and Chugh, 2005). Research studies carried out on such 
patients indicated that the age group was younger than its western 
counterparts, particularly UK and the USA. In some countries, 70-
80% of the dialysis population was in the age range of 20-50 years 
(Bamgboye, 2003; Naicker, 2010) compared to the UK which 
reported a mean age of 60 years (Rayner et al., 2004). It has equally 
been indicated that children are usually under-represented in the 
dialysis population because of the lack of pediatric dialysis units (Jha 
and Chugh, 2003b; Anochie and Eke, 2005; Olowu, 2003). This might 
indicate a younger dialysis population than originally reported; 
however, this is only a speculation, as there is not enough evidence to 
back that assumption due to the absence of a CKD registry in these 
countries.  
By 2005, the average kidney transplant rate in Latin American 
countries exceeded 10pmp and nearly half were living donors (Rizvi 
et al., 2005). As in other regions, there were differences among 
countries. Renal transplantation rate in Brazil reached 22pmp in 2001, 
which was double the Latin American average. Overall, renal 
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transplantation had improved in Latin American countries with nine 
out of eighteen countries surveyed having some type of registry (Rizvi 
et al., 2005). 
In Asian countries, the average annual kidney transplant rate was 
below 10 per million persons (pmp) (Zhang et al., 2008) in contrast to 
the developed world at 45 to 50 pmp with living donors’ 
transplantation forming the bulk of transplant activity (Rizvi et al., 
2005). Southern Asia had a generally low transplant rate though some 
of the economies are fairly prosperous with Thailand and Singapore 
having a kidney transplant rate using cadaveric donors, of 10pmp 
while Indonesia, the most populous country in the region had a very 
low kidney transplant rate (Rizvi et al., 2005). In Japan, 257,765 
patients with stage 5 CKD who required RRT were reported at the end 
of 2005 (Yamagata et al., 2008) and the country had an annual 
incidence rate of approximately 14% (Nakai et al., 2007; USRDS, 
2009). 
The availability of renal replacement therapy across the African 
nations is generally inaccessible to the poorer, less educated rural 
patient as opposed to their urban counterparts (Alebiosu and Ayodele, 
2005). The dialysis population within Africa accounts for only 4.5% 
of the world's dialysis population, with a prevalence of 74 pmp, 
compared to a global average of 250 pmp (Abu-Aisha and Elamin, 
2010).  
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In a study by Arije and Akinkugbe (2002) on dialysis sessions among 
CKD patients in Nigeria, 70.8% of the patients were able to remain on 
dialysis for less than one month, 12.7% for between three and six 
months, 5.1% for between 7 and 12 months, and only 1.9% remained 
on dialysis for more than 12 months. Other research studies within 
Nigeria (Alebiosu and Ayodele, 2005; Bamgboye, 2003; Olowu, 
2003) had shown the inability of patients to continue the treatment, 
because very few could afford the regular cost of treatment (Alebiosu 
et al., 2006). A recent study in the eastern part of Nigeria made a 
similar observation stating that approximately 50% of patients at the 
last stage of CKD underwent dialysis; however, a majority of this 
group stopped dialysis after only a few sessions (Ulasi and Ijoma, 
2010).  
In summary, renal transplant activity is correspondingly low 
compared with other developing countries outside the African 
continent with an average of 5pmp (Rizvi et al., 2005). Kidney 
transplantation has been limited to North African countries and South 
Africa as they currently have the highest record of transplant cases per 
year in relation to other African countries where there is little or no 
transplant cases recorded (Katz et al., 2011). To emphasise this, the 
first successful kidney transplant in Nigeria was successfully carried 
out in August 2009 (Orakpo, 2009).  
It can therefore be deduced that the availability of renal health care 
particularly RRT is severely limited in developing countries.  
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The overall outcome of these research studies within the countries 
discussed in section 2.6, throws some light on the geographical 
disparity of the prevalence of CKD.  
2.7 The utilization of Geographical Information Systems 
(GIS) in the African health sector 
It is important that relevant and current information is available to 
decision-makers at all levels of the public health system in order to 
appropriately plan, manage, and monitor any public health problem. It 
has been argued that geographical location is an important 
determinant of health outcomes (Carstairs and Morris, 1989; Haan et 
al., 1987). Geographical information systems (GIS) provides an 
analytical framework where public health authorities and researchers 
can understand problems by identifying spatially related risk factors in 
order to create a response by targeting resources and interventions to 
areas where they are needed (Beyer et al., 2010). From detecting and 
responding to infectious disease outbreaks, to delivering healthcare 
services, to preserving the safety of the water supply, and other 
amenities, the data integration and analysis capabilities of GIS supply 
better access to information and equally facilitate better decision 
making than relying only on statistical figures (UNAIDS, 2008).  
However, it has been less clear whether GIS technology is both 
applicable and sustainable in an African setting as a method to 
spatially evaluate health outcomes (Tanser and le Sueur, 2002). While 
developed countries are taking initiatives to establish a well-organised 
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GIS based health care system, the developing countries are still facing 
different problems mainly due to rapidly growing populations and 
severe resource constraints (Paik, 2000). Countries within the African 
continent are not an exception. Studies from Nigeria (Chukwujekwu et 
al., 2010), Ghana, South Africa and Tanzania (Borghi et al., 2009) 
have all highlighted the issue of the absence of reliable or current 
information in the health sector, which are essential for health care 
management and decision making.  
The focus of this section on GIS and health in Africa is to provide 
some balance in the discussion of the application GIS for healthcare in 
Africa. The review outlines the relevance of GIS development to 
African health sector and highlights some of the difficulties in the 
sustainable implementation of GIS. 
2.7.1 The application of GIS in combating and monitoring health 
issues in Africa 
Despite the increasing use of GIS in many areas of health care 
research and planning, its adoption in the African health research is 
still minimal. Other health research outside the continent especially in 
developed countries has demonstrated that the utilization of GIS 
within the health sector can help to recognize issues that have 
otherwise been ignored in the past, helping in projecting future 
phenomena, and also in managing the situation. Nevertheless, this 
review would show that most of the research studies across Africa that 
applied GIS were carried out on mainly infectious diseases especially 
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malaria, tuberculosis, and HIV. This is not surprising as these diseases 
have significant public health impact on the continent coupled with 
the fact that a majority of the research studies carried out on these 
diseases are adequately sponsored by large organisations like the 
United Nations Development Programme (UNDP) and the World 
Health Organisation (WHO). As such, medical researchers and the 
health geographers and GIS analysts present within the African 
countries are more likely to focus their studies on the study of these 
three diseases, as there are financial resources to support their 
research. This argument can be supported by the research studies on 
these diseases that are reviewed below, as the majority of these studies 
were sponsored by health organisations interested in the outcomes of 
these three diseases within Africa. 
2.7.1.1 Application of GIS in the study of Malaria in Africa 
Due to the high impact of malaria in Africa, a number of studies have 
been carried out on malaria epidemics, its impact on the economy 
(Teklehaimanot et al., 2007) as well as the climate conditions 
associated with the disease (Senay, 2005). Climatic factors play a 
major role in determining the distribution of malaria. Rainfall, 
temperature, humidity, and soil moisture are recognized factors that 
affect the transmission rate of malaria. It is therefore not surprising 
that compared to other diseases in the continent, GIS has been widely 
applied to the understanding and management of malaria in Africa. In 
its simplest application, GIS has been used in mapping out the 
prevalence of malaria in a number of countries and they include 
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malaria mapping using transmission models in Mali (Gemperli et al., 
2006b), and in countries in West and Central Africa (Gemperli et al., 
2006a). It has also been used in generating models of malaria 
occurrence using climatic and remotely sensed data (Craig et al., 
1999; Thomson et al., 2006) and transmission intensity (Gemperli et 
al., 2006a; Kleinschmidt et al., 2000; Rogers et al., 2002). The outputs 
of such models were combined with population data to estimate 
population exposure, mortality, and morbidity (Kleinschmidt et al., 
2002; Omumbo et al., 2005; Snow et al., 1999) and to analyse (Hay et 
al., 2002) and project future prevalence of Malaria (Lindsay and 
Martens, 1998). Other notable research on GIS and malaria is the use 
of GIS in studying the anopheles mosquito, which acts as a vector for 
the disease malaria (Coetzee et al., 2000). It has also been used in the 
monitoring and control of malaria (Booman et al., 2000; Martin et al., 
2002), to measure the effects of access to malaria treatment (Noor et 
al., 2003) and to evaluate the effects of intervention strategies.  
A majority of these reviewed studies on malaria highlighted that the 
outcome of their studies could contribute to the achievement of the 
Millennium Development Goal recommended by the UN Millennium 
Project for reducing the burden of malaria by 75% in Africa 
(Teklehaimanot et al., 2007). 
2.7.1.2 Application of GIS in the study of tuberculosis in Africa 
There have been fewer publications that utilized GIS in the study of 
tuberculosis within the African continent. The most recent study was 
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the spatial distribution of tuberculosis and the identification of 
significant tuberculosis clusters in Greater Banjul, in Gambia (Touray 
et al., 2010).  
Other studies investigated the association of various risk factors and 
places of transmissions of tuberculosis (Munch et al., 2003; Murphy et 
al., 2009). The study had identified significant associations of 
tuberculosis with unemployment, overcrowding, and the cluster of 
drinking places per enumerator sub-district of these communities. 
In 2008, a research study evaluated the geographical and temporal 
distribution of tuberculosis across African countries in order to 
identify possible high-risk areas (Uthman, 2008).  
Another study focused on the use of GIS/GPS technology to document 
improved access to tuberculosis treatment through a community-based 
programme (Tanser and Wilkinson, 1999). While another research 
study focused on the burden and risk factor of tuberculosis on children 
in an urban population in Cape Town (van Rie et al., 1999). In a 
previous study, GIS was used to map 4011 tuberculosis cases in two 
suburbs of the same city (Beyers et al., 1996). The findings of the 
study indicated that significant clustering of tuberculosis was 
associated with socio-economic factors. A similar result was equally 
identified in Madagascar, which indicated that spatial clustering of 
tuberculosis was significantly associated with socio-economic and 
patient care factors that related to the care of the patient such as 
patients lost to follow-up (Randremanana et al., 2009).  
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From the reviewed studies on the utilization of GIS in the study of 
tuberculosis within Africa, there appear to be more research studies 
carried out in the southern part of the continent particularly in Cape 
Town than other parts of the continent. Although the study by Uthman 
in 2008 attempted to give an overview of the spatial distribution of 
tuberculosis across the African countries, the implementation of GIS 
in the study of tuberculosis can still be classified as being at its initial 
stage. This is because there are fewer studies on tuberculosis 
compared to the number of studies on malaria that utilised GIS within 
the African health sector.  
2.7.1.3 Application of GIS in the study of HIV/AIDS in Africa 
There has been a significant literature within health geography that 
investigated the spatial pattern of HIV. This ranges from the 
geographical spread of the disease to the investigation into how people 
with HIV/AIDS use space differently as well as government responses 
to the epidemic (Turner, 2009). Although previous studies have shown 
the severity of the impact of HIV/AIDS in Africa (Bock and Johnson, 
2008; Bourne et al., 2009; Gouws et al., 2008; Weir et al., 2002) and 
also the benefits of GIS in the health sector, only four research studies 
could be located that applied GIS to the analysis of HIV. This is 
intriguing given the fact that HIV accounts for a significant proportion 
of the continent’s health burden and the reduction of the impact of 
disease within the continent is currently sponsored by WHO and the 
UNDP (Schim van der Loeff, 2005; UNDP, 2011). As mentioned 
earlier in section 2.4.2, HIV is classified as one of the known risk 
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factors of CKD. Therefore, a review of the studies on HIV/AIDS that 
utilised GIS can be regarded as relevant to my research as the outcome 
of these research studies could be beneficial in estimating the trend of 
CKD and it association with the prevalence of HIV within African 
countries. 
The first study was a project classified by the authors as an 
intervention study that focused on using participatory methods and 
GIS to prepare for an HIV community-based trial in Vulindlela, South 
Africa (Chirowodza et al., 2009). The research study was based on the 
effectiveness of combining participatory methodologies and GIS 
technology in order to understand and inform community-based 
intervention studies. Their research can be regarded as one of the ways 
in addressing the issue of data avaliablity as the authors were able to 
fill in the missing gap of previously incomplete data with the 
information they collected from the community members using the 
participatory mapping and transect walks.  
The second study attempted to justify the use of GIS in creating a 
model that predicted the prevalence of HIV/AIDS across the various 
countries in Africa from 2004 till 2010 (Kalipeni and Zulu, 2008). 
They began the study by evaluating the prevalence of HIV/AIDS in 
Africa for the period from 1986 to 2003. They concluded their study 
by defending the application of GIS in the study of health outcomes 
especially for extrapolating results when there are insufficient data 
available to cover the whole study area. They argued that their study 
was able to show how spatial patterns of HIV/AIDS prevalence in 
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sub-Saharan Africa have progressed over the past 20 years using GIS 
spatial interpolation. 
The third study can be referred to as a simple project that showed the 
spatial prevalence of HIV/AIDS and tuberculosis and its demographic 
consequences in selected countries in sub-Saharan Africa (Pillay, 
2003). The spatial dynamics and the association of tuberculosis with 
HIV involved using Cartographic and GIS techniques via choropleth 
mapping of HIV/AIDS and tuberculosis prevalence data. Although the 
project was not an in-depth study, the author however, argued on the 
relevance of his project as it may provide some guidelines to the 
possible trend that HIV/AIDS would take over the next four year 
cycle and how the relationship between HIV and tuberculosis would 
pan out in the future. He also mentioned the importance of its 
demographic impact on key population indicators for example life 
expectancy (Pillay, 2003). 
The fourth study on the use of GIS in the study of HIV described the 
difference in HIV prevalence among pregnant women in one of the 
health district in South Africa and its correlation with proximity of 
homestead to roads (Tanser et al., 2000). The study provided some 
indication for an ecological relationship between transport 
accessibility and HIV prevalence (Tanser and le Sueur, 2002). This 
involved the measurement of HIV prevalence among pregnant women 
who were measured through anonymous surveillance and stratified by 
their local village clinic. They explored the relationship between HIV 
prevalence and the proximity of homesteads to primary and to 
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secondary roads, which they found, had a close correlation. Tanser 
and Sueur have however, criticised their own finding stating, “the 
relationship needs to be tested at an individual as well as at an 
ecological level… much remains to be learnt about the causes and 
nature of this heterogeneity” (Tanser & le Sueur 2002, p. 4). 
2.7.1.4 Application of GIS in the study of other diseases in Africa 
Further review on the application of GIS and the study of diseases in 
Africa revealed that there were other diseases where GIS was applied. 
However, they could all be categorized as infectious diseases. They 
included a prediction model on cholera (Fleming et al., 2007), a 
prediction model on urinary schistosomiasis
19
in Tanzania (Brooker et 
al., 2001), the Rapid Epidemiological Mapping of Onchocerciasis
20
 in 
Nigeria (Abanobi, 1999) and mapping human Helminth
21
 infections in 
Southern Africa  (Brooker et al., 2000).  
It is therefore clear from the reviewed papers that in Africa, there is 
little or no research on the application of GIS on non-infectious 
diseases. This might be attributed to the fact that infectious disease 
like malaria and HIV/AIDS currently account for a majority of the 
disease burden of the continent particularly in sub-Saharan Africa. 
According to the global malaria report in 2006 by the World Health 
Organization, Africa accounted for about 86% of the estimated 247 
                                                 
19
 A tropical parasitic disease caused by the larvae of one or more of five types of 
flatworms or blood flukes known as schistosomes 
20
 Also known as river blindness.  
21
 A parasitic roundworm or flatworm 
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million malaria cases worldwide, 91 % of the malaria deaths the same 
year, and approximately 80% of these cases occurred within countries 
in sub-Saharan Africa (WHO, 2008). Studies equally indicated that 
sub-Saharan Africa had the highest prevalence of HIV/AIDS in the 
world, accounting for approximately two thirds of all incident and 
prevalent HIV infections and three quarters of all AIDS deaths 
(Vitoria et al., 2009; UNDP, 2011). 
Another contributing factor to the absence of spatial studies of chronic 
diseases within the African health sector is the unavailability of 
reliable database(s) or survey data for these chronic diseases at the 
national, regional, or state level. The only available data are hospital 
data, which are usually only available to health researchers that work 
within these hospitals. As a result their studies usually focus on the 
impact of the disease within the boundaries of the hospital and 
therefore do not provide information on the prevalence and severity of 
these chronic diseases across different geographical areas. 
Given the limited number of studies that spatially evaluate non-
infectious diseases within Africa, my research study which focuses on 
the utilisation of GIS in the spatial analysis of chronic kidney disease 
in Nigeria can be regarded as a contributor to spatial epidemiology 
using GIS to spatially evaluate chronic diseases in Africa. This is 
because there are currently no studies that have utilised GIS to 
examine the spatial distribution of CKD or estimate its attributed risk 
due to the associated risk factors of CKD.  
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2.7.1.5 Application of GIS in the study of health care services in Africa 
Given the role of healthcare services in the management of diseases 
within a society, its importance in the management of the public’s 
healthcare cannot be overemphasised. The need to improve the 
performance of the health systems is a major global health priority 
(WHO, 2000). This should have a high priority in Africa especially as 
emerging, and re-emerging diseases pose a serious public health threat 
to most countries of tropical Africa and therefore better laboratory 
services and disease surveillance systems are essential to monitor 
disease trends and to initiate public health strategies (Shears, 2000). 
Poorly managed health systems would hinder the effectiveness of 
health interventions especially for those who are classified as high-
risk groups relating to any disease or health outcome. This is 
particularly applicable to Africa where health systems often perform 
poorly and are unreliable (Tanser and le Sueur, 2002). 
 Regardless of its shortcomings, there are few published illustrations 
of the use of GIS in health systems research in Africa. The majority of 
the research studies were focused on healthcare accessibility. Past 
research studies have indicated that healthcare decisions are 
influenced by the type and quality of services available in the local 
area and the distance, time, cost, and ease of travelling to reach those 
services (Haynes et al., 1999).  
 A notable research study was on the creation of a model that was used 
to investigate differences in rural, urban, and sub-urban utilization of 
clinics by homesteads in rural areas of South Africa as well as to 
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quantify the effect of physical access to the utilization of the clinic 
(Tanser et al., 2006). They used a cost analysis within a geographical 
information system to estimate at any given location, the mean travel 
time to clinic and to derive the clinic catchments. They suggested that 
their model would constitute a framework for modelling physical 
access to clinics in many developing country settings, as conventional 
network analysis/cost models within a GIS are not suitable due to a 
number of difficulties that tend to be peculiar to many developing 
countries. Previous research carried out in 2004, addressed the issue of 
health accessibility. The research, which was conducted in South 
Africa, demonstrated the application of GIS in measuring the 
geographical accessibility to primary health care and its potential as a 
tool with assisting in planning and providing health services. They 
found that only a third of the population lived within 5 km of a clinic 
and the utilization of that clinic declined with increasing distance. 
They were able to argue that geographical accessibility to primary 
health care was not adequate and the utilization of each clinic 
depended on distance from primary health care facilities (Tsoka and le 
Sueur, 2004).  
A research study carried out in Malawi investigated the access to 
reproductive health services using GIS (Heard et al., 2004). The paper 
discussed its attempt to identify whether access to reproductive health 
services partially explained the use of modern contraception in 
Malawi. A geographic information system was employed to integrate 
health facility data from the Malawi health facilities register with 
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global positioning data from the 2000 Malawi demographic and health 
survey. An attempt was made to detect a practical connecting pathway 
by using distance to health services as a proxy variable for access to 
services. Based on their findings, they concluded that increased access 
to reproductive health services did not seem to be the driving force of 
the change in contraceptive practice in Malawi. 
A different research study was carried out in Kenya to create spatially 
defined databases for equitable health service planning in low-income 
countries (Noor et al., 2004). The authors focused on creating a 
comprehensive and spatially defined list of health service providers. 
Their research study identified a number of weaknesses in the existing 
national health management information systems, which they 
suggested could be redressed with better commitment and minimal 
costs. One such weakness included incomplete demographic data of 
patients. They recommended that the outcome would enable GIS to 
exploit more fully facility-based morbidity data, population 
distribution, and health access models to target resources and examine 
the ability of health sector development to achieve equity in service 
provision. A previous study in 2002 used GIS in the fair allocation of 
fieldworkers’ workload in a large health survey. The methodology 
predicted average inter-homestead walking time and divided the study 
area into units of equal workload (Tanser and le Sueur, 2002). The 
outcome of the study suggested that the method presented had 
numerous applications to health systems provision in developing 
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countries where limited physical access to primary health care is a 
major factor contributing to the poor health of populations. 
In summary, the reviewed literature on the application of GIS in the 
African health sector appears to indicate that the potential of GIS 
remains largely unrealised. GIS analysts within the continent should 
be encouraged to participate in the spatial analyses of health outcomes 
because the utilization of GIS within the health sector can help to 
recognize issues that might have been overlooked in the past and also 
provide information for decision makers in the health sector. 
Providing jobs for GIS researchers within the African health sector 
can serve as a means of encouraging GIS analysts to participate within 
the African health sector. Although some progress has been made in 
the study of infectious disease over the years, there has been little or 
no evidence shown in the application of GIS in the study of non-
infectious diseases within the continent of Africa. There is therefore a 
need to extend the potential of GIS into the research on the growing 
number of non-infectious diseases that are now becoming a concern 
within Africa.  Using GIS will allow disease control activities to be 
focused and cost-effective, and would help in establishing a system 
for community-based intervention. Most importantly, there is an 
urgent need for the creation of an up-to-date database to aid in the 
investigation of the utilization of GIS for health surveillance and 
monitoring, and health forecasting and control. In settings where 
census data are not available which is usually the case in rural areas of 
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developing countries, high-resolution satellite imagery can be used in 
the estimation and location of populations.  
The problem of the accessibility of spatial data is not limited to just 
the health sector but is also an issue in other disciplines that utilize 
GIS. There are similarities in the field requirements for GIS across a 
number of disciplines, these include forestry, ecology, archaeology, 
and epidemiology, and these disciplines could therefore benefit from 
sharing resources as well as experiences. Collaborations between 
various sectors should therefore be encouraged as well as funded, as 
this would result in the development of an up to date database for 
population and environmental studies, which can contribute to the 
growth of GIS in developing countries.  
2.8 The application of GIS in the study of CKD 
The application of GIS in the investigation of health issues is 
becoming a growing phenomenon as the advantages that are offered 
by GIS within the health sector has heightened the awareness amongst 
health-related practitioners and researchers. 
By implementing geographical thinking and modelling through GIS, 
digital maps and visual displays are produced that can be used for 
research, practice and / or health policy analysis (Soret et al., 2001). A 
good example is the creation of a Multi-Source Information System 
(MSIS) by Landais and his colleagues in 2002 (Landais et al., 2002). 
This was designed for the Renal Epidemiology and Information 
Network (REIN) dedicated to End-Stage Renal Disease (ESRD), 
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which is currently referred to as stage 5 CKD, and based in France. 
MSIS has been operational since 2002 and progressively deployed in 
nine regions in France. MSIS aims at providing reliable follow-up 
data for ESRD patients. MSIS facilitates documenting medical events, 
which occur during the course of ESRD patients’ health care, and 
provides a means to control the quality of each patient's record and 
reconstruct the patient’s line of care. Consolidated data are made 
available to a data warehouse and to a geographic information system 
for analysis and data representation in support of public-health 
decision making. An example of the analysis that can be carried out 
by the consolidated data provided by MSIS is that a user can choose to 
study CKD incidence in 2003 for one specific region of interest (Ben 
Said et al., 2005).  Given the available data provided by MSIS, more 
detailed spatial as well as temporal research studies could be carried 
out on CKD incidence and prevalence within France. The utilisation 
of a MSIS for CKD management within the Nigerian health sector 
could be beneficial especially since it makes use of consolidated data 
thereby solving the current problem of the absence of a CKD database 
in the country. However, a number of factors need to be considered. 
One of these is the establishment of an effective network of the renal 
institutes, hospitals, and clinics in the country. This network would be 
needed for the provision of reliable follow-up data for CKD patients 
within the country. Another factor that needs to be considered is the 
availability of trained data-entry officials and GIS analysts who are 
needed to update and process the consolidated data respectively. In 
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addition, a functioning back-up system should be in place to ensure 
that in the event of a system failure, data loss could be prevented. 
Another example is a Web-based Geographic Information System 
(Web-GIS), the SIGNe (Système d'Information Géographique pour la 
Néphrologie) in France, which was designed for the Renal 
Epidemiology, and Information Network (REIN) dedicated to the last 
stage of CKD. The Web-based application allows access to the 
epidemiology of the demand and the supply of care concerning Stage 
5 CKD cases. It is dedicated to medical professionals and public 
healthcare decision-makers who specialises in the management of 
stage 5 CKD cases (Richard et al., 2005). The system is described as a 
visualisation and decision-support tool for the management Stage 5 
CKD cases in France. Its main aim is to provide maps matching the 
offer of renal healthcare to the demand of Stage 5 CKD patients in 
France. 
It can however, be observed that the actual application of GIS to 
research on CKD is limited given the space of time that GIS has been 
made available in the health sector. In many cases where GIS had 
been applied, it had been for the simple application of visual display 
of results (Fan et al., 2007; van Woerden et al., 2007). This argument 
was equally supported by Toubiana and his colleagues when they 
reviewed the PubMed journal. They argued that of all the PubMed-
reviewed international literature, only 15 articles addressed GIS and 
medical decision making or health care planning and none of these 
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dealt with nephrology, CKD (Toubiana et al., 2005). Although their 
review on the issue is about six years ago, the utilization of GIS in the 
study of CKD has not greatly improved. As my attempt at carrying out 
a systematic review of available literature on the application of GIS in 
the study of CKD using databases such as web of Knowledge (WOK), 
Medline, and Google scholar, did not identify many studies that has 
contributed to the advancement of the utilisation of GIS in the study of 
CKD. It should be noted that out of the available studies that utilised 
GIS in their research on CKD none has currently been published 
within an African setting. Therefore, the absence of such study within 
an African context further highlights the importance of the outcome of 
my research study. Below is a review of some studies that utilised GIS 
in their research on CKD and although these studies were done within 
developed regions, I am of the opinion that their approach can be 
applied within an African setting. 
Christie et al (2005) examined the spatial analysis of renal service 
provision in south and mid Wales. They carried out a point prevalence 
analysis of the utilization of renal replacement therapy (RRT) by 
patients within the area that had CKD and required either dialysis or 
kidney transplantation. The renal/kidney units that were located in the 
study area provided the postcodes of CKD patients that required RRT 
and their postcodes were geocoded at the level of unit postcodes 
against the 1998 Postcode Directory for Wales. They used the 
geocoded patient dataset and mid 2002 resident population estimates, 
to calculate the RRT point prevalence for the 16 unitary authorities in 
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the area, fifths of small area deprivation defined by the 2001 
Townsend index for Welsh electoral divisions, and three bands of 
travel time. The spatial accessibility of renal services was investigated 
by constructing geographical polygons that represented the areas 
within 30 and 60 min road travel time from main renal/kidney units 
and all (main and satellite) units and the travel speeds were based on 
the Department for Transport surveys of off-peak driving speeds in 
England. Their results showed a variation in the point prevalence of 
RRT across the study area and also that the estimates of RRT 
prevalence were lower in more deprived areas. They however, stated 
that their point prevalence was not adjusted for age and as such, 
prevalence differences between populations may have reflected some 
variations in the age structure of the population. They also mentioned 
that their point prevalence estimate of 633 pmp was slightly higher 
than the figures reported by the UK Renal Registry in the 2001 
registry report, which estimated a prevalence of between 558 and 
632 pmp in Wales. They however, suggested that the differences were 
probably due to the different methods used, including differences in 
the denominator population used for prevalence calculations, 
differences in prevalence between the study area and the rest of 
Wales, and changes in the number of prevalent cases between the 
dates for the estimates. Since their model made no allowance for any 
travel other than via the quickest route to the nearest unit, it can be 
deduced that the results for their travel time were just rough estimates. 
Nevertheless, their research was able to demonstrate the utilization of 
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GIS as a method that can provide useful information for the planning 
of future service provision.   
A study done in California was classified by the researchers as a GIS-
based, multi-method approach to study the pressing issue of health 
care access to kidney transplantation (Soret et al., 2001). They started 
their research by comparing the underlying illness in this case-End 
Stage Renal Disease (ESRD or stage 5 CKD) and the demand it 
created for new kidneys, with actual kidney transplantation. ESRD 
and transplantation cases in California were identified, extracted and 
geocoded to GIS maps of California ZIP Code boundaries. The 
processed data set was used to show the proportion of kidney 
transplant procedures and the geographically varied proportion across 
California. Their result produced smoothed maps from California 
patient discharge data (1995-1998) to reveal spatial variation of 
recipient distributions. Smoothed maps were compared with patient 
clusters obtained through tests for spatial randomness. This resultant 
map showed a region of concern for public health officials and policy 
makers, where higher than expected levels of the underlying illness 
and poor access to treatment overlap.  From their result, they stated 
that GIS could be used to produce related information for the 
identified areas of concern that could help in generating interventions 
that are more effective as well as improve health policies. They also 
examined healthcare access to organ transplantation using 
geographical correlations of distance and intensity of competition.  
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They concluded their findings by saying that their analysis implied 
that the likelihood for the CKD population to receive a kidney 
transplant did not necessary follow the presence of stage 5 CKD, 
which was revealed in both smoothing techniques, and statistical tests 
of spatial randomness. They therefore suggested that geography 
seemed to play a role in access to kidney transplantation.  
The study has been able to show that a GIS-based approach helps to 
clarify and recognise the geographical variability of health 
differences. By utilising the visualisation of data, they were able to 
locate under-served or over-served regions.  
2.9 Summary 
Previous studies have identified a number of factors that are either 
directly or indirectly associated with the prevalence of CKD. The 
majority of the factors that directly influence the development of CKD 
in a person can be classified as biological risk factors. These include 
hypertension, chronic glomerulonephritis, diabetes, toxic nephropathy 
and other previously mentioned causes of CKD (see section 2.4.2 
above). The demographic factors discussed in section 2.5 can be 
regarded as factors that are indirectly associated with the CKD 
outcome of a patient. The varying influence of these biological risk 
factors as well as demographic factors on the outcome of CKD can be 
observed across the various research studies both at a local and global 
perspective.  
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It could be observed that there were variances in the prominent risk 
factors associated with CKD. For example, the presence of toxic 
nephropathy as one of the prominent risk factors of CKD in Asian and 
African countries could be attributed to the fact that the herbal 
medications are not as regulated as in the more developed countries. 
Therefore, the herbal medications in the Asian and African countries 
are more likely to contain harmful compounds, which could have been 
detected before they were allowed into public circulation if there were 
adequate regulatory bodies that monitor the quality of these herbal 
medicines.  
The review on the utilization of GIS within the African health sector 
has shown that there are benefits in the use of GIS in the African 
health sector. However, the majority of the GIS applications in the 
African health sector are currently located in the southern region of 
the continent. Despite the fact that the application of GIS has been 
focused on the monitoring, analysing, and management of infectious 
diseases, it can be argued that due to its adaptable capabilities, GIS 
can be applied to the study of non-infectious diseases within the 
African health sector. 
In regards to the spatial distribution of the prevalence of CKD, there 
were more detailed research studies on CKD that were applied within 
the developed countries than in developing countries. Furthermore, 
even where published research studies that focused on the developing 
countries were available, they mainly gave a simplistic overview of 
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the spatial distribution of the disease across the developing region. 
However, the emphasis on how GIS provides a framework for the 
combination of multidisciplinary approaches and techniques to present 
a full picture of health outcomes were made apparent in the majority 
of the studies reviewed. They focused on showing the health 
variations when analysing geographically defined data.  
It should be noted that not all academic research on CKD could be 
reviewed as a majority of these studies were written from a medical 
perspective. Therefore, an attempt at reviewing these studies from a 
geographical perspective turned out to be very restrictive. Efforts at 
getting enough academic researches on the use of GIS in the study of 
CKD proved equally to be challenging. However, this only confirms 
the underlying fact that there is a need to educate health practitioners 
and researchers affiliated with the study of CKD on the advantages of 
the application of GIS. This is particularly essential in developing 
countries where limited data resources are available. GIS could 
therefore be applied in order to highlight areas of concern that could 
otherwise be overlooked.  
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Chapter 3 The evaluation of the data collection process 
and the research methods 
3.1 Introduction  
The previous chapter focused on the basic concepts as well as the 
relevant literature associated with this research study. This chapter 
will outline the research approaches undertaken to answer the research 
questions outlined at the beginning of this thesis. The data collection 
process undertaken during the course of this research study as well as 
the research methods that were applied in the course of this study are 
examined in detail later in this chapter. 
3.2 Research design: A quantitative approach 
This research study can be classified within the field of health 
geography, which is a sub-discipline of human geography. This is 
because my study focuses on the spatial analysis of a health issue (i.e. 
the study of chronic kidney disease). It has been suggested that health 
geography can be broadly grouped into two main sectors – the spatial 
spread of diseases and the access to healthcare (Parr, 2003) and this 
gives a brief summary of what this research study focused on.  
Given the nature of my research study, the quantitative approach, 
which is regarded as quantitative geography within the geographical 
discipline, was adopted for this research study. Quantitative 
geography is the collection of methods that can be applied, by 
geographers and researchers in other disciplines, to study spatial 
phenomena, issues, and problems (Murray, 2010).  
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It has been argued that the emphasis of the quantitative approach in 
human geography is to gather enough evidence that makes the 
adoption of a particular explanation compelling (Bradley and 
Schaefer, 1998; Fotheringham et al., 2000). A known strength of the 
quantitative approach as noted by Fotheringham et al (2000 p. 6) is 
that…“it enables the measurement of the determinants that can be 
measured (and in many cases these provide very useful and very 
practical information for the real world decision-making) ...” 
The quantitative approach within a geographical research study is 
usually categorised into two perspectives. These are the research 
studies that focus on the statistical analysis of spatial data and those 
that focus on spatial modelling. The statistical approach, which ranges 
from descriptive statistical methods to statistical models (such as 
regression and analysis of variance) as well as non-parametric 
methods, have been an important part of quantitative geography 
(Murray, 2010). The application of statistical methods within the 
social sciences can be attributed to the need to account for errors and 
uncertainty in both data collection and model formulation 
(Fotheringham et al., 2000). It has been argued that the modelling 
approach can be classified as an important tool that could help 
researchers handle complexities in a variety of situations in order to 
produce a compelling explanation about spatial processes (Macmillan, 
1989; Wilson, 1989). Quantitative geography combined with 
geographical information systems (GIS) in the 1990s by using a 
descriptive, inductive, and applied view and this trend was supported 
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by the rapid development of computer technology and the data storage 
of geographical information (Yano, 2000). This has led to a boost in 
empirical investigations especially those that are computationally 
intensive, which could explain the application of GIS in a number of 
modelling research studies. Examples include location-allocation 
modelling (Ghosh and Rushton, 1987; Yeh and Chow, 1996), 
accessibility studies (Sherman et al., 2005), space-time modelling 
(Dijst et al., 2002; Kwan, 2004), and spatial interaction modelling 
(Beale et al., 2006; Fotheringham et al., 2000). It has been argued that 
for certain aspects of the modelling approach, the integration of GIS 
with a quantitative approach could lead to a reasonably high 
probability of producing insights that would otherwise be missed 
(Fotheringham, 1999). According to Poon (2004), the integration of 
GIS along with the increasing developments in geoprocessing 
capabilities has potentially allowed researchers to study at individual 
rather than group level in an attempt to reveal the heterogeneous 
positions and experiences of their population studies. This has been 
made possible because the use of GIS allows the incorporation of 
large amounts of geographic data that are essential for any meaningful 
analysis of human activity pattern that might have been previously 
difficult to attain before the integration of GIS (Kwan, 2004). Health 
geography can be regarded as one of the many fields where the 
utilisation of GIS has had a reasonable number of applications (Parr, 
2004; Verhasselt, 1993). This ranges from the simple mapping of 
diseases to the application of more in-depth analyses such as cluster 
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analyses of health outcomes (Mosavi-Jarrahi et al., 2007), spatial 
interaction models of exposure to pollution (Conley, 2011), as well as 
models on accessibility to healthcare (Tsoka and le Sueur, 2004). 
These applications have helped to highlight areas of concern thereby 
contributing to the implementation of more insightful policy decisions 
that could both benefit the population and the environment. An 
example is the identification of areas that might be under-served or 
over-served by available healthcare services in order to improve the 
healthcare provided to the population within the study area(s) 
(Christie et al., 2005, Soret et al., 2001). 
In summary, the quantitative approach in a geographical context 
provides a way for the production of strong evidence that can be used 
to support or disprove an idea/explanation about spatial processes.  
As previously mentioned in chapter one, my research study is a cross 
sectional study that relied mainly on secondary data, therefore the 
methods used within this quantitative approach can be regarded as a 
pragmatic or practical approach.  
3.2.1 What led to the development of my research questions? 
Given the fact that the research problem and the research questions 
has been outlined but not discussed in details in the first chapter, this 
section focuses on the factors that led to the development of the 
research questions outlined at the beginning of this thesis. 
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The commencement of this research study was born out of curiosity as 
I had originally intended to study the spatial prevalence of CKD 
within Sheffield and the rest of south Yorkshire in the United 
Kingdom. I had hoped to work with data that would be provided by 
the Sheffield Kidney Institute (SKI) in order to contribute to their on-
going study on the prevalence of CKD and the impact of socio-
economic factors on its prevalence in the community. However, the 
turning point of my research happened after a meeting with the lead 
medical investigator at the institute - Professor Meguid El Nahas, who 
informed me that there was currently an affiliation between the 
Sheffield Kidney Institute and the nephrology department of the 
University of Benin teaching hospital (UBTH) in Edo state. The 
affiliation between the institute and the hospital involved a routine 
medical training of renal doctors and nurses from UBTH for a period 
of three months at the SKI. This information resulted in my interest 
about what the equivalent research on the prevalence of CKD might 
show in a developing country, given that the UK is seeing a 
substantial growth in CKD (see chapter two).  The information about 
the affiliation raised two main questions. The questions were as 
follows - does what has been learned in the UK translate easily to a 
developing country and to what extent does the Nigerian context differ 
from what is experienced in the UK?  
However, a comparative study was soon abandoned as the extent of 
the data limitations in my study area was revealed (discussed in 
section 3.3). In addition, my early reading of the available literature on 
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the current CKD status of Nigeria, strongly indicated that most 
patients are diagnosed with CKD only after they had developed the 
last stage of CKD, which tended to be expensive to treat or manage as 
well as unaffordable by majority of the patients. Therefore, the aim of 
my research study was to identify ways of improving the early 
detection of CKD among patients by attempting to identify any 
variation(s) among the factors associated with CKD patients and 
determine if it can be regarded as an influence on to the severity of 
CKD at the time of diagnosis in patients (see chapter one). 
As mentioned earlier, the research study intends to address the 
following questions: 
1. Is there an association between socio-demographic factors and 
the severity of CKD at first presentation? 
2. Is there a relationship between the severity of CKD at first 
presentation in Edo state and known biological risk factors of 
CKD? 
3. What factors are likely to lead to the late diagnosis of CKD 
among patients in Edo State? 
4. What is the trend of diagnosed CKD within Edo state?  
5. What is the spatial pattern of diagnosed CKD cases within Edo 
state? 
6. Is the prevalence and distribution of CKD in the state 
appropriately serviced by the available CKD healthcare 
service? 
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Having already mentioned in the previous chapters that there are no 
registers of CKD in Nigeria, it was apparent that I needed reliable data 
sources for my study. These included  reliable data on who had been 
diagnosed with CKD. This data would be used in addressing the first 
four research questions outlined in this study. Also needed, was the 
data on the base population, which includes the population for the 
LGAs and the wards within the state, and boundary maps for the 
LGAs and the wards, as they would be relevant in addressing the fifth 
question of the research study. A road network dataset along with the 
data on the location of diagnosed CKD patients and available CKD 
health services within the state were required to address the last 
research question. The subsequent sections within this chapter 
examine the data collection process and the methods that were applied 
in the course of this study so as to answer the research questions. 
Equally discussed are the methods that were considered but were not 
applied in the course of this study. 
3.3 Data collection: Experience at the University of Benin 
Teaching Hospital (UBTH) and the Regional Centre for 
Training in Aerospace Surveys (RECTAS) 
As mentioned in chapter one, the University of Benin teaching 
hospital (UBTH) was selected as the source for the CKD data for my 
study area. This decision was based on the fact that at the time of the 
study, the hospital was the only health institute within the state with a 
functioning nephrology unit and this ensured that anyone in the state 
diagnosed with the disease would likely have a CKD health record 
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within that hospital. The nephrology department at the hospital is also 
responsible for the treatment of all CKD cases within the Niger-delta 
region; therefore, CKD patients who reside just within the boundary 
of Edo state do not travel to neighbouring states to receive treatment. 
This section also examines the data collection process experienced at 
the RECTAS agency in the retrieval of spatial datasets including the 
population data and the boundary data needed for the research study. 
3.3.1 Ethical approval for research study 
Since this research study required the collection of data on CKD 
patients from their health files within UBTH, there was the need to 
obtain ethics approval from the hospital. In order to access the health 
files of the CKD patients, a letter was written to the ethical committee 
of the hospital explaining the reason for accessing the files and the 
nature of the research study for which the CKD patients’ data would 
be used. Once the committee was able to determine that the data were 
only going to be used for research purposes and the privacy of the 
patients would be maintained, ethical approval was granted (see 
Appendix A). 
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3.3.2 CKD data collection 
There are currently four Adult Nephrologists
22
 and two Paediatric 
Nephrologists in UBTH and each nephrologist has approximately five 
doctors working on his/her team. 
The data collection process for the retrieval of data on CKD patients 
required visiting the study area twice in the course of this study. The 
first visit can be classified as the initial fieldwork, which was from the 
beginning of July to the 14
th
 of October 2009 while the second visit 
can be classified as the validation fieldwork and this was carried out 
for 6 weeks at the beginning of 2010. The need for a second period of 
fieldwork was because during the initial fieldwork, a number of CKD 
records were not retrieved which warranted the need for a second 
visit.  
During the initial data collection process, it was discovered that all 
patients that have ever attended UBTH have health files opened for 
them, which are kept in the records department. The patients’ files are 
catalogued according to their hospital identification number and not 
by any other criteria.  
One of the first things noticed at the records department was the 
difficulty in sorting out the required files from the rest of the records 
in the file room without prior knowledge of the exact hospital 
numbers that were for CKD patients in Edo state. Due to a staff 
                                                 
22
 A nephrologist is a Consultant that specialises in the treatment of the kidney 
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shortage problem at the hospital, it was difficult to get the adequate 
help needed to find the required files, as I was not allowed access to 
retrieve the files from the records department. A records officer at the 
department was eventually allocated the job of sorting out the files by 
extracting those that were relevant for my study. All the files that were 
under the head consultants in-charge of CKD diseases were located 
but since these consultants were also in charge of the treatment of 
patients with other diseases, the files found were further examined in 
order to extract those that were CKD patients and had been diagnosed 
between 2006-2009. It was clear that the format on how the files were 
catalogued was to make it easier for the records officials to locate a 
patient’s file once the patient or a health official had a hospital 
identification number for the file. However, difficulties did arise when 
there was no identification number(s) for the records official to use to 
locate the needed file(s).  
Due to the problem stated above, the renal department at the hospital 
began a new database project at the beginning of 2009 that involved 
the creation of a digital database for its CKD patients. Access to this 
database indicated that this database utilised a well-detailed format on 
which the necessary data for each patient can be recorded. However, 
in the absence of a data entry officer, the job of logging-in patients’ 
data was the responsibility of the house officers
23
 who had other 
                                                 
23
 House officer: A resident physician who is receiving further training, usually in a 
medical or surgical specialty, while caring for patients under the direction of the attending 
staff 
 
92 
 
duties that equally required their time. A cross-examination of the 
digital database with patients’ files indicated that most entries were 
incomplete and in some cases inaccurate. One of such inaccuracies 
was found among the address section for the patients and another was 
their mode of referral to the renal department. Since the creation of the 
digital database at the beginning of the year only 114 records were 
entered into the database as opposed to the large number of CKD 
cases diagnosed and managed by the renal unit over the years. The 
hospital had earlier reported that it catered for over a thousand patients 
with CKD. However, after the patients that resided outside Edo state 
were extracted from the rest of the records, along with those that were 
diagnosed before 2006, it was discovered that the patients qualified to 
be included in the research study totalled 609. 
During the course of the data collection process, different means were 
used in retrieving the required CKD data. One method was by 
following the doctors on their clinic days as they attended to patients. 
When they attended to CKD patients, their files were kept aside after 
their check-up and later passed on to me in order to extract the 
necessary information. Although this was part of the data collection 
process, this approach was time consuming, as there were instances 
where none of the patients they treated had the disease. Another 
approach was accessing the records on CKD patients that had 
undertaken any dialysis session. This information was retrieved from 
the dialysis unit, which had data on all the patients that has ever 
received dialysis, including patients that did not have CKD. Once the 
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relevant CKD data was extracted, the data was used to identify their 
hospital identification number, their diagnoses (whether they were 
medically classified as CKD patients or not), and the dates and 
number of dialysis sessions. Therefore, I was able to gather all the 
data for all the CKD patients that had received dialysis from 2006-
2009, which were predominantly those with stage 5 CKD. 
The patients that were excluded from this study were those who were 
diagnosed for acute kidney failure or any other non-chronic kidney 
disease e.g. kidney stones, as well as CKD patients that were 
diagnosed with the disease before 2006 and those that were not 
residing in Edo state. The last group were not easily identifiable as 
some patients stated a temporary address in Edo state as their 
permanent address. To resolve this problem, each patient’s files had to 
be searched for any information that indicated that he/she lived 
outside the state before coming to the hospital for treatment (for 
example, a reference letter from any health institute outside Edo state 
that referred the patient to UBTH). Another way that patients were 
excluded was if there was any mention within the health file that the 
patient did not originally reside in Edo state at the time of their 
diagnosis; therefore only Edo state residents were included within this 
dataset. 
The retrieved CKD dataset used for the research study contained 
variables on the following: 
 Hospital identification number of each patient 
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 Demographic variables (age, date of birth, sex, marital status, 
education, occupation, ethnicity, and religion) 
 Geographical variables (house number, street name, name of 
residential area, LGA, name of town or village) 
 Diagnosis variables (date of diagnosis, the various diagnosed 
risk factors, the stage of CKD at time of diagnosis, and the 
name of the health facility that referred the patient for 
treatment) 
 Management variables (the number of dialysis session (if 
required), the current health status of the patient, which 
indicates whether the patient is on follow up, deteriorating, or 
dead 
Following the criteria discussed above, a total of 609 patients was 
identified. However, 224 of these patients’ files could not be located 
as at the time of the initial fieldwork therefore, only 385 cases were 
initially collected. Out of these, 28 cases did not have adequate 
addresses needed to locate them on a map. Thus, there was concern 
that the results derived from the 357 cases may not produce valid 
results that would represent the CKD population. However, the dataset 
was validated when further cases, were collected during a second visit 
to the hospital (discussed in section 3.3.2.1). These were analysed and 
compared with the results obtained from the original 357 cases 
(discussed further in chapter four).  
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3.3.2.1 Validation dataset 
In order to discover if there was any systematic bias in the initial data 
collection process, there was the need to compare the initial dataset 
with a similar dataset. An example of the presence of a selection bias 
within the data was the possibility of having access to data on certain 
proportion of CKD patients and not having access to the rest of the 
other CKD patients. This could include having access to CKD patients 
diagnosed at the last stage of CKD and not having access to patients 
that were diagnosed at earlier stages of the disease. Since UBTH was 
currently the only tertiary hospital that managed CKD in Edo state, it 
was therefore necessary to attempt to locate some, if not all of, the 
missing case files that were not retrieved in the initial data collection 
process.  
In order to achieve this, the help of the staff at the UBTH records 
department as well as some doctors carrying out research on CKD was 
solicited. The same template was used for the data collection (see 
Appendix B). I should however, mention that due to some security 
problems that were being experienced in Edo State, I was unable to 
remain in the state for more than a few days, so I had to completely 
rely on the data collected by the staff and research doctors at UBTH. 
An attempt at retrieving additional CKD cases that were diagnosed 
between 15th October 2009 and 31st December 2009 failed, as the 
renal department’s new digital database system had crashed and they 
had lost all the records saved in the system. A total of 92 cases were 
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located and the necessary data were retrieved. However, after sorting 
through the data collected, and removing duplicated CKD records as 
well as those that did not reside within Edo state, they finally came to 
a total of 85 CKD health files. 
3.3.3 Missing data 
At the end of the CKD data collection process, a total of 139 CKD 
patients’ files could not be found by the record officer at the records 
department. This was attributed to a number of factors, one of these 
was that the patients’ consultants may have their files but since the 
records department could not identify the consultants without access 
to these file they could not be sure, especially since each of the six 
nephrologists usually had five doctors working within their team. 
Another reason given was that the files may have been mixed-up and 
filed in another medical section of the records department when they 
were being returned from the clinic (for outpatients) or the wards (for 
patients that were admitted).  
This left 442 cases eligible for the data analyses within the study. The 
study was therefore based on an estimate of 72.6% of the CKD cases 
treated in UBTH within the study period.  
Not all the records were complete. This might be attributed to patients 
refusing to answer some of the questions due to perceived health 
stigmas associated within chronic illnesses or they might have been 
worried about the possibility of been tracked down by the health 
authorities should they default in payment. Another possible 
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explanation might be that some of these questions were not asked by 
the health officers during the creation of these patients’ health files. 
3.3.3.1 Determining the appropriate method for calculating a patient’s 
stage of CKD at time of diagnosis 
Although the diagnosis of CKD was indicated in these patients’ files, 
the CKD stage at presentation (or stage of CKD at time of diagnosis) 
needed to be calculated. However, the needed indicators required in 
determining the stage of the disease were recorded.  
The formula that the doctors recommended was the Cockcroft-Gault 
formula. This formula is expressed as:  
Equation 3.1: A Cockcroft-Gault Formula 
 
Source 3.1: (Thorp, 2005) 
The Cockcroft-Gault formula is regarded as a widely accepted 
formula for calculating the Glomerular filtration rate of CKD patients 
(Larsson et al., 2004). The GFR that is derived from this formula is 
used to indicate the patient’s stage of CKD by comparing the value 
with the range of values that is used to identify the five stages of CKD 
(See Table 2.1). 
3.3.4 How the spatial dataset was collected from RECTAS 
Currently, the lowest hierarchical unit of health services delivery in 
Nigeria is at the ward level. The ward boundaries are geopolitical and 
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therefore arbitrary. This has been compounded further by the constant 
boundary disputes experienced within and among the settlements that 
make up the wards. As a result, there are no officially released 
administrative boundary maps for the wards. Therefore, the boundary 
map for the wards within the study areas had to be created and this 
was generated for this study by the Regional Centre for Training in 
Aerospace Surveys (RECTAS) agency at Ile Ife, Nigeria.  To do this, 
the RECTAS consultants required two separate lists on the settlements 
within Edo state from two different government agencies. The first list 
was from the Independent National Electoral Commission (INEC), 
which showed the various communities within each ward during an 
election exercise while the second list was data from the National 
Population Commission (NPC), which had the names of the 
communities that made up each ward during a census exercise. A 
request was therefore sent to INEC and NPC. These requests were 
approved by both government departments and a copy of these lists 
was sent to the agency. The information was cross-referenced to 
determine the similarities among the communities that were classified 
within a certain ward in order to delineate the boundaries for the ward. 
It was discovered that the communities within the wards classified by 
both agencies were the same, the only difference were in the names by 
which the wards were identified by both agencies. RECTAS also 
created an administrative state boundary map of Edo state, which also 
had some large settlement areas (which were represented as polygons) 
the largest settlement being the state’s capital, Benin City. Also 
 
99 
 
generated for the study was a road network dataset for the study area, 
which was required for the accessibility analyses for CKD healthcare. 
The road network comprised of five road types: these included the 
Benin roads, major roads, main roads, secondary roads, and other 
roads (discussed in section 7.3.1.1).  
3.3.4.1 Limitations experienced during the data collection process at 
RECTAS 
There were two main limitations with the dataset for the road network 
and these were attributed to insufficient data for the study area. The 
first was the absence of detailed street and road networks for towns 
and settlements outside the state’s capital. These therefore meant that 
only the access roads to and from these areas were included within the 
dataset. The second limitation was the absence of any road network 
data for the southwestern boundary of the state. This therefore meant 
that network analyses would not be carried out for that area within the 
state; however, given the small size of that area, a rough estimation 
was generated for some of the outcomes of the analyses (see chapter 
seven for details).  
Another problem was the issue of population data at the ward level. 
This was not published after each census. Attempts at retrieving the 
population data at the ward level was unsuccessful as I was informed 
that such data were only kept for a short time after each census before 
they were destroyed. The only data available was a 2008 survey data 
carried out by the National Population Commission (NPC), which was 
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based on approximately 5 per cent of the total population within each 
of the wards in the state. This was used to extrapolate the total 
population within each ward. A further issue was the absence of the 
population by sex or age group. As a result of these limitations, the 
analysis could only use population totals. 
3.3.5 Geocoding of the CKD dataset 
Once the spatial dataset was retrieved, the spatial locations of the 
CKD patients were geocoded. However, this was not a straight-
forward process as the required information needed within a GIS 
platform was not readily available for the study area.  
3.3.5.1 Georeferencing techniques attempted within the geocoding 
process 
The initial geo-referencing technique that I intended to use was to 
geocode the patients using the road shape files as a reference dataset 
and to create address locators in order to identify the associated 
geographic coordinates for each patient. However, the road data did 
not have the necessary features required in the creation of an address 
locator.  I therefore attempted to use some online mapping software. 
The best was OpenStreetMap, but the street names for most of the 
areas within Edo state were not labelled which therefore made it 
difficult to identify the location of the patients’ addresses on the map. 
3.3.5.2 Google Earth 
The next method was to use Google Earth as a platform. Authors 
have shown that the geo-information provided by Google earth 
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could be used for geospatial work as the range of error for geo-
referencing using satellite images on Google earth was within 15 
metres. A close look at the satellite images available on Google 
Earth showed that Edo state was not adequately labelled and as 
such, the right spatial location for each patient could not be easily 
identified. The next hurdle was to find a way to update the satellite 
images in Google Earth with enough information that would 
facilitate in identifying the spatial location for each patient. This 
necessitated uploading the road shape files for Edo state, which 
also contained a detailed and labelled road map for Benin City as 
well as a point shape file of various locations within the state. 
Google Earth can only read Keyhole Markup Language (KML) 
files and therefore any software that could convert shape files to 
KML files was needed. 
ExpertGPS software was ultimately used to export the road maps, 
the LGAs, and the ward boundaries within Edo state onto Google 
Earth. This improved the chances of geo-referencing the patients’ 
records on Google Earth. Another advantage of the ExpertGPS was 
its ability at converting the locations identified within Google Earth 
from a KML file back to shape files for further GIS analyses. 
Although an imbedded tool within ArcGIS version 9.3 did not have 
a KML conversion tool at the time of the geocoding process for my 
study, the recently released ArcGIS 10 now includes the tool that 
can convert between shape files to KML files.  
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The majority of the patients had enough address details to locate 
their homes or streets on Google Earth. The remaining cases 
(approximately 5% of the total number of CKD cases) were 
assigned to their corresponding wards using the available address 
detail. For some patients, their geographical location on Google 
Earth was blurred, i.e. no data capture at the appropriate scale, 
which was particularly noticed for some rural areas within the 
state.   
  
 
Figure 3.1 : A screen-shot from Google Earth of an area within Benin City, the red 
crosses are the locations of health services that referred CKD patients to 
UBTH for treatment, while the broad red lines are major roads and the thin 
red lines are minor roads. The white dots are the geocoded locations of CKD 
patients that reside within the area. 
 
To examine the accuracy of using Google Earth to geocode, I 
compared the outcomes generated using two approaches to locate 
some health services. This involved comparing the results derived 
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by using a global positioning system (GPS) with those identified 
using their addresses. After uploading the administrative 
boundaries for the LGAs and wards as well as the street and road 
layers on Google Earth, I inserted the GPS derived coordinates of 
UBTH and other health services within Benin City that referred 
patients to UBTH for CKD treatment. The results showed that 
Google Earth was able to identify, the location of each health 
service and their locations correctly matched the street and road 
addresses of these health services. 
3.4 Research methods 
This research study can be described as a quantitative research study 
that applies statistical and spatial analyses in the study of diagnosed 
CKD in Edo state. The discussion of the methods used in this research 
study were categorised into two broad groups. The first group focused 
on the methods used for statistical analyses while the second group 
were the methods used for spatial analyses.  
3.4.1 Choice of methods for statistical analyses 
In order to answer the first four research questions, the appropriate 
statistical test or method had to be determined. Three sets of statistical 
analyses were carried out on the CKD dataset. The first dealt with the 
statistical tests used for exploratory purposes to determine the level of 
association between variables. The second statistical analysis was a 
logistic regression, which was used to create a model in order to 
address the third research question. In order to answer the fourth 
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research question, the time series analysis was used to examine the 
trend of CKD diagnosis within the study period.  
In the course of this study, all statistical analyses were carried out 
using the Microsoft Excel program and SPSS software. 
3.4.1.1 Methods used in variable exploration 
Given the range of variables mentioned in section 3.3.2, the type of 
data used for the study had to be assessed, as it would help in 
determining the appropriate statistical test to use on the dataset. There 
are two main groups of statistical tests and they are the parametric 
tests and the non-parametric tests. A parametric test requires data on 
the interval, ratio scales while non-parametric test are used for ordinal 
(ranked), or nominal (categorised) data (Robinson, 1998). It was 
discovered that only the variables for the age of the patients and the 
number of dialysis sessions undertaken by the patients could be 
classified as an interval data while the remaining variables within the 
CKD dataset were categorised variables. For ease in the variable 
exploratory process, the age variable and the variable indicating the 
number of dialysis sessions were reclassified. Given the fact that 
parametric tests are based on the assumption that the data is normally 
distributed and should have similarity of variance (Clegg, 1983), none 
of the parametric techniques was used to test the data because none of 
the variables fulfilled the assumptions required for a parametric test. 
This was because when the variables were tested for normality using 
the Shapiro-Wilk test in SPSS, none of them were significant. Some 
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have argued that parametric tests are better than non-parametric tests, 
which is reflected in the transformations of data i.e. the conversion of 
non-normally distributed data into a normally distributed data, by 
some researchers (Rascati et al., 2001; Afifi et al., 2007). However, 
other researchers have argued against this procedure, stating that it 
alters the fundamental characteristics of the data and they therefore 
recommended that the appropriate non-parametric test should be used 
(Norcliffe, 1982; Robinson, 1998). 
According to Siegel (1956), non-parametric tests have five advantages 
over parametric tests (cited In Robinson, 1998): 
 Regardless of the probability distribution, the probability 
statements obtained from most non-parametric tests are exact 
probabilities. 
 Non-parametric test is not affected by small samples 
 There are non-parametric tests that are suitable for analysing 
samples from various different populations. 
 Non-parametric statistics can make use of data on a variety of 
measurement scales. 
 Non-parametric test do not make assumptions about the 
background population from which the sample is collected, 
therefore they are usually easier to apply than parametric tests. 
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In the course of this study, two non-parametric tests (chi-square test 
and correlation) were used to test the CKD data so as to draw 
inferences that could be used in answering the research questions 
outlined in this thesis.  
3.4.1.2 Logistic Regression 
Logistic regression is part of a group of statistical models called 
generalized linear models (Robinson, 1998). The mathematical 
concept that led to the logistic regression is the logit, which is the 
natural logarithm of an odds ratio (Peng et al., 2002). It is used for 
predicting the probability of an event occurring from a set of variables 
that may be either interval or categorical. Usually, the dependent 
variable is dichotomous (i.e. it has only two values). This means that 
the dependent variable can take the value 1 with a probability of 
success/present, or the value 0 with probability of failure/absent. In 
the cases of my study (see chapter five), the values for the dependent 
variable (i.e. the stage of CKD at the time of diagnosis) had been 
regrouped into only two possible outcomes which were earlier CKD 
stages or late stage of CKD at time of diagnosis (this was discussed in 
detail in chapter four). 
Logistic regression is usually estimated using maximum likelihood 
techniques, which is preferred over the weighted least squares 
approach (Peng et al., 2002). The maximum likelihood technique is 
created to maximize the likelihood of reproducing the data given the 
parameter estimates. According to Peng et al (2002), the null 
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hypothesis for the logistic regression model states that all the 
coefficients equal zero, which means that the logistic regression 
equation is unable to predict the probability of the outcome better than 
the mean of the dependent variable. When at least one coefficient does 
not equal zero in the population, the null hypothesis is rejected. This 
implies that the logistic regression equation predicts the probability of 
the outcome better than the mean of the dependent variable. The 
interpretation of results is made using the odds ratio for the predictors. 
Evaluations of the Logistic Regression Model 
In order to determine how effective a logistic regression model is, 
three major components have to be evaluated namely; the evaluation 
of the overall model, the statistical tests of individual predictors, and 
the goodness-of-fit statistics (Peng et al., 2002). 
The evaluation of the overall model 
A logistic model is said to provide a better fit to the data if it 
demonstrates an improvement over the null model (Field, 2000; Peng 
et al., 2002). The null model is a model that contains just the value of 
the constant and has no predictors included within the model. It is 
therefore regarded as the baseline in the creation of the overall model. 
An improvement over the null model is examined by an inferential 
statistical test called the likelihood ratio. 
The likelihood ratio statistic is transformed by multiplying it by its 
deviance (represented as -2 Log Likelihood or -2LL in the SPSS 
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software) and this means that the likelihood ratio statistic is multiplied 
by -2 times its natural logarithm (Luke, 2004).  
Goodness-of-fit statistics 
The goodness-of-fit statistics assesses the fit of a logistic model 
against the actual outcome of the model. An inferential test known as 
the Hosmer and Lemeshow test is used to determine the fit of the 
model. The Hosmer and Lemeshow test statistic is a Pearson chi-
square statistic, calculated from a 2×g table of observed and 
estimated expected frequencies, where g is the number of groups 
formed from the estimated probabilities (Peng et al., 2002, p.6). The 
Hosmer and Lemeshow’s goodness-of-fit test tests the hypothesis that 
the observed data is significantly different from the predicted values 
from the model (Field, 2002). This means that if the model is good 
then the chi-square should not be significant at p=0.05. Therefore, a 
non-significant value for this test would indicate that the model does 
not differ significantly from the observed data. 
3.4.1.3 Time series analysis 
One of the variables of interest within the CKD dataset was the time 
of diagnosis of each CKD patient. In order to determine the trend of 
CKD diagnosis within the study period, time series analysis was 
selected. Time series analysis is used in evaluating the set of values of 
a variable generated in an ordered sequence over a time period 
(Brockwell and Davis, 2009).  
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A time series analysis has two main functions. It can be used to obtain 
an understanding of the underlying factors as well as the structure 
(such a trend or seasonal variation) that produced the observed data. It 
can also be used to fit a model that can be used in forecasting and 
monitoring subsequent data. 
The time series analysis used here only focused at understanding the 
underlying factors that contributed to any variation(s) found within the 
variable (discussed in chapter five). The outcome of this analysis was 
used in providing an answer to the fourth research question. 
3.4.2 Choice of methods for spatial analyses 
Spatial analysis involves the accurate description of data relating to a 
process operating in space, the study of patterns, and the interactions 
within such data (Bailey and Gatrell, 1995). Three main spatial 
techniques were carried out in the course of this study. These were the 
simple mapping of the CKD data using choropleth maps, the use of 
kernel density estimator to evaluate the density distribution of CKD 
within the study area and two models of network analyses.  
3.4.2.1 Visualising spatial data using choropleth maps 
Choropleth maps were used to map the number of diagnosed CKD 
cases within area of interest (such as the LGAs and the wards) and to 
map the proportion of the diagnosed CKD cases in relation to the 
underlying population. These choropleth maps were used to highlight 
areas of concern for the disease within the study area. The choropleth 
maps showing the CKD counts across the study area were able to 
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indicate areas where there were a relatively high or low number of 
diagnosed CKD cases, which is important for allocating health 
resources while the proportion map was able to indicate the spatial 
distribution of the rate of diagnosed CKD across the state.  
As there were no available data on the total number of CKD cases in 
the country or any other African country or any similar country that 
could be used as a standard population for CKD rates, a standardized 
CKD morbidity rate could not be computed for the state. Therefore, 
only a simple crude rate could be calculated within this study 
(discussed in chapter six). 
Two other analyses that required their outcomes to be displayed using 
choropleth mapping were initially considered in this study – the 
standardised morbidity/mortality rate (SMR) and the geographically 
weighted regression (GWR). An overview of why these geo-statistical 
methods were initially considered as well as why they could not be 
applied in the study was discussed below. 
The standardised morbidity rate (SMR) 
The standardised morbidity/mortality rate (SMR) was one of the first 
methods that were considered at the onset of this study. The 
appropriate SMR was the standardised morbidity rate as the focus of 
the study was on diagnosed CKD patients and not on the death rate 
within the study area. The standardised morbidity rate is regarded as a 
measure of the relative risk. This method is used to give a 
geographical picture of the extent to which the disease rate observed 
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in an area exceeds an expected disease rate (Leyland and Davies, 
2005). The idea is to identify areas where the occurrence of the 
disease is in excess in order to study those areas in greater detail. The 
outcome of this method is mapped using choropleth mapping. One of 
the advantages of the SMR is that the method tends to be less sensitive 
to numerical instabilities (Breslow and Day, 1987). 
The main limitation that hindered the application of SMR in this 
research study was the absence of a population data at the ward level, 
which contained the demographic characteristics (such as the sex and 
age groups) of the population. Another limitation was the absence of a 
standardised population. This could be attributed to the lack of a CKD 
registry within the country or any similar country within Africa, which 
could have been used as the total number of diagnosed CKD cases 
within a standardised population. However, the total number of 
diagnosed CKD cases within the study area could theoretically be 
used as the standardised population that can be divided by sub 
populations such as the LGAs and ward population, to give estimated 
rates for these LGAs and wards. The absence of a reliable CKD 
dataset that contains an estimated number of the diagnosed CKD 
patients within the state is not currently available.  
In summary, what hindered the application of SMR in this research 
study was the absence of relevant population datasets (i.e. age-specific 
populations for the wards and a reliable morbidity rate of a 
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standardised population), which were needed in determining the 
expected CKD rates across the study area. 
Geographically weighted regression (GWR) 
Geographically weighted regression (GWR) was developed to allow 
the relationship between the dependent variable and the independent 
variables to vary spatially as the authors argued that regression 
coefficients do not always remain fixed over space (Brunsdon et al., 
1998). According to Brunsdon et al (1998), GWR can be described as 
a technique for producing local 'mappable' regression coefficients in 
order to see variations in relationships that were previously 
unobservable. 
The GWR technique was primarily of interest for my study as it could 
be used to investigate whether any relationships that exist between 
diagnosed CKD cases and associated risk factors were stable over 
space, or whether they changed to reflect the characteristics of 
different regions in the study area. Although the method appeared to a 
useful technique that could be used to explain the spatial distribution 
of the research problem, a couple of problems were encountered.  
The main problem encountered in the attempt of using the GWR 
method was the non-availability of independent/ explanatory variables 
at the ward level, which is the scale of the research study.  Also an 
attempt to apply the method at a higher scale (i.e. at the level of the 
LGA), equally proved unsuccessful as the data available for that level 
only had two independent variables available (i.e. sex and age 
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variables). The other relevant variables needed for the analysis such as 
the socio-demographic variables and associated biological risk factors 
diagnosed within the study area were not available at the LGA level. 
Based on these limitations, the GWR method could not be applied in 
this study. 
In conclusion, one problem associated with the use of choropleth 
maps is that physically large areas tend to dominate the resultant map 
even when they are not the area of interest (Martin, 1989). Given the 
fact that choropleth maps use aggregate data, a known problem 
associated with using aggregated data in spatial analysis is the 
modifiable areal unit problem (MAUP) (Openshaw, 1984). This tends 
to occur when a more detailed dataset is aggregated. Openshaw (1984) 
defined MAUP as a situation in which modifying the boundaries and 
scale of data by aggregating the initial dataset into a simpler dataset 
could significantly affects the result of the spatial analysis of the data. 
This means that the outcome from an aggregated data could result in 
the loss of information of spatial processes that would have been 
highlighted if the data were not aggregated.  
3.4.2.2 The kernel density estimation (KDE) technique 
In order to avoid the MAUP mentioned above, the Kernel Density 
Estimation (KDE) technique was used to analyse the CKD data. This 
is classified as one of the techniques used in point analysis. This was 
used to examine the spatial pattern of diagnosed CKD by estimating 
the spatial density of diagnosed CKD cases within the study area. The 
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KDE is a non-parametric method of extrapolating or interpolating 
point data over an area of interest and has the advantage of not 
invoking MAUP as it does not rely on fixed boundaries (Carlos et al., 
2010). This analysis was done using the LandScan™ 2008 Global 
Population Database. This population database was developed by the 
OakRidge National Laboratory (ORNL) using multiple techniques to 
disaggregate census counts within an administrative boundary and 
allocate the population distributions to a 30-second-by-30-second 
latitude/longitude grid (Dobson et al., 2000; Carlos et al., 2010). It 
was decided to use this dataset instead of the ward dataset created by 
RECTAS because of the grid format of the Landscan population 
dataset, which standardizes the areal unit for population values, unlike 
polygon formats representing administrative boundaries that vary in 
size (Carlos et al., 2010). This makes population at different locations 
more spatially comparable and facilitates spatial analysis operations. 
Although this study attempted to identify areas with high and low rate 
of diagnosed CKD, the use of cluster techniques as an approach was 
not explored in this study. The reason is the associated limitation 
known as the a priori choice of cluster size, which has been found to 
have significant effects on results and there seems to be no clear 
guidelines on how to deal with the problem (Besag and Newell, 1991; 
Cuzick and Edwards, 1990; Pfeiffer et al., 2008). According to 
Pfeiffer et al, "The main problem that arises, is that, by exploring a 
range of maximum cluster sizes, an upper cluster threshold can be 
chosen that presents a pattern of clustering best suited to support a 
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particular argument, rather than that which best reflects reality" 
(Pfeiffer et al, 2008, p. 66). This could become a problem, as the 
location of UBTH within Benin City is expected to result in more 
patients being diagnosed within the city than in other areas within the 
state. This is because there are indications that show that access to 
healthcare is likely to influence ones’ decision to seek medical 
treatment (Buor, 2003). Due to the possibility that Benin city could be 
identified as a clustered region as opposed to the rest of the study area 
coupled with the fact that gaps were expected in the dataset, the use of 
a cluster technique might not reveal any new information on the 
spatial spread of CKD within the state. The reason why gaps were 
expected in the dataset was because there was the possibility that 
some areas would not register the presence of CKD patients within 
their boundaries. This is attributed to the fact that within the state, not 
all residents that have the disease have been diagnosed particularly in 
remote areas that are of a considerable distance from the hospital.  
3.4.2.3 Network analyses 
The network analyses were used to address the last research question. 
Service area analysis and location-allocation analysis were selected. 
All the network-based spatial analyses were carried out using ArcGIS 
10. 
Service Area analysis 
Service area analysis was used to examine the CKD patients’ 
accessibility to CKD healthcare facilities within the state. There was 
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the need to evaluate the impact of distance to the hospital and the 
spatial distribution of diagnosed CKD cases within the study area. The 
outcome of this analysis could help to identify deficiencies in the 
current service area for CKD management as well as recognise 
populations who were at risk but had limited access to CKD 
healthcare. According to Haynes (2003), the measurement of 
geographical accessibility tends to focus on the physical separation 
that impedes contact. As variations in the use of health services are 
more strongly associated with road distance and estimated travel time 
than with Euclidean distance (Martin et al., 1998), travel times were 
used in creating the service area models for evaluating the 
accessibility of CKD patients to UBTH (see chapter seven). 
Location-allocation analysis 
Over the years, there has been progress in the research and 
development of methods for efficient allocation of healthcare 
resources, which address the planning issues of hospital locations and 
service allocations (Mitropoulos et al., 2006). The Location-allocation 
model provides a structure for evaluating service accessibility 
problems by comparing the effectiveness of available services and 
generating alternatives in order to improve the performance of the 
existing service systems (Rahman and Smith, 2000).  
There are three main techniques used in solving location-allocation 
problems. These are the exact, the heuristic, and the metaheuristic 
techniques (Densham and Rushton, 1991; Mladenovic et al., 2007). In 
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the exact technique, the location-allocation problem needs to 
determine the solution for finding a set of locations without using any 
approximation to get an optimal result. On the other hand, heuristic 
techniques use approximations to determine the optimal location for 
solving a location-allocation problem. However, the solution might 
not give an optimal result (Scott, 1970). Although the metaheuristic 
techniques also uses approximations to determine the optimal 
location, they can be classified as general strategies to design heuristic 
algorithms in order to produce a more accurate outcome with regard to 
a given measure of quality (Mladenovic et al., 2007). 
One of the most frequently used models within the location-allocation 
analysis is the “p-median problem” (Harper et al., 2005; Revelle et al., 
1970). Given the demands within an area, the main objective of the p-
median problem is to locate a number (p or less) of facilities, by 
minimising the total weighted travel distance or time between 
facilities and demand centres.  It is based on the assumption that all 
users of the facility choose to travel to the closest one, however, this 
model does not take into account the worst-case scenario as the results 
from the p-median model may be forcing a few users to travel far 
(Harper et al., 2005; Rahman and Smith, 2000). This may mean that 
the most distant users do not actually travel to their nearest facility or 
to any facility as it has been observed that the usage of service 
facilities declines rapidly when the travel time (distance) exceeds 
some critical value (Rahman and Smith, 2000). This has been 
classified as a distinctive situation with the use of health facilities 
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within rural areas in developing nations (Muller et al., 1998; Rahman 
and Smith, 2000). Given the limitation of the p-median problem, 
another model was formulated known as the location set covering 
problem (LSCP) and it considers the maximum distance or time 
constraints in formulating a location problem (Toregas et al., 1971). 
The main objective of the model is to locate the minimum number of 
facilities such that each demand centre is covered by at least one 
facility within a given maximum service distance or travel time. This 
model has been used in a study on renal replacement therapy for 
locating kidney dialysis machines, as it is a form of treatment for 
which the patient must make frequent and repeated journeys to the 
healthcare centre (Ebenchaime and Pliskin, 1992). A similar model to 
the LSCP is known as the pq-median problem. The main objective of 
this model is finding a functional set of facility locations, which can 
be associated with partitioning the catchment areas for two or more 
levels of facility (Serra and ReVelle, 1994; 1993). Both the LSCP and 
the pq-median models have a limitation, as there is the possibility that 
the outcome from these models can lead to more centres being 
required than is financially feasible. This is because there may not be 
enough resources to supply the number of facilities that would be 
needed for the optimum solution to the location problem (Mohan, 
1983; Rahman and Smith, 2000). 
Should the location of a facility be faced with the limitation 
mentioned above, another model could be used instead, which 
attempts to locate the facilities so that as few people as possible lie 
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outside the desired service distance. This model is referred to as the 
maximal covering location problem (MCLP) and its objective is to 
maximise coverage within a desired service distance by locating a 
fixed number of facilities (Church and ReVelle, 1974).  
Apart from the pq-median problem, the remaining three 
problems/models discussed are included within the Network analyst in 
ArcMap 10. Three other models were included within the location-
allocation analysis in ArcMap 10. These are the “maximum 
attendance”, “maximise market share” and the “target market share”. 
The objective of the maximum attendance problem is to identify the 
facility that maximises the total allocated demand (Holmes et al., 
1972). The model is based on the assumption that the probability of 
the utilisation of the facility decreases linearly as the distance from the 
facility increases. This model was found to be relevant in addressing 
part of the last question outlined in this study and is therefore 
discussed in detail in chapter seven. The maximize market share 
model solves the competitive facility location problem by attempting 
to find the location for a facility that will maximise the market share 
in the presence of other competitive facilities. The target market share 
is another form of the competitive facility location problem. Its 
objective is to locate facilities that will achieve the required market 
share in the presence of other competitive facilities. It also uses the 
gravity-based formula to determine the proportion of demand 
allocated to each facility and the minimum number of facilities 
required in achieving the required market share is chosen. 
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3.5 Summary  
This chapter has evaluated the research design as well as the data 
collection process that was completed in the course of this study. In 
order to answer the research questions formulated at the beginning of 
the thesis in chapter one, this chapter also discussed the methods that 
were used for analyses and those that were considered but not applied 
to the datasets that was available for this quantitative research study. 
The next chapter can be classified as the ‘preliminary analysis’ 
chapter as it involved the descriptive analysis of the variables within 
the dataset. The outcome of the preliminary analysis provides a profile 
of diagnosed CKD patients represented within the dataset. 
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Chapter 4 Profile of CKD cases in Edo state 
4.1 Introduction 
In the past decades, there has been an increase in the overall health, 
social, and economic development across the world and there has also 
been a marked decrease in some infectious diseases notably 
trypanosomiasis sleeping sickness also known as sleeping sickness 
(WHO, 2006) and cholera (Carrel et al., 2009). In some developing 
countries, despite the decrease in some of these infectious diseases, 
there has been an increase in the diagnosis of chronic and 
degenerative diseases (WHO, 2011). The current priority of many of 
these countries is how to develop and strengthen their health systems 
in order to support prevention, diagnosis, and treatment of notable 
chronic diseases (Dye et al., 2010). As discussed in chapter two, there 
is a gap in the development of a suitable health monitoring system for 
CKD in a number of countries particularly nations in Africa. This has 
resulted in their inability to manage the disease efficiently and monitor 
its effect on these nations’ populations. As previously mentioned in 
chapters one and two, little has been done about the implementation of 
a CKD register in Nigeria. In addition, no attempt has been made at 
creating a model for renal healthcare that can be combined with 
established national prevention programmes already functioning in the 
country such as the National Malaria Control Program (NMCP) and 
the National AIDS Control and Prevention Program (NACPP). There 
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is therefore the need to develop a programme that would help in 
recognising the current CKD prevalence in the country as well as 
develop an effective prevention and management programme to 
combat the disease. 
Before extensive analyses were implemented in order to answer the 
research questions and make any recommendations that would be 
relevant to CKD management in Edo state, a descriptive analysis was 
carried out of the CKD dataset. This is the focus of this chapter. The 
research evaluated the profile of CKD patients registered at the renal 
department of the University of Benin Teaching Hospital (UBTH) and 
their spatial distribution within Edo state. As mentioned in the 
previous chapters, CKD patients are referred to the nephrology unit at 
UBTH once they have been assessed by doctors from other clinics or 
hospitals in order to confirm the patients’ diagnosis; therefore it is 
expected that the patients’ stage of CKD within the hospital’s records 
represents the patients’ actual stage of CKD at the time of diagnosis. 
The outcome of this chapter can be regarded as an overview of the 
characteristics of CKD cases diagnosed within the study period. The 
first section of the chapter examines the profile of the 357 CKD cases 
contained in the initial dataset. The second section focuses on the 
CKD profile of a smaller dataset, which was used to validate and 
complement the initial dataset. The chapter concludes by examining in 
more details, descriptive analyses on the combined dataset and 
comparing the results with previous studies.  
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4.2 Descriptive statistical profile and spatial distribution of 
the initial CKD dataset 
The variables analysed in this study can be categorized into three 
groups, namely: the socio-demographic variables, the diagnosis 
variables, and the disease management variables. The socio-
demographic variables comprised of the sex, age, ethnicity, 
educational level, occupational status, and religion of the patients. The 
diagnosis variables were the date of diagnosis, four diagnosed 
biological risk factors/diseases that were mentioned in the CKD 
patients’ health files, the stage of CKD at time of diagnosis, and the 
type of referral centre (i.e. the type of healthcare service that referred 
the patient to the renal unit in UBTH for diagnosis and treatment). The 
management variables entailed the number of dialysis session taken 
by the patients that required it, and the health outcome of the patient, 
i.e. the current health status of the patient at the time when the data 
was collected for the research study. This included whether the patient 
was on follow up, deteriorated, or dead. Analysis was performed using 
the Statistical Package for Social Science (SPSS) version 15.0. Results 
are presented as frequencies and percentages.  
4.2.1 The socio-demographic variables for the initial dataset of 357 
CKD cases 
The initial dataset of 357 CKD cases indicated that more males were 
diagnosed with CKD than females (see Table 4.1). The result 
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indicated that a higher proportion of males than females were 
diagnosed with CKD with a ratio of 1.8:1. However, given the number 
of missing cases that were not included within this initial dataset a 
complete assessment on the proportion of male and females could not 
be justified at this point. 
Table 4.1: The number of males and females with CKD within the 357 dataset 
Sex Numbers Percentage 
Male 229 64.1 
Female 128 35.9 
Total 357 100 
 
According to the statistics results on the ages of the CKD patients, the 
mean age of the patients that were included in the study was 45years 
(See Table 4.2). The youngest and oldest ages were 11 years and 88 
years respectively. The mean age for the male patients was 46.5years 
while the mean age for female patients was 42.5years. A total of 297 
patients were between the ages of 18 and 65 years therefore, it can be 
argued that 83.2% falls within the working age population and this 
may have a negative impact on the future of the state’s economy.  
Table 4.2: The mean age of the 357 CKD patients in the initial dataset 
AGE 
sex Mean Age N Std. Deviation 
male 46.5 229 17.7 
female 42.5 128 16.7 
Total 45 357 17.5 
 
Within this initial dataset, two patients did not indicate their marital 
status. The majority of the patients were married with only one 
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divorced and the rest being single; none of the 357 cases was 
registered as widowed (see Table 4.3). The results show that 80.4% of 
the patients diagnosed with CKD were married.  
Table 4.3: Marital status of the 357 CKD patients in the initial dataset 
Marital status Numbers Percentage 
 married 287 80.4 
 single 67 18.8 
 divorced 1 0.3 
Unknown 2 0.6 
 Total 357 100 
 
There were 20 ethnic groups represented within the dataset with 5 
belonging to areas outside Edo state (see Table 4.4), Warake, Agbor, 
Isoko, Ika, and the Igbo ethnic groups. The patients that belong to 
these ethnic groups outside Edo state were included in the study 
because they had indicated an address within Edo State as their 
permanent address. A total of 172 patients (48.2%) out of the 357 
patients indicated their ethnicity.  
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Table 4.4: Ethnic groups of CKD patients in the initial dataset 
Ethnic group Numbers Percentage 
Bini 86 24.1 
Esan 33 9.2 
Igbo (Anioma) 13 3.6 
Urhobo 8 2.2 
Etsako 6 1.7 
Yoruba 6 1.7 
Akoko-edo 3 0.8 
Afuze 2 0.6 
Agbor 2 0.6 
Ika 2 0.6 
Ora 2 0.6 
Afemai 1 0.3 
Auchi 1 0.3 
Ibillo 1 0.3 
Ibie 1 0.3 
Igarra 1 0.3 
Irrua 1 0.3 
Isoko 1 0.3 
Unmima-fuga 1 0.3 
Warake 1 0.3 
Unknown 185 51.8 
Total 357 100 
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Figure 4.1:Map A shows the spatial distribution of CKD cases whose ethnic group were 
recorded within their health files, while map B shows the spatial distribution 
of CKD cases whose ethnic group were not included in their health files. 
 
128 
 
The spatial distribution of the CKD cases that had their ethnic groups 
identified in their health files (map A) was found to have a similar 
spatial distribution with those that did not have their ethnicity 
indicated (map B) in their health files (see Figure 4.1).  
As previously discussed in chapter two, studies have indicated an 
association between religion and health, which has been found to be 
generally positive (see section 2.4.6). Although there are still debates 
on the quality of these research inferences (Sloan and Bagiella, 2001), 
the inclusion of religion as a variable in this study was to check for 
any association with CKD. The religious beliefs of the patients were 
not fully indicated in most of the patients’ records, as only 170 
patients out of the 357 patients had their religious beliefs documented 
(see Table 4.5) and a total of 177 CKD cases had no indication of their 
ethnicity or their religious affiliation within their health records. 
According to the records, Christians represented 45.4% of the dataset. 
This is not surprising as Edo state has a high proportion of Christians 
in relation to the other two religions - the Muslims and traditionalist. 
This assumption has not been disputed within the state, even though 
there are no official records to indicate the proportion of religious 
groups within the state. Attempts at getting an estimate of the 
proportion of religious groups from past censuses proved 
unsuccessful, as there was no census data on religion that are made 
available to the public.  
 
 
129 
 
Table 4.5: Religious status of CKD patients in the initial dataset 
Religion Numbers Percentage 
Christian 162 45.4 
Muslim 5 1.4 
African traditionalist 3 0.8 
Unknown 187 52.4 
Total 357 100 
 
In regards to the occupational structure of the CKD patients, 10 out of 
the 357 patients (2.8%) did not indicate their occupational status. The 
remaining 347 patients indicated that students, which consists mainly 
of those in the secondary and tertiary institutions, represented the 
highest number of CKD cases with a total of 61 (17.1%) followed 
closely by traders with 51 (14.3%). The patients that are retired made 
up 13.2% with a total of 47. The number of cases registered among 
the students appeared to be high, because students usually are within 
the lower age groups as opposed to those that are employed. This is 
based on the fact that studies have indicated that CKD is more 
prominent among the older population than the younger age groups 
(El Nahas, 2005). The results from the CKD dataset indicated that 
only four students were over 29 years and none was older than 36 
years, this raises the question: ‘why is the frequency of diagnosed 
CKD high in this category of people?’ An assumption which applies 
mainly to those in boarding schools and those in tertiary institutions, is 
that they had access to free medical check-up at their institutions and 
they are likely to seek medical help once they felt unwell, which 
enabled the doctors to identify the disease and refer them to the 
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hospital for treatment. However, this can regarded as speculations that 
can only be verified with further studies on the issue.  
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Table 4.6: Occupational status of CKD patients in the initial dataset 
Occupation Numbers Percentage 
student 61 17.1 
trader 51 14.3 
retired 47 13.2 
business 38 10.6 
Civil servant 24 6.7 
farmer 23 6.4 
housewife 18 5 
driver 12 3.4 
teacher 10 2.8 
pastor 5 1.4 
police officer 5 1.4 
unemployed 5 1.4 
accountant 4 1.1 
tailor 4 1.1 
brick layer 3 0.8 
hair dresser 3 0.8 
mechanic 3 0.8 
carpenter 2 0.6 
musician 2 0.6 
nurse 2 0.6 
photographer 2 0.6 
technician 2 0.6 
welder 2 0.6 
apprentice 1 0.3 
barrister 1 0.3 
bike driver 1 0.3 
Caterer 1 0.3 
clerk 1 0.3 
doctor 1 0.3 
electrician 1 0.3 
engineer 1 0.3 
estate agent 1 0.3 
journalist 1 0.3 
lawyer 1 0.3 
lecturer 1 0.3 
painter 1 0.3 
palace chief 1 0.3 
plumber 1 0.3 
politician 1 0.3 
saw miller 1 0.3 
soldier 1 0.3 
typist 1 0.3 
Unknown 10 2.8 
Total 357 100 
 
The data on the educational status of the patients were incomplete as 
only 72 patients had their educational status indicated in their health 
files (see Table 4.7). This meant that 79.8% of the data was missing. 
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Therefore, the available educational status of CKD cases within the 
initial dataset is unlikely to give a true representation of the 
educational status of CKD patients in Edo State. However, a look at 
the table showed that there were more patients with a tertiary 
education while the lowest number of CKD patients was recorded 
among those without any educational background. This result could be 
attributed to a number of factors, one of this would be that the level of 
awareness of CKD is very low among those with no education and as 
such, they do not come to the hospital until it is too late. This is based 
on the assumption that the awareness programmes carried out among 
the general public may not be catering for those with little or no 
education. This is because the mass media, which is the general form 
in which information is generally disseminated to the public, is not the 
best means of disseminating information especially among those who 
are not educated. A survey by the Nigerian Population Commission 
(NPC) indicated that a large proportion of the population in the 
country do not have access to either a radio or television and they rely 
on other forms of message dissemination like a town crier (NPC, 
2005). However, these deductions can only be confirmed with further 
research studies focusing on the patients’ awareness of the disease 
especially before diagnosis. 
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Table 4.7: Educational status of CKD patients in the initial dataset 
Education Numbers Percentage 
 Unknown 285 79.8 
Tertiary education 42 11.8 
Secondary education 18 5 
Primary education 10 2.8 
No education 2 0.6 
Total 357 100 
 
4.2.2 The diagnosis variables for the initial dataset of 357 cases 
As mentioned in the beginning of the thesis, the study period for this 
research study was from January 2006 until 14
th
 October 2009. 
Therefore, in order to analyse the trend of the diagnosis of CKD cases 
(discussed in section 5.4), the patients’ year of diagnosis was included 
as a variable within the dataset. The frequency of the diagnosed cases 
within the time period indicate that there was an annual increase in the 
number of diagnosed cases as indicated in Table 4.8. Even though, 
data collected for 2009 was not for the whole year, it still registered 
the highest number of cases (27.7%) in respect to the previous years.  
Table 4.8: year of diagnosis for the 357 CKD cases in the initial dataset 
Year of diagnosis CKD cases percentage 
2006 76 21.3 
2007 84 23.5 
2008 98 27.5 
2009 99 27.7 
Total 357 100 
 
The referral centres that referred patients to the University of Benin 
Teaching Hospital (UBTH) were identified using the details on the 
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CKD patients’ health file. These referral centres were classed into 
their respective categories and this was included as a variable within 
the dataset (see Table 4.9). A total of 24 referral centres were 
identified. The addresses of these referral units indicated that most of 
them are concentrated in Benin City with only three referral units 
outside the state’s capital. Further explanation on the proportion of 
identified CKD referral centres in relation to the healthcare services 
available within the state is discussed in more details in chapter seven. 
Apart from the 24-referral units identified within the CKD patients’ 
records, there were a number of other medical departments within 
UBTH that also referred patients to the renal department. According 
to the results, the highest number of referrals came from the medical 
departments within UBTH (27.2%) as opposed to the other types of 
health centres within the state. The renal department within UBTH 
was however still responsible for diagnosing over half of the cases 
(53.5%) as these cases had no indication within their records of being 
diagnosed or referred from another department or health centre. The 
clinics were found to have the lowest referral rate of 0.8% for the 
public clinics and 4.2% for the private clinics (see Table 4.9). 
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Table 4.9: Referral rates of the 357 CKD patients by health centres in Edo State 
Type of referral unit Numbers Percentage 
Not referred / no referral information indicated 191 53.5 
Referred from within other departments in UBTH 97 27.2 
Referred by a Private Hospital 27 7.6 
Referred by a Public Hospital 24 6.7 
Referred by Private Clinic 15 4.2 
Referred by a Public Clinic 3 0.8 
Total 357 100 
 
In determining the stage of CKD at time of diagnosis for the CKD 
patients, the information required to calculate their estimated 
Glomerular filtration rate (GFR) was retrieved from their case files 
(discussed in chapter three). However, 10 (2.8%) patients did not have 
all the necessary indicators within their files that were needed to 
determine their stage of CKD. Their CKD status was only established 
later on as their treatment progressed. As such, the stage of CKD at 
time of diagnosis for these 10 patients (2.8%) was classified as “not 
indicated”. It was observed that there were no patients with CKD at 
the first stage. This was expected because of the difficulty in clearly 
identifying those at that stage. It was also observed that a high 
proportion of the patients were diagnosed with stage 5 of the disease 
as opposed to the rest of the CKD stages (see Table 4.10). Patients 
with stage 5 CKD accounted for 85.2% while the remaining stages 
only came to a total of 54 patients out of 357 patients.  The low 
number of stage four CKD cases within the dataset appears to indicate 
an underlying problem that can only be verified with further studies as 
one would expect that more cases should be diagnosed at this stage 
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than at the third stage. The high number of stage five cases confirmed 
that most patients are not diagnosed at the earlier stages, when it is 
cheaper and easier to treat, and allows more time for interventions that 
can slow its progress.  
Table 4.10: The 357 patients' stages of CKD at time of diagnosis 
Stage of CKD Frequency Percent 
stage 2 10 2.8 
stage 3 20 5.6 
stage 4 13 3.6 
stage 5 304 85.2 
Not indicated 10 2.8 
Total 357 100 
 
As mentioned in the previous chapters, studies have shown that the 
commonest causes of CKD in Nigeria are chronic glomerulonephritis, 
hypertension, Type 2 diabetes, and toxic nephropathy. Therefore, 
these four risk factors were included as variables within the dataset. 
Table 4.11: risk factors amongst CKD patients in the initial dataset 
Diagnosed risk 
factors 
Chronic 
glomerulonephritis 
Diabetes Hypertension Toxic 
nephropathy 
no 211 (59.1%) 288 (80.7%) 215 (60.2%) 323 (90.5%) 
yes 137 (38.4%) 60 (16.8%) 132 (37%) 24 (6.7%) 
missing data 9 (2.5%) 9 (2.5%) 10 (2.8%) 10 (2.8%) 
total 357 (100%) 357 (100%) 357 (100%) 357 (100%) 
 
The results from the data showed that 38.4% of the CKD patients 
within the initial dataset had chronic glomerulonephritis while 6.7% 
had toxic nephropathy (see Table 4.11). While retrieving data from the 
patients’ health files, it was observed that the exact type of Diabetes 
was not indicated. According to a recent study, about 90% of diabetic 
CKD patients have Type 2 diabetes (Williams, 2010). The renal 
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doctors at the renal unit at UBTH confirmed that most of the patients 
with Diabetes are likely to have Type 2 diabetes, this observation 
actually tallies with past studies, which showed that the main diabetes 
found among CKD patients in Nigeria is Type 2 diabetes (Alebiosu 
and Ayodele, 2005; 2006). However, this is an assumption. 
4.2.3 The management variables for the initial dataset of 357 cases 
The frequency of dialysis taken by the patients requiring dialysis as 
stated in their health files indicated that out of the 303 patients 
needing dialysis (diagnosed with CKD at stage 5 and recommended 
for dialysis by the nephrologist), 177 did not undergo dialysis while 
the remaining 126 patients that actually underwent dialysis only had 
few dialysis sessions.  
 
Figure 4.2: the number of dialysis sessions done by stage 5 CKD patients that required 
dialysis 
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The highest number of dialysis sessions was 121 and only one patient 
attempted this before discontinuing the treatment (see Figure 4.2). 
Within the initial dataset, three patients with stage 4 CKD had dialysis 
sessions and according to the renal consultants at UBTH, this was 
attributed to a lapse in the health of these patients, which resulted in a 
temporary failure of their kidneys and therefore they required dialysis 
for a short period. Those patients whose CKD stage was not indicated 
within their file appeared not to have undergone any dialysis sessions, 
which may indicate that they are not stage 5 CKD patients or they 
could not afford to begin the dialysis treatment. However, the former 
is more likely as some information on the latter would have been 
indicated in their files. Such information would include the 
recommendation of dialysis by the nephrologist and also the patient’s 
inability to afford the treatment would be stated as a reason why the 
dialysis session was not carried out.  
Information retrieved from the patients’ case files also included their 
current health status. This indicated whether they were improving, 
deteriorating, on follow up or deceased. However, 11 patients did not 
have any current health status on their case files while five patients 
were confirmed as dead at the time of the retrieval of the data and they 
had all been stage-5 CKD patients. Only one patient during the time of 
the research study discontinued treatment, citing both financial and 
personal reasons for the decision. A summary of the management 
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outcomes of the CKD patients collected for this study is indicated in 
Table 4.12. 
Table 4.12: Health status of CKD patients in the initial dataset 
Health status Numbers Percentage 
on follow up 313 87.7 
improved and on follow up 18 5 
unknown 11 3.1 
died 5 1.4 
in hospital 5 1.4 
discharged and on follow up 2 0.6 
Deteriorated and discharged 1 0.3 
discharged self from treatment 1 0.3 
In poor health but stable and on 
follow up 1 0.3 
Total 357 100 
 
4.2.4 The spatial distribution of the initial dataset of 357 cases 
Most health and human related issues can be viewed within a 
geographical context. Therefore understanding these issues requires a 
reasonable understanding of their geography. In order to evaluate the 
spatial prevalence of CKD within Edo state, there was the need to 
identify the spatial distribution of the disease. 
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Figure 4.3: Spatial distribution of the 357 CKD patients within the large settlements in 
Edo State 
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Figure 4.4: The distribution of the CKD patients from the initial dataset across the 
LGAs in Edo State  
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Figure 4.5: The spatial distribution of the 357 CKD cases across the wards in Edo State  
To display the spatial distribution of the CKD cases within the state, 
the location of the CKD cases using their addresses were identified. 
This enabled their distribution to be aggregated and displayed within 
the large settlements, their LGAs, and their wards respectively. The 
natural breaks (Jenks) classification was used to determine a five-class 
interval. However, the first class interval was manually set to zero in 
order to identify the areas without diagnosed CKD cases. The first 
map of the spatial distribution of CKD within the large settlements in 
the state (Figure 4.3) indicated that most of the CKD patients were 
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concentrated in the state’s capital with a few cases located in smaller 
towns or settlements around the north eastern part of the state. The 
settlements displayed on the map (see Figure 4.3), are classified as 
large settlements, which were projected within the scale of the map, 
this does not represent the complete distribution of the inhabited areas 
within Edo State. The spatial distribution of the CKD patients within 
the LGAs showed that Ikpoba-okha LGA had the highest number of 
patients (see Figure 4.4). The distribution of CKD cases within the 
wards showed that Geretti ward had the highest number of patients 
(see Figure 4.5). It should be noted that these were all urban areas 
with very few CKD cases registered in the rural areas. However, this 
pattern might be an indication of the first order-effect due to the 
underlying population as urban areas are more populated than the rural 
areas. It can also be argued that the higher number of diagnosed CKD 
cases within the urban areas might be attributed to the poorer 
screening practices noted among nephrologists and physicians, which 
may be more emphasized in the rural areas, which has no registered 
nephrologists. According to a nationwide research study on self-
reported screening
24
 amongst nephrologists in Nigeria, it was 
discovered that self-reported screenings among the nephrologists were 
very poor as only 12.7% had ever estimated their glomerular filtration 
rate (GFR) (Agaba et al., 2009). This poor practice of self-screening 
among nephrologists might also be transferred to the services the 
                                                 
24
 The self-reported screening study was a cross-sectional study of Nigerian nephrologists 
in order to determine the nephrologists that had ever got themselves screened for CKD and 
its known risk factors  
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nephrologists and physicians give their patients. Particularly those 
physicians located in rural areas, as they might not routinely screen 
their patients for CKD until it is too late.  
 
Figure 4.6: The distribution of the 357 CKD cases within each ward and their associated 
LGAs along with the location of the large settlements in Edo state 
The spatial pattern of the distribution of CKD visually displayed 
across the map of Edo State appears to indicate that the highest 
concentration of the disease is within the state’s capital (see Figure 
4.6). However, other factors need to be taken into account about the 
current spatial distribution of CKD within the state before any 
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meaningful conclusions can be made. A factor that should be taken 
into consideration is the issue of distance to the hospital as this might 
have an impact on the actual number of patients that actually go to the 
hospital to undergo treatment from other areas within the state. This 
assumption was examined further in chapter seven. There is also the 
possibility that some residents that already have CKD may not have 
been referred by their local health centre to UBTH for treatment. 
Another assumption might be that residents located in rural areas are 
not coming forward for treatment as they might be using alternative 
treatments from their local vicinities. In order to verify these 
assumptions, further investigations have to be carried out on CKD 
patients within the state, as this cross sectional study is unable to 
verify most of these assumptions due to the limited information that 
can be derived from patients’ health files. 
4.3 Descriptive statistical profile and spatial distribution of 
the subsequent dataset 
As mentioned earlier, not all the CKD cases from Edo state that were 
diagnosed between 2006 and 2009 in UBTH could be included in the 
dataset that was used for this research study and this was because the 
case files for some of the patients could not be located. To discover if 
there was any systemic bias on why some files were missing during 
the collection of the initial dataset, there was the need to compare the 
results with a similar dataset. Since UBTH was currently the only 
tertiary hospital that managed CKD cases in Edo state, it was therefore 
necessary to attempt to locate as many as possible of the missing case 
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files that were not included in the initial dataset. The health files for a 
total of 92 cases were located and the required data were retrieved. 
However, after sorting through the data collected, and removing any 
duplicated CKD records as well as those that did not reside within Edo 
state, they finally came to a total of 85. The edited database containing 
the 85 CKD patients is examined in order to check for similarities in 
the sex, age, proportion of the stages of CKD at the time of diagnosis, 
and the geographical distribution of the CKD cases generated for the 
357 CKD patients. The other socio-demographic variables included 
within both the initial and subsequent datasets were not discussed in 
this section due to the missing data originally registered within the 
initial dataset.  
4.3.1 The socio-demographic variables for the dataset of 85 CKD 
cases 
The result on the proportion of males and females with CKD within 
this dataset indicated that a total of 51 patients were males while 34 
were females. This meant that 60% of the data consisted of males 
while the remaining 40% were females. As a result, the ratio of male 
and female CKD patients was 1.5:1. The CKD distribution between 
the sexes within this data appeared to validate the CKD distribution of 
the previous dataset of 357 patients (see Table 4.1). This is because 
both datasets indicated that nearly twice the numbers of males than 
females were diagnosed with CKD. In order to verify the similarities 
within both datasets, a t-test was used to compare the sex variable in 
both datasets. This test failed to reveal a statistically reliable 
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difference between the mean number of males and females from the 
initial CKD dataset (mean = 1.6, SD = 0.5) and the subsequent dataset 
(mean = 1.6, SD = 0.5; t (440) = 0.9, p = 0.4). This therefore meant 
that the variability of the sex variable within both datasets were 
approximately equal or similar. 
The mean age of the patients that were included in the subsequent 
dataset was 47 years (see Table 4.13). The age and sex of the 
subsequent dataset showed that their distribution is not so different 
from the result for the distribution of the sex and age of the 357 CKD 
patients (see table 4.2). There was a difference of 2.1 years between 
the mean age of the subsequent dataset and the initial dataset of 357 
CKD patients, while the difference between their standard deviation 
was 0.2. Furthermore, a t-test failed to reveal a statistically reliable 
difference between the mean age from the initial CKD dataset (mean 
= 45.3, SD = 17.2) and the subsequent dataset (mean = 47.1, SD = 
17.7; t (438) = 0.9, p = 0.4). This therefore meant that there was no 
significant difference between the mean age in each dataset.  
Table 4.13: the mean age of both male and female CKD patients in the subsequent data 
Sex 
Number of 
cases Mean Age 
Std. 
Deviation 
male 51 47.4 17.9 
female 34 46.7 17.6 
Total 85 47.1 17.7 
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4.3.2 The diagnosis variables for the dataset of 85 cases 
The stage of CKD for the patients within this dataset showed that most 
of the patients had stage 5 CKD at the time of their diagnosis 
accounting for 60% of the patients, followed by stage 3 CKD with 
21.2%, while stage 4 CKD accounted for 16.5% and stage 2 CKD had 
the lowest with 2.4% (see Table 4.14). The distribution of the stages 
of CKD at the time of diagnosis among the patients shows a similar 
pattern with the results generated among the 357 patients. These 
similarities appear to indicate that the distribution of the stages of 
CKD at time of diagnosis among the CKD patients within Edo state 
may actually follow the same pattern because CKD cases with stage 5 
accounted for the highest number followed by stage 3, then stage 4 
and finally stage 2 CKD. Similar to the results from the initial dataset, 
the number of cases that were diagnosed at stage 4 of the disease was 
equally lower than expected. This seems to raise more questions than 
answers, which further highlights the need for an extensive study on 
CKD diagnosis practices within Edo state focusing particularly on the 
reason(s) behind the frequency of CKD cases diagnosed at stage 4.  
Table 4.14: A comparison of the diagnosed stages of CKD for the 85 CKD cases and the 
357 CKD cases in the initial dataset 
85 CKD cases 357 CKD cases 
STAGE OF 
CKD Numbers Percentage 
STAGE OF 
CKD Numbers Percentage 
Not indicated 0 0 
 Not indicated 
10 2.8 
stage 2 2 2.4 stage 2 10 2.8 
stage 3 18 21.2 stage 3 20 5.6 
stage 4 14 16.5 stage 4 13 3.6 
stage 5 51 60 stage 5 304 85.2 
Total 85 100 Total 357 100 
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4.3.3 The spatial distribution of the dataset of 85 cases 
 
Figure 4.7: Spatial pattern of CKD within Edo state using both the original dataset of 
357 cases and the subsequent dataset of 85 cases 
Although the map containing the distribution of the 85 CKD patients 
had a smaller proportion than the original map that had 357 patients, 
there were still similarities in the spatial distribution of CKD within 
the state (see Figure 4.7).  The Geretti ward located within Ikpoba 
Okha LGA had the highest number of cases in both maps, with 
majority of the cases located around the south western part of the 
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state, which is within and around Benin City, the state’s capital. It was 
observed that the wards away from the state’s capital that had 
relatively high numbers of cases compared to their surrounding wards 
in the initial dataset were equally represented in the map created using 
the subsequent dataset namely Ekpoma, and Auchi wards respectively. 
In summary, it can be argued that the variables collected from the 85 
cases, which were used as a subsequent dataset validates the original 
dataset of 357 cases. This is because there were no significant 
differences that existed between the initial dataset and the subsequent 
dataset when comparing the variables of the CKD patients within both 
datasets.  
Therefore, there is the likelihood that the variables within the initial 
dataset represented a good profile of the CKD patients in Edo state. 
4.4 Descriptive statistical profile of the combined dataset 
The initial dataset of 357 cases and the subsequent dataset of 85 cases 
were combined to create one dataset of 442 cases used in later 
analyses. The analyses of the spatial pattern of the combined dataset 
are discussed in details in subsequent chapters (see chapter six and 
chapter seven). 
4.4.1 The Descriptive analysis of the socio-demographic variables for 
the combined dataset of 442 cases 
As previously mentioned in chapter two, studies have shown that 
socio-demographic factors, such as sex, age, marital status, education, 
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income, ethnicity, occupational class, and religion are closely 
associated to the health outcome of an individual (see section 2.4).  
It is therefore no surprise that the study of CKD across the globe has 
some of its focus on the socio-demographical profile of the patients 
(see Lewis, 2008; Neild, 2010). 
4.4.1.1 Sex and CKD in Edo state 
Results from the combined dataset of the 442 CKD cases used in this 
research study showed that 63.1% of the cases were males while the 
remaining 36.9% were females (see Table 4.15). This result appear to 
be consistent with literature that indicates the possibility of sex bias in 
healthcare where males are more likely to be diagnosed and ultimately 
receive treatment for CKD than females (see Ulasi, 2008).  
Table 4.15: Frequency of CKD between male and female patients within the combined 
dataset 
Sex Numbers Percentage 
Male 279 63.1 
Female 163 36.9 
Total 442 100 
 
4.4.1.2 Age group and CKD in Edo state 
In respect to the association between age and CKD in Nigeria, one 
must take into account the life expectancy in the country, which is 
currently lower than most developed countries and even some 
developing countries. The nation’s life expectancy is currently 
estimated at 46.9 years and ranked at 216 in comparison to other 
nations in the world (CIA, 2010). Therefore, it is expected that after a 
certain age, there should be a decline in the frequency of CKD 
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amongst the age group as there are a lower number of people that 
reach that age group.  
The results from the data indicated that the mean age of the patients 
that were included in the study was 45.7 years. The mean age for the 
male patients was approximately 46.6 years while the female patients’ 
mean age was 43.9 years. The result appears to be similar to previous 
studies in Nigeria, which indicated that the prevalence of CKD was 
higher among the ages between thirty years and fifty years (Akinsola 
et al., 1989; Alebiosu, 2001; Salako et al., 2002).  
For the purpose of future comparison of the profile of CKD cases 
within the state with other studies that might be associated with the 
Nigerian census or any other similar population study, the ages of the 
patients were grouped using a 5-year band. It should be noted that the 
use of the 5-year band was only used for the evaluation of the profile 
of CKD cases within this chapter.  Since, there were no registered 
cases of patients below 10 years within the dataset; the age group 
began from 10 years to above 85 years. This resulted in a total of eight 
age groups. A total of 440 patients (99.6%) had their age registered 
within their health records. Only two cases had no indication of their 
age or date of birth within their health files.  
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Table 4.16: Number of CKD cases across the age group of the 442 patients 
National classified age group Numbers Percentage 
10-14 3 0.7 
15-19 22 5 
20-24 30 6.8 
25-29 41 9.3 
30-34 38 8.6 
35-39 41 9.3 
40-44 34 7.7 
45-49 43 9.7 
50-54 39 8.8 
55-59 37 8.4 
60-64 42 9.5 
65-69 32 7.2 
70-74 14 3.2 
75-79 14 3.2 
80-84 6 1.4 
85+ 4 0.9 
Total number of patients with a known age group 440 99.6 
Missing cases 2 0.5 
Total CKD cases 442 100 
 
The frequency of CKD cases among the age groups showed that there 
was not much variability from 25-69 years until it got to those patients 
who were above 70 years then there was a steady decline in the 
frequency of CKD within the remaining age groups. The age group of 
45 years to 49 years had the highest number of CKD cases accounting 
for 9.7%, while the age groups with the lowest were the age group 10-
14years with 0.7% and the patients above 85 years with 0.9% (see 
Table 4.16). This result indicates that a considerable number fell 
within the working age population. Apart from the age groups below 
20 years and patients above 69 years, the frequency of CKD cases did 
not appear to vary too much across the age categories as the highest 
frequencies ranged between 6.8% and 9.7%.  
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4.4.1.3 Marital status and CKD in Edo state 
Married patients accounted for the highest number of cases (79.9%). 
This result appears to support previous studies mentioned in section 
2.4.3, which indicated that more married patients are more likely to 
seek out treatment than the unmarried CKD patients because they 
have the support of their spouses (Bapat et al., 2008). As a result of 
the support of their spouses, they are more likely to seek out and 
accept treatment in order to increase their chances of survival. 
The marital status variable is further tested and discussed in the next 
chapter to determine whether there was any significance between the 
marital status of a patient and its association with the severity of CKD 
at time of diagnosis.  
Table 4.17: Frequency of marital status for the 442 CKD cases 
marital status Numbers Percentage 
Married 353 79.9 
Single 86 19.5 
Widowed 2 0.5 
Divorced 1 0.2 
Total 442 100 
 
4.4.1.4 Ethnicity and CKD in Edo state 
There are approximately 250 ethnic groups within Nigeria (CIA, 
2011). As discussed in section 2.4.5, there have been several studies 
on the association between racial groups and CKD (See Atkinson et 
al., 2010; Filler et al., 2010; Kramer et al., 2008). Yet, there has not 
been any known study on the prevalence of CKD among ethnic 
groups or tribal groups (as they are commonly called in Nigeria) of the 
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same racial descent within Africa and particularly within Nigeria. This 
has been compounded further by the absence of ethnicity data from 
the Nigerian census. According to the results, the Bini ethnic group 
had the highest proportion of CKD cases with 28.5% of the 442 cases, 
followed by the Esan ethnic group with 12.4%. The Igbo and Etsako 
ethnic groups both had a proportion of 4.1% and 2% respectively (see 
table 4.18). The origin of both the Bini and the Esan ethnic groups are 
predominantly located in urban areas. One could argue that the ethnic 
groups located within urban areas are more likely to be aware of the 
prevalence of CKD because of the CKD awareness programmes that 
are made available via the mass media in these areas. This observation 
is based on the assumption that the ethnic groups are residing in their 
area of origin however, this might not ring true in all cases, as there 
are some ethnic groups whose area of origin are not located within 
Edo state even though they reside in Edo state such as the Igbo, and 
Akwa-Ibom ethnic groups.  To analyse the distribution of CKD across 
all the ethnic groups that were identified within the dataset, the ethnic 
groups were classified into five groups based on their area of origin. 
These were the ethnic groups located in the north eastern region of the 
state, those located in the north western region, the ethnic groups from 
the south western region, and the ethnic groups from the south eastern 
region of Edo state. The fifth group were the ethnic groups whose 
areas of origin are outside Edo state. The table below shows what 
region the ethnic groups were classified into and the frequency of 
CKD within these regions (see Table 4.19). The south eastern region, 
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which is predominately occupied by the Bini ethnic group, had the 
highest CKD frequency with 28.5% followed by north western region 
with 12.7%. As there are no previous studies to compare the 
distribution or prevalence of CKD among local ethnic groups 
especially within Nigeria as well as the absence of population data for 
the ethnic groups, this result can only be regarded as a baseline for 
further study on ethnicity and the prevalence of CKD within a 
Nigerian state.  
Table 4.18: Frequency of the 442 CKD cases across the ethnic groups 
Ethnic groups Numbers Percentage 
Missing data 185 41.9 
Bini 126 28.5 
Esan 55 12.4 
Igbo 18 4.1 
Etsako 9 2 
Urhobo 8 1.8 
Yoruba 8 1.8 
Ika 5 1.1 
Ora 4 0.9 
Akoko-edo 3 0.7 
Isoko 3 0.7 
Afuze 2 0.5 
Agbor 2 0.5 
Auchi 2 0.5 
Owan 2 0.5 
Afemai 1 0.2 
Akwa-Ibom 1 0.2 
Ibillo 1 0.2 
Ibie 1 0.2 
Igarra 1 0.2 
Ijaw 1 0.2 
Irrua 1 0.2 
Itsekiri 1 0.2 
Unmima-fuga 1 0.2 
Warake 1 0.2 
Total 442 100 
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Table 4.19: The distribution of the 442 CKD cases within the reclassified ethnic groups 
Region Ethnic groups Number Percentage 
South-eastern Bini 126 28.5 
North-western Esan, Irrua 56 12.7 
outside Edo state 
Warake, Akwa-Ibom, Ijaw, 
Agbor, Isoko, Ika, Igbo 31 7 
Northeastern 
Afemai, Owan, Akoko-edo, 
Etsako, Afuze, Unmima-fuga, 
Igarra, Ibillo, Ibie, Ora, Auchi 27 6.1 
Southwestern Urhobo, Itsekiri, Yoruba 17 3.8 
missing data 185 41.9 
total 442 100 
 
4.4.1.5 Religion and CKD in Edo state 
The religious beliefs of the CKD patients were not fully indicated in 
many of the patients’ records, as only 57.7% out of the 442 patients 
had their religious beliefs indicated in their health files (See Table 
4.20). According to the records, Christians represented 55.7% of the 
data set while only 0.7% of the CKD cases were regarded as African 
traditionalists.  
Table 4.20: Frequency of the 442 CKD cases among the three main religions in Edo state 
Religion Numbers Percentage 
Christian 246 55.7 
Muslim 6 1.4 
African traditionalist 3 0.7 
Missing Data 187 42.3 
Total 442 100 
 
4.4.1.6 Occupation and CKD in Edo state 
In analysing the occupational status of the 442 CKD patients, the 
various occupations were classified into seven classes. The specialized 
jobs that usually required a tertiary degree or a higher qualification 
were classified as the professional occupation and these included 
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doctors, lawyers, and engineers. The next class were the semi-
professionals including nurses, technicians, and also 
businessmen/businesswomen. The reason why business was included 
within this category is due to the general assumption that 
entrepreneurs are generally classified as businessmen/businesswomen 
and not entrepreneurs at least within the Nigerian context (Schatz, 
1977). The next category were the non-manual workers and these 
were the people that require little or no level of specialization but were 
not manual labour intensive in their occupational skills. These 
included clerks, hairdressers, musicians, and petty traders. A petty 
trader, in this context, ranges from a person that sells small items 
using just a table and a chair while under a small shade to a small 
shopkeeper that sells a variety of little items, which are mainly needed 
for everyday use in a home. This occupational category does not 
require the person to have a tertiary education or a similar degree to 
qualify to work within this group. The next category was the manual 
workers. Jobs within this category included farmers, cleaners, drivers, 
and bricklayers. 
The next three categories are separated from the previously mentioned 
occupational categories, as they do not fall within any of those 
categories. The first of this unique category were the students. The 
student category, which ranges from primary school pupils to tertiary 
students are full-time students and they do not work part-time. This 
assumption was based on the fact that such jobs were not mentioned 
within their health files and although it might not be the case as some 
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might have had part-time jobs, there was nothing to support that 
prospect. The second unique category was the retired patients, the 
majority of which had attributed their retirement to old age. All of 
these within the retired category were above the age of 50 years. The 
last category within this group was the unemployed, these were the 
patients that were looking for employment before they became ill and 
could not work. This category also included full-time housewives 
because both the employed and unemployed patients that had families 
(spouses and or children) also have the similar responsibilities of the 
full-time housewives (Whooley et al., 2002). These last three 
categories (i.e. the students, retired and unemployed) are often 
excluded in occupational classification resulting in an underestimation 
of socio-economic differences within a population (Galobardes et al., 
2007; Martikainen and Valkonen, 1999). The distribution of CKD 
patients within the various occupational categories indicated that the 
highest proportion of cases were among the semi-professionals with 
25.1%, followed by the non-manual workers with 20.6% of all the 
CKD cases, the students constituted 16.1%, while the professionals 
had the lowest with 2.5% of the cases (see Table 4.21). It should be 
noted that 2.3% (10 patients) of the cases did not have their 
occupational status registered in their health files.  
In order to determine whether the diagnosed patients are either a 
genuine cross-section of the population in Edo State or are 
disproportionately drawn from the more affluent parts of that society, 
the socio-economic profile of diagnosed CKD patients was compared 
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to that of the wider population. The outcome for this is potentially 
very useful as it allows insight into how widespread access to CKD 
diagnosis and treatment is within the state, which has major 
implications on how the later results can be interpreted, as well as any 
potential policy implications arising from them. However, it was not 
possible to compare the socio-economic profile of diagnosed cases to 
that of the state population as there were no state level socio-economic 
data. Instead, the socio-economic profile for Nigeria was compared 
with the diagnosed CKD dataset.  
A comparison of the socio-economic group for diagnosed CKD 
patients with the national socio-economic group indicated that the 
diagnosed CKD patients might be disproportionately drawn from the 
affluent group in the society. According to the Federal Office of 
Statistics (2002), 59% of the Nigerian working population were 
employed in agricultural and other manual jobs however, 
approximately 15% of diagnosed CKD patients were manual workers 
and while 16% of the Nigerian working population were employed in 
white collar occupations, 27.6% of the CKD patients were in 
‘professional/semi-professional’ jobs. The question that rises from this 
is ‘whether CKD is unusually prevalent among affluent groups or 
whether differential access to healthcare is a factor underlying the 
disproportional over-representation of the most affluent socio-
economic groups within the diagnosed CKD dataset?’ I would argue 
the latter because there is currently no substantial evidence that 
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indicates that the prevalence of CKD is higher among those with a 
higher socio-economic status (see section 2.5.4). 
It can also be deduced from the results of the occupational groups for 
the CKD dataset that a significant number fell within the potential 
working population as well as the present working population and this 
may have an impact on the future of Nigeria’s economy. This tallies 
with a similar argument presented in a report on the likely impact of 
CKD on the economy of the country by the nation’s Kidney 
Consultants (Kidney Consultants International, 2007). They argued 
that if the prevalence of CKD were left unchecked, there would be a 
significant impact on the nation’s future as a considerable number of 
CKD cases were diagnosed among the working population in Nigeria. 
Table 4.21: Frequency of 442 CKD cases across the occupational groups 
Occupational Status Numbers Percentage 
Semi-Professionals 111 25.1 
Non-manual workers 91 20.6 
Students 71 16.1 
Manual workers 64 14.5 
Retired 57 12.9 
Unemployed 27 6.1 
Professionals 11 2.5 
Missing cases 10 2.3 
Total number of CKD cases 442 100 
 
4.4.1.7 Educational level and CKD in Edo state 
As discussed in section 2.4.4, the educational level of an individual is 
one of the commonly used measures for accessing his/her socio-
economic status. A number of studies have indicated that the socio-
economic status of an individual is a significant determinant of health 
in an individual. 
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The frequency of CKD among the various educational levels indicated 
that the highest number of CKD cases was found among patients with 
a tertiary education (16.1%) while the lowest number of CKD cases 
was registered among those without any education (1.4%). However, 
the result of the CKD distribution among the various educational 
levels is based on only 35.5% of the patients as 64.5% of the patients 
did not have their educational status registered in their health files.  
Table 4.22: Frequency of CKD across the educational levels of the 442 patients 
Educational status Numbers Percentage 
Tertiary education 71 16.1 
Secondary education 54 12.2 
Primary education 26 5.9 
Uneducated 6 1.4 
Total number of patients with a known educational status 157 35.5 
missing data 285 64.5 
Total CKD cases 442 100 
 
4.4.2 Descriptive analysis of the diagnosis variables for the combined 
dataset of 442 cases 
In the midst of increasing emphasis on the early detection of diseases 
especially for chronic diseases, studies have shown that early 
detection of chronic diseases such as cancer (Wulfkuhle et al., 2003) 
as well as CKD (Locatelli et al., 2005) can help improve the survival 
rate of the patients. The search is currently on for reliable ways that 
will be helpful in the early diagnosis of diseases. As mentioned 
earlier, the diagnosis variables in this study were the variables that 
were related to the diagnosis of CKD at the time the patient was first 
diagnosed with the disease at UBTH.   
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4.4.2.1 Frequency of diagnosed CKD cases from 2006 to 2009 
The prevalence of CKD within Nigeria is not a new development as 
there have been noted studies of the disease that date back to over two 
decades such as the study by Akinsola et al (1989) in which they 
carried out a prospective study on the risk factors associated with 
CKD in Nigeria. However, as previously mentioned in chapter one, it 
is only recently that there has been an attempt at a nation-wide 
awareness campaign to tackle the issue of CKD in Nigeria. In order to 
examine the annual count of CKD within the state, the total number of 
cases for each year between 2006 and 14
th
 October 2009 were 
collected and assessed. The results showed that there was a steady 
increase in the total number of cases each year with the highest 
registered number of cases in the year 2008 (see Table 4.23). 
However, it should be stated that the total number of cases in 2009 is 
not for the whole year; therefore, there is a probability that the total 
number of cases for the beginning of 2009 to the end of 2009 might be 
more than the total number of cases registered in 2008. The variable 
was further analysed for any association with the severity of CKD at 
time of diagnosis and a time series analysis was carried out in order to 
examine the trend of diagnosed CKD cases within the study period 
(discussed in chapter five).   
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Table 4.23: The annual frequency of the 442 diagnosed CKD cases from 2006 - 2009 
Year of Diagnosis Numbers Percentage 
2006 92 20.8 
2007 108 24.4 
2008 126 28.5 
2009 116 26.2 
Total 442 100 
    
4.4.2.2 Stage of CKD at time of diagnosis 
The results indicated that the number of cases diagnosed at the last 
stage of the disease greatly exceeded all the cases that were diagnosed 
at the earlier stages of the disease. The high number of diagnosed 
cases at the last stage of CKD supports previous studies that have 
indicated that a high number of CKD cases were diagnosed at the late 
stage within Nigeria (discussed earlier in chapter one). This highlights 
the burden of CKD in Nigeria given the fact that late diagnosis of 
CKD is more expensive to treat and unaffordable by majority of the 
population.  
Table 4.24: The stage of CKD at time of diagnosis for the 442 patients 
Stage of CKD Numbers Percentage 
stage 2 12 2.7 
stage 3 38 8.6 
stage 4 27 6.1 
stage 5 354 80.1 
missing data 11 2.5 
Total number of cases with registered stage of CKD 431 97.5 
Total number of CKD cases 442 100 
 
4.4.2.3 Biological Risk factors and CKD in Edo state 
For the purpose of this study, four main biological risk factors were 
included in the analyses of the variables that were collected from the 
health files of the CKD patients: hypertension, chronic 
glomerulonephritis, diabetes, and toxic nephropathy. According to the 
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nephrologists at UBTH, these risk factors were determined either 
before the patients developed CKD or after an extensive examination. 
None of the patients that were diagnosed with toxic nephropathy as a 
risk factor had a predated record of the risk factor before their 
diagnosis of CKD. This could be attributed to the possibility that the 
risk factor was identified only after the exclusion of the other three 
risk factors in an attempt to determine the cause of the disease. 
According to their health files, toxic nephropathy was recorded as a 
risk factor after it had been confirmed that the patient had a history of 
self-medication (such as drugs to relieve pains or reduce fever) and/or 
used traditional medications. Further tests were sometimes carried out 
to confirm the presence of the disease but the full details were not 
disclosed within their health files. The diagnosis of chronic 
glomerulonephritis as a risk factor among the CKD patients was 
similar to how those with toxic nephropathy were diagnosed with 
CKD. This was because most of the CKD patients diagnosed with 
chronic glomerulonephritis as the cause of the disease were diagnosed 
about the same time that they were diagnosed with CKD. Chronic 
glomerulonephritis was identified as a probable cause after the 
symptoms were examined and then confirmed as the cause of CKD 
within a patient after urine test had indicated the presence of protein 
and blood. In some cases, an imaging test of the kidney using X-rays 
or ultrasound scanning was done before chronic glomerulonephritis 
was confirmed as the cause of CKD within the patient. Although 
kidney biopsy is one of the ways of confirming the presence of the 
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disease as discussed in chapter two, this procedure was not carried out 
because the hospital did not have access to the necessary facilities 
needed for the procedure.  
There were approximately fifteen other biological risk factors 
recorded within the CKD health files however, most of them were 
diagnosed along with the four main biological risk factors and were 
classified as secondary causes of CKD within the health files of such 
patients. Some of these other biological risk factors were diagnosed as 
primary causes of CKD in some patients but the frequency of these 
risk factors within the dataset was small. Fourteen of these risk factors 
were included as primary causes of CKD among some of the patients 
and these were a total of 11.1% of all the risk factors documented 
within the dataset. A total of 20 CKD cases had no documentation 
within their health files that identified any biological risk factor as the 
cause of CKD (see Appendix C). It was observed that most CKD 
cases had more than one risk factor attributed to their development of 
CKD. A total of 15 CKD cases had three biological risk factors 
documented within their health files as possible causes for their 
development of CKD. In situations where a patient had more than one 
of the risk factors diagnosed and identified as the probable cause of 
CKD and none of these risk factors was identified as the primary 
cause, each of these risk factors was counted and included in the 
database. This resulted in the frequency of the documented risk factors 
exceeding 442 cases. Appendix C shows the actual distribution of all 
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the risk factors documented within the health files of the CKD 
patients.  
 
Figure 4.8: Bar chart showing the distribution of risk factors among the 442 CKD 
patients 
The distribution of the biological risk factors among the 442 
diagnosed CKD cases showed that hypertension had the highest 
frequency amongst the CKD cases with 39.8% while toxic 
nephropathy was present in just 7.01% of the cases (see Table 4.25 
and Figure 4.8). This result, which shows hypertension as the main 
risk factor present in CKD patients, also corresponds with past studies 
that have been carried out on the association between biological risk 
factors and CKD and they have all identified hypertension as a major 
risk factor of CKD (Laliberte et al., 2009; Muntner et al., 2010; 
Sabanayagam et al., 2010). 
Table 4.25: The distribution of biological risk factors present in CKD patients 
Diagnosis 
Toxic 
nephropathy Hypertension Diabetes 
chronic 
glomerulonephritis 
Missing Data 10 (2.3%) 10 (2.3%) 9 (2.0%) 9 (2.0%) 
No 401 (90.7%) 256 (57.9%) 360 (81. 5%) 261 (59.1%) 
Yes 31 (7.0%) 176 (39.8%) 73 (16.5%) 172 (38.9%) 
Total 442 (100%) 442 (100%) 442 (100%) 442 (100%) 
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In relation to the presence of toxic nephropathy as a risk factor, all of 
the CKD cases diagnosed with toxic nephropathy gave reasons related 
to the accessibility and affordability of health care services as the 
reason for their use of traditional treatments (Kadiri et al., 1999; 
Ojogwu and Anah, 1983). 
4.4.2.4 Referral centres and CKD in Edo state 
There is a general agreement about the importance of early referral to 
the nephrologist and predialysis educational programmes because this 
strategy prevents the progression and complications of renal disease 
(Triolo and Savoldi, 2008). However, studies have shown that the 
awareness of the disease amongst the general public (Vassalotti et al., 
2010) as well as some medical professionals (Agaba et al., 2009) is 
rather low and as such there are incidences where the disease is not 
diagnosed until it gets to the late stage when it becomes both difficult 
and expensive to manage. The inclusion of the referral centres that 
indicate the proportion of cases referred from the various health care 
services in the state can be crucial in identifying the referral process of 
CKD patients in the state. 
To analyse the number of referrals, it was necessary to identify the 
number of healthcare services that actually referred the patients within 
the study period to UBTH to confirm their diagnosis as well as receive 
treatment for the disease. Out of the 442 cases, 251 patients (i.e. 
56.8%) were referred to the renal department in UBTH for treatment. 
However, 33% came from other departments within UBTH (see Table 
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4.26). Both the private and public clinics had the lowest CKD referrals 
to the renal department accounting for 4.5% and 0.7% respectively. 
The result indicated a low number of referrals of CKD cases among 
the healthcare centres within the state. One hundred and ninety-one 
cases had no indication of being referred from another health centre 
within their health files as they were likely diagnosed by the renal unit 
after they arrived in the hospital for an underlying symptom or illness. 
The result is similar to a previous study done in another state within 
Nigeria that identified the problem of poor referrals of CKD patients 
to nephrologists for treatment (Alebiosu, 2001). A plausible reason for 
the low number of referrals from the health centres could be due to a 
poor awareness of CKD among the health practitioners within these 
healthcare centres. Although there is not enough evidence to support 
this argument, this result might support the comments made by the 
nephrologists at the renal department during informal discussions with 
them while collecting my data and following them during their clinical 
rounds. They suggested that medical practitioners should be made 
more aware of the effect of CKD on the general public. They stated 
that although there has been an increase in the referral rates of CKD 
patients with early stages of CKD from other hospitals, they still 
believed that most health centres within the state especially those in 
the rural areas still need to be informed about how to effectively 
identify CKD at its early stages.   
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Table 4.26: Proportion of health centres that referred cases to the renal department in 
UBTH 
Referral centre Number Percentage 
Not referred / diagnosed by the renal unit 191 43.2 
Within UBTH 146 33 
public Hospital 43 9.7 
private hospital 39 8.8 
private clinic 20 4.5 
public clinic 3 0.7 
Total number of referred cases 251 56.8 
Total number of  cases 442 100 
 
4.4.3 The descriptive analysis of the management variables for the 
combined dataset of 442 cases 
The management variables refer to the various factors that contributed 
to the management of the CKD cases. These included the number of 
dialysis sessions taken by the patient (when it was applicable) and the 
health status of the patient at the time the data was collected for the 
study. 
4.4.3.1 Number of dialysis session among the 442 CKD patients 
The number of dialysis sessions done by the patients were grouped 
into three categories, beginning with the group of patients that never 
had any dialysis session, those that had undertaken 1-30 dialysis 
sessions while the last group of patients were those that had more than 
30 sessions. In order to identify the CKD patients that required 
dialysis, their health files were checked for any indication that dialysis 
was suggested by the doctor as the choice for their renal replacement 
therapy. The number of dialysis sessions among the patients 
diagnosed at the 5
th
 stage of CKD was identified, as this stage of CKD 
is more likely to require some form of renal replacement therapy than 
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any of the other CKD stages. Within the 442 cases that were included 
in this study, 354 patients were diagnosed with stage 5 CKD however, 
187 (42.3%) of these patients did not take part in any dialysis session 
even though it was noted in their health files that they required 
dialysis to manage the disease.  
Table 4.27: The number of the dialysis sessions among the CKD patients  
Number of dialysis 
taken 
Stage of CKD 
Total Unknown stage 2 stage 3 stage 4 stage 5 
less than 1 11 11 27 15 187 251 
1-30 0 1 11 12 162 186 
greater than 30 0 0 0 0 5 5 
Total 11 12 38 27 354 442 
 
Only five patients had taken more than 30 dialysis sessions since their 
first diagnosis as stage 5 CKD patients. Health records indicated that 
all the patients were not undertaking the optimal number of dialysis 
sessions required to maintain their kidney functions (discussed in 
section 2.4.3). An insufficient number of dialysis sessions usually lead 
to a build-up of toxins in the systems. This results in further 
complications that generally require additional medical attention in 
order to resolve the problems that arise and these could include 
swelling of face, swelling of arms/legs, nausea, and kidney failure 
(Murtagh et al., 2010). All the patients cited in their health files that 
lack of funds was their primary reason for either refusing to take any 
dialysis session or why they discontinued their dialysis sessions. This 
situation tallies with previous studies (discussed in section 2.6.1). The 
importance of detecting CKD at its early stage cannot be over 
emphasized as this could enable early interventions, reducing the high 
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risks of heart disease, progression to stage 5 CKD and premature 
mortality, which are usually associated with CKD (Stenvinkel, 2010). 
4.4.3.2 Health status of CKD patients 
The high cost of treatment of CKD especially among stage 5 CKD 
patients within the state and Nigeria as a whole, draws attention to the 
issue of how these patients are managed once they have been 
diagnosed with the disease. Many patients with CKD require life-long 
follow-up in order to manage the disease (Tomson and Udayaraj, 
2007). At the onset of the analysis, eleven cases (2.5%) did not have 
their current health status recorded in their health file and as such, 
their management outcomes could not be determined and therefore 
were recorded as missing. The cases that were registered as ‘follow-
up’ were those patients whose CKD status was stable and their health 
had not deteriorated at the time the data were collected. They made up 
74.7% of the cases. Sixty-one patients (13.8%) were dead by the end 
of the study period and 53 out of the 61 patients were diagnosed at 
stage 5, seven were diagnosed with stage 4 CKD, and one patient was 
diagnosed at stage 3 CKD. All 61 patients died within one year of 
their diagnosis.  
In addition, 6.6% of the patients who were originally admitted when 
they were first diagnosed had now been discharged and they were on 
‘follow up’. Only one patient was ‘lost’ during the time period of the 
study, as the patient’s record gave no account of the present location 
of the patient and no reason was specified for the patient’s absence 
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from the hospital or why the patient had stopped treatment. One 
patient was found to have deteriorated, was discharged from the 
hospital, and was no longer taking medical treatment, because the 
patient did not think there was anything else that the hospital could do 
to improve his/her health. As at the time of the collection of data, only 
five patients (1.1%) were still admitted in the hospital while 
undergoing treatment for complications related to CKD. During the 
time period of the study, only one patient refused treatment once he 
was diagnosed with CKD citing lack of finance for not taking any 
treatment and as such, he discharged himself from the hospital. 
Although over 70% of the patients were still on follow up as at the 
time the data was collected, there was still the underlying fact that 
most of the patients are not receiving adequate treatment due to 
financial constraints. Notably, those that were diagnosed at the late 
stage of the disease were not undertaking the recommended dialysis 
treatment, as they could not afford it.  
4.5 Summary 
442 cases with CKD diagnosed from 1
st
 January 2006 to 14
th
 October 
2009 were retrieved from the renal department at UBTH. Of these 
63.1% were males, and approximately 85% were in the economically 
active age range, most commonly were semi-professionals, although 
with a surprisingly large number of students. The majority of the 
patients (80%) were diagnosed at stage 5, which results in very poor 
health outcomes. Sustained treatment is beyond the financial 
capability of almost all the patients, this emphasises the need to raise 
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awareness among both the public and the health professionals to 
achieve earlier diagnosis of CKD.  
Following the evaluation of the profile of CKD cases diagnosed 
within the study period, the next three chapters will proceed with the 
analyses of diagnosed CKD within the state using the combined 
dataset. The outcome from the subsequent chapters will attempt to 
answer the research questions outlined at the beginning of this 
research study (see chapter one and three).  
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Chapter 5 Exploring the factors influencing the severity of 
CKD at the time of diagnosis and evaluating the 
trend of diagnosed CKD 
5.1 Introduction 
This chapter aims at answering four of the research questions raised in 
chapter one. These are: 
1. Is there an association between socio-demographic 
factors and the stage of CKD at first presentation? 
2. Is there a relationship between the severity of CKD at 
first presentation in Edo state and known biological risk 
factors of CKD? 
3. What factors are likely to lead to the late diagnosis of 
CKD among patients in Edo State? 
4. What is the trend of diagnosed CKD within Edo state? 
The first two research questions are addressed in the first section of 
the chapter by exploring the dataset to examine the variables for any 
relationships.  
The second section of the chapter addresses the third research question 
by creating a logistic regression model to help predict the probability 
of diagnosing the stage of CKD of a patient given the variables 
present within the CKD dataset. This model aims to identify any 
factor that might have influenced the patient’s stage of CKD at the 
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time of his/her diagnosis. The model was based on the selection of the 
significant variables identified in the analyses from the previous 
section.  
The chapter concludes by attempting to answer the fourth research 
question by using a time series analysis to identify trends in diagnosed 
CKD within Edo state during the study period.  
5.2 Determining the variables associated with the severity of 
CKD at the time of diagnosis.  
As mentioned in chapter one, one of the problems faced by many 
countries including Nigeria concerning the diagnosis of CKD, is the 
relatively large number of CKD cases that are diagnosed at the last 
stage of the disease. As previously discussed in chapter two, early 
detection of CKD is one of the best ways of treating and managing the 
disease and it would be useful to recognize any variable(s) or factors 
that may be significantly associated with the detection of CKD at 
either the earlier stages or late stage. Therefore, for the purpose of this 
study, cases defined as earlier stages of CKD were those diagnosed 
with stage 2 to stage 4 between January 2006 and 14
th
 October 2009. 
This is because stage 5 CKD patients require the use of some form of 
renal replacement therapy (RRT) such as dialysis or kidney transplant 
to manage the disease effectively. Although stage 4 CKD is 
characterised by a low kidney function, it can still be adequately 
managed using other forms of treatments, which are more affordable 
in comparison to the treatment required for stage 5 CKD. Given the 
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low number of cases diagnosed at stage 4, one could argue that any 
improvement in the diagnosis of cases at this stage could reduce the 
number of cases that would eventually have been diagnosed at stage 5. 
Research has shown that a sizable percentage of patients with stage 4 
CKD had maintained a stable renal function (El Nahas, 2005). 
Thirteen variables were examined with the stages of CKD. These were 
sex, age, marital status, education, ethnicity, religion, occupation, the 
year of diagnosis, the biological risk factors (i.e. chronic 
glomerulonephritis, hypertension, diabetes, and toxic nephropathy), 
and the type of referral centre. These thirteen variables were classified 
into two main groups: the socio-demographic variables and the 
diagnosis variables (i.e. the year of diagnosis variables, the biological 
risk factors, and the type of referral centres). The socio-demographic 
variables could highlight any significant characteristic among CKD 
patients that might have been influential in their stage of CKD at the 
time of diagnosis while the diagnosis variables could give an 
indication of the choices relating to CKD that the patients had made 
that might have resulted in the early or late diagnosis of CKD. To 
measure the significance of the association between the variables and 
the stage of CKD at time of diagnosis, the Chi-square test, and the 
correlation analysis were used to test the relationship between the 
variables and the stages of CKD at time of diagnosis. The analyses 
were done using a two-tailed test in order to measure the relationship 
between the variables, as the directions of the relationships were not 
the point of interest at this point. The choice of using the correlation 
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analysis and not just the chi-square test was because the assumption 
for the expected counts was not met in order to validate the chi-square 
test for the categories of some of the variables. This assumption states 
that ‘as a rule of thumb no more than 20% of expected counts should 
be less than 5’ (Field, 2000, p.69). 
The Phi and Cramer’s V correlation coefficient was used to test the 
association between the variables (excluding the sex of the patients, 
their age groups, marital status, and the variables for the four 
biological risk factors) and the stages of CKD. The choice of using the 
Phi and Cramer’s V instead of the Spearman’s coefficient is because 
the variables were nominal (categorical) variables and the Phi and 
Cramer’s V statistics are used in determining the degree of association 
that exists between nominal variables. 
The sex of the patients, their age groups, marital status, and the 
variables for the four biological risk factors were tested against the 
stage of CKD using the chi-square test.  
5.2.1 Socio-demographic factors and stage of CKD at time of 
diagnosis 
Due to 11 cases not having their stage of CKD at time of diagnosis 
indicated in their health files, a total of 431 cases were used in the 
analysis. A total of 77 cases (17.9%) had ‘earlier’ stages of CKD at 
time of diagnosis; 29 of these were females while 48 were male cases. 
The late stage of CKD had a total of 354 diagnosed cases (82.1%) 
with 224 males (63.3%) and 130 females (36.7%). The stage of 
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diagnosis between the males and the female, indicated that there were 
more male diagnosed at both the earlier stages of CKD and the late 
stage of CKD with the males accounting for almost twice the 
proportion of females in both stages of diagnosis (see Table 5.1). This 
supports the finding of Jungers et al., 1996, discussed in section 2.4.1.  
However, a chi-square test for the significance of the association 
between both variables indicated that the association was not 
statistically significant (χ2 =0.02, 1df, p=0.88), which indicated that 
the sex of a patient did not have a significant effect on the stage of 
diagnosis for the patient.  
Table 5.1: The association between the sex variable and the stage of CKD at time of 
diagnosis 
Stage of CKD at time of diagnosis 
Sex of CKD patients 
Total Female Male 
Earlier stages of CKD 
Count 29 48 77 
% of CKD patients 37.7 62.3 100 
late stage of CKD 
Count 130 224 354 
% of CKD patients 36.7 63.3 100 
Total 
Count 159 272 431 
% of CKD patients 36.9 63.1 100 
Chi-square test: χ2 =0.02, 1df, p=0.88 
 
As mentioned earlier in section 2.5.2, studies indicated that CKD is 
increasingly prevalent with older age groups. Although the age groups 
for the CKD patients were initially explored in the previous chapter 
using a 5-year band, for the purpose of this analysis, the age groups 
were reclassified into three categories. The three categories within the 
age group variable included those whose age were below 45 years old, 
those whose ages were between 45 years to 65 years old and finally 
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those who were above 65 years old. This is because the profile for the 
CKD patients indicated that the average age was approximately 45 
years and past studies in both developed and developing countries had 
argued that people above 65 years should be classified as a high-risk 
population group (see section 2.5.2). 
 
Figure 5.1: The distribution of CKD cases according to their age groups and their stage 
of CKD at the time of diagnosis 
The difference in the number of CKD cases across each age group for 
those that were diagnosed at the earlier stages of the disease was 
relatively small compared to those that were diagnosed at the late 
stage of the disease. However, the pattern appeared to be similar 
across both stages of the disease as the number of CKD cases 
decreased across the age groups (see Figure 5.1). There was no 
statistically significant association at the 95% level between the age 
groups and the stage of CKD at the time of diagnosis (χ2 =4, 2df, 
p=0.1). This indicated that the age group of the patients was not a 
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significant risk factor for determining the stage of CKD at the time of 
diagnosis for a patient
25
. 
As discussed in section 2.4.3, there have been indications that the 
marital status of an individual could have an impact on the health 
outcome of an individual and significant findings had also been found 
among CKD patients.  
In order to evaluate the association between the marital status of CKD 
cases and their stage of CKD at the time of diagnosis, the categories 
within the marital status variable had to be reclassified because two 
categories (divorced and widowed) had very small number of cases 
registered (see Table 5.2).  
Table 5.2: The distribution of CKD cases according to theit marital status and their 
stages of CKD at the time of diagnosis 
Stage of CKD 
marital status 
Total divorced married single widowed 
Earlier stages of CKD 0 60 15 2 77 
late stage of CKD 1 283 70 0 354 
Total 1 343 85 2 431 
 
The reclassified marital status variable had two categories. The 
married category, which consisted of patients who were married and 
were still living with their spouses while the second category, was 
termed “others”; this consisted of patients who were single, divorced, 
or widowed. The basis for using these two categories was to identify if 
                                                 
25
 A t-test of the average age of late and early diagnosis of CKD was also carried out using 
the actual ages of the CKD patients and the result was equally not significant 
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having a spouse might have an influence in the stage at which a 
patient would seek medical treatment for CKD.  
 
Figure 5.2: The distribution of CKD cases according to their marital status and their 
stage of CKD at the time of diagnosis 
At both stages of CKD diagnosis, the married patients were more than 
the other cases that did not have spouses. However, a chi-square test 
on the association between the marital status of CKD cases and their 
stage of CKD at the time of diagnosis indicated that the association 
was not significant (χ2 =0.2, 1df, p=0.7). The result of this analysis 
indicated that the marital status of a patient might not have a 
significant influence in determining a patient’s stage of CKD at the 
time of diagnosis. This therefore means that the distribution of CKD 
cases among the marital groups might be likely due to chance. 
In regards to the educational level of the CKD patients, only 155 cases 
registered their educational status (discussed in section 4.4.1.7). A 
total of 59 cases were diagnosed at the earlier stages of CKD while 96 
cases were diagnosed at the late stage of CKD.  
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Figure 5.3: The distribution of CKD cases according to their educational status and 
their stage of CKD at the time of diagnosis 
The highest number of diagnosed cases for those at the earlier stages 
of CKD and those at the late stage of CKD were those with a tertiary 
education while those that were uneducated had the lowest number of 
diagnosed cases (see Figure 5.3). However, the Phi and Cramer’s V 
statistics to test the significance of the association between both 
variables indicated that the association was not significant (R = 0.1, 
p=0.7). This indicated that the educational level of a patient is not 
likely to have had a significant influence on the patients’ stage of 
CKD at the time of diagnosis.  
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Figure 5.4: The distribution of CKD cases according to their occupational status and 
their stage of CKD at the time of diagnosis 
The association between the occupational groups and their stage of 
CKD diagnosis show that of the 74 cases diagnosed at the earlier 
stages, the semi-professionals had the highest number of diagnosed 
cases with 24 accounting for 32.4% of the total number of diagnosed 
cases with the earlier stages of CKD (see Figure 5.4). The 
professionals had the lowest number of diagnosed cases registered 
with the earlier stages of CKD with just one case from this group 
accounting for 1.4%. A similar pattern was identified within the 
occupational groups diagnosed with late stage CKD as the highest 
number was registered among the semi-professionals with 83 cases 
representing the 23.9% of the total number of late stage CKD cases 
within the dataset while the professionals still had the lowest with ten 
cases (2.9%). The Phi and Cramer’s V statistics to test the significance 
of the association between both variables indicated that the association 
was not significant (R = 0.1, p=0.6). This indicated that the 
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occupational status of a patient did not have a significant influence on 
the patients’ stage of CKD at the time of diagnosis. 
To analyse the association between the stages of CKD at time of 
diagnosis and the ethnic groups, the ethnic groups were classified into 
five groups based on their area of origin (discussed in section 4.4.1.4). 
However, 184 cases did not indicate their ethnic group and so could 
not be classified within the five ethnic groups as such, a total of 247 
cases were analysed.  
 
Figure 5.5: The distribution of CKD cases according to their ethnic groups and their 
stage of CKD at the time of diagnosis 
The ethnic groups within the south eastern zone had the largest 
number of cases that were diagnosed with both the earlier stages of 
CKD (accounting for 54.5% of all the earlier stages of CKD 
diagnoses) and the late stage of CKD with 47.1% of all the late stage 
of CKD diagnoses. The ethnic groups from the south western zone 
had the lowest number of cases that were diagnosed with the earlier 
stages of CKD (accounting for 5.2% of all the earlier stages of CKD 
diagnoses). The ethnic groups whose origins were outside Edo state 
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had the lowest number of cases that were diagnosed with the late stage 
of CKD accounting for only 5.9% of all the late stage of CKD 
diagnoses (see Figure 5.5). There was no statistical significance (R = 
0.1, p=0.7) in the relationship between the ethnic groups and the 
patients’ stage of CKD at the time of diagnosis. This therefore 
indicated that the patients’ ethnic group was not likely to have 
influenced their decision to seek treatment either earlier or at a late 
stage of the disease. Although there is not much information that can 
be derived from the result of this variable, it can be argued that the 
ethnicity of an individual in relation to their ethnic or cultural 
practices might not be a significant determinant for determining the 
stage of CKD that the patients would seek treatment.  
As discussed in section 4.4.1.5, a total of 247 cases were analysed for 
a relationship between religion and the stage of CKD diagnosis 
because these were the total number of CKD cases that indicated their 
religious affiliation. According to the results, the African 
traditionalists and the Muslims had the lowest number of diagnosed 
earlier stages of CKD with just two cases each (accounting for 2.6% 
for each of the religion) while the remaining 94.8% of diagnosed 
earlier stages of CKD were registered among the Christians.  Among 
those that were diagnosed with late stage CKD, there were no African 
traditionalists that were diagnosed and only three were Muslims 
(1.8%) while the remaining cases were Christians (98.2%). Although 
Edo state is generally perceived to have more Christians than Muslims 
within its borders, the exact proportion of the three major religions are 
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not known due to the absence of religion as an indicator within the 
censuses (BBC News, 2006). There are only speculations on the actual 
proportions of the three religious groups within the state. Previous 
surveys and censuses from previous years have been dominated by 
controversies. Their results have been disputed by both members of 
the general public and religious groups particularly the Muslim and 
Christian organisations (Abdulrasheed, 2008; Aguwa, 1997). 
However, the results for the association between religion and CKD 
diagnosis appear to indicate that the African traditionalists have the 
lowest number of cases that are diagnosed for CKD. One might 
assume that this group of people are not seeking treatment within the 
hospital environment or they might be living a healthier life than those 
from the other religions. I would however, lean towards the first 
assumption. This is because a recent study that attempted to map the 
use of conventional and traditional medicines / traditional healers 
among the general population indicated that a large proportion of the 
residents within the state used traditional healers and this was above 
the nation’s average use of traditional healers (Ojo et al., 2010). 
However, this result can only be verified after further studies have 
been carried out on the religious practices of CKD patients in the 
state, which was not covered within the scope of this study. The 
correlation test to determine the significance of the association 
between both variables indicated that the association was not 
significant (R = 0.1, p=0.1). This indicated that the religion of a 
patient did not have a significant influence on the patients’ stage of 
 
188 
 
CKD at the time of diagnosis. This may be an indication that the 
distribution of CKD cases among the various religious groups might 
be due to chance.  
Table 5.3: The proportion of CKD cases across the religious groups in relation to their 
stage of CKD at the time of diagnosis 
Stage of CKD 
Religion 
Total 
African 
traditionalist Christian Muslim 
Earlier 
stages of 
CKD 
Count 2 73 2 77 
% of CKD cases within 
the earlier stages of 
CKD 2.6 94.8 2.6 100 
late stage of 
CKD 
Count 0 167 3 170 
% of CKD cases within 
the late stage of CKD 0.0 98.2 1.8 100 
Total 
Count 2 240 5 247 
% of CKD cases within 
both stages of CKD 0.8 97.2 2.0 100 
 
5.2.2 Diagnosis variables and Stage of CKD at time of diagnosis 
As previously mentioned, the study focused on the prevalence of CKD 
from 2006 until 2009, in order to observe whether there are significant 
variations in the number of CKD cases that have been diagnosed 
annually within the state. Although further analysis was carried out to 
analyse the trend of CKD diagnosis, which is discussed in section 5.4, 
the time of diagnosis was included as a variable to identify any 
significant relationship with the stage of CKD at the time of diagnosis. 
This is because the result could indicate whether the influence of the 
variable for the year of diagnosis is significantly associated with the 
patients’ stage of CKD at the time of diagnosis. As discussed in 
section 2.1, the world kidney day, which started in 2006, is one of the 
global CKD awareness programmes, which aims to increase the 
awareness of CKD among the general public and within the health 
 
189 
 
sector. Therefore, there is the possibility that the impact of this 
awareness campaign might have influenced the number of CKD cases 
diagnosed at each stage of the disease. The number of the yearly 
diagnosis of cases that were diagnosed with earlier stages of CKD 
appeared to have a steady annual increase with the highest number 
recorded in 2009 accounting for 49.4% of all the cases diagnosed at 
the earlier stages of CKD (see Table 5.4).  The number of cases that 
were diagnosed at the late stage of CKD also had a steady annual 
increase even though there was a drop in the number of cases in 2009 
but this could be because the dataset did not include the whole year of 
2009 as data collection stopped in October. The chi-square test to 
determine the relationship between both variables indicated that the 
association was highly significant (χ2 =31.5, 3df, p<0.001). This 
indicated that the year of diagnosis had a significant influence on the 
patients’ stage of CKD at the time of diagnosis. This means that the 
proportion of early stage diagnoses goes up over time relative to the 
proportion of late stage diagnoses. One could therefore argue that the 
increased number of diagnosed cases might be attributed to a likely 
improvement in the awareness of CKD among the general population 
and members in the health sector. As mentioned earlier, this result was 
further analysed in section 5.4 in order to identify the trend of 
diagnosis throughout the study time period and determine the level of 
influence the variable had on diagnosed CKD within the state. 
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Table 5.4: The proportion of CKD cases diagnosed between 2006 and 2009 according to 
their stage of CKD at the time of diagnosis 
Stage of CKD 
Year of Diagnosis 
Total 2006 2007 2008 2009 
earlier 
stages of 
CKD 
Count 7 10 22 38 77 
% of CKD cases within the earlier 
stages of CKD 9.1 13.0 28.6 49.4 100 
late stage of 
CKD 
Count 82 96 103 73 354 
% of CKD cases within the late 
stage of CKD 23.2 27.1 29.1 20.6 100 
Total 
Count 89 106 125 111 431 
% of CKD cases within both 
stages of CKD 20.6 24.6 29.0 25.8 100 
 
As discussed in section 4.4.2.3, four main biological risk factors were 
included in the analyses as variables. These were chronic 
glomerulonephritis, hypertension, Diabetes, and Toxic nephropathy.  
 
Figure 5.6: The presence or absence of chronic glomerulonephritis among CKD cases 
diagnosed at the earlier stages and the late stage of CKD 
 
In regards to the presence of chronic glomerulonephritis, 26 cases 
already had it when they were diagnosed with the earlier stages of 
CKD (33.8% of all the earlier stage of CKD) while 145 cases of those 
that were diagnosed with the late stage of CKD were found to have 
chronic glomerulonephritis (41.9% of all the late stage of CKD). 
However, the chi-square test indicated that the relationship between 
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the chronic glomerulonephritis and the stage of CKD at the time of 
diagnosis was not statistically significant (χ2 =1.7, 1df, p=0.2). 
Although chronic glomerulonephritis accounted for 38.9% of the 
diagnosed cases of CKD (see section 4.4.2.3), it did not appear to 
contribute significantly to a patient’s stage of CKD at the time of 
diagnosis. This means that the presence of chronic glomerulonephritis 
in a patient may not significantly determine whether they are likely to 
be diagnosed at the earlier stages or late stage of CKD. 
Hypertension was found among 49 cases with the earlier stages of 
CKD thereby accounting for 63.3% of all the cases diagnosed with the 
earlier stages of CKD while 120 cases among those diagnosed with 
the late stage CKD had hypertension (34.6% of all the late stage of 
CKD). Although there were less cases diagnosed with earlier stages of 
CKD, there appeared to be a higher proportion of cases with 
hypertension that were diagnosed at the earlier stages of the disease 
than with those diagnosed at the late stage of CKD (see Table 5.5). 
The chi-square test used in examining the significance of the 
association between both variables indicated that the association was 
highly significant (χ2 =22.2, 1df, p<0.001). This indicated that the 
presence of hypertension in patients had a significant influence on the 
patients’ stage of CKD at the time of diagnosis. This means that the 
presence or absence of hypertension in a patient may significantly 
determine whether they are likely to be diagnosed at the earlier stages 
or late stage of the CKD. 
 
 
192 
 
Table 5.5: The proportion of CKD cases with or without hypertension at the time of 
CKD diagnosis in relation to their stage of CKD. 
Stage of CKD 
hypertension 
Total no yes 
Earlier stages of CKD 
Count 28 49 77 
% of CKD cases within the 
earlier stages of CKD 36.4 63.6 100 
late stage of CKD 
Count 227 120 347 
% of CKD cases within the 
late stage of CKD 65.4 34.6 100 
Total 
Count 255 169 424 
% of CKD cases within 
both stages of CKD 60.1 39.9 100 
 
The total number of CKD patients that had diabetes was relatively 
small when compared to the patients that had either chronic 
glomerulonephritis or hypertension, because they only account for a 
total of 70 cases within the dataset (accounting for 16.5% of all 
diagnosed cases). A total of 21 cases that were diagnosed with earlier 
stages of CKD had diabetes (27.3% of all cases diagnosed with the 
earlier stages of CKD) while 49 cases with diabetes were diagnosed at 
the late stage of CKD (14.1% of the total cases diagnosed at the late 
stage of CKD) (see Table 5.6). However, the chi-square test used in 
examining the significance of the association between the diabetes 
variable and the variable for the stage of CKD indicated that the 
association was highly significant (χ2=22.2, 1df, p<0.001). This 
indicated that the presence or absence of diabetes in patients had a 
significant influence on the patients’ stage of CKD at the time of 
diagnosis.  
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Table 5.6: The proportion of CKD cases with or without diabetes at the time of CKD 
diagnosis in relation to their stage of CKD. 
Stage of CKD 
Diabetes 
Total no yes 
Earlier stages 
of CKD 
Count 56 21 77 
% of CKD cases within the earlier 
stages of CKD 72.7 27.3 100 
late stage of 
CKD 
Count 298 49 347 
% of CKD cases within the late 
stage of CKD 85.9 14.1 100 
Total 
Count 354 70 424 
% of CKD cases within both 
stages of CKD 83.5 16.5 100 
 
Patients with toxic nephropathy accounted for a smaller proportion of 
diagnosed CKD cases within the dataset with a total of just 31 cases 
(7.3% of all diagnosed CKD cases). As discussed in section 4.4.2.3, 
this risk factor is more likely diagnosed as an underlying cause of 
CKD. This means most patients that have toxic nephropathy only are 
diagnosed with the disease after they have developed CKD and are 
seeking treatment for CKD. Therefore, there is the possibility that the 
diagnosis of toxic nephropathy might be ignored, as the primary focus 
would be the treatment and management of CKD in such patients. 
This means that there is the likelihood that there might be more CKD 
patients that had toxic nephropathy but the disease was not indicated 
in their health files. As this assumption cannot be readily verified, the 
outcome of this analysis would be based on those that were identified 
as having toxic nephropathy.  
Among those that were diagnosed at the earlier stages of CKD, 12 
cases had toxic nephropathy, which accounted for a total of 15.6% of 
all cases diagnosed at the earlier stages of CKD. Among those that 
were diagnosed at the late stages of CKD, just 19 cases out of the 348 
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cases had toxic nephropathy, which accounted for a total of 5.5% of 
all cases diagnosed at the late stages of CKD (see Table 5.7). 
However, the chi-square test used in examining the significance of the 
association between the toxic nephropathy variable and the variable 
for the stage of CKD, indicated that the association was highly 
significant (χ2 =9.6, 1df, p<0.001). This indicated that the presence or 
absence of toxic nephropathy in patients had a significant influence on 
the patients’ stage of CKD at the time of diagnosis.  
Table 5.7: The proportion of CKD cases with or without toxic nephropathy at the time 
of CKD diagnosis in relation to their stage of CKD 
Stage of CKD 
Toxic 
nephropathy 
Total no yes 
Earlier stages of CKD 
Count 65 12 77 
% of CKD cases within the 
earlier stages of CKD 84.4 15.6 100 
late stage of CKD 
Count 329 19 348 
% of CKD cases within the 
late stage of CKD 94.5 5.5 100 
Total 
Count 394 31 425 
% of CKD cases within both 
stages of CKD 92.7 7.3 100 
 
In relation to the four biological risk factors, hypertension, diabetes, 
and toxic nephropathy appeared to have a highly significant influence 
on the patients’ stages of CKD at the time of diagnosis. However, the 
presence or absence of chronic glomerulonephritis did not appear to 
have a statistically significant influence on the patients’ stages of 
CKD at the time of diagnosis. 
The type of referral centres that referred cases to UBTH for 
treatment was examined. The reason for including this variable is so 
that it can be used to understand the patients’ choice of health service 
in regards to receiving conventional medical treatment. It should be 
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stated that medical treatment in this case, refers to treatments received 
at a conventional health facility and not treatments received at 
alternative
26
 clinics or traditional centre. Therefore, it should not be 
confused with the choice of seeking alternative medicine or treatment 
before seeking conventional treatment. However, only 247 cases 
indicated the health centres that referred them for treatment and so the 
result is based on 55.9% of the 442 cases that were used in this study.  
 
Figure 5.7: The distribution of CKD cases according to their mode of referral to the 
renal department and their stage of CKD at the time of diagnosis 
The result indicated that for cases that were diagnosed at the earlier 
stages of CKD and those that were diagnosed at the late stage of CKD, 
the various departments within UBTH had the highest referral rate 
accounting for 58.3% for both earlier stages of diagnosis and late 
stage of CKD (see Figure 5.7). The lowest referral rate was found to 
be those from the public clinics for both earlier stages of diagnosis 
(1.4%) and those diagnosed at the late stage of CKD (1.1%). Due to 
the proportion of cases whose mode of referral to UBTH’s renal 
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department could not be identified, the variable for the referral centres 
was not statistically tested for an association with the stages of CKD 
at time of diagnosis. However, according to discussions with some of 
the nephrologists at the renal unit in UBTH, they identified that the 
general physicians and even nephrologists have an equally important 
role to play in the early identification and treatment of CKD. They 
noted that there has been an increase in the referral rates of CKD 
patients with early stages of CKD from other hospitals although they 
still believe that most health centres within the state especially those 
in the rural areas still need to be informed about how to effectively 
identify CKD at its early stages. 
In summary, the statistical tests for the association between the 
various variables and the stage of CKD at the time of diagnosis 
showed that only four variables out of the thirteen variables were 
statistically significant. All the socio-demographic variables namely 
sex, age groups, marital status, education, religion, ethnic group, and 
occupation were not statistically significant when tested for an 
associated with the patients’ stage of CKD at the time of diagnosis. 
This shows that the socio-demographic variables may not have had an 
influence on the patients’ stage of CKD at point of diagnosis. 
Therefore, their distributions among the various stages of CKD 
diagnosis were probably due to chance. Among the four biological 
risk factors associated with CKD, three risk factors namely: 
hypertension, diabetes, and toxic nephropathy were found to be 
statistically significant at the 99% level. A likely reason why these 
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risk factors were significant and seemed to be more common among 
early stage diagnoses than late stage diagnoses could be attributed to 
the fact that patients who already had any of these risk factors were 
being monitored by their doctors, which made it easier for them to 
identify CKD at its earlier stages. Chronic glomerulonephritis was 
however, not significant when tested for an association with the stage 
of CKD at the time of diagnosis.  
The year of diagnosis was found to be highly significant at p<0.001 
level when tested against the patients’ stages of CKD at the time of 
diagnosis. The high significance noted between the stage of CKD at 
the time of diagnosis and the year when they were diagnosed, showed 
that theproportion of early stage diagnoses goes up over time relative 
to the proportion of late stage diagnoses . It could be suggested that 
the distribution of the cases across the various stages of CKD could be 
due to the recent attempt at increasing the awareness of the disease 
within the state particularly during the World kidney Day programme. 
This might have enabled healthcare officials as well as members of 
the public to be more aware of the problem of CKD, which might 
have resulted in health officials taking necessary actions to identify 
and treat the disease once a patient showed any symptom(s), which 
might have been overlooked in the past. However, this assumption can 
only be confirmed by carrying out further analysis as the actual 
procedure on how the diagnosis was determined for patients was not 
documented in detail within their health files. To identify any trend of 
diagnosed CKD within the study period that might give any indication 
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to these assumptions, a time series analysis was carried out (discussed 
in section 5.4). 
In the next section, a feasible model was created in order to predict the 
severity of the stage of CKD at time of diagnosis using the statistically 
significant variables that were discussed in this section.  
5.3 A logistic regression model for predicting the severity of 
CKD at time of diagnosis for CKD patients in Edo state 
This section looks at creating a suitable model for the dataset to 
predict the possibility of a CKD patient to be diagnosed at either the 
earlier stage of CKD or the late stage of CKD (discussed earlier in 
Section 5.2). The result from this model should provide an answer to 
the fourth research question stated at the beginning of this chapter. 
The logistic regression was chosen for this analysis because the 
outcome variable of interest (stage of CKD) is classified into two 
categories (earlier stage or late stage of CKD at time of diagnosis).  
The logistic regression equation is stated as follows: 
Equation 5.1: the equation for a logistic regression model 
 
Source 5:1: http://www.eje-online.org/content/162/5/869.full (Barbosa et al., 2010)  
where b0 is a constant; b1,b2…bp  are the regression coefficients for 
each predictor; X1,X2…Xp  are the explanatory variables. The value P 
represents the probability of a particular outcome, given that set of 
explanatory variables.  
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5.3.1 Choice of predictor variables and method for Logistic regression 
analysis 
The stage of CKD at the time of diagnosis was set as the outcome 
variable with the earlier stage of CKD coded as zero (0) and the late 
stage category coded as 1; this was because the late stage category had 
a larger number of diagnosed CKD cases than the category for the 
earlier stages (see section 4.4.2.2). The three significant variables 
were included within the first block using the forced entry method, 
which simultaneously adds the selected predictor variables into the 
model. The chronic glomerulonephritis was added along with the three 
variables from the first block to the second block using the forward 
stepwise selection (likelihood ratio) method. This method was chosen 
for the second block because some studies indicate that chronic 
glomerulonephritis (CGM) is a known predictor/risk factor of CKD 
(Frontera et al., 2008; Ijoma et al., 2010). 
The forward stepwise method selects the predictor variable that best 
predicts the outcome variable and if this predictor variable 
significantly improves the ability of the model to predict the outcome 
then it is retained in the model, another predictor is considered, and a 
removal test is made of the least useful predictor (Field, 2000, p. 120). 
This procedure ensures that the regression equation of the model is 
constantly being reassessed to identify any redundant predictor 
variable that can be removed from the model. It has been argued that 
because the stepwise methods relies on the computer basing its 
selection of the predictor variables on a mathematical criterion, the 
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methodological decisions is taken out of the hands of the researcher 
and should be used only in exploratory model building (Field, 2000; 
Menard, 1995). It was for this reason that the forward stepwise 
method was chosen as the method for the second block as the aim of 
the model was to explore the data for other variables that would 
significantly predict the stage of CKD at time of diagnosis. 
5.3.2 Saving Residuals for evaluation of regression Model and the 
Option settings for analysis 
To examine how well the model fitted the observed data, residuals 
were identified using the save dialog box. The boxes for the predicted 
values, the values for the residual statistics and the influence statistics 
were ticked.  
The casewise listing of residuals was selected and the standard 
deviation for any outliner was set to 2.5. This value was chosen 
because 5% of the database is allowed to lie above +/- 2 and 1% to lie 
above +/- 2.5 but any value outside the +/- 2.5 should be examined 
further (Field, 2000, p. 188). The criteria of the probability for 
stepwise, the classification cut-off value was set to 0.5, the maximum 
iteration value was set to 20 iterations, and the constant in the model 
was included. 
5.3.3 Discussion of results for the first block of the model 
A summary table of the analysis indicated that 422 cases (95.5%) 
were analysed out of the 442 cases within the dataset while 20 cases 
were classified as missing cases as these cases had missing categories 
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within the variables that were analysed in the model (Table 5.8). The 
parameter coding table for the predictor variables, which are important 
for calculating the probability of the outcome variable (stage of CKD 
at time of diagnosis), was included and this confirmed the categorical 
settings that were chosen in the categorical dialog box (Table 5.9). 
Table 5.8: A summary table of CKD cases used in the Logistic regression model 
Case Processing Summary 
Cases N Percent 
Selected Cases Included in Analysis 422 95.5 
Missing Cases 20 4.5 
Total 442 100.0 
Unselected Cases 0 .0 
Total 442 100.0 
 
Table 5.9: Categorical Variables coding for the predictor variables 
Categorical Variables Coding 
  Frequency 
Parameter 
coding (1) 
chronic glomerulonephritis 
(CGM) 
no 251 1 
yes 171 0 
Hypertension (HTN) 
no 254 1 
yes 168 0 
Toxic nephropathy 
no 393 1 
yes 29 0 
Diabetes (Dtm) 
no 353 1 
yes 69 0 
 
The first model which was done using a forced entry method began 
with including just the constant in the regression equation and by 
default, SPSS attempts to predict that every case belongs to the 
category in which the most observed cases fell, in this case, it 
attempted to predict cases diagnosed at the late stage of CKD. This is 
because SPSS attempts to maximise how well the model predicts the 
observed data (Field, 2000, p. 176). The -2 log likelihood statistics (-
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2LL) for a model was also calculated, used in indicating the extent to 
which the model fails to perfectly predict the values of the outcome 
variable, i.e. it tells how much improvement is needed before the 
predictors provide the best possible prediction of the dependent 
variable. The value of the -2LL for the constant was 400.993, which 
indicated the total amount of information that needed to be explained 
by the model while the value of the constant (β0) in the model was 1.5 
(see Table 5.10).   
According to the model prediction with only the constant, the model 
was unable to predict any of the cases diagnosed with earlier stages of 
CKD (0%) but it correctly predicted all the cases diagnosed with late 
stage CKD (100%). The overall prediction percentage of the model 
with only the constant was 81.8%, which is a weighted average of the 
prediction values for correctly predicting both stages of CKD (see 
Table 5.11). 
Table 5.10: The value of the -2LL for the constant and the value of the constant 
Iteration Historya,b,c 
Iteration 
-2 Log likelihood 
Coefficients 
Constant 
Step 0 1 404.474 1.270 
2 401.007 1.485 
3 400.993 1.500 
4 400.993 1.500 
a. Constant is included in the model. 
b. Initial -2 Log Likelihood: 400.993 
c. Estimation terminated at iteration number 4 because parameter estimates changed by 
less than .001. 
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Table 5.11: The classification table for the model with only the constant 
Classification Tablea,b 
Observed 
Predicted 
new CKD stage 
Percentage 
Correct 
Earlier stages of 
CKD 
Late stage 
of CKD 
Step 0  
CKD 
stage 
Earlier stages of 
CKD 
0 77 .0 
Late stage of CKD 0 345 100.0 
Overall Percentage     81.8 
a. Constant is included in the model. 
b. The cut value is .500 
 
The model evaluated the variables that were yet to be included in the 
model at this first stage (step 0) and identified that the Roa’s efficient 
score of all the three predictors from the first block were highly 
significant and as such, the model proceeded to include them in the 
regression equation (Table 5.12). 
Table 5.12: Predictor variables for the first block that was not yet included in the model 
Variables not in the Equation 
  Score df Sig. 
Step 0 Variables Dtm(1) 8.215 1 .004 
HTN(1) 22.313 1 .000 
Toxic nephropathy (1) 11.171 1 .001 
Overall Statistics 40.131 3 .000 
 
The iteration history table for the model indicated that the -2LL had 
dropped from 400.993 to 363.219 (see Table 5.13), which indicated a 
change of 37.774 (the value of the model chi-square). The Model Chi-
Square with a significant value indicates that one or more coefficients 
differ from zero, but it does not identify which ones. However, the 
Block chi-square indicates whether one or all of the variables included 
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in this block have effects that differ from zero. While the step chi-
square indicates the improvement of the predictive power of model 
since the last stage i.e. whether the effect of the variable that was 
entered in the final step is significantly different from zero. The 
significance level for the model chi-square indicated that the model 
chi-square values as well as the chi-square values for the block and 
step were all highly significant (χ2 = 37.77, 3df, p<0.0001). It should 
be noted that the chi-square values for the step, block, and model are 
all the same because the predictor variables were simultaneously 
added into the model (see Table 5.14). 
Table 5.13: The values for the -2 log likelihood and the values for the constant and 
coefficients of the predictor variables 
Iteration Historya,b,c,d 
Iteration 
-2 Log 
likelihood 
Coefficients 
Constant Dtm(1) HTN(1) 
Toxic nephropathy 
(1) 
Step 1 1 374.091 -.510 .535 .703 .977 
2 363.563 -.915 .774 1.103 1.292 
3 363.219 -1.011 .823 1.207 1.359 
4 363.219 -1.015 .825 1.212 1.362 
5 363.219 -1.015 .825 1.212 1.362 
a. Method: Enter 
b. Constant is included in the model. 
c. Initial -2 Log Likelihood: 400.993 
d. Estimation terminated at iteration number 5 because parameter estimates changed by 
less than .001. 
 
Table 5.14: Chi-square test for the step, block and model of the logistic regression 
Omnibus Tests of Model Coefficients 
  Chi-square df Sig. 
Step 1 Step 37.774 3 .000 
Block 37.774 3 .000 
Model 37.774 3 .000 
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The Hosmer and Lemeshow’s goodness-of-fit test (see Table 5.15), 
which tests the hypothesis that the observed data is significantly 
different from the predicted values from the model (Field, 2002). 
Therefore, a non-significant value for this test would indicate that the 
model does not differ significantly from the observed data. The result 
was found not to be significant (χ2 = 3.22, 3df, p< 0.360) and as such, 
the hypothesis for the Hosmer and Lemeshow’s goodness-of-fit test is 
rejected and it therefore indicates that the model is predicting the data 
for the stage of CKD at time of diagnosis fairly well. 
Table 5.15: Hosmer and Lemeshow’s goodness-of-fit test 
Hosmer and Lemeshow Test 
Step Chi-square df Sig. 
1 3.215 3 .360 
 
The SPSS Output included a classification table that documented the 
validity of predicted probabilities (Table 5.16). The cut-off point was 
set at 0.5 and the prediction for the stages of CKD at time of diagnosis 
after the three-predictor variables were added to the model correctly 
classifies six earlier stages of CKD cases but misclassifies 71 cases as 
late stage CKD instead of earlier stages of CKD cases. This meant that 
for the earlier stage of CKD, the model correctly predicted only 7.8%. 
Although there was an increase in the prediction for this category 
compared to when the model only had the constant, the prediction was 
still low. For the late stage of CKD category, the model correctly 
classified 339 cases as late stage CKD but wrongly classified six cases 
thereby having a prediction percentage of 98.3% although this was a 
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very high prediction percentage, there was however, a drop of 1.7% in 
the prediction level for this category. The overall accuracy of the 
classification was a total of 81.8%, which was the same as the 
weighted overall percentage of the model with only the constant 
included. However, the classification can still be regarded as an 
improvement because even though the prediction dropped by 1.7% in 
classifying the late stage cases, it improved by 7.8% in the 
classification of the earlier stages of CKD. 
Table 5.16: The Observed and the Predicted Frequencies for stages of CKD at time of 
diagnosis by Logistic Regression with the Cut-off of 0.50 
Classification Tablea 
Observed Predicted 
stage of CKD 
Percentage 
Correct 
Earlier stage 
of CKD 
Late stage 
of CKD 
Step 1 CKD 
stage 
Earlier stage of CKD 6 71 7.8 
Late stage of CKD 6 339 98.3 
Overall Percentage     81.8 
a. The cut value is .500 
 
The regression coefficients for all the three variables in the model 
were highly significant, indicating that hypertension, diabetes and 
toxic nephropathy significantly predicted the stage of CKD at time of 
diagnosis.  
If  exp β, which is an indicator of the change in the odds resulting 
from a one unit change in the predictor, is greater than 1 then the odds 
of a predicted outcome happening are larger than the odds of it not 
happening. This means that the odds of being diagnosed at the late 
stage of CKD are larger than the odds of being diagnosed at the earlier 
stage of CKD and this is because the late stage of CKD at time of 
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diagnosis is the reference category (i.e. late stage of CKD=1). 
However, if exp β is less than 1, this indicates that the odds of being 
diagnosed at the late stage of CKD are less than the odds of being 
diagnosed at the earlier stage of CKD. As the predictor variables were 
coded as “0” for cases where the risk factor was present at time of 
diagnosis and “1” for cases where it was not (see Table 5.9), exp β 
shows how much larger or smaller the odds of being diagnosed with 
CKD late rather than early are for those who were not diagnosed with 
the risk factor than for those who were known to have an ‘at risk’ 
condition. The odds of a case without diabetes being diagnosed at the 
late rather than the early stage of CKD were 2.3 times greater than the 
odds for a case with diabetes. The odds of a case without hypertension 
being diagnosed at the late rather than the early stage of CKD were 
3.4 times greater than the odds for a case with hypertension and the 
equivalent odds of a case without toxic nephropathy were 3.9 times 
greater than the odds for a case with toxic nephropathy. This can be 
regarded as plausible as the presence of these risk factors in a patient 
enables them to seek medical help early or if they are already 
undergoing treatment for these risk factors, their physicians may be 
able to identify the development of CKD thereby diagnosing it at an 
earlier stage.  
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Table 5.17: The values for the Coefficients in the model 
Variables in the Equation 
  
β S.E. Wald df Sig. exp β 
95% C.I. for 
exp β 
Lower Upper 
Step 
1a 
Dtm(1) .825 .317 6.767 1 .009 2.282 1.226 4.250 
HTN(1) 1.212 .270 20.205 1 .000 3.359 1.981 5.698 
toxic 
nephropathy (1) 
1.362 .430 10.033 1 .002 3.904 1.681 9.068 
Constant -1.015 .506 4.029 1 .045 .362     
a. Variable(s) entered on step 1: Dtm, HTN, toxic nephropathy. 
 
Using the equation for the Logistic Regression Model (see Equation 
5.1), the Logistic Regression Model for the probability of a patient to 
be diagnosed at the late stage of CKD could therefore be determined. 
Given the fact that within the equation, the exp β values for the 
constant was represented as b0, diabetes was b1, hypertension was b2, 
and toxic nephropathy was b3, the model for the possibility of 
predicting that a patient is diagnosed at the late stage of CKD is 
expressed as: 
Equation 5.2: A model expressing the probability of the severity of CKD at the time of 
diagnosis 
 
5.3.3.1 The Hosmer and Lemeshow’s measure (RL2) 
The Hosmer and Lemeshow’s measure (RL
2
), which indicates the 
proportional reduction in the absolute value of the likelihood measure 
(-2LL) can therefore be used to indicates how much the goodness-of-
fit of the model improves because of the inclusion of the predictor 
variables. The RL
2 
was calculated by
 
dividing the model chi-square 
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value (for the model when the predictors are included in the model) by 
the initial value of the -2LL (which is the -2LL value when only the 
constant is included in the model).  
Model chi-square = 37.774; -2LL= 400.993 
Therefore: RL
2 
= 37.774 ÷ 400.993 = 0.094 
RL
2 
= 9.4% 
This meant that the model could account for 9.4% of the variance in 
the stage of CKD at time of diagnosis, which meant that 90.6% of 
what helps in the prediction of the stage of CKD at the time of 
diagnosis is yet to be accounted for. This outcome further places an 
emphasis on the need for an extensive investigation into the severity 
of diagnosed CKD within both the state and the country as a whole.  
5.3.3.2 Testing for multicollinearity 
Multicollinearity exists when there is a strong association between 
two or more predictors in a regression model and in order to ensure 
that there are no correlations between the predictor variables, a 
collinearity diagnostics in the form of a correlation matrix was 
generated in SPSS to test for any correlation among the predictor 
variables. The results from the collinearity Statistics indicated that 
none of the variables had any strong correlation with any of the other 
variables. According to Menard (1995), a tolerance value of less than 
0.1 likely indicates collinearity while Myers (1990) suggests that a 
VIF value greater than 10 indicates a collinearity problem (Menard, 
1995; Myers, 1990; cited by Field, 2000). As none of the variables 
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have any tolerance value less than 0.1 or a VIF value greater than 10, 
there were no indications of multicollinearity within the model. 
Table 5.18: A Collinearity Statistics to test for multicollinearity among the predictor 
variables 
Coefficientsa 
Model Collinearity Statistics 
Tolerance VIF 
1 Diabetes .997 1.003 
hypertension .996 1.004 
Toxic nephropathy 1.000 1.000 
a. Dependent Variable: stages of CKD at time of diagnosis 
 
5.3.4 The forward stepwise method for the second block 
The results from the second block of the model which consisted of the 
diabetes, hypertension, toxic nephropathy, and chronic 
glomerulonephritis variables as predictor variable was unable to 
produce a better model than the first block as the chronic 
glomerulonephritis variables could not make a significant contribution 
to the predictive power of the model. As a result of this, the regression 
model terminated at this point but the output also produced an analysis 
of the model to show if any of the significant variables from the first 
block were removed. The result in table below indicated that all the 
values for the log-likelihood ratio for the variables were highly 
significant. This showed that the removal of any of these variables 
would have a significant effect on the predictive ability of the model. 
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Table 5.19: Test to show the significance of the predictor variables to remain in the 
model 
Model if Term Removed 
Variable Model Log 
Likelihood 
Change in -2 
Log Likelihood df 
Sig. of the 
Change 
Step 0 Dtm -184.813 6.407 1 .011 
HTN -192.197 21.175 1 .000 
toxic nephropathy  -186.262 9.305 1 .002 
 
The SPSS output for the logistic regression also produced a table to 
indicate the variables that were not included in the model, this showed 
that the score statistics significance values for the chronic 
glomerulonephritis variable was not significantly different from zero, 
therefore it was not included to the model. This indicated that the 
chronic glomerulonephritis variable was not a significant predictor for 
the diagnosis of CKD at the late stage. 
Table 5.20: A statistical test on the variables that could not be included in the model 
Variables not in the Equation 
  Score df Sig. 
Step 1 Variables CGN(1) 2.958 1 0.085 
  Overall Statistics 2.958 1 0.085 
 
5.3.5 Interpreting the residuals 
In order to identify any case that the model fitted poorly, the 
studentized residual, standard residual and deviance statistics were 
examined for values that were above ±2.5 and for cases that may exert 
an undue influence on the model the cook’s distance, the leverage, and 
the DFBata for the three predictors variables were examined. An 
examination of the standard residual and deviance statistics for values 
above ±2.5 showed that none of the values was above ±2.5 (see 
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Appendix D) as residual values above ±2.5 indicate that the model is a 
poor fit of the dataset (Field, 2000, p. 123). In order to also confirm 
that less than 5% of the dataset had studentized residual values less 
than ±2, the outlier’s standard deviation value set at 2 so that a 
casewise list of the studentized residuals with values above ±2 were 
listed. The SPSS output produced a table of 19 cases with studentized 
(the ZResid variable) residual values above ±2 representing 4.3% of 
the dataset and since this was less than 5% of the total dataset, there 
was no evidence that the model is a poor representation of the actual 
dataset (Table 5.21). 
Table 5.21: Predicted Probability for stages of CKD at time of diagnosis with outliners 
cases 
Casewise Listb 
serial 
number 
Case 
number Selected 
Statusa 
Observed 
Predicted 
Temporary Variable 
new CKD stage Resid ZResid 
1 5 S 1** .916 -.916 -3.293 
2 11 S 1** .916 -.916 -3.293 
3 14 S 1** .916 -.916 -3.293 
4 15 S 1** .916 -.916 -3.293 
5 113 S 1** .916 -.916 -3.293 
6 125 S 1** .916 -.916 -3.293 
7 136 S 1** .916 -.916 -3.293 
8 252 S 1** .916 -.916 -3.293 
9 253 S 1** .916 -.916 -3.293 
10 256 S 1** .916 -.916 -3.293 
11 257 S 1** .916 -.916 -3.293 
12 258 S 1** .916 -.916 -3.293 
13 259 S 1** .916 -.916 -3.293 
14 316 S 1** .916 -.916 -3.293 
15 319 S 1** .916 -.916 -3.293 
16 322 S 1** .916 -.916 -3.293 
17 324 S 1** .916 -.916 -3.293 
18 326 S 1** .916 -.916 -3.293 
19 327 S 1** .916 -.916 -3.293 
a. S = Selected, U = Unselected cases, and ** = Misclassified cases. 
b. Cases with studentized residuals greater than 2.000 are listed. 
 
To determine if any of the cases were exacting undue influence over 
the parameters of the model in order to determine whether the 
regression model was stable across the dataset or was biased by a few 
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influential cases, the cook’s distance, the leverage, and the DFBeta for 
the three predictors were examined. The cook’s distance is a measure 
of the overall influence of a case on the model (Field, 2000) and it has 
been suggested that values greater than 1 may be a reason for concern 
(Cook and Weisberg, 1982). Another measure for influential cases is 
the leverage statistics, which gauges the influence of the observed 
value of the outcome variable over the predicted values. The leverage 
values can lie between zero indicating a case with no influence, to one 
indicating that the case has complete influence over prediction 
however, cases with large leverage values will not necessarily have a 
large influence on the regression coefficients because they are 
measured on the outcome variables instead of the predictors. The third 
method for measuring the influential cases is known as the DFBeta 
statistics in SPSS, it measures the difference between a parameter 
estimated using all cases and estimated when one cases is excluded 
from the dataset. In SPSS, the DFBeta, which is a standardized 
version of the Cook’s distance statistics, is calculated for the constant 
and the predictor variables in the model and a value above one (1) 
indicates cases that influence the model parameters. 
As mentioned earlier when the parameters for the model was set, the 
SPSS programme was instructed to save the values for the residuals 
for each case as variables in the dataset in order to carry out a residual 
diagnostics on the model. A case summary for the leverage and the 
DFBeta residuals for each predictor variable using the report option 
were created. The values for the leverage statistics were assessed for 
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values high (close to the value of one) however, none of the values 
were above 0.61.  The values for the DFBeta residuals were assessed 
for values that were above one. However, none of the values in any of 
the DFBeta statistics for the predictor variables was greater than 1 
therefore there were no cases that appeared to be exacting undue 
influence on the model (see Appendix E).  
Although the model had a low classification percentage for predicting 
earlier stages of CKD at time of diagnosis, it had a 98.3% 
classification for cases at the late stage of CKD and the model was 
found to have an overall classification of 81.8% for predicting the 
stage of CKD at time of diagnosis. The logistic regression model can 
be regarded as a good representation of the dataset as the diagnostics 
of the residuals indicated that there were no outliners or influential 
cases within the dataset that could lead to a biased model. Since the 
values of the exp β for each predictor variables in the model were 
significant, it can be argued that the relationship found between these 
three predictor variable and the stage of diagnosis in this dataset is 
true for the whole population within Edo state. 
In conclusion, if any of the three biological risk factors are absent in a 
patient, the odds of being diagnosed at the late stage of CKD are 
larger than the odds of being diagnosed at the earlier stages. This can 
be regarded as plausible as the presence of these risk factors in a 
person enables them to seek medical help early or if they are already 
undergoing treatment for these risk factors, their physicians may be 
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able to identify the development of CKD thereby diagnosing it at an 
earlier stage. Therefore, in the development of strategies that might 
help in the early diagnosis of patients, those without any previously 
known risk factors should equally be taken into account. 
5.4 A time series analysis of CKD diagnosis in Edo state 
There are awareness programmes that are sponsored by private and 
public organizations using the media, as well as grass-root initiatives, 
created to combat CKD within the country. There have been issues 
raised that the disease may have a current and future impact on the 
nation’s health and economy. One such initiative within Edo state is 
the location of a free CKD screening centre in Ogbona ward of Etsako 
central LGA, which is at the northern part of the state, which began in 
2008 and runs for 6 weeks each year. This initiative is led by the 
nephrology department of UBTH to reach out to the population that is 
too far from the hospital. The World Kidney Day is still the main 
CKD awareness programme currently running within the country to 
promote the awareness of CKD. As previously mentioned in chapter 
one, although there is no renal registry, the Nigerian Association of 
Nephrology (NAN) has stated that hospital records show that CKD 
accounts for 10% of medical admissions within the country (NAN, 
2008). Apart from this report by NAN, there has been no other report 
or statistics to support or dispute this figure. 
Before the World Kidney Day, which began in 2006, there have been 
previous attempts at making both the health officials and the general 
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public aware of the prevalence of CKD within the country (Akinsola 
et al, 1989) and in other nations around the world (Alebiosu & 
Ayodele, 2005; Jones et al., 1998; Jungers et al., 1996). However, the 
World Kidney Day in 2006 marked the first attempt at combating the 
disease from a global viewpoint and as such marked the choice for the 
start of the study period for this research study.  
5.4.1 The trend of CKD within Edo state 
To identify the impact of CKD in Edo State, there is the need to 
identify high CKD prevalence areas along with areas with low CKD 
prevalence and observe as well as analyse the changes within these 
areas over the years. However, before such spatial analysis can be 
done, there is the need to evaluate the trend of diagnosed CKD cases 
during the study period. One of the ways that the trend of CKD 
diagnosis can be assessed is by identifying the diagnosed CKD cases 
for each month from the time of the first globally recognised 
awareness programme for CKD in 2006, in which Nigeria took part. 
The result from the time series analysis was used to identify the trend 
of CKD diagnosed within the study period in the state. These results 
were cross-referenced with the geographical locations of the 
diagnosed patients thereby identifying areas where the disease likely 
had an impact as well as areas where there were little or no indications 
of diagnosed cases within certain times during the study period. These 
analyses will help the organizers of the healthcare delivery services to 
manage the impact of CKD across the state more effectively. The 
outcome could also enable them to create ways to reach out to the 
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general public so as to make them aware of the benefits of the 
prevention of CKD and the early detection of the disease if they 
already have it.  
The date CKD diagnosis for each of the 442 CKD cases was recorded 
within their case file, which was included in the dataset as a time 
variable. These were totalled for each month. A time series analysis 
was carried out on the aggregated dataset. To reduce or remove any 
random fluctuations present within the time series, a moving average 
was used to smooth the dataset. A 3-month or quarterly moving 
average was used in order to identify the underlying trend of CKD 
diagnosis for each quarter within the study period. 
The result of the time series analysis showed that there was an upward 
trend in the number of cases diagnosed each year, which is indicated 
by the red line on the chart below (see Figure 5.8).  
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Figure 5.8: The trend of diagnosed CKD within the study period of 2006 to October 
2009 
The time series for the original dataset is represented by the blue line 
and as mention earlier, it appears to have a number of fluctuation 
within its pattern, which might be attributed to noise or variations 
within the dataset.  
Using the 3-month moving average, the trend showed that there 
appeared to be an increase in the number of diagnosed cases followed 
by a drop in the number of diagnosed cases as one moves from one 
quarter to the next quarter with January within the thirteenth quarter 
(January 2009) registering the lowest number of cases within the 
series. However, the highest number of diagnosed cases was also 
registered in the same year within the fourteenth quarter in the month 
of July 2009.  
To identify the geographical locations of the lowest and the highest 
number of diagnosed cases within the dataset, the date of diagnosis for 
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the patients represented within these two time periods were cross-
referenced in the original dataset with the patients’ corresponding 
Local Government Areas (LGA). 
It showed that the month of January 2009 had a total of five cases (see 
Table 5.22) while the month of July 2009 had a total of 17 cases (See 
Table 5.23). Ikpoba-okha LGA had the highest number of cases within 
the month of January 2009 with just two diagnosed cases while the 
remaining three LGAs each had one diagnosed case. In July 2009, 
Ikpoba-okha LGA also had the highest number of diagnosed cases 
with a total of eight cases distributed among three wards within its 
boundaries. 
Table 5.22: Frequency distribution of diagnosed CKD cases within the LGAs and 
corresponding wards in January 2009 
LGA Ward number of diagnosed CKD cases  
Ikpoba Okha St. Saviour 2 
Oredo New Benin II 1 
Esan West Ekpoma 1 
Egor Uselu II 1 
Total number of diagnosed cases   5 
 
Table 5.23: Frequency distribution of diagnosed cases within the LGAs and their 
corresponding wards in July 2009 
LGA Ward 
number of 
diagnosed 
CKD cases 
in the wards 
Total number of 
diagnosed cases in 
the LGA 
Ikpoba Okha 
Geretti 5 
8 
Iwogban 2 
Ogbeson 1 
Oredo 
New Benin II 1 
2 GRA 1 
Esan West 
Ekpoma 1 
2 Uke 1 
Egor 
Uselu I 1 
2 Uselu II 1 
Etsako West Auchi I 2 2 
Esan North East Efandion 1 1 
Total number of diagnosed cases   17 17 
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5.4.2 The impact of the World Kidney Day on the number of 
diagnosed CKD in Edo state 
Studies carried out on the prevention and management of CKD 
suggest that the way forward is to focus on improving on the early 
detection of CKD in patients, such as carrying out routine screening 
(Bosa, 2006) and intensifying the awareness of CKD among the 
general public and the medical professionals. As mentioned earlier, 
the main route taken by the country to combat the disease was by 
raising awareness of CKD among the general public. One of the 
forerunners in this campaign was the initiation of the World Kidney 
Day (WKD) in 2006, in which Nigeria was among the first countries 
in Africa to participate (ISN, 2006). To mark the World Kidney Day, 
the Nephrology Association of Nigeria (NAN) along with charities 
affiliated with kidney diseases would organise a series of activities 
across the country. These include free kidney disease screening 
exercise, charity walks with kidney patients and health promoters, 
seminars and workshops, and audience participatory programmes on 
local radio and televisions stations (Nigerian Association of 
Nephrology, 2007).  
During the period of this study, four World Kidney Days have been 
marked in Nigeria, on 9
th
 March 2006, 8
th
 March 2007, 13
th
 March 
2008, and 12
th
 March 2009. Although free screenings were carried out 
during these periods, there were no diagnosed cases on these dates 
within the dataset used for this study. This might be attributed to the 
fact that during this event in Edo state, screened cases are referred 
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back to UBTH for more test before a diagnosis is made as such, there 
is the possibility that referred cases do not go to the hospital on the 
same day that they are screened. The preparations for the WKD 
usually includes a series of awareness campaigns especially with the 
use of the media – TV, radio and billboard advertisement, which 
usually begins several weeks before the actual date for the World 
Kidney Day. It is expected that these activities along with the actual 
WKD event should help increase the awareness of kidney disease 
even though some may argue that it would only hold the public’s 
attention for a short time. However, it is expected that around this 
period, more people should be screened for CKD, which could 
potentially lead to more CKD diagnosis at this period each year. To 
determine the trend of CKD diagnosed around these periods, a time 
series analysis was carried out on CKD cases that were diagnosed 
between February and April each year from 2006 to 2009. In addition, 
a weekly aggregate of the diagnosed cases for the three months in 
each of the four years was created resulting in a 48-week dataset with 
a total of 106 diagnosed cases. 
In order to smooth the result of the trend for the diagnosed cases 
within the time series, a 2-week moving average was calculated and 
plotted with the frequency of the diagnosed cases. The result of the 2-
week moving average gave an overview of the trend of diagnosed 
CKD around the weeks that preceded the WKD events as well as the 
weeks that were after the events within the months that were analysed 
in the time series. 
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Figure 5.9: The trend for diagnosed CKD from February to April 2006 until February 
to April 2009 
The result showed a steady increase in the number of diagnosed cases 
within the time periods (this is represented by the black straight line). 
The original time series (CKD cases) was represented by a blue line 
while the smoothed time series data, which is the 2-week moving 
average (represented by a red line). Using the 2-week moving average, 
the time series analysis indicated that there was a sharp rise in the 
number of diagnosed cases between the 3
rd
 week of March 2006 and 
the 1
st
 week of April 2006 (see Figure 5.9). This was followed by a 
sharp decline from the 2
nd
 to the 4
th
 week of April 2006; the number of 
diagnosed cases in 2007 around the same time period was rather low 
with just about half the number from the previous year. The number of 
diagnosed cases around the same period in 2008 showed a slight 
increase between the 1
st
 and the 3
rd
 week of February before recording 
a drop on the 4th week of February followed by a slight increase in the 
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2
nd
 and 3
rd
 week of March. The year 2008, recorded the lowest 
number of diagnosed cases amongst the four-time periods, as there 
was a sharp drop from the 4
th
 week of March to the 1
st
 week of April. 
The number of diagnosed cases in 2009 during the same time period 
was higher than the previous two years with a rise in the number of 
diagnosis from the 3
rd
 week of February and the 1
st
 week of March. 
There was however, a sharp drop in the number of diagnosed cases in 
the 4
th
 week of March before sharply rising in the 1
st
 week of April 
and peaking in the 2
nd
 week of April. 
To determine the frequency of the various stages of CKD among the 
diagnosed cases within these time periods, the stages of CKD for the 
106 cases were cross-referenced with their corresponding months of 
diagnosis (see Table 5.24). The year 2006 had 24 diagnosed cases 
with one case classified as an unknown stage. Another case was 
diagnosed at stage 4 while the remaining 22 cases were diagnosed at 
stage 5 with the highest number of diagnosis recorded in March that 
year. The year 2007 had the first stage 2 cases diagnosed within that 
time period and this was in the month of March during the WKD 
period and the first stage 3 cases was also diagnosed that year in the 
month of February, a total of  21 cases were diagnosed within the 
months around the 2007 WKD. In 2008, no stage 2 CKD case was 
diagnosed but it registered the second stage 3 CKD case in February 
and a stage 4 CKD case in March, the remaining 20 cases were stage 5 
cases. In 2009, there were a total of 39 cases, which was the highest 
number diagnosed within the four time periods. There was one stage 2 
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CKD and one stage 3 CKD cases diagnosed in February, however, 
within the three months there were a total of six stage 3 cases that 
were diagnosed while one stage 4 CKD was diagnosed in March and 
another in April.  
Table 5.24: Diagnosed Stage of CKD within the months around the events for the World 
Kidney Day 
MONTHS 
Diagnosed Stage of CKD within the months around World Kidney 
Days  
Total Unknown stage 2 stage 3 stage 4 stage 5 
Feb 06 0 0 0 1 3 4 
Mar 06 0 0 0 0 14 14 
Apr 06 1 0 0 0 5 6 
Feb 07 0 0 1 1 3 5 
Mar 07 0 1 0 0 6 7 
Apr 07 1 0 0 0 8 9 
Feb 08 0 0 1 0 9 10 
Mar 08 0 0 0 1 4 5 
Apr 08 0 0 0 0 7 7 
Feb 09 1 1 1 0 10 13 
Mar 09 1 0 2 1 8 12 
Apr 09 0 0 3 1 10 14 
Total 4 2 8 5 87 106 
 
The trend of diagnosed cases around these time periods indicated that 
there was a possibility that the awareness programme had an impact 
on the number of diagnosed cases each year especially just before and 
after the WKD. However, these impacts were usually short-lived as 
these increases in the number of diagnoses around these periods were 
usually followed by a decrease in the number of diagnoses within the 
following weeks or months. Although there are no studies on the trend 
of diagnosed cases before 2006, the common findings of previous 
studies have indicated that most cases have been diagnosed at the last 
stage of the disease (see section 1.1). A common belief among the 
nephrologists at UBTH was that the WKD had significantly improved 
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the number of diagnosed cases particularly at the earlier stages. Their 
belief was however misplaced since the findings above suggest this 
was not the case. It  is therefore  unlikely that the WKD had any 
serious impact on public awareness of CKD. Therefore a more 
permanent and consistent awareness programme should be put in 
place that can help make the general public and the health professional 
more aware of the issue of CKD within the state. 
5.4.3 The CKD screening centre and the trend of diagnosed cases in 
Edo State 
The University of Benin Teaching Hospital (UBTH), which is 
currently in charge of the treatment and management of CKD within 
the state, took on an initiative in 2008 to improve the awareness of 
CKD by offering free CKD screening for the public in the northern 
parts of the state. According to the nephrologists at the UBTH renal 
department who are in charge of the programme, part of the cost of 
running the screening centre is borne by the hospital while interested 
personnel within the renal department contribute the rest of the funds. 
They however, mentioned that the current model for the programme is 
being reviewed as the programme is too expensive to run and they are 
currently sourcing funds to keep the programme running. To notify 
the population residing within and around Ogbona community about 
the free screening programme, I was informed by management staff at 
the renal department that the people in Ogbona ward and surrounding 
communities are informed of the screening programme by their 
community leaders. They are also made aware of the programme by 
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UBTH medical staff that visit the areas before the programme starts 
and this is done usually by making announcements in public places, 
such as, markets and village squares within these areas. 
The free CKD screening has run for 6weeks every year since 2008 but 
the dates each year changes due to different factors such as 
availability of funds from the hospital and medical staff of the renal 
department. In 2008 the screening ran between May and June for 6 
weeks while in 2009, it ran between April and May for 6 weeks. There 
were no readily available documents to indicate the exact dates these 
screenings were carried out or the exact number of patients that were 
screened for CKD. This could be due to their assumption that every 
screened case that was positive for CKD was expected to travel down 
to Benin city to begin treatment at UBTH. However, none of the CKD 
cases used in this study showed any indication of being referred from 
the screening centre. Another reason could be that since the screening 
centre is part of the programme run by UBTH, it could be assume that 
the personnel that took down the diagnosed patients’ details did not 
feel the need to indicate the screening centre as a CKD referral centre. 
Another assumption may be that the patient may have failed to 
indicate during the creation of his/her health file that he/she had been 
referred from the screening centre. However, these are just 
assumptions, which cannot be currently verified due to the nature of 
how the data was collected for the study. To evaluate how productive 
the availability of the free screening service is to the diagnosis of 
CKD within the state, a time series was carried out during the two 
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months in 2008 and 2009 when the screenings were known to have 
taken place. The diagnosed cases within the two months in 2008 and 
2009 were aggregated into a weekly table, which was used to carrying 
out the time series analysis and the result was smoothed out using a 
two-week moving average. In order to identify the locations of 
diagnosed cases that were residing near the ward or LGA where the 
screening centre is located, the months used in the times series 
analysis were cross-referenced with LGAs and wards of CKD cases 
that were diagnosed during these months. This result gave an 
indication of the impact of the screening centre on the trend of CKD 
diagnosis within the state. 
 
Figure 5.10: The trend of diagnosed CKD during the dates when the CKD screening 
centre gave free renal screening in 2008 and 2009 
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A total of 48 cases were diagnosed during the two annual screening 
sessions and these were aggregated into their corresponding week of 
diagnosis with a total of 16 weeks used for the analysis. The trend in 
the number of diagnosed cases during the two screening sessions 
showed a very slight increase across the two periods (see Figure 5.10) 
with the lowest number of diagnosed cases recorded between the 3
rd
 
week of May 2008 and the 2
nd
 week of June 2008. The highest 
number of diagnosed cases was recorded in the 1
st
 week of April 
2009.  
However, only two LGAs near the LGA where the screening centre 
was located, recorded any diagnosed cases during the screening 
periods (see Table 5.25). These were Esan North East and Esan West 
LGAs, with the closest LGA being Esan North East having one case 
diagnosed in the Efandion ward (see Table 5.26) in May 2008 and two 
cases both from the Uromi ward diagnosed in May 2009. The Esan 
West LGA had a total of six diagnosed cases recorded during the 
screening periods all of which were residing within Ekpoma ward. 
The remaining LGAs and their corresponding wards that had patients, 
who were diagnosed during the screening periods, were located closer 
to UBTH and these are located either within or around Benin City and 
as such they were not likely to have travelled up north to the screening 
centre to take part in the screening exercise.   
The three wards that were located close to the screening centre are 
known to have urban towns within their boundaries, which might 
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explain the number of diagnosed cases registered within these wards. 
Given the absence of diagnosed CKD cases referred from the 
screening centre within the dataset, one might argue that the screening 
centre may be failing in its attempt at reaching out to the northern part 
of the state where majority of the rural areas are located. Giving the 
limited data or information on the number of diagnosed CKD cases 
from the screening centre during the course of this study, none of 
these assumptions could be readily verified. Therefore, an 
examination of the impact of the screening centre on it surrounding 
areas needs to be investigated further before a final decision can be 
made. 
Table 5.25: The LGAs of the cases that were diagnosed during the period of the 
screening exercises in 2008 and 2009 
LGA May 08 Jun 08 Apr 09 May 09 Total 
Egor 1 4 1 1 7 
Esan north east 1 0 0 2 3 
Esan West 1 3 1 1 6 
Ikpoba Okha 3 4 8 7 22 
Oredo 2 1 3 1 7 
Ovia North East 1 0 1 1 3 
Total 9 12 14 13 48 
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Table 5.26: The wards of the cases that were diagnosed during the period of the 
screening exercises in 2008 and 2009 
Wards May 08 Jun 08 Apr 09 May 09 Total 
Aduwawa 0 0 1 2 3 
Efandion 1 0 0 0 1 
Ekpoma etc 1 3 1 1 6 
Geretti 3 3 6 2 14 
GRA 0 1 1 0 2 
Igushodin 1 0 0 1 2 
New Benin I 0 0 1 1 2 
New Benin II 2 0 1 0 3 
Ogbeson 0 0 1 1 2 
Oregbeni 0 0 0 1 1 
St. Saviour 0 1 0 0 1 
Ugbeku 0 0 0 1 1 
Ugbowo 1 0 1 0 2 
Uromi 0 0 0 2 2 
Uselu II 0 1 0 1 2 
Utoka 0 0 1 0 1 
Uwelu 0 3 0 0 3 
Total 9 12 14 13 48 
 
5.4.4 The proportion of diagnosed earlier stages of CKD and late 
stage of CKD across Edo State 
Section 5.2.2 of this chapter has already established that there has 
been a steady increase in the number of early cases that were 
diagnosed between 2006 and October 2009 although the number of 
patients for 2009 is just from January to 14th October. However, there 
is still a large margin between the number of diagnosed cases with 
earlier stages of CKD and late stage of CKD. For the purpose of this 
analysis, the cases defined as early stage CKD were those diagnosed 
with stage 2 to stage four between January 2006 and 14
th
 October 
2009 (discussed earlier in section 5.2).  
To identify areas that registered the presence of diagnosed CKD 
within their boundaries, the number of CKD cases within the wards in 
relation to the patients’ stages of CKD at the time of diagnosis was 
examined. New Benin ΙΙ and Geretti wards both had the highest 
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number of stage 2 CKD (with three cases), which is the earliest stage 
of the disease that has been diagnosed within the hospital while Uselu 
ΙΙ ward, Ugbeku ward, Ogbeson ward, Obayantor ward, Otoruwa II 
ward, and Auchi ward each had a single stage 2 CKD case. For 
patients diagnosed with stage 3 CKD, it was observed that Geretti 
ward had the highest with five cases, Uselu Ι ward with four cases, 
New Benin II and Uwelu wards both had three cases respectively. 
Geretti ward had seven cases while Uselu Ι ward had three patients 
diagnosed with stage 4 CKD. A total of twelve cases were diagnosed 
with stage 2 CKD, stage 3 CKD had a total of thirty-eight diagnosed 
patients while a total of twenty-seven cases were diagnosed with stage 
4 CKD. There were a total of eighty-eight early CKD stage cases from 
2006 until October 2009 and Geretti ward had the highest number of 
cases diagnosed at an early stage with a total of eighteen cases 
followed by Uselu Ι ward, which had ten cases and New Benin ΙΙ ward 
with eight cases (see Appendix F). 
In summary, it can be observed that the distribution of diagnosed 
CKD patients indicate that most cases are concentrated within the 
urban areas, which brings up the question of why are most rural areas 
are still showing little changes in the number of diagnosed CKD cases. 
Another question, which the distribution of these cases raises, is 
whether the presence of these diagnosed cases was attributed to the 
impact of these awareness programmes that are currently active within 
and outside the state or whether it might be attributed to other factors. 
One could argue that due to the high number of stage 5 CKD cases 
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being diagnosed, there is the possibility that most medical health 
officials may not have the necessary skills required in the early 
diagnosis of CKD until the patients’ condition worsens. However, 
there is still the possibility that the diffusion of information from a 
diagnosed patient(s) and their families to other members of their 
communities might have contributed to the increase of diagnosis 
within certain areas. All these assumptions can only be verified or 
rejected after further study has been carried out on the matter. 
The results of this analysis indicated that the number of diagnosed 
CKD cases within the state appeared to be higher within the urban 
areas than in the rural areas since the number of diagnosed patients 
appeared to be concentrated mainly within the urban areas and not 
within the rural areas. Although this spatial pattern is analysed further 
against the underlying population within the LGAs and the wards (see 
chapter six), one could argue that the rural areas may not be 
adequately informed about the impact of the disease and this may 
account for the low number of diagnosed cases within these areas. 
One would therefore recommend that adequate CKD awareness 
programmes should be put in place that will be tailored to reach out to 
the rural areas probably in the native dialects of these areas as well as 
create training programmes for the health officials within the rural 
areas on the awareness of CKD and how it can be identified in 
patients.  
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Table 5.27: The frequency distribution of diagnosed stages of CKD from 2006 to 
October 2009 
 
Year Of Diagnosis 
Total 2006 2007 2008 2009 
Stage of 
CKD 
Unknown 2 1 2 6 11 
stage 2 0 2 4 6 12 
stage 3 4 3 11 20 38 
stage 4 3 5 7 12 27 
stage 5 82 96 103 73 354 
Total 91 107 127 117 442 
 
5.5 Summary 
The results of the statistical test on the association of the socio-
demographic variables with the stages of CKD indicated that none of 
the socio-demographic variables was statistically associated to the 
stage of CKD at the time of diagnosis (see section 5.2.1 above).  
Out of the four biological risk factors that were present in the CKD 
dataset, the only risk factor that was not significantly association with 
the stage of CKD at the time of diagnosis for a CKD patient was 
chronic glomerulonephritis. The other three risk factors were all 
highly significant in their relationship with the stage of CKD at time 
of diagnosis and they were found to be significant predictor variables 
in the regression model for the possibility of predicting the stage of 
CKD for a patient in Edo state. The forced entry method and the 
forward stepwise selection method of the logistic regression model 
both identified diabetes, hypertension, and toxic nephropathy as 
predictors of the severity of CKD at time of diagnosis.  The results 
from this model indicate that there is a possibility that patients that 
develop CKD without previously being diagnosed with any of these 
biological risk factors are more susceptible to late diagnosis of CKD. 
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This statement was also supported by the positive coefficients 
associated with predictor variables for these biological risk factors. 
This finding supports other studies, which have already identified the 
presence of diabetes, hypertension, and toxic nephropathy as 
indicators for the likelihood of developing CKD (refer to literature 
review). This outcome has important implications for formulating 
renal health policies and designing research studies within the 
population. Therefore, in the development of strategies that might help 
in the early diagnosis of patients, this category of patients (i.e. those 
without any previously known risk factors) should equally be taken 
into account. 
I should mention at this point that interaction variables such as an 
interaction variable for occupation and age or marital status and age, 
were excluded from the model, as neither of these variables were 
significant from the onset. In addition, other possible interactions 
could not be included within the model due to the presence of 
redundancies within the data when they were included. This could be 
attributed to the low sample within the categories of some of these 
variables. 
The result from the time series analyses indicated that the number of 
diagnosed CKD cases within the state was increasing and this might 
be partly attributed to the awareness programme (WKD), which 
appeared to have an impact on the number of diagnosed cases 
recorded at certain times each year. However, these impacts were 
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usually momentary as the increase in the number of diagnoses around 
these periods was usually followed by a decrease in the number of 
diagnoses within the following weeks or months. This indicated that 
the impact of the awareness of CKD during the WKD was not strong 
enough at raising the awareness of CKD within the state. Therefore a 
more permanent and consistent awareness programme should be put 
in place that can help make the general public and the health 
professionals more aware of the issue of CKD within the state. 
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Chapter 6 Spatial pattern of chronic kidney disease (CKD) 
within Edo State 
6.1 Introduction 
This chapter addresses the fifth research question outlined at the 
beginning of this study:  
“What is the spatial pattern of diagnosed CKD cases within Edo 
state?” 
In this chapter, the spatial distribution of the disease across the study 
area was analysed in order to identify the areas where there are high 
and low numbers of diagnosed CKD cases. To determine the spatial 
pattern across the state, two main analyses were carried out on the 
geocoded CKD dataset.  
The first section of this chapter began with the evaluation of the 
diagnosed rate of CKD across the state. This was calculated for each 
of the LGAs within the state. The spatial distribution of CKD across 
the wards showed that only 54 wards out of the 194 wards, registered 
the presence of CKD within their boundaries (see Figure 4.7). This 
meant that just 27% of the wards within the state had patients that 
were diagnosed with CKD from 2006 to October 2009. Therefore, it 
was not practical to produce a spatial distribution of the diagnosed rate 
of CKD across the wards. 
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The second section focused on the point analysis of CKD cases using 
the kernel density estimate to evaluate the spatial distribution of CKD 
cases within the state. This involved the analysis of the distribution of 
CKD cases in relation to their underlying population to determine the 
areas of high and low density of diagnosed CKD cases across the 
state. 
The spatial distribution based on the outcome of both analyses could 
give an indication of the areas with high and low counts of the disease 
within the state as well as highlight areas of concern, which might 
explain the absence of diagnosed CKD cases within certain areas. The 
results from these analyses could provide more insight into the spatial 
distribution of diagnosed CKD within the state that would be useful in 
the creation of a suitable health policy that would be relevant for CKD 
management within the state.  
6.2 The rate of diagnosed CKD in Edo state 
It is apparent from various studies carried out on the prevention and 
management of CKD that the way forward is to focus on improving 
on the early detection of CKD in patients, such as carrying out routine 
screening (Bosa, 2006) and intensifying the awareness of CKD among 
the general public and the medical professionals. The main route taken 
by the country’s health policy to combat the disease was by raising 
awareness of CKD among the general public. As discussed in chapter 
one, one of the forerunners in this campaign was the initiation of the 
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World Kidney Day in 2006 in which Nigeria was among the first 
countries in Africa to participate (ISN, 2006).  
Although the identification and geographical location of the CKD 
patients gives an idea of the impact of the disease within the state, it is 
however, essential to assess the impact of the disease in relation to the 
population at risk within both the LGAs as well as the wards. 
Therefore, the population at risk of CKD had to be determined. It 
should be noted that although the age group  recorded among the CKD 
patients ranged from 10 years to above 80 years (see Table 4.16), past 
studies have shown that CKD also occurs among younger children 
(Olowu, 2003; Mak and Bakris, 2010; Saland et al., 2010). Based on 
this notion as well as the outcome of the analyses carried out in 
section 5.2.1, the total population was regarded as the population at 
risk for CKD regardless of their sex or age group. Due to the limited 
resources available for the management of healthcare services within 
the state, it can be argued that the use of the state’s population as the 
population at risk might not be very realistic. However, there is 
currently not enough evidence to identify those that are at a higher risk 
of CKD without clinically identifying those that have one of the 
known biological risk factors that are currently associated with CKD 
(discussed in section 5.5). Therefore, the outcome of the analysis 
based on the use of the whole population as the population at risk can 
be regarded as a baseline for determining the prevalence of CKD 
within the state.  
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In order to evaluate the diagnosed rate of CKD, the most recent census 
data on Edo state was used. As the study period was for CKD cases 
diagnosed from 2006 to 2009, the census data for 2006 was used as 
the risk population. The analyses were carried out using ArcMap in 
ArcGIS
® 
and the results were displayed using a quartile classification 
to determine a four-class interval.  
6.2.1 The diagnosed rate of CKD within the LGAs 
In order to display the results of the diagnosed rate of CKD within the 
LGAs in the state, the number of diagnosed CKD cases within each 
LGA from 2006 to 14
th
 October 2009 was determined and divided by 
the corresponding estimated population of their LGA. The diagnosed 
rate for CKD per 100000 of the population within each LGA was 
determined by multiplying the result for the diagnosed rate of CKD 
within each LGA by 100000.  
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Figure 6.1: Diagnosed rate of CKD across the LGAs from 2006 to 14th October 2009 in 
Edo state 
The diagnosed rate of CKD per 100000 across the eighteen LGAs in 
Edo state showed that four LGAs were classified within the upper 
quartile. Ikpoba-Okha LGA had the highest diagnosed rate with a total 
of 42.54 per 100000, Oredo LGA had 22.18, followed by Egor LGA 
with 21.46 while Esan west LGA had 16.87. The results showed that 
five LGAs were classified within the lower quartile (see Figure 6.1). 
However, there appears to be a considerable variability within the 
 
241 
 
results and this could be attributed to the small sample size (442 cases) 
that was used to estimate the diagnosed CKD rates for the study area. 
Research indicates that estimates based on finite population sampling 
tend to be unstable due to the use of small samples especially within 
small areas (Farrell et al., 1997). Therefore, the variability present 
within the results of the spatial distribution of CKD rates within the 
LGAs might likely have errors associated with small sample sizes, 
which are sometimes called “the small area problem” (Anselin, 2003 
p.60). In order to take into account the small CKD counts within the 
LGAs and correct the variance instability of the CKD rate, a 
smoothing procedure was applied. The smoothing technique used in 
this analysis was the Empirical Bayes estimation. This smoothing 
technique has been found to be useful in the estimation within small 
areas with populations at risk (Anselin, 2003; Farrell et al., 1997). The 
technique applies the estimation of the mean value of the rates in each 
area using the method of moments (Anselin, 2003; Bailey and Gatrell, 
1995). The technique basically involves borrowing information from 
an area's neighbours, and generating an adjusted estimated CKD rate 
based on the average value of the area of interest and the overall mean 
of the study area (i.e. the global mean). 
The GeoDa software was used to perform the Empirical Bayes 
estimates and a box map, which is a type of quartile map, was set as 
the map theme. The preference of the box map in this analysis is that 
it ensures that the resultant map highlights any outliers present within 
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the smoothed CKD rates. The values are classified as outliers if they 
are 1.5 times higher than the interquartile range (IQR)
27
.  
 
 
Figure 6.2: Empirical Bayes estimates of CKD morbidity in Edo state, highlighting the 
CKD rate within Ikpoba-Okha LGA as a high outlier 
The spatial CKD pattern generated using the Empirical Bayes 
estimates, is broadly similar to the map for the crude rates. However, 
Ikpoba-Okha LGA has been identified as an outlier due to the 
relatively high rate recorded within its boundaries. In addition, Esan 
Northeast LGA has now been classified within the upper quartile once 
the outlier was taken into account. According to the CKD dataset, 
there was no diagnosed CKD case within Etsako-East LGA. However, 
                                                 
27
 Interquartile range IQR is the difference between the 75th percentile (Q3) and the 25th 
percentile (Q1) or Q3-Q1. It describes the range of the middle of the distribution since 25% 
of values are above the interquartile range and 25% below it (Anselin, 2003). 
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it was not classified as an outlier. This could be attributed to very low 
rates recorded within the lower quartile.  
Although the UBTH hospital is located in Egor LGA, Ikpoba-Okha 
and Oredo LGAs both have a close proximity to Egor LGA. However, 
there may still be other factors that may account for the high rate of 
diagnosed CKD among these LGAs. The issue of the proximity of 
these LGAs to UBTH does not support the reason for the relatively 
high diagnosed CKD rate within Esan-West LGA and Esan-Northeast 
LGA, as they are not near UBTH. Neither was there any indication 
within the UBTH renal unit’s health records stating that any health 
centre within Esan-West LGA and Esan-Northeast LGA referred 
patients to UBTH for diagnosis or treatment. Therefore, in order to 
determine if there is a significant association between diagnosed CKD 
cases and their accessibility to available healthcare, the geographical 
accessibility to the hospital is examined in chapter seven. 
Although no CKD was diagnosed within the Etsako-East LGA, this 
does not necessarily rule out the possibility of CKD within the area. 
However, it brings up the subject for further investigation into that 
area as there is the possibility that there may be cases within that area 
that may not be diagnosed until it is too late. 
The diagnosed rate of CKD within the LGAs showed that the rate of 
the disease was higher within the boundaries that contain urban 
settlements in comparison to those located within rural areas. This is 
made evident by the fact that Egor LGA, Ikpoba-Okha and Oredo 
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LGAs, all have Benin City located within their boundaries while 
Ekpoma town as well as the Ambrose Alli University is located within 
Esan West LGA and Uromi town is located within Esan Northeast 
LGA.  
6.2.2 Prevalence of CKD within the state 
Having determined the diagnosed rate of CKD within the LGAs, the 
period prevalence of diagnosed CKD using the CKD data for the 
study was calculated. This result would provide the estimated 
prevalence of diagnosed CKD within Edo state as this has not been 
calculated nor has any information on CKD at the state level been 
made available to the public. The period prevalence of CKD was 
carried out to estimate the proportion of the state’s population that had 
been diagnosed with CKD over the study period, which was from 
2006 to 2009. The population data that was used for this analysis was 
the census population for 2006. For comparative purposes, the period 
prevalence was estimated per million persons (pmp).  
Period prevalence (pmp) = total CKD cases ÷ 2006 population for Edo 
state × 1000000 
Period prevalence = 442 ÷ 3233366 × 1000000 
Period prevalence = 137 pmp 
The result indicated that within 2006 to 2009, it was estimated that the 
period prevalence of diagnosed CKD within Edo state was 
approximately 137 CKD cases per million persons. This result 
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appeared to be similar to the prevalence of CKD in central India, 
which was 181 per million population (Rajapurkar and Dabhi, 2010). 
The diagnosed CKD prevalence for the last stage of CKD within the 
dataset was also calculated which was estimated at 109 cases per 
million persons. The result of the prevalence of diagnosed CKD at the 
late stage appears to be lower than an estimated prevalence of 500 per 
million for Nigeria (Kidney Consultants International, 2007). This 
result indicates that the prevalence of stage 5 CKD in Edo state is 
likely to be lower than the national prevalence of stage 5 CKD. 
6.3 A point pattern analysis of CKD cases in Edo state 
As discussed in section 2.9, there have been a number of studies that 
have evaluated the spatial distribution of CKD and its associated 
outcomes within different regions particularly in Europe and USA. 
However, there is presently no known literature within Nigeria that 
has attempted to evaluate the disease from a spatial perspective.  
In order to examine further the spatial distribution of CKD within Edo 
state, an estimation of the high and low density areas of diagnosed 
CKD within Edo state was carried out. This section discusses the 
analysis of the spatial distribution of the 442 CKD cases in relation to 
the underlying population within the study area so as to identify any 
pattern. A spatial statistics method (Moran’s I) was applied together 
with a spatial analysis tool (kernel density estimation) in a GIS 
environment and these were used to analyse the spatial autocorrelation 
of the spatial distribution and the varying density of diagnosed CKD 
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cases across Edo state. The Moran’s I and the density maps were 
created using CrimeStat
® 
(Levine, 2004) and the results were 
displayed using ArcMap in ArcGIS 10
®
 as the GIS platform.  
6.3.1 Spatial Autocorrelation of CKD in Edo state 
The concept of spatial autocorrelation indicates that events from 
locations near one another in space are more likely to be similar than 
events from locations remote from one another (Cliff and Ord, 1973). 
Spatial autocorrelation may be classified into three main groups 
namely - positive autocorrelation, negative autocorrelation, or 
noncorrelation / zero autocorrelation (O'Sullivan and Unwin, 2003). 
Positive spatial autocorrelation occurs when all similar observations 
are clustered together, while negative spatial autocorrelation occurs 
when observations from nearby locations appear to be different from 
each other. The zero auto correlation occurs when no spatial effect or 
pattern is noticeable and observations appear to vary randomly across 
the study area (O'Sullivan and Unwin, 2003). In order words, when no 
statistically significant spatial autocorrelation exists, the pattern of 
spatial distribution is considered random. 
Therefore, before attempting to evaluate the spatial pattern of CKD 
within the state, the degree of autocorrelation present in the CKD 
pattern across the state was assessed. This is because the statistics of 
spatial autocorrelation provides a useful indicator of spatial patterns.  
To accomplish this, a global spatial autocorrelation method known as 
Moran’s I (Moran, 1950) was used to test whether the CKD cases 
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within the study area were spatially correlated or not. The Moran’s I 
statistic is regarded as one of the oldest indicators of spatial 
autocorrelation and it is applied to zones or points (Levine, 2007). 
Since the Moran’s I measures spatial autocorrelation based on feature 
locations and attribute values i.e. aggregated data, the dataset with the 
lowest aggregation size, which is the CKD cases at the ward level was 
used to compute the Moran’s I statistic. However, the areas within the 
wards that had no diagnosed CKD case residing within their 
boundaries were also taken into account during the computation of the 
Moran’s I. The values within these areas were classified as missing 
values and this was to ensure that only the wards with registered CKD 
cases were used in the analysis. I would add that due to the inability to 
verify whether the areas within the wards that had no diagnosed CKD 
case could be classified as missing values, I ran the analysis again 
including the areas within the wards that had no diagnosed CKD case 
and I arrived at a similar result. Strictly, the value of Moran’s I is not 
constrained to ranges between -1.0 and +1.0. However, they can be 
adjusted to fall within the (-1,1) range (Bailey and Gatrell, 1995). 
When an observed Moran’s I value is below the expected value of 
Moran’s I, this indicates a negative spatial autocorrelation. A value 
that is negative and close to zero or equal to the expected Moran’s I 
would indicate a spatially random pattern. 
Results from the Moran’s I test on the distribution of CKD cases 
across the wards in Edo state indicated that a positive spatial 
autocorrelation exists among CKD incidence within the study area. 
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The result for the Moran’s I for CKD cases was 0.27 (p<0.001) while 
the Z score was 9.94. The result indicated that the spatial distribution 
of CKD cases in the area was more spatially clustered than would be 
expected if underlying spatial processes were random. Table 6.1 
shows the result of Moran’s I analysis. This suggested that CKD cases 
were positively spatially autocorrelated, which meant that wards with 
many CKD cases tended to be located close to wards that also had 
many CKD cases and, equally, wards with few cases tended to be 
located close to wards, which also had few cases. Therefore, it can be 
argued that the spatial pattern of CKD within the state is not randomly 
distributed. Given the significance of the result for the spatial 
autocorrelation, the spatial distribution of CKD within the state was 
evaluated further to draw out inferences from the outcomes of the 
spatial analyses of the CKD patterns within the state. 
Table 6.1: The result of the spatial autocorrelation of CKD cases at the wards level-
using Moran's 'I' statistics 
Spatial Autocorrelation (Global Moran's I) Value 
Moran's I index 0.27 
Z Score 9.94 
significance level 0.001 
Expected value -0.005 
 
6.3.2 Kernel density estimation of CKD in Edo State 
Although the distribution of CKD cases within the state had already 
been aggregated and analysed in section 6.2 and also analysed above 
for spatial autocorrelation at the ward level, there are studies that have 
highlighted problems associated with the use of aggregated data 
(Duque et al., 2006; Holt et al., 1996; Jelinski and Wu, 1996). One of 
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the known problems associated with spatial analysis using aggregated 
data is the modifiable areal unit problem. The modifiable areal unit 
problem (MAUP) tends to occur when a more detailed dataset is 
aggregated to a less detailed dataset. As a result, any pattern that is 
observed across the various boundaries within the study area may be 
due to the function of the type of boundary chosen, as well as the 
underlying spatial distribution of attribute values (Bailey and Gatrell, 
1995). For example, data collected on individuals might be aggregated 
to the neighbourhood level, ward level, state, or national level and 
when the original data are aggregated, the values for the various 
parameters used during the data collection will change because of the 
loss of information.  
To adequately explore the CKD pattern and avoid the modifiable areal 
unit problem (MAUP), the kernel density estimation (KDE) technique 
was used to create a density map of diagnosed CKD cases in Edo 
state. As mentioned earlier in chapter three, KDE is a non-parametric 
method of extrapolating point data over an area of interest without 
invoking MAUP or relying on fixed boundaries for aggregation 
(Carlos et al., 2010 p.2). This involves placing a proportional surface 
over each point, calculating the distance from the point to a reference 
location based on a mathematical function, and summing the value of 
all the surfaces for that reference location. Then the procedure is 
repeated for all the reference locations within the study area (Levine, 
2004). 
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The density maps were created using CrimeStat
®
 (Levine, 2004) and 
the results were displayed using ArcMap in ArcGIS 10
®
 as the GIS 
platform. In order to make use of a linear unit of measure during the 
analysis within CrimeStat, the geocoded dataset (see chapter three for 
details) was projected using the WGS 1984 UTM Zone 31N Projected 
Coordinate Systems before they were uploaded in CrimeStat for 
analysis. For the purpose of this study, the unit of interest was in 
miles, therefore, the areas and distances computed were computed 
using that unit. 
Selection of kernel function / Method of Interpolation 
To determine the most suitable function for the spatial pattern of the 
CKD cases, a Moran correlogram was plotted using the spatial 
autocorrelation tab in CrimeStat. The shape of the Moran correlogram 
and the spread is a good indicator of the type of kernel function to use 
(Levine, 2004). The Moran’s correlogram involves plotting the indices 
of the Moran’s I statistic at different distance intervals in order to 
indicate the distribution of the spatial autocorrelation of the dataset. 
To ensure that the I values for cases that were spatially close did not 
become exceptionally large or small, the small distances were adjusted 
therefore the maximum weighting was set at one. The Moran’s 
correlogram was set to run 10 different distance intervals (this was the 
default) and to calculate approximately the confidence intervals 
around the I value, a Monte Carlo simulation, which inputs random 
data and calculates the “I” value was set to run 100 simulations. 
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Figure 6.3: Moran's correlogram of CKD cases in Edo state 
The plot of the Moran’s correlogram indicated that the I value at 
distances of about 12.3 mile had the highest value of 0.5. As the 
distance increased (i.e., the search circle radius got larger), the I value 
dropped off until about 61.2 miles whereupon it approached the global 
I value. However, for all distance intervals, the empirical I value was 
higher than the maximum simulated I value with random data (Figure 
6.3). This meant that because of the distribution of random I values, 
the empirical I values obtained for each of the distance intervals was 
not likely due to chance. A general overview of the plot indicated that 
the CKD appeared to be clustered at small distances but gradually 
dispersed as the distances between them increased. 
The shape of the Moran correlogram and the spread, which is a good 
determinant of the type of kernel function to use, indicated that the 
quadratic kernel function was the most suitable function to use. This is 
because the quadratic kernel function applies added weight to CKD 
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cases closer to the centre of the bandwidth. It weights near points 
more than far points, but the fall off is gradual.  The equation for the 
quadratic kernel function within a specified radius is shown below:  
Equation 6.1 : A formula for a quadratic kernel function 
 
Source 6:1 CrimeStat manual: - 
http://www.icpsr.umich.edu/CrimeStat/files/CrimeStatChapter.8.pdf 
where dij is the distance between the location of an event (e.g. CKD 
case) and any reference point in the region, h is the radius of the 
search area (the bandwidth), Wi is a weight at the point location (e.g. 
number of CKD cases) and Ii (e.g. the number of population at risk) is 
an intensity at the point location. 
Choice of bandwidth 
There are two main choices of bandwidth that can be used in kernel 
density estimation, the fixed, and the adaptive bandwidths. Due to the 
variation in the distribution of diagnosed CKD cases across the study 
area, the adaptive bandwidth was used instead of the fixed bandwidth. 
This is because the adaptive bandwidth adjusts the bandwidth interval 
so that a minimum number of points are found and ‘this has the 
advantage of providing constant precision of the estimate’ over the 
study area (Levine, 2004, p. 8.15). Therefore, in areas that have a high 
concentration of points, the bandwidth is narrow whereas in areas 
where the concentration of points is more dispersed the bandwidth 
will be larger (Carlos et al., 2010; Levine, 2004). Given the sparse 
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distribution of the CKD cases outside the state’s capital – Benin City, 
the sample size of the bandwidth interval was set to a minimum of 10 
points per square mile within the bandwidth radius. The choice of 
using 10 cases as the minimum sample size was an attempt at 
identifying areas with a number of cases particularly outside the 
state’s capital, which had a relatively high density of diagnosed CKD 
cases.  
6.3.2.1 Kernel Density Estimates of CKD cases in relation to Edo state’s 
population 
The possibility of CKD patients travelling to other renal units in 
neighbouring states is not an option within Edo state because UBTH is 
currently the only health institution responsible for the treatment of 
CKD within the Niger-delta region. This therefore rules out the 
possibility of ‘edge effects’ around the state’s boundary.  
It was necessary to examine the density of CKD in relation to the 
underlying population and not just the concentration of the cases 
across the study area. This is because health outcomes generally 
involve people and the spatial patterns of these outcomes are likely to 
reflect the spatial distribution of the underlying population (Carlos et 
al., 2010). However, the inclusion of the underlying population or the 
population at risk requires a prior knowledge of the category of people 
that are susceptible to the health outcome that is being studied. In the 
case of CKD, while there have been studies that have noted some 
variation in the diagnosis of the disease between the males and 
females, the disease is not determined by sex (e.g. prostate cancer in 
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men and ovarian cancer in women). In regards to age, although there 
have been studies that have identified the prevalence of CKD within 
various age groups of the adult population, the disease is also 
diagnosed among children (Saland et al., 2010; Mak and Bakris, 2010; 
Staples et al., 2010). According to the 2010 USRDS Annual Data 
Report, the incidence in the United States of end-stage renal disease 
(ESRD) or the last stage of CKD in young people ages 0 - 19 years is 
109 per million people (USRDS, 2010). As discussed in section 6.2, 
due to presence of the disease in both sexes and across the various age 
groups, the population at risk cannot be currently adjusted by sex or 
age therefore the whole population for the study area was used as the 
population at risk. 
Choice for a GIS based population data for the underlying 
population in Edo state 
The majority of the population datasets used in GIS analyses are in 
polygon format with a population count allocated to each polygon. 
These polygons are often irregular in shapes and sizes, and they lack 
data about how people are geographically dispersed within the 
polygon (Carlos et al., 2010). An alternative to polygon based 
population data is the LandScan™ 2008 Global Population Database, 
which was developed by the OakRidge National Laboratory (ORNL) 
using multiple techniques to disaggregate census counts within an 
administrative boundary and allocate the population distributions to a 
30-second-by-30-second latitude/longitude grid (Dobson et al., 2000; 
Carlos et al., 2010).  
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Figure 6.4: A LandScan™ 2008 Population Data set for Edo state, which was based on 
the Nigerian 2006 census 
The LandScan population data was based on a census count done 
before or by July 2008 however, the last census in Nigeria was the 
2006 census. Therefore, the population distribution for Edo state was 
based on the 2006 census and not on a projected population census for 
2008 as LandScan population data was not based on a projected 
population (Dobson et al., 2000). There are a number of advantages of 
using the LandScan™ 2008 Global Population Data; one is its grid 
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format, which standardizes the areal unit for population values, unlike 
polygon formats representing administrative boundaries that vary in 
size. This makes population at different locations more spatially 
comparable and facilitates spatial analysis operations (Carlos et al., 
2010). However, one of the shortcomings of the dataset is that it 
separates the population counts from the related demographic data, 
which were included in censuses (Carlos et al., 2010) and equally 
needed for demographic related studies. Since the density estimate for 
the CKD cases was an exploratory analysis in relation to the 
population in Edo state, the LandScan™ 2008 Global Population Data 
was a suitable population dataset to use (Figure 6.4). The outcome of 
the density map can then be compared with the results of the 
diagnosed rate of CKD at the LGAs in the state (discussed earlier in 
section 6.2 of this chapter).  
The LandScan population for Edo state was extracted from the 
LandScan™ Global Population Dataset using the ‘extract by mask’ 
tool in the Spatial Analyst extension for ArcGIS.  
Dual kernel density estimates of the rate of CKD within the 
population 
In order to use the Landscan dataset in CrimeStat for the density 
analysis, the population dataset, which was in an ESRI Grid format, 
was converted to a point shapefile, with the population count within 
each of the 30×30 cells assigned to a point. A total of 23046 points 
was created to represent the LandScan population data for Edo State. 
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The dual kernel density routine in CrimeStat, which is applied to two 
point files (one file set as the primary file while the other is the 
secondary file) was used for this analysis. The primary file was the 
point file for the CKD cases while the secondary file was the point file 
for the LandScan population of Edo state, of which the population at 
each point was identified as an intensity variable. Since each point in 
the primary file represented one CKD case, the weight was set as one. 
As stated earlier, the quadratic kernel estimator was used as the 
method of interpolation due to the result of the Moran correlogram. 
The adaptive interval was used as the bandwidth for the density 
estimation with a sample size of the bandwidth interval set to a 
minimum of 10 points per square mile within the bandwidth radius. 
The adaptive bandwidth adjusts for the fact that there are fewer cases 
and census population at the edges of the state especially at the south 
and western part of the state. To estimate the CKD density within the 
state’s population, the ‘ratio of densities’ was selected for the density 
calculation of the datasets, which ensured that the kernel density 
estimate for CKD was divided by the kernel density estimate for the 
Edo state population.   
6.3.2.2 Discussion of results for CKD density within Edo state 
Areas with the highest density were displayed with red shades, 
followed through to a pale orange to indicate areas with moderately 
low intensity, and a bright yellow colour to represent areas with the 
lowest density or absence of CKD.  
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Figure 6.5: The spatial distribution of the kernel density estimate of CKD within Edo 
State 
The effect of adjusting the CKD distribution for the underlying 
'population at risk' highlighted the areas with high densities of 
diagnosed CKD. The density map for CKD indicated that a high 
density of diagnosed rates covered several miles at the southwestern 
part of the state. Three smaller locations registered high densities of 
the disease and these were located towards the central parts of Edo 
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state while another high density of diagnosed CKD was registered at a 
small area towards the northern area of the state.  
In order to identify the locations where the disease was prevalent, the 
LGA and the ward boundaries were overlaid on the density map 
(Figure 6.5). This confirmed that the highest rate of diagnosed CKD 
was located within the LGAs and wards that were within the boundary 
of Benin City. The high rate of CKD located at the northern part of the 
state was found to be within the boundary of Etsako west LGA in two 
wards – Auchi I and Uzaire southeast wards. The three other high 
rates of CKD located at the central part of the state were located in 
Esan west LGA (in Ekpoma ward), in Esan north east LGA (in Uromi 
and Efandion wards), and at Esan central LGA (within Otoruwa ІІ and 
Uwessan II wards). The moderately low rate was also registered in 
Esan central LGA within Ewu І and Ewu ІІ wards.  
It should be stated that the five locations with high rates of diagnosed 
CKD have relatively large populations within their boundaries. For 
example, both Otoruwa ІІ and Uwessan II wards are located within a 
town called Irrua while the wards in Esan west LGA and Esan 
northeast LGA are all located within towns that bear the same name 
with them (see Figure 6.6).   
 
260 
 
 
Figure 6.6: The spatial distribution of the kernel density estimate of CKD within the 
large settlements in Edo State 
There is therefore a discrepancy in the rate of diagnosed CKD cases 
within the urban and rural areas. It can be argued that the discrepancy 
in the dissemination of information on CKD awareness between the 
rural and urban areas could have contributed to the low number of 
diagnosed cases within the rural areas. The ineffective dissemination 
of information in the rural area is likely to have affected both the 
general population within the rural areas and the health workers 
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residing within these areas. A survey carried out by the NPC
28
 in 
identifying the level of awareness among the public as well as the 
most effective way of reaching the public, showed that most people 
within the rural area did not have access to mass media  used in 
dispersing information to the general public. Their reports showed that 
within the rural areas there is a high reliance on “interpersonal 
channels as sources of information”, a record of three-quarter of the 
rural communities hold community meetings where information is 
shared (NPC, 2005). These findings indicate that there is the 
probability that the CKD awareness programmes that are currently 
going on within the state as well as nation-wide may not be having the 
desired impact on the general public. This could be attributed to the 
use of the mass media as their primary approach of disseminating 
information about awareness programmes or campaigns on CKD to 
the general public. This may therefore account for one of the reasons 
why the number of CKD diagnosis is higher among the urban areas 
than the rural areas. 
6.3.2.3 Kernel density estimate of CKD cases within Benin City 
Out of the 442 diagnosed CKD cases within the study area, 345 cases 
were residing within Benin City. Therefore, it became necessary to 
examine the spatial distribution of the density of diagnosed CKD 
within the city in order to have a more detailed outlook of the spatial 
distribution of the disease.  
                                                 
28
 NPC-National Population Commission 
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In order to carry out the analysis for the density of diagnosed CKD 
within Benin City, the total number of CKD cases residing within the 
city was extracted from the CKD dataset while the Landscan 
population data for Benin City was also extracted from the population 
dataset using the same methods discussed earlier.  
Dual kernel density estimate of the rate of CKD within Benin City 
A total of 227 points were created to represent the LandScan 
population data for Benin City. 
The quadratic kernel estimator was used as the method of 
interpolation because the result of the Moran correlogram for Benin 
City was similar to the result of the Moran correlogram for Edo State 
(see Figure 6.3). The adaptive interval was used as the bandwidth for 
the density estimation with a sample size of the bandwidth interval set 
to a minimum of 10 points per square mile within the bandwidth 
radius. To estimate the CKD rate within the city’s population, the 
‘ratio of densities’ was selected for the density calculation of the 
datasets, which ensured that the kernel density estimate for CKD was 
divided by the kernel density estimate for the Benin City population.   
Discussion of result for the rate of CKD within Benin City 
The result was displayed using a quartile classification to determine 
a four-class interval. The four classes indicated the range of intensity 
of the rate of CKD within the city. 
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Figure 6.7: The spatial distribution of the kernel density estimate of diagnosed CKD 
within Benin City 
The results indicated that Aduwawa, Ugbeku, and Uselu ІІ wards 
registered within their boundaries, diagnosed CKD rates within the 
upper quartile of between 0.003-0.02 while Uselu ІІ and Ugbeku 
wards registered a moderately high rate within their boundaries. 
Although UBTH is located within Ugbowo ward, the CKD density 
within the area was low and this was also the case for Uwelu ward, 
G.R.A ward and New Benin ІІ ward.  
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In order to identify the areas within the city that have a high 
population density, a density map of Benin City using the Landscan 
population data was created (Figure 6.8). 
 
Figure 6.8: A LandScan™ 2008 Population Data set for Benin City, which was based on 
the Nigerian 2006 census 
One of the most intriguing outcomes from the analysis was the 
moderate rate of diagnosed CKD within Geretti ward, which ranged 
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between 0.0006-0.002. Although the ward registered the highest 
number of diagnosed CKD cases with a total of 102 CKD cases (see 
Appendix F), there appeared to be no indication of a high rate of 
diagnosed CKD within the ward. This might be attributed to the 
relatively high population density within the ward (see Figure 6.8), 
therefore, when the underlying population was taken into account 
while estimating the density of diagnosed CKD, the proportion of 
diagnosed CKD within the ward was classified as moderate instead of 
falling within the upper quartile. 
The result for the density rate of diagnosed CKD within the study 
area appeared to be similar to the result derived from the diagnosed 
rate, which indicated that Ikpoba-Okha LGA had the highest 
diagnosed CKD rate. This is because all the wards within this LGA 
registered relatively high rates within their boundaries, which ranged 
from the moderate or middle quartiles of between 0.0006-0.002 to as 
high as 0.02 in the upper quartile. One could suggest that the results 
from the density estimate analysis gives additional information on the 
spatial distribution of CKD within the state. This is because the KDE 
did not limit its analysis to the available administrative areas (i.e. the 
LGAs and the wards) during the course of the density analysis. 
Therefore, the technique was able to search for spatial patterns within 
small areas across the study area. The results generated from the KDE 
were therefore able to identify areas of concern within the state once 
the wards and even settlement boundaries were overlaid on the density 
maps. 
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  Given the technique used by the kernel density estimate in 
determining the spatial distribution of the rate of CKD and its 
advantage of avoiding the modifiable areal unit problem, it can be 
argued that the result derived from using the kernel density estimate 
has provided a detailed outcome of diagnosed CKD rates within the 
state particularly at the wards level. 
In summary, the spatial distribution of diagnosed CKD within Benin 
City and Edo state further points to the need for an extensive 
investigation of the spatial distribution of CKD in order to reach any 
meaningful conclusions regarding the association of the socio-
demographic factors and underlying spatial processes on the impact of 
CKD within the study area. However, such an investigation cannot be 
carried out within the scope of this research study due to insufficient 
socio-demographic data as well as healthcare data for the city and the 
state in general. Therefore, it should be stressed that the outcomes 
presented here are preliminary assessment of the spatial distribution of 
CKD within the Edo State. 
6.4 Spatial inequality of diagnosed CKD in the region 
An observation that is evident in the spatial pattern of CKD within the 
study area is the variation of diagnosed CKD between the urban and 
rural areas. It is apparent that the urban areas registered a higher 
number of diagnosed CKD cases than the rural areas. However, one 
cannot rule out the possibility that there could be a significant number 
of undiagnosed CKD cases within the rural areas. Apart from the 
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earlier suggestion that the use of the mass media as the primary means 
of raising CKD awareness might not be effective especially within the 
rural areas, there are likely to be other contributing factors that might 
have led to the spatial pattern of diagnosed CKD within the study 
area. One such contributing factor could be that the higher diagnosed 
rate of the CKD in the urban areas could be attributed to the high 
population density within their boundaries as opposed to the rural 
areas. However, the density maps have taken this into account and this 
argument might not be the only reason for this CKD pattern within 
Edo state. 
Another suggestion might be that the variation in the CKD pattern 
within the state could be due to the level of awareness of CKD both 
among the general population and among health practitioners. As such 
there are instances where the disease is not diagnosed until it gets to 
its late stage when it becomes both difficult and expensive to manage. 
One possible implication is that poor CKD awareness within the state 
may have had an impact on the rate of CKD diagnosis thereby leading 
to poor referral rates of patients to UBTH for treatment especially 
from the rural areas. If true, this would support previous findings that 
identified the importance of adequate access to vital health 
information, which is needed in improving the accessibility to 
available health services especially for rural dwellers (Agee, 2010; 
Awoyemi et al., 2011). 
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Another factor that might have contributed to the spatial distribution 
of CKD diagnosis is the accessibility to CKD healthcare within the 
study area. There is the possibility that some accessibility factors 
might have influenced the outcome of the spatial distribution of 
diagnosed CKD cases within the state. This assumption was further 
investigated in detail in the next chapter of this thesis. 
Nevertheless, it should be stressed that the results and supporting 
arguments presented within this study are exploratory. Therefore, 
there is a need for a more extensive analysis of the underlying spatial 
processes that could have contributed to the distribution of CKD in 
order to reach any meaningful conclusions regarding the spatial 
distribution of CKD within the urban and rural areas. 
6.5 Conclusion 
Although the high rate of CKD and areas with high-density of 
diagnosed CKD within the LGAs and wards are known to have urban 
population within their boundaries, the CKD patterns raise some 
questions on the spatial distribution of the disease within the state. The 
foremost question has to do with the low number of cases registered 
within the rural areas as opposed to the urban areas. As previously 
mentioned, the majority of the awareness campaigns currently done 
within the country uses the mass media such as awareness campaigns 
on the radio and television as well as billboard advertisement to pass 
on information about public related issues. A report by the Nigerian 
Population Commission (NPC) has already indicated that the mass 
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media as a tool in disseminating information to the general public 
would not be completely effective (NPC, 2005). Therefore, it can be 
argued that the current dissemination of CKD awareness campaigns 
and programmes appears to favour mainly the population that have 
access to the mass media. It therefore indicates that those in the urban 
areas that have access to these media facilities are more likely to come 
forward for treatment than those in the rural areas. It can be argued 
that this finding is consistent with the presence of the inverse care law. 
This is because there is the possibility that access to vital information 
needed in identifying CKD patients as well as available options for 
CKD healthcare are not being accessed by rural dwellers that might 
have the disease. 
 However, the proportion of CKD distribution between the urban and 
rural areas can only be addressed with extensive investigations in 
order to draw out reasonable conclusions on the factors behind this 
pattern. Given the inadequate nature of the population data due to 
criticisms on the census process in Nigeria (Igah and Okpokpo, 1998; 
Okolo, 1999; Bamgbose, 2009), the results presented within this 
chapter should be interpreted as a broad view on the distribution of 
CKD, which still has important policy implications in addressing 
CKD within the state.   
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Chapter 7 Accessibility of CKD patients to healthcare 
7.1 Introduction 
Accessibility to healthcare involves a number of factors and processes 
including proximity to suitable service providers, transportation 
networks (over which distance, travel time and travel cost can be 
estimated), socioeconomic characteristics and decision-making 
strategies of the individuals, and their ability to pay for services 
(Meade and Earickson, 2000). Apart from the high cost of treatment 
for CKD (discussed in section 2.4.3.1), the distance to the hospital for 
treatment is likely to also have an impact on the effectiveness of CKD 
management within the state. Studies have already suggested that 
distance to healthcare services has an influence on the accessibility 
and utilisation of such services especially in developing countries 
(Buor, 2003). Given the fact that an increase in distance is likely to 
result in an increase in the cost of transportation, there is the tendency 
for the cost of transportation to become an impeding factor especially 
for CKD patients that reside outside the state’s capital where the 
hospital is located. It can be argued that a service has to be accessible 
before it can be utilised. In order to analyse the impact of the 
accessibility and utilisation of the renal department in UBTH by CKD 
patients within the state, this chapter evaluates the service area for the 
hospital using the travel time to the hospital from various parts of the 
state. To examine the issue of accessibility to UBTH for CKD 
healthcare, the chapter begins by evaluating the referral rate of 
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patients from other healthcare services within the state. This is to 
determine whether geographical accessibility to UBTH might have 
influenced the number of health centres that referred CKD patients to 
UBTH as well as the spatial distribution of diagnosed CKD patients 
within the state. The outcome of these analyses is an attempt at 
addressing the final research question: “Is the prevalence and 
distribution of CKD in the state appropriately serviced by the 
available CKD healthcare service?” 
7.2 Proportion of health care services within Edo state that 
refer CKD patients to UBTH 
The University of Benin Teaching Hospital (UBTH) is the tertiary 
health institution used as a focal point of reference for most diseases 
by all other health institutions within Edo state. As such, the renal unit 
in the hospital is currently the only institute responsible for the 
treatment of CKD in the state and also has been found to treat some 
patients from neighbouring states. As discussed in chapter five, the 
state has a centre outside Benin City where free CKD screening is 
done at certain times of the year and this is located in Ogbona ward in 
Etsako Central LGA of Edo State.  
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Figure 7.1: Location of UBTH and the 24 health centres in Edo State that referred CKD 
patients, including the location of the CKD screening centre at Ogbona ward 
in Etsako Central LGA 
Twenty-four health centres that referred CKD patients to UBTH were 
identified and geocoded. Most of these centres were concentrated in 
Benin with only three health centres outside the state’s capital (see 
Figure 7.1). Out of the twenty-four health centres, only twelve of them 
referred more than one patient to the renal department for CKD 
treatment within the study period and this included one of the three 
health centres located outside the city known as Irrua Specialist 
Hospital, which is located in Esan Central LGA.  
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Although twenty-one of the twenty-four health centres that referred 
CKD patients to UBTH, were located within Benin City, it was 
observed that they were unevenly distributed. Three of these centres 
were located within Egor LGA, nine were within Oredo LGA, and the 
remaining nine were within Ikpoba-Okha LGA. In regards to the three 
health centres located outside the city, it was discovered that each of 
them was located within three LGAs towards the northern and central 
parts of the state. The first of these three health centres outside Benin 
City is called Alafia specialist clinic and maternity, which is located 
within the Etsako west LGA in Auchi І ward. The second health 
centre was the Irrua Specialist Hospital, which is located within Esan 
central LGA in Otoruwa II ward while the last health centre was the 
St. Camillus hospital that is located within Esan northeast LGA in 
Efandion ward. The Alafia specialist clinic and maternity is a 
privately owned clinic located within a town called Auchi in Auchi І 
ward while Irrua Specialist hospital is a Teaching Hospital located in 
Irrua town within Otoruwa II ward. It is one of the three teaching 
hospitals within the state with the other two hospitals located within 
Benin City (i.e. UBTH and Benin Central Hospital). The last health 
centre was St. Camillus hospital, which is located within a town in 
Efandion ward called Uromi town and the hospital is currently owned 
by the Catholic Diocese of Uromi therefore the hospital was classified 
as a private hospital since it was not owned by the state or the federal 
government. This meant that only six LGAs out of the eighteen LGAs 
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within the state had health centres within their boundaries that referred 
CKD cases to the renal department at the hospital. 
There is however, room for improvement in the number of registered 
healthcare centres that refer CKD patients to the renal unit in UBTH 
because according to the last publication by the Ministry of Health in 
Edo State in May 2007, there were 844-registered Health services in 
the state. The list of registered health services showed that the state 
has a total of 290 public health services and 554 private health 
services with Etsako central LGA (where the Ogbona CKD screening 
centre for the state is located) and Oredo LGA having the lowest and 
highest number of health services respectively (Table 7.1). This means 
that according to the UBTH’s renal records, it can be estimated that 
during the study period, only 2.8% of all the registered health centres 
within the state referred CKD patients to the renal department at the 
hospital. 
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Table 7.1: Summary of Registered Hospitals/Health Centres in Edo State 
LGA 
  Levels     
Total 
   Types 
Tertiary Secondary Primary Public Private 
Akoko-Edo 0 6 33 39 32 7 
Egor 2 49 71 122 7 115 
Esan Central 1 2 15 18 12 6 
Esan N. East 1 12 16 29 7 22 
Esan South East 0 6 21 27 21 6 
Esan West 0 13 30 43 19 24 
Etsako Central 0 1 13 14 12 2 
Etsako East 0 3 13 16 12 4 
Etsako West 1 18 21 40 13 27 
Igueben 0 6 7 13 8 5 
Ikpoba-Okha 0 32 53 85 10 75 
Oredo 1 77 144 222 9 213 
Orhionmwon 1 4 26 31 26 5 
Ovia N. East 1 1 27 29 27 2 
Ovia S. West 0 2 21 23 17 6 
Owan East 0 7 23 30 17 13 
Owan West 0 6 31 37 18 19 
Uhunmwonde 0 1 25 26 23 3 
Total 8 246 590 844 290 554 
Source 7:1: Edo State Government 2009 
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Figure 7.2: The location of the screening centre and the distribution of CKD referral 
centres in relation to registered Health care services per 1000 within each 
L.G.A in Edo State 
 
Based on the data for the number of registered health services within 
the LGAs (see Table 7.1) and the number of health centres within 
each LGA that referred CKD patients, it was discovered that there was 
a very poor CKD referral rate present within the state. This is because 
the number of health centres that referred patients for treatment were 
rather small compared to the number of registered health centres 
within each LGA. The proportion of health centres that referred CKD 
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patients within Egor LGA was just 2.5%, Oredo LGA was 4.1%, 
Ikpoba-Okha LGA was 10.6%, Esan central LGA was 5.6%, Esan 
north east LGA was 3.6%, while Etsako west LGA was 2.5%. 
Equally noticeable from the spatial distribution of the registered health 
centres and health centres that referred CKD patients to UBTH was 
that although there were a number of registered health centres in 
certain areas, there was an absence of health centres that referred CKD 
patients to UBTH particularly within the mid-region and boundary 
regions of the state. It was observed that these LGAs are 
predominantly rural areas. 
The proportion of the health facilities within each LGA in relation to 
its corresponding population was found to be very low with less than 
one healthcare service to every 1000 persons within each LGA (See 
Figure 7.2). The spatial distribution of the health units that referred 
CKD patients to UBTH in relation to the total healthcare services 
available within their LGA, demonstrated that most health services 
within the state might have a poor knowledge of the impact of CKD 
within the state. This statement has been supported by the doctors at 
the renal department within UBTH. They indicated that the number of 
referred CKD patients is very small in relation to the number of CKD 
patients that are diagnosed within the hospital. As previously 
discussed, some of the doctors at the renal department suggested that 
the reason for the high number of late diagnosis among CKD patients 
could be attributed to poor knowledge of the disease by doctors in 
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many of the health centres within the state especially those residing in 
rural areas.  
However, we cannot rule out the issue of accessibility to UBTH in 
order to receive CKD healthcare. This is because the health centres 
outside Benin City that referred patients to UBTH and the number of 
referred CKD patients were small. There were a total of 22 CKD 
patients from the three health centres outside Benin City that referred 
patients to UBTH. There is the possibility that the number of health 
centres that are located outside Benin City and are registered within 
the UBTH’s renal records to have referred patients to UBTH, might be 
attributed to accessibility issues experienced by diagnosed CKD 
patients across the state especially in areas outside the state’s capital. 
It is likely that there might be diagnosed CKD patients from health 
centres across various parts of the state that are not coming to UBTH 
for treatment due to accessibility issues and this could range from the 
issue of distance to UBTH to the cost of transportation to UBTH from 
their homes.  
In summary, two issues are likely to have contributed to the number 
and the spatial distribution of the health centres that referred CKD 
patients to UBTH. The first has to do with the issue to CKD 
awareness among health professionals as this might have contributed 
to the poor referral rates among health centres particularly as one 
moves further away from the state’s capital. However, this could not 
be examined in more detail within the scope of this study because this 
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study was based on secondary data therefore such data was not 
available within the health records that were used in this study. The 
second issue that might have contributed to the small number of health 
centres that referred CKD patients to UBTH, is the issue of 
geographical accessibility to UBTH from various parts of the state. 
The next sections will therefore evaluate the issue of accessing UBTH 
from various areas within Edo State in order to examine whether the 
number and the spatial distribution of diagnosed CKD patients is 
associated with their accessibility to healthcare. 
7.3 Evaluating the accessibility to CKD treatment within Edo 
state 
Accessibility can be classified as the ability of an individual to get a 
service as and when needed (Schneider and Symons Jr., 1971; Kumar, 
2004). As distance is likely to be an impeding factor to the 
accessibility of renal healthcare by CKD patients within the state 
especially those living further away from the city, the role of distance 
in the spatial access to the CKD department within UBTH was 
analysed. Studies have indicated that increased distance has an impact 
on healthcare accessibility and utilisation (Ensor and San, 1996; 
Ganatra and Hirve, 1994; Muller et al., 1998; Okafor, 1990). This is 
particularly true for those living in rural areas in developing countries 
(Buor, 2003). This section therefore investigates the spatial 
accessibility of the renal department located within the University of 
Benin Teaching Hospital (UBTH) by estimating within a travel model, 
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the average travel time of CKD patients that commute to UBTH from 
their home.  
7.3.1 Preparing the network dataset 
In order to evaluate the spatial accessibility to the renal department 
from various parts of the study area, a network dataset had to be built 
using the road network produced by RECTAS (1972).  
 
Figure 7.3: The road network within Edo state showing five different types of roads 
The road network comprised of five road types, these included the 
Benin roads, major roads, main roads, secondary roads, and other 
roads. The Benin roads were the detailed road network for Benin City 
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and it comprised of the main roads and streets within the city. The 
major roads consisted of the three high ways within the state. The 
main roads were the expressways that traverses the state while the 
secondary roads were the roads that linked the major roads and main 
roads to most parts of the state. The other roads could be classified as 
access roads to various areas particularly rural settlements across the 
state. One of the problems faced with the available road network was 
the absence of roads within the south western boundary of the state. 
Efforts at retrieving an updated road network for that area proved 
unsuccessful, as the RECTAS institute had no road data for that 
region. Attempts at creating a road network for that region using 
Google Earth was equally unsuccessful as the satellite image was not 
visible enough to trace the road networks that might be present in that 
area. The absence of roads within that area therefore limited the 
results derived from the network analyst, as there were no results 
available for that area. A cross-examination with the residences of the 
CKD patients showed that none of them resided within this area. 
Therefore, the absence of network data did not restrict the results 
generated for the CKD patients. However, this was not the case when 
the travel model was used to analyse the population at risk (discussed 
in section 7.3.2).  
Before the network dataset was built from the road network, a new 
field was created within its attribute table. This was the drive time 
field, which held the information on the length of time it took to 
traverse each road. In order to achieve this, an estimate of the number 
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of miles covered per hour for each road type within the network was 
carried out. Since the condition of each road was included within the 
dataset, the estimated time across each road type was not the same. 
For example, a tarred road within Benin City was given a drive time 
estimate of 30 miles per hour while an un-tarred road within the city 
was given a drive time estimate of 20 miles per hour. The choice of 
using low speed mileages and not higher mileages has to do with the 
poor condition of most un-tarred roads within the city and across the 
state (leadership, 2010; Okonta et al., 2002). Drive time across such 
roads could take longer in the rainy season when most roads get 
flooded and driving through would be slower and in worst situations, 
these roads are not accessible. The major and main roads were all in 
good conditions and therefore did not have different speed limits 
assigned to them while the ‘other roads’ were all in poor conditions 
and therefore had one speed limit assigned (Table 7.2). The table 
below shows the estimated speed limit for the different road types 
within the road network. 
Table 7.2: Estimated speed limit used for the different roads within the road network 
Road type Tarred road Un-tarred road 
Benin roads 30 miles/hr 20 miles/hr 
Major roads 50 miles/hr N/A 
Main roads 50 miles/hr N/A 
Secondary roads 40 miles/hr 30 miles/hr 
Other roads N/A 20 miles/hr 
 
The unit for the drive time field was in minutes therefore the 
calculation is stated below: 
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Drive time = [road length in miles] × 60 ÷ [estimated speed limit for 
each road type] 
The result for the field indicated the estimated drive time in minutes 
for each road within the network.  
Once the field was included within the attribute table, the road 
network was then used to build a network dataset and the drive time 
(in minutes) was set as the cost attributes for the dataset. This was 
created using the network analyst tool in ArcGIS 10. 
7.3.2 Evaluating the travel time to the CKD department in UBTH 
Travel time was used instead of travel distance as the impedance 
because travel time is more likely to indicate a more realistic estimate 
of how long it would take to reach the hospital. In situations where the 
roads are poorly managed, the length of time it would take to cover 
the distance to the hospital would be longer. Furthermore, a longer 
distance would result in an extended travel time that would equally 
cost more in terms of transportation either by public transport or the 
cost of fuel (if using a personal vehicle). As such, travel time has been 
regarded as an appropriate indicator for geographical access 
(McLafferty, 1988). 
The service area analysis within the network analyst tool was used to 
carry out the analysis. Within the analysis setting, the impedance was 
set to drive time (in minutes) while four default breaks were chosen to 
indicate the various travel time towards the hospital. These were 10 
minutes, 30 minutes, 90 minutes, and 150 minutes.  
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Figure 7.4: The distance in minutes it takes to travel to the hospital where the renal 
department is located from various parts of the state 
As mentioned earlier, regions within the south western boundary of 
the state were excluded from the analysis as there were no road data 
for those areas. It could be safe to state that residents within those 
areas would likely exceed the furthest travel time of 145 minutes. It 
appeared that even though the maximum travel time that was included 
within the analysis setting was 150 minutes, the maximum time it 
would take the furthest areas that were accessible by road was 145 
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minutes (Figure 7.4). The travel estimation was based on the use of a 
vehicle as the mode of transport. This did not take into consideration 
other factors, such as those that use public transport e.g. waiting time 
at a public station for the vehicle to get enough passengers or interval 
stops in order to drop or pick up passengers. Also excluded from this 
analysis was the estimation of pedestrian travel time. This was 
because there were no pedestrian path data available for this analysis 
and using the available road data was not likely to give a realistic 
result for pedestrian travel time as most roads especially outside Benin 
City (such as the major and main roads) were not likely to have 
pedestrian paths.  Even though these other factors were not taken into 
consideration during the analysis, the result gives a rough estimation 
of how long it would take for patients residing within different parts of 
the state to get to the hospital for renal treatment.  
The result equally showed that within Benin City, two-travel time 
bands were created. A total of 304 out of 345 CKD patients lived 
within 10 minutes from the hospital while the remaining 36 CKD 
patients in the city were approximately 30 minutes away from the 
hospital. 
The result of the various travel times to the hospital were cross-
referenced with the residences of the CKD patients within the state. 
The mean travel time to the hospital for the diagnosed CKD cases 
within the dataset was approximately 29 minutes (see Appendix G). 
The result indicated that almost 70% of the CKD patients diagnosed 
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within the study period resided within 10-minute travel distance from 
the hospital, while 1.8% of the CKD patients had to travel for about 
91 to 145 minutes in order to receive treatment at the renal department 
(see table 7.3). 
Table 7.3: Travel distance in minutes for the 442 CKD cases within Edo state to the 
hospital for CKD treatment 
Distance in minutes to 
Hospital Number of CKD cases Percentage of CKD cases 
0 - 10mins 309 69.9 
11 - 30mins 46 10.4 
31 - 90mins 79 17.9 
91 - 145mins 8 1.8 
Above 145mins 0 0.0 
 
In order to determine the amount of time spent travelling to the 
hospital for treatment by those who were diagnosed at either the 
earlier stages of CKD or at the late stage of the disease, both groups 
were cross-referenced with the result of the travel time to the hospital. 
The result for those that were diagnosed at the earlier stages of CKD 
indicated the average travel time to the hospital was 28 minutes (see 
Appendix H) and that 69.3% resided within a 10 minutes travel to the 
hospital while 1.8% had to travel for between 90 to 145 minutes to the 
hospital (see Table 7.4). Equally intriguing was the fact that there 
were more patients that resided between a 31 minutes to 90 minutes’ 
drive than those that resided within an 11 minutes to 30 minutes’ drive 
to the hospital. This could be attributed to the presence of a major 
urban centre (Ekpoma town) within that band as opposed to the rural 
settlements within the previous band of the travel time model as well 
as a network of secondary roads within that town that connects it to 
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Benin City. Based on my argument about the impact of geographical 
accessibility to UBTH, it is plausible that cases residing in urban areas 
that are further away from the hospital are more likely to be diagnosed 
than those residing in rural areas that are closer to UBTH due to 
available road networks. 
Table 7.4: Travel distance in minutes to the hospital for patients diagnosed at the earlier 
stages of CKD 
Distance in minutes to 
Hospital 
Number of CKD cases at 
the earlier stages 
percentage of earlier stages 
of CKD 
0 - 10mins 61 69.3 
11 - 30mins 10 11.4 
31 - 90mins 16 18.2 
91 - 145mins 1 1.1 
Above 145mins 0 0.0 
 
Patients diagnosed at the late stage of CKD indicated a decline in the 
number of cases as the travel time to the hospital increased with a 
mean travel time of 29 minutes (see Appendix I). Approximately 70% 
of the cases resided within a 10 minutes’ drive to the hospital. 
However, there was a sharp decline in the number of diagnosed cases 
that resided within the next travel time band of 11 to 30 minutes and 
the number of diagnosed cases dropped as the time interval increased 
(see Table 7.5). As expected the patients that resided within the first 
two time bands (i.e. within a 30 minutes’ drive) all resided within 
Benin City. It should be noted that this analysis only estimated for a 
single trip. Patients with stage 5 CKD or those that require regular 
dialysis will have to travel at least 3 times a week. Therefore, there is 
the possibility that some of these patients might have moved closer to 
the hospital (even though it was not indicated within their health 
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records). This might explain the large proportion of stage 5 patients 
residing within a 10-minute distance from UBTH. The assumption 
stated above that patients are moving closer to the hospital will require 
further investigation because the number of these patients is unknown. 
There is also the possibility that these patients represent only those 
that can afford to move closer to the hospital either because they have 
family/friends residing near the hospital or these patients themselves 
can afford to buy or rent accommodation near the hospital. 
Table 7.5: travel distance in minutes to the hospital for patients diagnosed at the late 
stage of CKD 
Distance in minutes to 
Hospital 
Number of CKD 
cases at the late stage 
Percentage of patients at 
the late stage of CKD 
0 - 10mins 248 70.1 
11 - 30mins 36 10.2 
31 - 90mins 63 17.8 
91 - 145mins 7 2.0 
Above 145mins 0 0.0 
 
7.3.3 Comparison with Edo State’s population 
To some extent, the location of CKD patients might be a function of 
the wider population geography of Edo state: even if there were no 
inverse care issues at play, we would expect that places with distinct 
concentrations of population such as towns and cities would have 
more CKD patients than more sparsely-populated areas, just because 
more people live in the former areas than in the latter. But this did not 
in fact account for the geography of diagnosed CKD patients’ 
locations relative to the UBTH renal facility. This is confirmed by 
comparing the proportion of CKD patients in each band of travel time 
from UBTH with the proportion of the overall state population (based 
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on the estimated 2006 ward populations) in the same band (table 7.6). 
The two geographies – of patients and of the public – are quite 
different from each other. On average, the general population resided 
much further away from the hospital than did the CKD patients: the 
average mean travel time to the hospital for the state population at 
large was 90minutes. Approximately forty percent of the population 
lived about 31 to 90 minutes away from the hospital and 
approximately 11% resided within a 10 minutes’ drive from the 
hospital while 5.3% resided more than 145 minutes away from the 
hospital (see Table 7.6). Only 11 wards out of the 193 wards had their 
centroids located within a 10 minutes’ drive from the hospital. The 
relative differences in travel times to the hospital for patients and for 
the public at large are substantial, as illustrated by the last column in 
table 7.6, which expresses the percentage of all CKD patients living in 
each travel time band as a ratio of the equivalent percentage of the 
total population. The percentage of CKD patients living within 10 
minutes of UBTH was 7 times higher than the percentage of the 
population doing so. But in all other travel time bands, the relative 
share of the state population living there exceeds the relative share of 
patients, and the under-representation of patients relative to the 
population as a whole worsens dramatically at increasing distance 
from the hospital. 
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Table 7.6: Travel distance in minutes to the hospital for the general population, the total 
diagnosed CKD cases, and the ratio between both datasets within Edo state 
Distance in 
minutes to 
Hospital 
Number 
of wards 
Total 
population 
percentage 
of the total 
population 
percentage 
of the total 
diagnosed 
CKD cases 
Ratio of all 
diagnosed 
CKD cases 
and the 
total 
population 
0 - 10mins 11 367833 11.4 69.9 7:1 
11 - 30mins 21 596874 18.4 10.4 0.6:1 
31 - 90mins 94 1283490 39.7 17.9 0.4:1 
91 - 145mins 60 817205 25.2 1.8 0.07:1 
Above 
145mins 
8 171334 5.3 
0 0.000:1 
 
 
 
Figure 7.5: The travel time to the renal department at the University of Benin Teaching 
Hospital (UBTH) for CKD patients diagnosed at either stages of CKD as well 
as the general population within the state. The error bars show the standard 
error for each group 
 
The outcome of these results further points to the possibility that 
distance is an impeding factor to the diagnosis of CKD. This is 
because the proportion of diagnosed cases with either stage of CKD 
residing in the various travel bands in relation to the proportion of the 
general population residing within the same travel bands appears to be 
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different. Since approximately 70% of both stages of CKD resided 
within 10 minutes from the hospital, one would have expected a 
similar proportion of the population to reside within the same travel 
time if distance was not an impeding factor to the diagnosis and 
treatment of the disease. Since this is not the case, there is the 
likelihood that there might be more CKD cases that may not be 
coming to the hospital for treatment because of the long distance. One 
might argue further that there might be the possibility that clinics and 
hospitals outside the city might actually be referring patients to the 
hospital for treatment but these patients might not be going to the 
renal department in UBTH once they considered the long trip. This 
assumption might also explain why there were no referred cases 
located within the CKD dataset from the screening centre located in 
Ogbona ward (previously discussed in section 5.4.3). The distribution 
of both stages of CKD across the travel time bands gives an indication 
of the impact of travel time on the spatial access of CKD patients to 
renal health care at the hospital.  The travel time evidence displays a 
steep distance decay effect in access to healthcare at the renal 
department by patients diagnosed at either stages of the disease. 
Furthermore, the slight increase in the number of CKD patients in the 
third travel band is not an indication of some deviation from the 
distance decay effect as the overall population also increases in this 
band compared to the 11-30 minute band. However, the relative 
increase in patient numbers is smaller than that for the population as a 
whole: so even taking this into account, considerably fewer patients 
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live in this band than expected in relation to the general population 
within the same band (Table 7.6).  
CKD patients are over-represented relative to the general population 
in the travel time band nearest the hospital, but are noticeably under-
represented in all the other bands. The question that arises is why does 
this happen? There are at least two possibilities: the first possibility 
could be that there is a strong inverse care process where only those 
living very close to the hospital have a realistic chance of being 
diagnosed. This could be because proximity to the hospital results in 
increased CKD awareness for the general population as well as 
medical professionals that refers patients to UBTH for treatment 
(discussed in sections 5.4.4 and 6.4). The second possibility is that 
individuals diagnosed with CKD from elsewhere in the state move 
into Benin City and live with friends/relatives or rent/buy 
accommodation when they realise they need treatment at UBTH. 
Therefore, it is difficult to ascertain how many people from the rural 
areas can rent/buy accommodation or still have friends/relatives in 
Benin City that they can live with when they realise they need 
treatment at UBTH and who can help them with the cost of the CKD 
treatment. Therefore, due to the limitation of my research data, I do 
not have the evidence to decide which of the two possible 
explanations could have accounted for the over-representation of 
diagnosed CKD cases relative to the general population in the travel 
time band nearest the hospital. However, I would argue that both 
circumstances are likely to have contributed to the spatial distribution 
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of diagnosed CKD cases within the state. This can be attributed to the 
fact that geographical accessibility as well as affordability of CKD 
treatment is likely to be responsible for the spatial distribution of 
diagnosed cases within the state. Although there is the assumption that 
those that are able to easily access the renal unit would be diagnosed 
and ultimately get access to CKD treatment, we cannot rule out the 
possibility that only those who can afford the treatment will be willing 
to access the renal unit for treatment. This could therefore explain why 
the diagnosed CKD cases appear to be disproportionately drawn from 
the more affluent parts of that society even though there is no 
substantial evidence that indicates that the prevalence of CKD is 
higher among those from more affluent parts of the society (see 
section 2.5.4). In other words, the inverse care law applies. 
Although the travel time model to the hospital took into consideration 
the speed limit for the road types, one could argue that the settlement 
type within the travel bands of the model might have also influenced 
the number of diagnosed cases for both stages of CKD. It was 
observed that the sharp decline in the number of diagnosed cases in 
the travel bands away from the hospital were found to have only rural 
settlements within their boundaries. Equally intriguing was the fact 
that these rural areas where the sharp drop in diagnosed cases where 
registered, happened to be the rural settlements surrounding Benin 
City. However, the slight increase in the number of diagnosed cases 
registered within the travel band(s) away from Benin City in the travel 
time model indicated that urban areas were located within those travel 
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bands. For example, Ekpoma town, which is an institutional town, is 
located within the 60minutes to 90 minutes band of the travel time 
model. However, the settlements located within the previous travel 
band of the travel time model, only consisted of rural settlements. 
This result highlights the problem of accessible road networks in rural 
areas compared to their urban counterparts. One could argue that 
another factor that might have contributed to the poor number of 
diagnosed CKD within the rural areas might be due to the problem of 
accessible road networks within the state. According to a study on 
rural roads within Nigeria, it was reported that more than 70% of rural 
roads  are in deplorable conditions and their accessibility can be 
classified as seasonal due to the obstruction of these roads during the 
rainy season (Ipingbemi, 2008). Because these rural roads serve as 
feeder roads that connect to the rest of the road network (see section 
7.3.1), the problem of inaccessibility from these rural areas using 
these feeder roads might account for the poor number of diagnosed 
cases that are being registered. This might also explain why there 
appears to be more diagnosed CKD cases from urban areas that are 
further away from Benin City than the rural areas that are closer to the 
city.  
 
 
 
 
295 
 
7.4 Determining the location of suitable satellite centres for 
CKD treatment 
Given the assumption that was discussed in the previous sections of 
this chapter, which suggests that accessibility to CKD healthcare 
might have contributed to the spatial distribution of diagnosed CKD, 
one has to look at ways of improving access to CKD healthcare within 
the state. In recent years, significant progress has been made in the 
research and development of methods for the efficient allocation of 
healthcare resources (Mitropoulos et al., 2006; Syam and Côté, 2010). 
Given the results from section 7.3, which indicates that there is the 
possibility that travel time is an impedance to effective CKD 
management in the state, there is the need to examine the prospect of 
locating other CKD centres that can serve as satellite centres for CKD 
treatment within the state. These satellite centres will not be newly 
built health centres but already established health centres where CKD 
healthcare services can be integrated with the health services they 
offer to the residents in their areas. In order to identify a suitable site 
for the location of a satellite CKD centre, a location-allocation model 
was created using ArcGIS 10. A location-allocation model seeks to 
simultaneously determine optimal facility locations and the 
assignment of demand to the selected facilities (Syam and Côté, 
2010).  
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7.4.1 Determining the location for more CKD facilities within Edo 
state to cater for the treatment of earlier stages of CKD 
As mentioned in the previous chapters, a number of studies have 
already established that one of the ways of addressing the issue of 
CKD is by carrying out routine screening so as to detect the disease at 
an earlier stage when it is cheaper and easier to treat. There is the 
possibility that physicians and health officials in other health centres 
can help to screen the population for CKD, diagnose, and also manage 
CKD patients at the earlier stages of the disease instead of referring all 
diagnosed cases to UBTH. As such, there might be the need to set up 
interim CKD facilities within the state that are also cost effective in 
the management of the earlier stages of CKD within the state. The 
idea behind the establishment of such CKD facilities would be to 
reduce the distance between the patients and accessible CKD 
healthcare facilities. Previous analyses on the available CKD facilities 
within the state such as the screening centre in Ogbona ward (see 
chapter five) and the UBTH accessibility issues discussed in section 
7.3, both indicate that the current structure for CKD management 
might not be adequate. However, given the fact that it would not be 
financially feasible to establish several new CKD facilities within the 
state, I would suggest that already established health centres within 
certain areas of the state could be chosen to offer CKD screening to 
the general public and treatments for CKD at the earlier stages. These 
centres can also be equipped to carry out awareness programmes 
within their local vicinities, which would help improve CKD 
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awareness among the public and this could lead to an improvement in 
the diagnosis of CKD at the earlier stages. Therefore, in order to 
minimise the distance between CKD patients and CKD healthcare 
facilities, there was the need to carry out a location-allocation analysis 
in order to locate satellite CKD centres close to population centres for 
each LGA, which would serve as population thresholds for the 
satellite CKD facilities. This objective was based on the argument that 
people tend to attend nearby health facilities than attend those that are 
farther away. This argument is based on the results from the previous 
section (see Table 7.3) that indicated a sharp drop in the number of 
diagnosed CKD cases after a certain limit. 
7.4.1.1 Criteria for new CKD healthcare services 
For the optimal location for the CKD facilities, one main factor was 
considered. This was the travel time to these CKD facilities from 
population centres within the study area. The objective is reflected in 
the minmax criterion where the aim is to minimise the maximum 
distance that CKD patients must travel to access healthcare treatment 
(Marsh and Schilling, 1994; Mitropoulos et al., 2006). Based on the 
argument stated above that the CKD facilities should be located from 
already established health centres within the state (either hospitals or 
clinics), the model for the location of the CKD facilities was based on 
the following assumptions: 
 The number of established health centres that could potentially 
offer CKD healthcare services were specified in advance 
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 The existing demand for the CKD healthcare services can be 
satisfied either at a clinic or hospital 
 The patients would choose to travel to the closest CKD 
healthcare service 
At this point, I must highlight that the intention of locating these CKD 
healthcare services is to cater for the CKD screening of the general 
public and also the management of patients with earlier stages of CKD 
where the possibility of needing specialised renal treatment is low and 
likely to be absent. This is because the physicians within these 
healthcare service areas could adequately manage the patients at these 
earlier CKD stages. Using the average travel time derived from the 
travel time model (see sections 7.3.2), the pre-specified threshold 
value for the maximum allowable travel time was set at 29 minutes.  
In order to ensure that the general population could have access to 
these CKD healthcare services, the centroids of the wards were chosen 
as the demand points for the model and their populations were 
assigned as weights. The choice of using the general population and 
not the number of diagnosed CKD patients was because any member 
of the population could develop CKD and also these facilities would 
serve as CKD screening centres for the population. However, this led 
to another problem, as not all the wards could be located within the 
model. This was because of the problem mentioned earlier in 
section7.3.1, as the network dataset was incomplete and as such, the 
wards located at the south western boundary of the state could not be 
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located within the model. This meant that 188 wards out of 195 wards 
were included within the model. Therefore, approximately 3.6% of the 
population within the state were excluded from the analysis. 
An alternative would be to use the Euclidean distance, as this would 
not exclude areas without road networks. However, this technique was 
not considered in this study because it does not incorporate access to 
transportation and transportation networks (Alvanides and Gilmore, 
2004). Therefore, the results generated might not be as close to reality 
as those produced using road networks because people are more likely 
to travel along transport routes than in a straight line especially across 
long distances where transportation and transportation networks are 
available. 
Determining the number of CKD healthcare services 
The actual number of CKD healthcare services that could be included 
within this model is a rather subjective decision. However, in order to 
create a sense of objectivity, one CKD healthcare service was 
assigned to each LGA within the state, this meant that 18 CKD 
healthcare services were to be included in the model in order to assess 
whether the presence of these facilities would improve the 
accessibility of the population to CKD healthcare within the state.  
The option of what type of healthcare service to use i.e. whether it is a 
hospital or a clinic, or whether it is a privately or publicly owned 
health facility, was not considered within this model. This was due to 
the absence of data on the spatial location of all the health facilities 
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within the state as well as the lack of data on the resources within 
these facilities. 
Since the spatial location of the health services within each LGA 
could not be determined, the centroid of each LGA was used as the 
spatial location for the health services that would serve as potential 
CKD healthcare services within the model. To ensure that these 
locations were accessible, the locations were snapped to their nearest 
road or road junction before carrying out the analysis. 
7.4.1.2 Analysis and results for the location of CKD healthcare services 
that could manage patients with earlier stages of CKD 
Since the objective of the analysis was to locate CKD healthcare 
services while minimising the travel time, the maximal covering 
location problem (MCLP) known as the “maximise coverage 
problem” in ArcGIS 10 (see chapter three) was used to solve the 
problem within a location-allocation model. The MCLP was chosen 
instead of the p-median problem because of the limitation associated 
with the p-median problem. As mentioned in chapter three the p-
median problem does not take into account the worst-case scenario as 
the results from the p-median model, may be forcing a few users to 
travel far to receive CKD healthcare (Harper et al., 2005; Rahman and 
Smith, 2000). Another advantage of the MCLP is that it attempts to 
locate the facilities so that as few people as possible lie outside the 
desired travel time to a service. 
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The model began by first solving the optimal distance to UBTH based 
on the average travel time (in minutes) as impedance for the analysis. 
A linear impedance transformation was used in solving the problem. 
This ensured that ArcGIS used a linear decay in calculating people’s 
propensity to seek CKD treatment at a CKD healthcare service. The 
results were then compared with the results derived from the model 
that analysed the inclusion of the 18 CKD healthcare services that 
would serve the LGAs within the state. 
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Figure 7.6: The current optimal demand to UBTH using travel time as impedance, 
which based on a 29-minute threshold value 
The result of the model for the optimal travel time to UBTH, showed 
that given the assumptions stated in section 7.4.1.1, only 36 wards out 
of the 188 wards within the model would optimally access UBTH for 
CKD treatment. I should mention at this stage that although seven 
wards were not included within the study, their inclusion within the 
model were not likely to have increased the number of wards that 
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could optimally access UBTH. This is because these seven wards are 
not located within the threshold value of 29 minutes distance from the 
hospital. The result also stated that the total population that optimally 
had access to the hospital was approximately 1072244. 
In order to minimise the travel time while increasing the  demand 
within the available CKD healthcare services, the centroid for the 18 
LGAs, which represented the sites for the possible CKD health 
facilities, were included within the model.  
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Figure 7.7: The predicted scenario using the LGA centroid as the service points for the 
potential CKD healthcare services that would cater for earlier stages of CKD 
Once the 18 locations for the potential CKD facilities were included 
within the model, the results indicated that the number of wards that 
would optimally access UBTH for renal treatment had reduced to 18 
wards instead of the 36 wards originally identified when UBTH 
served as the only CKD facility within the state. The total number of 
wards that would adequately have access to the 19 potentially 
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available CKD healthcare services had increased from 36 wards to 
150 wards. This meant that the total population that would potentially 
have access to CKD healthcare had increased from 1072244 people to 
approximately 2731076 people.  
However, it was discovered that in spite of the inclusion of the other 
18 potential CKD healthcare services that would cater for CKD 
patients at the earlier stages, UBTH still had the highest allocated 
demand for its CKD healthcare service (see Appendix L). The 
potential site for the CKD healthcare service in Ovia southwest had 
the lowest allocated demand with just 1 ward and approximately 
31493 people allocated to it. According to the Ministry of Health’s 
records, there are a total of 23 healthcare services within Ovia 
southwest LGA. Two of these are secondary healthcare services while 
the remaining twenty-one are primary healthcare services. Given the 
low numbers allocated to the CKD healthcare service within this 
LGA, I would argue that either of the secondary healthcare services 
within the LGA would be suitable as a potential site for including a 
CKD healthcare service.  
Due to the lack of data on the capacity of these healthcare services and 
also the ownership of these health services (i.e. whether it is privately 
owned or publicly owned), the actual choice on where to locate the 
CKD healthcare services within these LGAs would require further 
investigations as well as other considerations such as financial and 
political considerations. 
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7.4.1.3 An alternative method for determining the location of CKD 
healthcare services that could manage patients with the earlier 
stages of CKD 
A problem  with using the LGA centroid as the service locations was 
the possibility of locating a centre within an unpopulated area. This 
appeared to be the case for three of the LGA centroids – Esan west 
LGA, Esan north east LGA, and Etsako west LGA (see Table 7.7). 
Table 7.7: The LGA centroids located within an unpopulated area 
LGA LGA Head Quarters 
Settlement within or around the location of 
the LGA centroid 
Esan west Ekpoma 
Ugbiyokha (closest settlement to unpopulated 
location) 
Esan northeast Uromi Awo (closest settlement to unpopulated location) 
Etsako west Auchi 
Ayeri-Ubiane (closest settlement to unpopulated 
location) 
 
Therefore, to improve on the outcome of the model, a different 
criterion for choosing the locations for the potential CKD services to 
cater for patients with the earlier stages of CKD was selected. Instead 
of using the LGA centroids as the locations for the potential CKD 
services, suitable road junctions within each LGA were used as the 
location for the potential CKD services. 
Another technique that was considered but not employed in this thesis 
was to generate population-weighted centroids for the LGAs, which 
would represent the potential CKD healthcare facilities.  Although this 
can be classified as the most appropriate technique to use, it could not 
be done because the data needed for this technique were not available. 
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Criteria for choosing a suitable road junction as the location for 
the CKD healthcare services to cater for patients with the earlier 
stages of the disease 
There were 4022 junctions represented within the road network 
dataset. To determine the junctions that could be included within the 
model as a suitable location for the CKD healthcare service within 
each LGA, a number of criteria had to be considered. The first 
criterion for selecting the appropriate junction was that the junction 
had to be linked to a major, minor, or a secondary road as these roads 
were in relatively good condition and also had a higher level of 
accessibility than the other roads. Another criterion was that the 
junction had to be located within a populated area. 
In order to ensure these criteria were met, the road junctions were 
exported to Google Earth and overlaid on the study area. Once the 
criteria was met within a LGA, the appropriate road junction was 
selected for that area and a total of eighteen junctions were selected as 
the potential location of the CKD healthcare service within the Edo 
state (see Table 7.8). Equally intriguing, was the fact that only four 
out of the eighteen locations were within an urban centre. This 
therefore improves the access to CKD healthcare in the rural areas as 
this meant that 77.8% of the potential CKD health services could be 
located within rural areas where accessibility has been very poor. 
Although it can be argued that most healthcare staff might not be 
willing to relocate to a rural area, which could defeat the purpose of 
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assigning one of these rural centres as a CKD health facility. I would 
argue that these CKD facilities are only to screen for CKD, diagnose, 
and manage patients at the earlier stages of CKD. This does not 
require the need for a renal specialist, such as a nephrologist or a renal 
nurse. Rather, the available health workers in these health centres are 
given the necessary training required for screening for CKD and 
managing patients with earlier stages of CKD, referring patients to a 
nephrologist when their conditions deteriorate beyond the capability 
of the health centre. 
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Table 7.8: The eighteen selected junction used in the model 
Junction ID Settlement within the location of the junction LGA 
12 Iguobazowa Ovia southwest 
600 Oluku Ovia northeast 
966 Ibiwe Oredo 
1127 Ugbowo Egor 
2632 Oka Ikpoba-okha 
3608 Sabon-Gida Owan west 
3623 Ehor Uhunmwonde 
3635 Ugo Orhionmwon 
3661 Isokka Owan east 
3686 onumu Akoko-edo 
3753 Akahia Esan west 
3805 Irrua Esan central 
3809 Ebele town Igueben 
3858 Ayeri-Ubiane Etsako west 
3925 Amendhokian Esan northeast 
3957 Ugun Esan southeast 
3965 Imiegba Etsako east 
3989 Ogonmeri Etsako central 
 
7.4.1.4 Analysis and results for using the road junctions to determine the 
location of CKD healthcare services that could manage patients 
with earlier stages of CKD 
Using the same criteria for the location-allocation models discussed in 
section 7.4.1.1, a similar analysis was carried out using the selected 
road junctions as the potential locations for the CKD healthcare 
services. This meant that the maximise coverage problem in ArcGIS 
10 was used to analyse the CKD health services within a location-
allocation model.  
In order to minimise the travel time while increasing the number of 
demand within the available CKD healthcare service, the 18 potential 
locations /suitable junctions, which represented the settlements where 
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the CKD health services could be located were included within the 
model. I should point out that the location-allocation analysis, which 
had just UBTH within the model was not repeated in this section, as 
the result would be the same as the previous analysis. However, the 
outcome from the analyses in this section was compared with the 
outcome from the analyses that used just UBTH to create the model.  
 
Figure 7.8: The predicted scenario using a suitable junction within each LGA as the 
service points for the potential CKD healthcare services that would cater for 
earlier stages of CKD  
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When the 18 locations for the potential CKD facilities were included 
within the model, the results indicated that the number of wards that 
would optimally access UBTH for renal treatment had reduced to 9 
wards instead of the 36 wards originally identified when UBTH 
served as the only CKD facility within the state. The total number of 
wards that would adequately have access to the 19 potentially 
available CKD healthcare services had increased from 36 wards to 
159 wards. This represented a considerable increase.  
The potential site for the CKD healthcare service in Ovia Northeast 
LGA had the lowest allocated demand with just three wards and a 
total of approximately 49487 people allocated to it. According to the 
Ministry of Health’s records, there are 29 healthcare services within 
Ovia Northeast LGA. It has one tertiary hospital, one secondary 
healthcare service, and the remaining twenty-seven are primary 
healthcare services. Given the low  demand allocated to the CKD 
healthcare service within this LGA, I would argue that either the 
tertiary hospital or the secondary healthcare service within the LGA 
would be suitable as a potential site for including a CKD healthcare 
service.  
The variations in results generated in this chapter highlight the 
problem of data availability and its impact on the outcome generated 
within a study that relies on a limited dataset. This is one of the 
problems faced by health geographers and other researchers working 
within a developing country where relevant data are not usually 
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readily available. Given the fact that the scope of this study does not 
include a detailed field investigation of all the registered healthcare 
services within the study area, the alternative approach utilised in this 
location-allocation analysis appears to have produced an outcome that 
can be regarded as a plausible result. This is because this approach 
took into account the relevant criteria needed in locating an accessible 
site. 
In conclusion, I would recommend that the travel time to the location 
of potential CKD healthcare services must be included during the 
proposal for additional CKD healthcare services that would cater for 
the CKD screenings in the state and the management of CKD at the 
earlier stages of the disease. 
7.4.2 Determining the location for a CKD facility within Edo state to 
cater for the treatment of patients at the late stage of CKD 
The establishment of an optimal CKD health service that caters to the 
treatment and management of patients with the late stage of CKD can 
be regarded as a capital and structurally intensive project. This is 
because such a health service requires certain facilities in place, such 
as the establishment of RRT facilities (e.g. renal dialysis machines) as 
well as the employment of an adequate number of renal health staff 
(e.g. nephrologists, renal nurses and medical technicians to manage 
the dialysis equipment). Therefore, it would not be financially feasible 
to allocate this type of facility within each LGA within the study area. 
Based on these circumstances, another option has to be considered 
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where some facilities are already available within an established 
healthcare centre, preferably a tertiary health institute. According to 
the state’s health ministry, there are currently eight tertiary hospitals 
within the state (see Table 7.1). Since one of these tertiary hospitals is 
the University of Benin Teaching Hospital (UBTH), the location of 
another CKD health service would have to be chosen from the other 
seven hospitals. UBTH is located within Egor LGA and according to 
the report by the state’s health ministry, there are two tertiary health 
services within that LGA but according to my investigation, the 
second tertiary health service was a Psychiatry hospital. This therefore 
meant that the remaining six LGAs that had a tertiary hospital within 
their boundary could be considered within the location-allocation 
model. These were Irrua specialist hospital in Esan central LGA, 
Uromi central hospital in Esan north east LGA, Auchi central hospital 
in Etsako west LGA, Specialist Hospital Ossiomo in Orhionmwon 
LGA, the Benin central hospital in Oredo LGA, and Ovia north east 
LGA. Further investigation showed that the Specialist Hospital 
Ossiomo is a Leprosarium and Haematology hospital, therefore the 
hospital was removed. This therefore meant that apart from UBTH, 
only five tertiary hospitals could be considered. However, certain 
criteria had to be met before any of these listed hospitals were 
included in the analysis.  
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7.4.2.1 Criteria for locating another CKD health service for managing 
the late stage of CKD 
The objective of the analysis is to locate one more facility in any of 
the other tertiary hospitals, which would serve as another specialist 
CKD health facility in addition to the UBTH renal unit. Because 
UBTH is located within the south western region of the state, the main 
criteria for locating another CKD facility would be that it must not be 
spatially close to UBTH. Therefore, it should not be within Benin 
City. In addition, the new facility should ideally be more centrally 
located so that it could cater for other patients that reside further away 
from the state’s capital where UBTH is located. Based on these 
criteria, the tertiary health service in Oredo LGA was excluded from 
this analysis, as it was located within Benin City. It was discovered 
that one of the referral centres included within this study was 
classified as one of the remaining four tertiary hospitals that could be 
included within the analysis. This was the Irrua specialist hospital, 
which is located within Esan central LGA (see section 7.2). Therefore, 
its geographical co-ordinates were used instead of the LGA centroid 
Esan central. The other four hospitals were geocoded and mapped. 
Determining the appropriate problem for the location-allocation 
model 
The “maximise attendance” model was considered for the location-
allocation analysis. The objective of this model was considered 
appropriate for solving the stated problem (see section 7.4.2.1). This is 
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because, according to the originators of this model, the model aims to 
solve three main problems (Holmes et al., 1972): 
 Determine the maximum distance that people are willing to 
travel to secure a service 
 Maximise the number of people served by the facilities 
 Minimise the average distance travelled per person in relation 
to the proportion of the total population which is served 
Given that the maximise attendance model can determine the facility 
that can be allocated to the maximum number of people while 
reducing the average distance travelled for each person, therefore the 
facility that had the highest demand allocated to it apart from UBTH 
was classified as the optimal centre for locating another CKD centre. 
7.4.2.2 Analysis and results for the location of another CKD health 
service that could manage patients with the late stage of CKD 
The model was set to choose only two facilities from five facilities 
included in the model. Within the parameters for the facilities 
included within the model, the status of UBTH was set as a required 
facility while the remaining four facilities were classified as 
candidates. This was to ensure that UBTH was included in the results 
while attempting to find another tertiary hospital that would be the 
optimal location for another CKD healthcare service that provides 
specialised healthcare for CKD patients.  
The travel time variable was used as impedance in solving the 
problem of identifying another CKD healthcare service for patients 
 
316 
 
with CKD at the late stage of CKD. Using the same parameters 
discussed in section 7.4.1.1, the pre-specified threshold value for the 
maximum allowable travel time and travel cost, were set to 29 
minutes. This was done in order to model the maximum distance that 
people were willing to travel to the proposed CKD centre. 
Just like the previous location-allocation analyses, a linear impedance 
transformation was used in solving the problem, which ensured that 
ArcGIS used a linear decay in calculating people’s tendency to seek 
CKD treatment at any of the CKD healthcare service.  
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Figure 7.9: Predicted scenario for the optimal location for another CKD service that 
would cater for patients with the late stage of CKD and offer specialised 
CKD healthcare for the state  
The result from the model showed that apart from UBTH, Irrua 
Hospital, which is located in Esan Central LGA, had the highest 
demand with a total of 35 wards allocated to it. Although UBTH was 
allocated 35 wards, it had a higher population demand of 
approximately 527253 people, while Irrua hospital was found to have 
approximately 207013 people. This result indicates that Irrua hospital 
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is likely to cater for a higher number of patients than the other four 
candidate tertiary hospitals, which were also considered for the 
establishment of a CKD healthcare service. 
The result of the predicted scenario for the optimal location for 
another CKD service that would offer specialised CKD healthcare 
along with UBTH, indicate that 70 wards and approximately 734267 
people would be catered for in this scenario. It is apparent from using 
travel time as impedance that Irrua hospital appeared to be the most 
likely location to establish another CKD service that would cater to 
CKD patients with the last stage of the disease.   
Exploring the capacity of Irrua hospital and the available resources 
needed to establish the CKD service within the hospital is currently 
beyond the scope of this thesis. This is primarily due to the absence of 
readily available data on the issue. However, a detailed investigation 
into the available resources that can be used in the establishment of 
another CKD service within state (preferably within Irrua hospital) 
should be considered in future studies.  
7.4.3 Limitations associated with the location-allocation models. 
A major limitation of the outcomes generated from these location-
allocation models is the lack of data to indicate the capacity of the 
healthcare services within the state. As a result, the model failed to 
take into consideration whether these healthcare services that were 
identified as the optimal locations for the CKD facilities could 
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adequately manage the demand (i.e. the estimated population in the 
wards) assigned to them if or when they come for CKD screening. 
Another limitation is that the models did not take into account all the 
population within the study area as 3.6% of the population had to be 
excluded from the analyses because of the missing road network data 
for the south western boundary of the state. 
Furthermore, there have been some apprehensions that have been 
raised about the suitability of capturing the complexities of real-life 
location issues by adopting these accessibility models. Such 
limitations include the inability to capture the unpredictability in 
patients’ mode of transport, distances, travel times, and uncertainty 
over patient preferences for travelling to different centre locations, and 
complexities over consideration of healthcare services involving 
multiple services rather than a single service (Harper et al., 2005).  
Another shortcoming of the use of accessibility models in evaluating 
service accessibility problems such as CKD healthcare facility within 
the state is that an optimal solution cannot be guaranteed. This is 
because real-life location planning is subject to various constraints and 
other factors, such as political considerations (Harper et al., 2005). In 
many developing nations, decisions pertaining to resource allocations 
and facilities locations are generally taken locally by government 
officers or by local elected leaders or by both and in the absence of 
any formal analysis and generation of alternatives, the final decision 
may be made on political or practical considerations (Rahman and 
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Smith, 2000). As a result, the decisions made regarding the location of 
another CKD health service might be far from optimal because it 
cannot solve the problem but only inform decision makers. 
7.5 Conclusion 
This chapter began by suggesting that proximity to UBTH could likely 
be an impedance that resulted in the low number or absence of 
diagnosed CKD in certain areas especially among rural dwellers 
within the state. The travel time model to the hospital has indicated 
that those residing further away particularly rural dwellers are more 
affected by the spatial accessibility to the renal department within 
UBTH. This may have resulted in patients not seeking medical 
treatment even though they might have been diagnosed with CKD by 
the medical practitioner within their community.  
Furthermore, the limitations associated with the data and the 
unpredictability of patients cannot be measured within a static model 
such as the ones created within this study. Therefore, the outcome of 
the results discussed within this chapter can only serve as a baseline 
on which further investigations on the suitability of an optimal 
location for CKD healthcare service can be implemented. The 
outcomes from the models could help health planners to evaluate the 
organization of the available CKD services and the impact on the 
spatial distribution of the population, both from the managers of the 
healthcare service and patients’ viewpoints. 
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The next chapter summarises the main findings of this thesis and also 
discusses the recommendations that would address the research 
questions that have been outlined in this thesis. 
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Chapter 8 Concluding statements 
8.1 Introduction 
This concluding chapter focuses on the implications of the findings of 
this research study. Therefore, the implications of the findings from 
both the research process and results of the study are discussed in line 
with the structure of the thesis. 
The first section of this chapter begins with a summary of key 
findings. The methodological limitations of the research as well as the 
possible effects of sample bias due to missing records and non-
response within the CKD dataset are outlined in section 8.3. Section 
8.4 focuses on the discussion of the implications of the findings from 
the research study. The recommendations for future study are 
discussed in section 8.5 while some concluding comments are outlined 
in section 8.6. 
8.2 Summary of findings 
This study attempted to answer the following six research questions: 
 Is there an association between socio-demographic factors and the 
severity of CKD at first presentation? 
 Is there a relationship between the severity of CKD at first 
presentation in Edo state and known biological risk factors of 
CKD? 
 What factors are likely to lead to the late diagnosis of CKD among 
patients in Edo State? 
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 What is the trend of diagnosed CKD within Edo state? 
 What is the spatial pattern of diagnosed CKD cases within Edo 
state? 
 Is the prevalence and distribution of CKD in the state 
appropriately serviced by the available CKD healthcare service? 
The results from this study showed that there was no significant 
association between the socio-demographical characteristics of the 
patient and the severity of CKD at the time of diagnosis. However, 
more detailed socio-demographical data (for both the general 
population and CKD patients) as well as health data on CKD within 
the state is needed to explore this further. 
There appeared to be a significant association between the severity of 
CKD at the time of diagnosis and three out of four of the main 
biological risk factors of CKD. The highly significant biological risk 
factors were diabetes, hypertension, and toxic nephropathy. Although 
previous studies had identified chronic glomerulonephritis as one of 
the leading risk factors of CKD in Nigeria, chronic glomerulonephritis 
was not found to be independently associated with the severity of 
CKD at time of diagnosis. Based on the results from the logistic 
regression, there was evidence that the absence of diabetes, 
hypertension, or toxic nephropathy in a patient increases the odds of 
being diagnosed at the late stage of CKD and decreases the odds of 
being diagnosed at the earlier stage of CKD. 
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The trend of diagnosed CKD within the study period appeared to be 
increasing. However, there were indications that the majority of the 
CKD cases were still diagnosed at the last stage when it was too 
expensive to treat. In addition, there were indications that the impact 
of the CKD awareness programmes particularly the World Kidney 
Day (WKD) programme, appeared to have only a momentary impact 
on the number of CKD cases diagnosed each year. Furthermore, the 
number of patients diagnosed at the final stage of the disease was 
found to be relatively too high in comparison to the number of patients 
diagnosed at the earlier stages of the disease. 
The result of the spatial pattern of diagnosed CKD within the state 
indicated that the majority of the diagnosed cases were located within 
urban areas with few cases diagnosed in rural areas. However, further 
investigations into the reason behind the spatial pattern of the disease 
needed to be explored as there are indications that there might be more 
rural dwellers with CKD who are not diagnosed or receiving 
treatment. 
The final key finding of the study appeared to indicate that the current 
structure for CKD management within the state is very inadequate. 
This might be due to the issue of accessibility from various parts of 
the study area. There are indications that the travel time to the hospital 
for CKD treatment might be a contributing factor to the number of 
diagnosed CKD cases currently observed in the state. These findings 
appear to indicate that spatial inequalities and access to CKD 
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healthcare are critical issues that need to be addressed in order to 
manage the disease effectively. 
8.3 Limitations of the Research 
In the previous chapters, particularly in chapters three and four, the 
limitations experienced during the course of the research study were 
discussed. Below is a summary of the limitations of the datasets used 
in the study. Recommendations on how to resolve these limitations are 
subsequently discussed in section 8.5. 
8.3.1 Limitations to the datasets 
This research study was limited to the CKD data that was made 
available for Edo state. Given the diversity of the population within 
the country, the inferences that can be made from this study, can only 
be used loosely for the rest of the states in Nigeria until an in-depth 
study is carried out.  
Another limitation is that only secondary data was taken into account 
in the course of this study. However, as the research progressed, I 
became aware that other data sources would be valuable. For example, 
a qualitative approach (particularly the use of interviews and group 
discussions of CKD patients) was not incorporated into my research 
design. Therefore, as the research progressed, I discovered that the use 
of secondary data within a quantitative approach could not give a 
detailed account for some of the outcomes derived during the course 
of my study. An example is the relatively low number of patients 
diagnosed at the fourth stage of CKD as opposed to those diagnosed at 
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the third stage of the disease (see chapter four). This pattern within the 
CKD dataset required further investigation, which could not be 
verified within the scope of my research design. Such an investigation 
would require the use of a mixed approach (i.e. using  quantitative and 
qualitative approaches) so as to extensively draw out reason(s) behind 
this pattern of diagnosed CKD within the state. 
One of the main limitations of the CKD dataset was the absence of 
data for some of the variables especially within the socio-
demographical variables such as  education, religion and ethnicity (see 
chapter four). This limitation in the data is likely to have affected the 
statistical outcome derived from the regression model as an attempt to 
include such variables resulted in the occurrence of redundancies 
within the model. 
Another limitation was the absence of census data at the ward level for 
the study area. There were no demographical data available at the 
ward level and the total counts for the population data were only 
estimated figures. This resulted in less detailed analyses at the ward 
level.  
8.3.2 Possible effect of sample bias in CKD dataset 
Given the problem of retrieving CKD data, which was discussed in 
chapters three and four of the thesis, there is the possibility that the 
missing data might have affected the outcome of this study. Even 
though the subsequent dataset was used to evaluate the possible 
presence of structural bias within the CKD dataset, one cannot rule out 
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the likelihood that the quality of the data might have improved if the 
missing data were included. For example, the inclusion of these 
missing records might have reduced the occurrence of redundancy 
within the regression analysis when certain variables were included 
within the model.  
Another possibility that should be considered is that the missing data 
might actually represent rural dwellers that had been diagnosed with 
CKD. Should this be the case, this might have an impact on the 
outcome of the spatial analyses carried out within this study.  
8.4 Implications of findings 
The main contributions of this study are its information on the trend 
and spatial distribution of diagnosed CKD in Edo state. 
The first main finding of this study is that patients that develop CKD 
without previously having been diagnosed with known risk factors 
such as hypertension, diabetes, and toxic nephropathy are more 
susceptible to a late diagnosis of CKD. These findings have important 
implications for formulating renal health policies and designing 
research studies within the population. This is because there is the 
probability that people without these risk factors might be overlooked 
when creating renal health policies, which might lead to the late 
diagnosis of CKD among such people. Therefore, in the development 
of strategies that might help in the early diagnosis of patients, this 
category of patients (i.e. those without any previously known 
biological risk factors) should equally be taken into account. One way 
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that this might be accomplished is by ensuring that in the creation of 
adequate CKD awareness programmes and the establishment of 
routine CKD screening exercises, people without these risk factors 
should also be encouraged to partake in the CKD screening exercises.  
Another of the main findings of this study was the relatively high 
number of patients that were diagnosed at the last stage of the disease, 
when it is too expensive to treat and unaffordable by most of the 
patients. The high number of diagnosed cases at the last stage of CKD 
supports previous studies that were carried out before the inception of 
the nation-wide CKD awareness programmes that began officially in 
2006 (discussed in section 5.4). Although the outcomes were from 
different states and periods, the relatively high numbers of late 
diagnosis of CKD were still present in all studies. Therefore, it can be 
argued that the result from this study further highlights the burden of 
CKD both at the state level and at the national level given the fact that 
late diagnosis of CKD is more expensive to treat and unaffordable by 
the majority of the population.  
Another outcome from this study was the low level of referral of CKD 
cases to the renal department in UBTH from other health institutions 
within the state. This might be attributed to a poor understanding 
among medical personnel within these health institutions about CKD 
and its health implications. The lowest referral rates were found to be 
among clinics that ideally are regarded as the first point of call once a 
person experiences any health symptoms. However, it would appear 
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that the clinics in the state might have a very poor knowledge of the 
disease in comparison to other healthcare centres, which may have 
resulted in the very low number of referrals from these clinics. 
Therefore, in the strategies that might be put in place, there should be 
avenues that include the training of medical staff particularly at clinics 
to be more aware of the disease in order to diagnose the disease early 
among their patients and refer them early to nephrologists for 
treatment. This would help reduce complications that are usually 
associated with late diagnosis of CKD as well as enable the patient to 
have a better chance of survival due to the possibility of affordable 
treatments that are available at the earlier stages of the disease. 
It is worth adding at this point that some of the biological risk factors 
of CKD are also risk factors for other serious conditions such as 
cardiovascular disease. Therefore, it would be beneficial that these 
risk factors are detected early as this could help reduce the impact of 
such diseases in the society. 
8.4.1 Implications of findings on the spatial pattern of diagnosed CKD 
cases within the state 
The results of the analyses indicated that the proportion of diagnosed 
CKD cases within the state appeared to be higher within the urban 
areas than in the rural areas since the number of diagnosed patients 
appeared to be concentrated mainly within the urban areas and not 
within the rural areas. Does this mean that CKD is more prevalent in 
the urban areas than the rural areas? I argue that the answer is no! A 
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previous study carried out within the southern-eastern part of the 
country, found a higher CKD prevalence among the rural population 
as opposed to the urban areas (Ulasi et al., 2009). This was similar to 
another study, which reported a prevalence of 19.9% of undetected 
renal diseases including CKD in a rural area in western Nigeria 
(Kuteyi et al., 1999). There is therefore the possibility that most rural 
dwellers that have CKD are not being diagnosed while more urban 
dwellers that have access to CKD treatment facilities have been 
diagnosed. 
Based on the outcomes from this study, two main factors could be 
attributed to the disparity in the prevalence of CKD between the urban 
and rural areas. Although this spatial analysis took into account the 
underlying population (discussed in chapter six), one could argue that 
the rural areas may not be adequately informed about the impact of the 
disease. This might be attributed to the methods currently used in the 
dissemination of kidney awareness programmes within the country. 
There is the probability that the approach of using the mass media as 
the primary means by which the information is disseminated to the 
public might not be effectively reaching out to the majority of the 
population. Therefore, better efforts and resources may need to be 
focused toward dissemination activities by the Nigerian Ministry of 
Health, medical associations (e.g., the Nigerian Association of 
Nephrology (NAN) and the Nigerian Medical Association (NMA)), 
and charities affiliated with kidney diseases to increase awareness of 
CKD among medical practitioners and in the general public. The 
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focus should not only be those with known risk factors but also those 
who are less likely to be aware, such as those without diabetes, toxic 
nephropathy, or hypertension, and those without regular access to 
healthcare particularly within the rural areas.  
There have been suggestions put forward to help in the improvement 
of CKD both within and outside Nigeria, especially since the 
inception of the WKD programme. One such suggestion is that the 
government should be persuaded to support policies of prevention, 
early detection, and treatment using humane grounds, plus cost 
effectiveness as good reasons, estimates of which should factor in 
delay of disability and death among members of society (Smith et al., 
2008). This is because the government does not currently consider 
CKD as a national health concern even though studies indicated 
otherwise and as such, there are no government funded CKD 
programmes or policies in place within the country.  
Another factor might be the problem of the accessibility of CKD 
healthcare services within the study area particularly between the 
urban and rural areas. This could be attributed to poor CKD 
awareness, inability to afford treatment, and poor proximity or 
inaccessibility to CKD healthcare by rural dwellers. These may 
account for the low number of diagnosed cases within these rural 
areas.  
One would therefore recommend that adequate CKD awareness 
programmes should be put in place that will be tailored to reach out to 
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the rural areas probably in the native dialects of these areas as well as 
creating training programmes for the health officials within the rural 
areas on the awareness of CKD and how it can be identified in 
patients. Equally, the establishment of satellite CKD healthcare 
centres should be considered in order to cater for a higher proportion 
of members of the public as this would improve the accessibility 
issues to CKD healthcare within the state. 
8.4.2 Theoretical Implications 
As discussed in section 2.2, the inverse care law suggests that 
populations with the poorest health outcomes also tend to have poorer 
access to high-quality healthcare. This thesis has highlighted the 
possibility that access to CKD healthcare could have contributed to 
the spatial pattern of diagnosed CKD cases within the state. This is 
because there is the likelihood that the large proportion of diagnosed 
CKD cases (approximately 70%) that reside close to the only hospital 
in the region which provides services for CKD could be as a result of 
one of the two factors discussed in section 7.3.3. Given the large 
proportion of rural dwellers, approximately 70% of the total Nigerian 
population (NPC, 2005), the possibility that a significant proportion of 
these rural dwellers will have family or friends within Benin City able 
and willing to help them in bearing the cost of treatment and 
accommodation is unlikely. This has been compounded further by the 
absence of reliable data on the socio-economic status and migration 
data between the urban and rural areas within the state and the 
country, which makes it difficult to determine the reasons for and/or 
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number of those who have actually migrated as a result of their 
diagnosis. This has therefore made it difficult to estimate how many 
diagnosed CKD patients from rural areas actually relocated to Benin 
City in order to have better access to CKD treatment because they 
could afford to do so or because they still had family or friends in 
Benin City with adequate resources to help them. Establishing which 
of the assumptions discussed in section 7.3.3 that is the most likely, 
could have significant policy implications. On one hand, if most of 
those diagnosed with CKD can move to Benin City to receive 
treatment, the argument for locating additional renal centres in other 
parts of the states is less compelling. However, given the possibility 
that many diagnosed CKD patients from rural areas could be unable to 
relocate to Benin City because they cannot afford it or may not have 
family or friends in Benin city with enough resources to help them, 
then in the presence of either the first or second assumptions, there is a 
strong argument for locating other renal centres elsewhere in the state. 
Due to the non-availability of data regarding the prevalence rate of 
CKD within the country as well as the migratory patterns within the 
state and the country as a whole, it is not currently possible to decide 
which of the two assumptions currently influences access to 
healthcare by CKD patients within the state. Regardless of the stated 
assumptions, we cannot rule out the possibility that limited 
accessibility from rural areas to Benin City where the renal healthcare 
is currently available could have played a role in the current spatial 
pattern of diagnosed CKD within the state. In addition, the current 
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mode of information dissemination on CKD awareness does not 
favour rural dwellers and this could have led to rural dwellers with 
CKD having poorer access to available CKD healthcare. The findings 
from this study supports previous studies that identified that distance 
to improved healthcare need to be reduced to enhance accessibility to 
improved health services by various socio-economic groups in the 
country as well as the need for locally-tailored knowledge about 
healthcare access for CKD patients across the state (Agee, 2010; Antai 
et al., 2010; Awoyemi et al., 2011). 
In summary, this study has attempted to investigate the applicability 
of the inverse care law by showing that it is not only in the probability 
of a late or early diagnosis of a CKD patient that healthcare is found to 
be unequal but also the dissemination of vital health information that 
could prevent CKD or lead to early diagnosis. 
8.5 Recommendations for further study 
Although none of the socio-demographic variables was found to be 
statistically significant determinants of the severity of CKD at time of 
diagnosis, the influence of these variables cannot be ruled-out as the 
current extent of this research study is limited in its approach.  
I would recommend that a different approach to the study of CKD 
might be more efficient, preferably a longitudinal study and the use of 
a mixed approach. This involves the use of quantitative and  
qualitative approaches within this longitudinal study, where data 
would be collected directly from patients and not relying completely 
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on information in their health files. This is because the use of the 
mixed approach in the data collection process could improve the data 
that is used as the primary source of information for CKD patients. 
Using the life course approach to study CKD patients is likely to be 
regarded as a relevant framework that can be utilised for such a study 
thereby resulting in a more extensive study of the outcome of the 
disease. This approach requires information that dates from a patient’s 
childhood to their present status, but this approach requires more time, 
which was beyond the time-scale of this research study. However, the 
life course approach might be able to shed more light on the outcome 
of CKD than what has been currently evaluated within the scope of 
this research study. This is because the approach could deduce other 
factors that had not been considered within this research, such as the 
patients’ diet, their source of water supply, and also their cultural life 
style all of which might have individually or collectively contributed 
to the development of CKD in the patients. 
Another approach could be the evaluation of the biological risk factors 
from a behavioural concept. This involves the study of the association 
of the behaviour of CKD patients with the presence of these risk 
factors in order to identify behavioural factors that might have 
influenced the development of these risk factors. For example, 
studying the diet behaviours of diabetic CKD patients, the cultural life 
styles of CKD patients with hypertension or toxic nephropathy, the 
outcome of this study could shed more light on the development of 
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CKD and this could be termed the study of the “causes of the causes” 
(Marmot, 2006 p.3).  
In addition, a participatory and interdisciplinary nature of the research 
should be considered in order to gain a wider view of the impact of 
CKD within the country. Participatory in the sense that the population 
should be actively involved in the course of the research study in order 
to understand their behavioural or lifestyle patterns and how it relates 
to the development of CKD in individuals. In regards to 
interdisciplinarity, various sectors within the society such as health 
officials, policy makers, and health geographers should be included 
within a more detailed study of CKD to explore how the disease can 
be effectively managed and even reduced in the society. This could 
result in the development of more practical solutions to the problem of 
CKD prevalence especially since the stakeholders are involved in the 
research study process. 
8.5.1 Recommendations for improving on healthcare data collection 
Due to the problems experienced during the data collection process in 
UBTH, it became clear that a better structure is needed to improve the 
storage and retrieval of patients’ data within the renal department and 
other departments within the hospital. The management of the hospital 
will need to consider an investment in the installation of a reliable 
digital database and the employment of a data entry officer to log 
patients’ data. This investment will contribute to the development of 
reliable and current health data in the state. This can be regarded as a 
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starting point to the development of a CKD register as the 
establishment of a national CKD registry cannot be over-emphasised. 
This is because a national CKD registry could help in the effective 
monitoring of the disease and conducting CKD prevalence studies and 
risk factors within the country. 
8.5.2 Recommendations for prevention and early detection of CKD 
Medical and government policies need to agree about 
recommendations for screening and early detection of CKD. The 
majority of evidence from CKD screenings should come from 
individuals of all ages, and recommendations about whether to modify 
these proposals in older individuals will have to come from analysing 
subsets of older individuals that took part in the CKD screenings. 
Furthermore, future studies of CKD awareness should focus on 
intervention by examining patient, health provider, and societal (e.g., 
public relations campaigns) factors that can lead to better CKD 
awareness (Plantinga et al., 2008). 
There is an increase in the number of research studies on known risk 
factors of CKD such as hypertension and diabetes within Nigeria 
(Kayode et al., 2010; Okeahialam et al., 2011). However, there are no 
readily available registers on these diseases within the country. I 
recommend that similar spatial studies on risk factors such as 
hypertension and diabetes should be equally carried out within the 
state in order to compare the spatial patterns of these diseases with the 
spatial pattern of CKD. The outcome of these analyses might be able 
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to indicate a more detailed pattern of the population that are medically 
regarded as being more at risk of developing CKD. Although the 
findings of this study indicated that there are other predictors of CKD 
apart from these noted biological risk factors, I believe the spatial 
analyses of these mentioned risk factors could serve as a baseline in 
highlighting the spatial distribution of the risk population of CKD 
until a more comprehensive CKD database is established within the 
state. 
In addition, other methods, such as modelling CKD outcomes across 
the state, could be used to determine how best to structure the health 
policy that would effectively manage early detection of CKD within 
the state. However, it is not enough to develop recommendations. 
These recommendations must be promoted to both patients and their 
health providers in order to make a significant impact within the 
population (Frame, 2001).  
8.5.3 Recommendations for additional CKD health centres 
The results from this study have been able to highlight the problems 
associated with having just one major CKD health care service within 
the state. Although there are plans by some health practitioners to 
build privately owned renal centres within the state, which have been 
in the pipeline for a while now, the issue of accessibility and 
affordability are major factors that must be taken into consideration. 
The establishment of a well-equipped renal centre is capital intensive. 
Therefore, the option of locating such a facility anywhere without 
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taking into consideration its accessibility and affordability by the 
targeted population might not reduce the current impact of the disease 
within the state. Given the high cost of establishing a fully equipped 
renal centre, I would recommend that already established health 
centres across the state particularly within the rural areas should be 
upgraded with the necessary amenities to cater for the screening and 
treatment of earlier stages of the disease. However, there should be 
plans in place to provide another fully functional renal health service 
outside Benin City in the near future so as to improve the accessibility 
to CKD healthcare within the state. Such a facility should be centrally 
located within the state, as this would reduce the travel time by CKD 
patients within the state to receive treatment. According to the result 
from the location-allocation model discussed in chapter seven, a 
possible candidate for the establishment of another renal health centre 
would be Irrua Specialist Teaching Hospital, which is located in Irrua 
town within Otoruwa II ward. This is because it is centrally located 
within the state and it is an established hospital that can be 
appropriately equipped to support the establishment of a renal 
department including on-site kidney consultants/nephrologists without 
having to refer complicated cases elsewhere. I must however, mention 
at this stage that this is just a theoretical proposition as other factors 
need to be considered such as the cost of infrastructure for 
establishing a renal department within this hospital as opposed to 
another location entirely. There is also the issue of the cost of training 
of available staff to help in the management of the renal department as 
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well as the employment of specialised staff such as nephrologists and 
renal nurses.  
Finally, the government would need to consider the possibility of 
subsidising the cost of healthcare including renal treatment as this 
might encourage patients to come to the hospital where the disease 
can be diagnosed earlier and managed effectively. 
8.6 Conclusion 
The results of this thesis have highlighted the spatial distribution of 
diagnosed CKD and evaluated the likely predictors for the severity of 
CKD at time of diagnosis in Edo State by examining the socio-
demographic and known biological risk factors such as diagnosed 
hypertension, and diabetes. It has also highlighted the areas of concern 
regarding the spatial distribution of diagnosed CKD within the state. 
There is therefore a clear indication that more needs to be done in the 
management of the disease within the state especially among the rural 
areas, which appear to be neglected in the current approach of CKD 
management within the state. There is also the possibility that this 
situation within Edo state might be similar to other states within the 
country and as such, more needs to be done within the rural areas in 
the country, as there is the probability that many cases are left 
undetected until it is too late. Although it can be argued that CKD 
might not be currently classified as a serious threat to the health status 
of Nigeria because of other diseases such as malaria and HIV/AIDS 
that need immediate attention, we cannot rule out the advantages of 
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preventive measures on health outcomes in the society. Early 
preventive measures for CKD such as the location of accessible CKD 
screening centres and easier access to vital health information could 
contribute in improving the health status of the society in the near 
future. 
The findings derived from this research study would be helpful both in 
the policy-making decisions that pertain to the health sector and the 
development of a health care accessibility model for CKD patients 
that could be beneficial in the location of new healthcare centres. 
Further work using population projections, and the future prevalence 
and distribution of known risk factors, will enable the development of 
a model that can predict future prevalence patterns within the state as 
well as the country. This could ultimately lead to the improvement of 
treatment outcomes and the quality of life of patients with CKD. 
This study has indirectly highlighted the advantages as well as the 
challenges faced in the application of spatial analyses in the health 
sector within a Nigerian context. This study has shown that it is 
possible to utilise GIS within the health sector of a developing country 
where data is limited because spatial processes, which had previously 
been overlooked, can now be examined in better detail. This approach 
can therefore help in the development of insightful health policy-
decisions that would lead to the adequate management of healthcare 
issues within the study area. 
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In summary, this study can be classified as a preliminary research 
study on the spatial analysis of CKD in one of the states in Nigeria. 
The outcome of this study can therefore pave the way for more 
extensive investigations on the spatial pattern of CKD within Nigeria.  
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Appendices 
Appendix A: A photocopy of the ethics approval form from the University of Benin 
Teaching Hospital (UBTH) 
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Appendix B: A template used in the data collection process at UBTH 
Template for CKD data collection at UBTH 
Hospital number   
Sex (Male/Female)   
marital status   
Date of birth   
age   
Place of birth   
Address   
L.G.A   
Ethnic group   
Occupation   
Religion   
Education   
First date on patient's file   
Definitive diagnosis   
Chronic glomerulonephritis (Y/N)   
Diabetes mellitus (Y/N)   
Hypertension (Y/N)   
Toxic nephropathy (Y/N)   
Other Risk factors   
Stage of CKD at time of diagnosis   
HIV (Y/N)   
Type of referral centre   
Name of referral centre   
Admitted/outpatient   
Dialysis taken (Y/N)   
Reason for not taking dialysis   
Steps taken when dialysis was refused   
Date of 1st dialysis   
Number of dialysis session   
Management outcome (is the patient on follow-up, deteriorating, or deceased.)   
Date of death   
Cause of death   
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Appendix C: A list of the biological risk factors documented within the health files of the 
CKD patients 
Biological risk factors Frequency Per cent 
Missing cases/unknown causes 20 4.52 
Acute pulmonary oedema 1 0.23 
Anaemia 1 0.23 
chronic glomerulonephritis and diabetes 1 0.23 
Chronic glomerulonephritis and Chronic Lung Disease   1 0.23 
congenital kidney disease 1 0.23 
Diabetes and obstructive uropathy 1 0.23 
Diabetes and toxic nephropathy 1 0.23 
Diabetes and uremic nephropathy 1 0.23 
HBB 1 0.23 
HIV associated Nephropathy 1 0.23 
hyperlipidaemia 1 0.23 
Hypertension and anaemic heart failure 1 0.23 
Hypertension and Benign prostatic hyperplasia 1 0.23 
Hypertension and HIV associated nephropathy 1 0.23 
Hypertension and multiple myeloma 1 0.23 
Hypertension and polycystic kidney disease 1 0.23 
Hypertension, chronic glomerulonephritis and uremic nephropathy 1 0.23 
Hypertension, diabetes and autonomic neuropathy 1 0.23 
Hypertension, toxic nephropathy, and obstructive uropathy 1 0.23 
lupus nephritis 1 0.23 
toxic nephropathy and HIV associated nephropathy 1 0.23 
chronic glomerulonephritis and toxic nephropathy 2 0.45 
Hypertension and obstructive uropathy 2 0.45 
Hypertension, chronic glomerulonephritis, and toxic nephropathy 2 0.45 
Hypertension, diabetes and uremic nephropathy 2 0.45 
Hypertension, toxic nephropathy, and uremic nephropathy 2 0.45 
Uremic encephalopathy 2 0.45 
HIV associated nephropathy and Chronic glomerulonephritis 3 0.68 
Hypertension and toxic nephropathy 3 0.68 
Nephrotic syndrome 3 0.68 
Polycystic Kidney Disease 3 0.68 
sickle cell nephropathy 3 0.68 
Toxic nephropathy and uremic nephropathy 3 0.68 
Uremic nephropathy 3 0.68 
Hypertension and uremic nephropathy 4 0.90 
Hypertension, diabetes, and toxic nephropathy 4 0.90 
chronic glomerulonephritis and uremic nephropathy   4 0.90 
Hypertension, diabetes, and chronic glomerulonephritis 5 1.13 
HIV associated nephropathy 10 2.26 
toxic nephropathy 12 2.71 
obstructive uropathy 18 4.07 
Hypertension and chronic glomerulonephritis 20 4.52 
Hypertension and diabetes 22 4.98 
Diabetes 35 7.92 
Hypertension 102 23.08 
chronic glomerulonephritis 132 29.86 
Total 442 100.00 
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Appendix D: the case summaries showing the standard residual and deviance statistics 
for the logistic regression model 
Case Summaries 
Case 
Number 
Logit 
residual Predicted group 
Predicted 
probability 
Difference 
between 
observed and 
predicted 
probabilities 
Standard 
residual 
Deviance 
value 
1 -5.75256 Late stage of CKD 0.82616427 -0.82616427 -1.88465 -1.87064 
2 -5.75256 Late stage of CKD 0.82616427 -0.82616427 -1.88465 -1.87064 
3 -5.75256 Late stage of CKD 0.82616427 -0.82616427 -1.88465 -1.87064 
4 -2.21741 Late stage of CKD 0.54902338 -0.54902338 -1.30247 -1.26201 
5 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
6 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
7 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
8 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
9 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
10 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
11 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
12 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
13 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
14 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
15 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
16 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
17 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
18 -2.41478 Late stage of CKD 0.58588421 -0.58588421 -1.34286 -1.32786 
19 -1.36241 Earlier stage of CKD 0.26600623 -0.26600623 -0.80685 -0.78645 
20 -1.36241 Earlier stage of CKD 0.26600623 -0.26600623 -0.80685 -0.78645 
21 -1.36241 Earlier stage of CKD 0.26600623 -0.26600623 -0.80685 -0.78645 
22 2.209028 Earlier stage of CKD 0.45268785 0.547312146 1.289369 1.259009 
23 2.209028 Earlier stage of CKD 0.45268785 0.547312146 1.289369 1.259009 
24 2.209028 Earlier stage of CKD 0.45268785 0.547312146 1.289369 1.259009 
25 2.209028 Earlier stage of CKD 0.45268785 0.547312146 1.289369 1.259009 
26 2.209028 Earlier stage of CKD 0.45268785 0.547312146 1.289369 1.259009 
27 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
28 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
29 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
30 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
31 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
32 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
33 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
34 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
35 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
36 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
37 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
38 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
39 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
40 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
41 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
42 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
43 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
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Case 
Number 
Logit 
residual Predicted group 
Predicted 
probability 
Difference 
between 
observed and 
predicted 
probabilities 
Standard 
residual 
Deviance 
value 
44 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
45 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
46 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
47 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
48 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
49 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
50 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
51 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
52 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
53 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
54 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
55 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
56 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
57 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
58 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
59 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
60 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
61 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
62 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
63 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
64 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
65 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
66 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
67 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
68 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
69 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
70 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
71 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
72 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
73 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
74 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
75 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
76 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
77 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
78 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
79 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
80 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
81 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
82 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
83 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
84 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
85 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
86 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
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Case 
Number 
Logit 
residual Predicted group 
Predicted 
probability 
Difference 
between 
observed and 
predicted 
probabilities 
Standard 
residual 
Deviance 
value 
87 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
88 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
89 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
90 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
91 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
92 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
93 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
94 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
95 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
96 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
97 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
98 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
99 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
100 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
101 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
102 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
103 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
104 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
105 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
106 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
107 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
108 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
109 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
110 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
111 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
112 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
113 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
114 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
115 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
116 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
117 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
118 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
119 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
120 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
121 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
122 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
123 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
124 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
125 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
126 1.309703 Late stage of CKD 0.76353177 0.236468228 0.737065 0.734575 
127 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
128 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
129 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 
0.784119 
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130 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
131 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
132 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
133 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
134 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
135 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
136 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
137 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
138 1.359914 Late stage of CKD 0.73534055 0.264659446 0.798309 0.784119 
139 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
140 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
141 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
142 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
143 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
144 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
145 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
146 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
147 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
148 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
149 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
150 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
151 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
152 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
153 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
154 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
155 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
156 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
157 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
158 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
159 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
160 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
161 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
162 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
163 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
164 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
165 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
166 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
167 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
168 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
169 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
170 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
171 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
172 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
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173 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
174 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
175 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
176 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
177 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
178 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
179 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
180 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
181 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
182 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
183 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
184 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
185 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
186 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
187 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
188 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
189 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
190 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
191 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
192 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
193 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
194 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
195 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
196 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
197 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
198 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
199 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
200 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
201 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
202 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
203 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
204 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
205 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
206 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
207 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
208 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
209 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
210 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
211 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
212 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
213 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
214 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
215 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
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216 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
217 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
218 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
219 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
220 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
221 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
222 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
223 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
224 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
225 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
226 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
227 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
228 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
229 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
230 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
231 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
232 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
233 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
234 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
235 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
236 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
237 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
238 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
239 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
240 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
241 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
242 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
243 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
244 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
245 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
246 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
247 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
248 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
249 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
250 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
251 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
252 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
253 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
254 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
255 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
256 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
257 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
258 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
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259 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
260 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
261 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
262 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
263 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
264 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
265 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
266 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
267 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
268 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
269 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
270 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
271 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
272 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
273 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
274 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
275 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
276 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
277 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
278 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
279 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
280 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
281 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
282 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
283 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
284 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
285 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
286 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
287 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
288 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
289 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
290 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
291 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
292 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
293 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
294 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
295 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
296 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
297 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
298 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
299 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
300 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
301 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
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302 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
303 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
304 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
305 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
306 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
307 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
308 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
309 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
310 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
311 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
312 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
313 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
314 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
315 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
316 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
317 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
318 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
319 1.092195 Late stage of CKD 0.91558725 0.084412751 0.420802 0.419975 
320 -1.82711 Earlier stage of CKD 0.45268785 -0.45268785 -1.12442 -1.09794 
321 -1.82711 Earlier stage of CKD 0.45268785 -0.45268785 -1.12442 -1.09794 
322 -1.82711 Earlier stage of CKD 0.45268785 -0.45268785 -1.12442 -1.09794 
323 -3.77844 Late stage of CKD 0.73534055 -0.73534055 -1.66004 -1.63053 
324 -3.77844 Late stage of CKD 0.73534055 -0.73534055 -1.66004 -1.63053 
325 -3.77844 Late stage of CKD 0.73534055 -0.73534055 -1.66004 -1.63053 
326 -3.77844 Late stage of CKD 0.73534055 -0.73534055 -1.66004 -1.63053 
327 -3.77844 Late stage of CKD 0.73534055 -0.73534055 -1.66004 -1.63053 
328 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
329 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
330 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
331 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
332 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
333 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
334 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
335 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
336 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
337 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
338 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
339 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
340 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
341 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
342 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
343 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
344 1.210413 Late stage of CKD 0.82616427 0.173835729 0.622629 0.617999 
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345 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
346 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
347 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
348 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
349 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
350 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
351 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
352 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
353 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
354 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
355 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
356 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
357 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
358 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
359 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
360 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
361 1.210413 
Late stage of 
CKD 0.82616427 0.173835729 0.622629 0.617999 
362 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
363 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
364 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
365 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
366 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
367 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
368 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
369 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
370 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
371 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
372 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
373 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
374 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
375 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
376 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
 
387 
 
377 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
378 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
379 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
380 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
381 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
382 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
383 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
384 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
385 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
386 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
387 -4.2289 
Late stage of 
CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
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388 -4.2289 
Late stage 
of CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
389 -4.2289 
Late stage 
of CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
390 -4.2289 
Late stage 
of CKD 0.76353177 -0.76353177 -1.70395 -1.6982 
391 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
392 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
393 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
394 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
395 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
396 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
397 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
398 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
399 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
400 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
401 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
402 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
403 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
404 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
 
388 
 
405 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
406 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
407 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
408 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
409 -11.8466 
Late stage 
of CKD 0.91558725 -0.91558725 -2.22791 -2.22353 
410 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
411 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
412 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
413 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
414 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
415 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
416 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
417 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
418 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
419 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
420 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
421 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
422 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
423 1.706822 
Late stage 
of CKD 0.58588421 0.41411579 1.045734 1.034053 
424 3.75931 
Earlier 
stage of 
CKD 0.26600623 0.733993767 1.669621 1.627412 
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Appendix E: A case summary for the leverage and the DFBeta residuals of the logistic 
Regression model 
Case 
Number 
DFBETA for 
constant 
DFBETA for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
1 -0.03398 0.064139 -0.03532889 -0.017196534 0.071465431 0.014814 
2 -0.03398 0.064139 -0.03532889 -0.017196534 0.071465431 0.014814 
3 -0.03398 0.064139 -0.03532889 -0.017196534 0.071465431 0.014814 
4 -0.12574 0.048715 -0.01871685 0.096130502 0.079312663 0.061164 
5 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
6 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
7 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
8 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
9 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
10 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
11 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
12 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
13 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
14 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
15 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
16 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
17 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
18 -0.04864 0.046389 0.01829703 -0.006221753 0.032142892 0.022215 
19 -0.07159 0.023585 0.011383857 0.048859134 0.019042628 0.049921 
20 -0.07159 0.023585 0.011383857 0.048859134 0.019042628 0.049921 
21 -0.07159 0.023585 0.011383857 0.048859134 0.019042628 0.049921 
22 0.098415 0.009406 -0.02280338 -0.096257994 0.05901195 0.046538 
23 0.098415 0.009406 -0.02280338 -0.096257994 0.05901195 0.046538 
24 0.098415 0.009406 -0.02280338 -0.096257994 0.05901195 0.046538 
25 0.098415 0.009406 -0.02280338 -0.096257994 0.05901195 0.046538 
26 0.098415 0.009406 -0.02280338 -0.096257994 0.05901195 0.046538 
27 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
28 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
29 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
30 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
31 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
32 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
33 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
34 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
35 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
36 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
37 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
38 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
39 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
40 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
41 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
42 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
43 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
 
390 
 
Case 
Number 
DFBETA for 
constant 
DFBETA for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
44 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
45 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
46 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
47 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
48 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
49 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
50 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
51 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
52 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
53 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
54 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
55 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
56 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
57 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
58 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
59 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
60 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
61 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
62 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
63 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
64 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
65 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
66 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
67 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
68 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
69 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
70 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
71 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
72 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
73 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
74 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
75 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
76 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
77 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
78 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
79 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
80 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
81 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
82 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
83 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
84 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
85 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
86 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
 
 
391 
 
Case 
Number 
DFBETA for 
constant 
DFBETA for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
87 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
88 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
89 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
90 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
91 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
92 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
93 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
94 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
95 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
96 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
97 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
98 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
99 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
100 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
101 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
102 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
103 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
104 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
105 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
106 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
107 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
108 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
109 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
110 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
111 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
112 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
113 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
114 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
115 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
116 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
117 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
118 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
119 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
120 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
121 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
122 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
123 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
124 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
125 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
126 -0.00073 0.005524 -0.00704753 0.004095234 0.002102456 0.006743 
127 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
128 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
129 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
 
 
 
 
392 
 
Case 
Number 
DFBETA for 
constant 
DFBETA for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
130 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
131 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
132 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
133 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
134 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
135 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
136 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
137 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
138 0.035878 0.004751 0.009036195 -0.043224375 0.013144579 0.035235 
139 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
140 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
141 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
142 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
143 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
144 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
145 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
146 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
147 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
148 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
149 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
150 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
151 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
152 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
153 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
154 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
155 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
156 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
157 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
158 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
159 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
160 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
161 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
162 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
163 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
164 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
165 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
166 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
167 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
168 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
169 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
170 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
171 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
172 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
 
 
 
 
393 
 
Case 
Number 
DFBETA for 
constant 
DFBETA for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
173 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
174 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
175 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
176 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
177 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
178 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
179 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
180 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
181 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
182 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
183 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
184 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
185 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
186 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
187 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
188 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
189 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
190 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
191 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
192 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
193 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
194 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
195 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
196 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
197 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
198 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
199 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
200 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
201 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
202 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
203 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
204 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
205 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
206 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
207 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
208 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
209 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
210 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
211 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
212 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
213 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
214 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
215 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
 
 
394 
 
Case 
Number 
DFBETA for 
constant 
DFBETA for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of Cook's 
influence statistics 
Leverage 
value 
216 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
217 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
218 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
219 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
220 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
221 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
222 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
223 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
224 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
225 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
226 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
227 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
228 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
229 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
230 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
231 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
232 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
233 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
234 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
235 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
236 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
237 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
238 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
239 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
240 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
241 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
242 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
243 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
244 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
245 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
246 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
247 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
248 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
249 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
250 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
251 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
252 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
253 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
254 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
255 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
256 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
257 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
258 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
 
 
395 
 
Case 
Number 
DFBETA for 
constant 
DFBETA for 
Dtm(1) DFBETA for HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
259 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
260 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
261 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
262 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
263 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
264 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
265 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
266 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
267 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
268 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
269 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
270 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
271 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
272 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
273 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
274 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
275 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
276 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
277 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
278 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
279 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
280 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
281 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
282 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
283 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
284 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
285 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
286 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
287 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
288 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
289 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
290 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
291 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
292 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
293 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
294 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
295 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
296 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
297 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
298 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
299 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
300 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
301 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
 
 
396 
 
Case 
Number 
DFBETA 
for 
constant 
DFBETA 
for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
302 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
303 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
304 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
305 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
306 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
307 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
308 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
309 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
310 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
311 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
312 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
313 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
314 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
315 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
316 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
317 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
318 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
319 -0.00371 0.002046 0.003649375 0.002315636 0.000363448 0.003927 
320 -0.0814 -0.00778 0.018860927 0.079616038 0.040370811 0.046538 
321 -0.0814 -0.00778 0.018860927 0.079616038 0.040370811 0.046538 
322 -0.0814 -0.00778 0.018860927 0.079616038 0.040370811 0.046538 
323 -0.09969 -0.0132 -0.02510653 0.120096358 0.101472633 0.035235 
324 -0.09969 -0.0132 -0.02510653 0.120096358 0.101472633 0.035235 
325 -0.09969 -0.0132 -0.02510653 0.120096358 0.101472633 0.035235 
326 -0.09969 -0.0132 -0.02510653 0.120096358 0.101472633 0.035235 
327 -0.09969 -0.0132 -0.02510653 0.120096358 0.101472633 0.035235 
328 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
329 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
330 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
331 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
332 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
333 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
334 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
335 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
336 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
337 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
338 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
339 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
340 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
341 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
342 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
343 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
344 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
 
397 
 
Case 
Number 
DFBETA 
for 
constant 
DFBETA 
for 
Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of 
Cook's 
influence 
statistics 
Leverage 
value 
345 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
346 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
347 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
348 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
349 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
350 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
351 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
352 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
353 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
354 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
355 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
356 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
357 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
358 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
359 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
360 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
361 0.007149 -0.0135 0.007433659 0.003618375 0.003164035 0.014814 
362 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
363 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
364 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
365 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
366 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
367 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
368 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
369 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
370 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
371 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
372 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
373 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
374 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
375 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
376 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
377 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
378 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
379 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
380 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
381 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
382 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
383 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
384 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
385 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
386 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
387 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
 
398 
 
Case 
Number 
DFBETA for 
constant 
DFBETA 
for Dtm(1) 
DFBETA for 
HTN(1) 
DFBETA for 
Toxic_nep(1) 
Analog of Cook's 
influence 
statistics 
Leverage 
value 
388 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
389 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
390 0.002353 -0.01784 0.022755743 -0.013223093 0.021919745 0.006743 
391 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
392 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
393 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
394 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
395 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
396 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
397 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
398 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
399 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
400 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
401 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
402 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
403 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
404 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
405 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
406 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
407 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
408 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
409 0.040187 -0.02219 -0.03958313 -0.025116662 0.042758855 0.003927 
410 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
411 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
412 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
413 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
414 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
415 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
416 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
417 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
418 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
419 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
420 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
421 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
422 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
423 0.03438 -0.03279 -0.01293274 0.004397671 0.016058499 0.022215 
424 0.197531 -0.06508 -0.03141159 -0.134817517 0.144986646 0.049921 
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Appendix F: wards in Edo State showing the stages of diagnosed cases for the 442 CKD 
patients within their boundaries 
Ward Unknown stage 2 stage 3 stage 4 stage 5 Total 
Aibiokunla 1 0 0 0 0 1 1 
Amaho etc 0 0 0 0 1 1 
Ewohimi I 0 0 0 0 1 1 
Fugar III 0 0 0 0 1 1 
Idganke E 0 0 0 0 1 1 
Igarra II 0 0 0 0 1 1 
Iguobazuwa E 0 0 0 0 1 1 
Isi N 0 0 0 0 1 1 
Okedo 0 0 0 0 1 1 
Otoruwa I 0 0 0 0 1 1 
Ozalla 0 0 0 0 1 1 
Ubierumu 0 0 0 0 1 1 
Ugbegun 0 0 0 0 1 1 
Ugbeka 0 0 0 0 1 1 
Ugboko 0 0 0 0 1 1 
Uhen 0 0 0 0 1 1 
Uhi 0 0 0 0 1 1 
Uzebba 1 0 0 0 0 1 1 
Uzebu 0 0 0 0 1 1 
Obayantor 0 1 0 0 0 1 
Oluku 0 0 1 0 0 1 
Okhoro 0 0 0 1 0 1 
Idogbo 0 0 0 0 2 2 
Igarra I 0 0 0 0 2 2 
Ubiaju I 0 0 0 0 2 2 
Uke etc 0 0 0 0 2 2 
Umagbae S 0 0 0 0 2 2 
Uokha 0 0 0 0 2 2 
Uwalor 0 0 0 0 2 2 
Sabon-gida 0 0 1 0 1 2 
Ewu I 0 0 0 1 1 2 
Ewu II 0 0 0 0 3 3 
Idigun 0 0 0 0 3 3 
Uromi 0 0 1 1 2 4 
Otoruwa II 0 1 1 0 4 6 
Utoka 0 0 2 0 4 6 
Igushodin 1 0 2 0 4 7 
Oregbeni 0 0 0 1 6 7 
St. Saviour 0 0 1 0 7 8 
Efandion 0 0 0 2 6 8 
GRA 2 0 0 0 7 9 
Ugbowo 0 0 2 0 8 10 
Auchi I 1 1 2 0 6 10 
Ogbeson 0 1 2 0 7 10 
Uwelu 0 0 3 2 5 10 
Aduwawa 0 0 2 0 11 13 
Iwogban 0 0 0 2 11 13 
Ugbeku 0 1 0 2 12 15 
Uselu II 0 1 2 2 11 16 
Ekpoma etc 0 0 2 2 17 21 
New Benin II 1 3 3 1 28 36 
Uselu I 3 0 4 3 32 42 
New Benin I 0 0 2 0 41 43 
Geretti 3 3 5 7 84 102 
Total 11 12 38 27 354 442 
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Appendix G: The average distance to the hospital for all the diagnosed CKD patients 
Statistics 
Distance in minutes to the hospital for all CKD patients 
Mean 28.91 
Std. Error of Mean 1.64 
Std. Deviation 34.43 
 
Appendix H: The average distance to the hospital for patients diagnosed at the earlier 
stages of CKD 
Distance in minutes to the hospital for patients at the earlier stages of CKD 
Mean 28.41 
Std. Error of Mean 3.54 
Std. Deviation 33.25 
 
Appendix I: the average distance to the hospital for patients diagnosed at the late stage 
of CKD 
Distance in minutes to the hospital for patients at the late stage of CKD 
Mean 29.04 
Std. Error of Mean 1.847 
Std. Deviation 34.758 
 
Appendix J: the average travel time to the hospital for the population within Edo state 
Travel in minutes to the hospital for CKD patients 
Mean 89.76 
Std. Error of Mean 0.03 
Std. Deviation 52.24 
 
Appendix K: the location-allocation model using travel time (in minutes) as impedance 
to UBTH with 26 minutes as the threshold value 
Hospital 
Demand 
count 
(number 
of wards) 
total demand 
(total 
population) 
total distance 
(in minutes) 
total weighted 
distance (in minutes) 
UBTH 36 1072243.87 564.77 15736612.77 
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Appendix L: A location-allocation model using travel time (in minutes) as impedance to 
UBTH and the proposed 18 CKD healthcare locations 
Name 
Type of 
facility  
Demand 
Count 
(number 
of wards) 
Demand 
Weight 
(population 
in the 
wards) 
Total time 
travelled (in 
Minutes) 
Total 
Weighted 
time (in 
Minutes) 
OVIA SOUTHWEST Chosen 1 31493 12.08 380423.99 
OVIA NORTHEAST Chosen 2 25586 25.50 315852.54 
ESAN WEST Chosen 3 49870 26.01 400980.26 
ETSAKO EAST Chosen 3 41288 48.58 694684.47 
IKPOBA-OKHA Chosen 3 60962 18.11 447174.68 
ORHIONMWON Chosen 5 63814 79.62 1086144.85 
EGOR Chosen 6 227911 62.27 2459709.08 
ESAN SOUTHEAST Chosen 6 69240 123.46 1393912.32 
OWAN EAST Chosen 6 126176 93.94 1862827.42 
AKOKO-EDO Chosen 7 129647 107.87 1947136.36 
UHUNMWONDE Chosen 7 143881 94.00 1714824.23 
OREDO Chosen 8 234073 124.80 3432244.80 
OWAN WEST Chosen 9 116905 154.13 2000880.40 
ESAN NORTHEAST Chosen 10 113070 168.14 1819774.77 
IGUEBEN Chosen 10 112530 135.84 1650626.74 
ETSAKO WEST Chosen 14 186828 237.46 3218239.94 
ESAN CENTRAL Chosen 16 245660 232.98 3702680.59 
ETSAKO CENTRAL Chosen 16 199814 303.54 3823474.39 
UBTH Required 18 552327 219.51 5852438.64 
 
Appendix M: A location-allocation model using the road junctions as facilities and travel 
time (in minutes) as impedance to UBTH and the proposed 18 CKD 
healthcare locations 
Location of junction 
Type of 
facility  
Demand 
Count 
(number 
of wards) 
Demand 
Weight 
(population 
in the 
wards) 
Total time 
travelled 
(in 
Minutes) 
Total 
Weighted 
time (in 
Minutes) 
OVIA NORTHEAST Chosen 3 49487 44.42 702928.91 
EGOR Chosen 4 118959 44.21 1336041.66 
IGUEBEN Chosen 4 55762 68.81 960331.63 
OWAN EAST Chosen 5 110111 74.74 1819070.77 
ETSAKO EAST Chosen 5 72755 100.24 1529089.78 
ORHIONMWON Chosen 5 63814 71.15 937361.34 
ESAN SOUTHEAST Chosen 5 50881 83.36 824409.54 
UHUNMWONDE Chosen 6 115541 73.13 1336189.64 
OVIA SOUTHWEST Chosen 6 98935 99.76 1850518.93 
ESAN CENTRAL Chosen 7 81279 61.34 687750.48 
IKPOBA-OKHA Chosen 8 256467 96.31 3107275.95 
UBTH Required 9 225740 93.72 1968361.49 
ESAN WEST Chosen 9 192314 110.86 2126980.39 
AKOKO-EDO Chosen 9 172256 128.92 2574672.86 
OWAN WEST Chosen 12 174460 172.90 2609331.35 
OREDO Chosen 13 469727 173.77 5506705.63 
ETSAKO WEST Chosen 13 167831 175.98 2276060.92 
ETSAKO CENTRAL Chosen 15 183292 288.87 3563812.60 
ESAN NORTHEAST Chosen 21 219365 353.49 3481730.18 
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Appendix N: A location-allocation model using travel time (in minutes) as impedance to 
identify the optimal location for another CKD health service that would cater 
for patients at the last stage of CKD 
Name 
Type of 
facility  
Demand 
Weight 
(population in 
the wards) 
Demand 
Count 
(number of 
wards) 
UBTH Required 527253.2456 35 
Irrua Specialist Teaching Hospital Chosen 207013.3801 35 
Uromi central hospital Candidate 0 0 
Igbenedion university teaching hospital Candidate 0 0 
Auchi central hospital Candidate 0 0 
 
